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by Valerio MARINO
Proteins are biomolecules involved in virtually every process occurring in cells,
characterized by a sequence of amino acids, which confer them peculiar structural
features implying specific functions. Ca2+-sensor proteins are a family of proteins
whose function is determined by structural changes occurring upon Ca2+-binding,
taking part in a wide range of physiological and pathological processes, among
which muscle contraction and phototransduction. Unraveling the complex machin-
ery behind these physiological processes is fundamental not only for the sake of
expanding our knowledge, but also to understand which mechanisms are altered
in inherited pathological conditions, in order to develop potential therapeutic ap-
proaches that may help relieving or treating these disorders. Protein therapy is
one of the most promising potential treatments, allowing for the substitution of
dysfunctional protein pool with physiological variants. Here, a collection of bio-
chemical and biophysical studies focused on the physiological and pathological as-
pects of some Ca2+-sensor proteins is presented, together with possible therapeutic
implications in nanomedicine using CaF2 nanoparticles (NP) as protein carriers.
The combination of experimental and computational techniques revealed itself a
complementary and exhaustive approach, allowing for a multiscale investigation of
protein structural and functional properties. Indeed, the high-resolution structural
information provided by Molecular Dynamics (MD) simulations and Protein Struc-
ture Network (PSN) analysis can be proficiently integrated into the biophysical and
iv
biochemical experimental framework constituted by Circular Dichroism (CD) and
fluorescence spectroscopy, Dynamic Light Scattering (DLS), Ca2+-binding assays
and enzymatic assays. Such integrated approaches allowed us to discover that mu-
tations of the Neuronal Calcium Sensor (NCS) protein Guanylate Cyclase Activat-
ing Protein 1 (GCAP1) associated to retinal dystrophies did not necessarily altered
protein Ca2+-affinity, but rather that the pathological dysregulation of the target en-
zyme Guanylate Cyclase (GC) depended on more complex mechanisms, proba-
bly involving modified intramolecular communication. Moreover, PSN analysis of
MD trajectories of GCAP1 highlighted that small conformational variations may
strongly impact protein functionality, as the switch between activator and inhibiting
states occurs through minor structural rearrangements subsequent to the Ca2+/Mg2+
exchange in specific binding sites. This suggested again that the investigation of
intramolecular communication may be the key to clarify unknown complex mecha-
nisms of not only of Ca2+-sensor proteins, but also of proteins belonging to different
superfamilies.
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Introduction
1.1 Ca2+-sensor proteins
Calcium (Ca2+) is one of the most important and versatile metals in biological sys-
tems, as it is involved in several complex and diverse processes, spanning from
bone mineralization, to muscle contraction, to signal transduction [1], to vision
[2]. The importance of the Ca2+ ion calls for a class of proteins called the Ca2+-
binding protein family [3] which bind and release Ca2+ ions in response to varia-
tions in Ca2+ concentration. Although several Ca2+ binding motifs have been iden-
tified in Ca2+-binding proteins, such as C2 [4], PERCAL, EGF-like [6], Dockerin
[7], Cadherin [8] and S100 domains [9], most of the proteins belonging to this
family share a structural motif which allows them to bind Ca2+ and other divalent
cations, the EF-hand motif [10, 11]. This helix-loop-helix is composed by a stretch
of 10 residues folded as an α-helix followed by a 12 residues loop with a consen-
sus sequence of D-W-[DNS]-ILVFYW-[DENSTG]-[DNQGHRK]-GP-[LIVMC]-
[DENQSTAGC]-x-x-[ED] [12] and another 10-residue α-helix where x stands for
any residue, square brackets indicate one of the enclosed residues, curly brackets in-
dicate all but enclosed residues. The coordination of Ca2+ ions occurs through a pen-
tagonal bi-pyramidal geometry of negative charges provided by the side chains of
residues in position 1, 3, 5 and 9, the backbone C=O of residue 7, a water molecule
and residue 12, which is of crucial importance for Ca2+-binding since it is the only
amino acid responsible for a bidentate coordination [13]. Although EF-hands are
highly selective for Ca2+-binding, they are also capable of binding other divalent
cations such as Zn2+, Fe2+,Cu2+ and most importantly Mg2+, which is present at
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above-millimolar concentration in several tissues [14] including photoreceptor cells
[15]. Indeed, Mg2+ ions can be bound four to five orders of magnitude more weakly
with respect to Ca2+ ions through a octahedral geometry, in which residue 12 pro-
vides a monodentate coordination [16].
FIGURE 1.1: Ca2+ (left) and Mg2+ (right) coordination in EF-hands. Adapted from [17]
The reason for the lowMg2+-affinity of EF-hands lies in the thermodynamical prop-
erties of binding, indeed the radius of Mg2+ increases 400-fold upon hydration,
16-fold higher respect to the increase shown by Ca2+, meaning that Mg2+ binding
requires a much higher energy [18]. The entropic contribution to the free energy
is also one of the main factors influencing different calcium affinities exhibited by
Ca2+-binding proteins, as the presence of water molecules implied in ion hydration,
rather than the coordination by a protein ligand, lowers Ca2+-protein affinity. In
this respect, the presence of specific residues in positions 9 and 12 [13] such as
Glu or Gln instead of the shorter Asp or Asn residues is responsible for increasing
Ca2+-affinity, as Asp or Asn require an additional water molecule for the completion
of the coordination sphere [19, 20]. This, for example, is also evident when com-
paring the sequence of the highest Ca2-affinity EF-hand (EF3) of human GCAP1
DVDGNGCIDRDE, whose affinity is around 80 nM [21], with the second-highest
affinity EF-hand (EF3) of A. thaliana CaM1 DVDGDGQINYEE, whose affinity is
around 4.4 μM [22].
Ca2+-binding proteins can be identified as Ca2+-buffer proteins or Ca2+-sensors, two
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different classes of proteins which differ in their behavior upon ion binding. At
odds with Ca2+-buffer proteins, Ca2+-sensors are in fact able to change their con-
formation. Ca2+-sensor proteins can be classified as ubiquitous like Calmodulin or
tissue-specific, like the Neuronal Calcium Sensor (NCS) family, which is entitled
of regulating a variety of neuronal processes [23, 24, 25], among which phototrans-
duction.
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1.1.1 Phototransduction
Phototransduction is a complex cascade of processes that allows the conversion of
a light stimulus to diverse biochemical signals which ultimately triggers vision in
the visual cortex of the brain. This cascade starts inside rods and cones, specialized
neuronal cells dedicated to scotopic and photopic vision respectively, which are lo-
cated in the most external layer of neuronal cells of the retina.
FIGURE 1.2: Retinal layers, from [26]
The phototransduction cascade is finely regulated by variations of the concentra-
tion of the two second messengers cGMP and Ca2+, which are strictly dependent on
one another. Several different NCS are therefore involved in different steps of the
cascade, and in spite of the highly conserved sequence, each NCS has its specific
physiological function [27].
When a photon is absorbed on the disc membranes by the G-protein coupled re-
ceptor Rhodopsin, the associated G-protein Transducin exchange GDP with GTP
upon Rhodopsin binding, releasing its activated α-subunit to activate PDE6, which
starts hydrolyzing cGMP to 5’-GMP. The drop in concentration of cGMP causes
the closing of CNG-channels on the plasma membrane, preventing Na+ and Ca2+
ions from entering in the cytosol, which in combination with the simultaneous ex-
trusion of Ca2+ ions by a Na+/Ca2+,K+ exchanger causes a drop of the intracellular
Ca2+ concentration from 500-600 nM to 100 nM [28]. NCS detect this decrease of
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FIGURE 1.3: Main signaling mechanisms in phototransduction cascade. A) Rhodopsin
activation, B) Recoverin-mediated Rhodopsin deactivation, C) GCAPs-mediated GC reg-
ulation, from [32]
the intracellular Ca2+ and exert their function as regulators of their specific molec-
ular targets, that is CNG-channels in the case of CaM, rhodopsin kinase GRK1 in
the case of Rec, and membrane-bound guanylate cyclases in the case of GCAPs
[29, 30, 31].
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1.1.2 GCAP1
GCAP1 is one of the three isoforms of GCAPs present in human photoreceptors and
is a 23 kDa all α-helix protein composed by 4 EF-hand motifs arranged in two do-
mains. Exception made for EF1, whose CPxG sequence impairs Ca2+-coordination
[33], all other EF-hands can bind 3 Ca2+ ions with sub-micromolar affinity and up to
2 Mg2+ ions in EF2 and putatively EF3 [Paper 3] [30] with sub-millmolar affinity.
GCAP1 is involved in the Ca2+ mediated negative feedback mechanism of regula-
tion of the GC, and has the peculiarity of being both activator and inhibitor of its
target according to different Ca2+ levels [34], working in a Ca2+-relay fashion with
the cognate GCAP2 [35]. CNG-channels, restoring the high intracellular [Ca2+] of
the dark state.
FIGURE 1.4: Ca2+-relay mechanism, from [35]
Indeed, in the dark, when [Ca2+] is high, GCAP1 acquires a conformation that pre-
vents GC from synthesizing cGMP, thus keeping the catalytical activity below its
basal value. When [cGMP] and [Ca2+] drop as a consequence of the light stimulus,
Ca2+ is released by GCAP1 EF-hands in decreased order of affinity (first EF4, then
EF2, finally EF3), which then bind Mg2+ and switch to a conformation that activates
GC. The newly synthesized cGMP can therefore replenish the intracellular pool to
the concentration of 5 μM [36], allowing the opening of the The three-dimensional
structure of GCAP1 in its Ca2+-loaded form was solved via X-ray diffraction [37]
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and was found not to be drastically different from the EF2-Mg2+ bound form [Paper
3], which was recently solved via NMR spectroscopy [38], nevertheless this subtle,
yet significant conformational change is sufficient to switch on and off the target
GC.
FIGURE 1.5: Three dimensional structure of Ca2+-loaded (left) and Mg2+-bound (right)
myristoylated GCAP1. Protein backbone is represented as cartoons, myristoyl group is
shown as orange spheres, Ca2+ ions are shown as red spheres, Mg/textsuperscript2+ ion
is represented as a blue sphere. EF1 is colored in cyan, EF2 in green, EF3 in blue, EF4 in
yellow, their molecular surface is shown in transparency.
The N-terminal myristoylation of GCAP1, a feature also shared by all other NCS,
has a peculiar role in adjusting both the Ca2+-sensitivity and the interaction with
the target GC by mediating intramolecular communication between N and C do-
mains [39, 40][Paper 9]. Unlike other NCS like Rec, the myristoyl group is always
sequestered inside an hydrophobic crevice encompassing the N-domain and the C-
terminus of the protein, even upon Ca2+-binding.
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1.1.3 Retinal dystrophy related GCAP1 mutations
GCAP1 is the only isoform associated with retinal dystrophies, a set of autosomal
dominant degenerative pathologies ultimately leading to blindness. Retinal dys-
trophies can be classified in Macular Dystrophy, Cone Dystrophy and Cone-Rod
Dystrophy, depending on the area of the retina and on the type of photoreceptor
cells involved. The specific diagnosis of patients affected by retinal dystrophies is
not trivial due to the heterogeneity of the symptoms [41, 42], as the clinical pheno-
type associated with these mutations is a combination of photophobia, nystagmus,
reduction of visual acuity, color blindness, nyctalopia, hemeralopia and loss of cen-
tral and peripheral vision. To this date, 15 missense mutation of have been identified
in patients, namely P50L, L84F, E89K, Y99C, D100E/G, N104K, I107T, I143N/T,
L151F, E155G/A, G159V, L176F, Y99C, L151F [41, 43, 44, 45, 46, 47, 48, 49,
50, 51, 52, 53, 54][Paper 6][Paper 7][Paper 8], and even though a precise patho-
logical mechanism has not been identified, all these mutants exhibited alterations
in the regulation of the GC resulting in its constitutive activation at physiological
[Ca2+]. Biochemical and biophysical investigations made by us and other research
groups highlighted that most mutants had decreased Ca2+ affinity, but some vari-
ations like L84F and L176F showed wild type like affinity [Paper 7][Paper 8].
This suggested that the altered intramolecular communication from the ion binding
sites, rather than merely their affinity for Ca2+, was the main reason leading to the
constitutive GC activation in the dark.
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1.1.4 Recoverin
Recoverin is a 23 kDa all-α-helix prototypical NCS protein, with 4 EF-hand motifs
arranged in two domains, two of which (EF2 and EF3) are Ca2+-binding sites with
micromolar affinity. Like other NCS, Rec is also myristoylated at the N-terminus,
and the covalently attached myristoyl group, which is buried in an hydrophobic mi-
lieu in Ca2+-free conditions, gets extruded from its pocket upon Ca2+-binding, with
the so-called “myristoyl-switch” mechanism [56, 28]. This conformational change
allows Rec to exert its biological function, which take place during the recovery
phase of the phototransduction cascade, where it regulates the target Rhodopsin Ki-
nase GRK1. In the dark, when [Ca2+] is elevated, Rec is in a “relaxed” Ca2+-bound
state, where the protein is anchored to the disc membrane by its myristoyl group
and bound to GRK1 to inhibit the phosphorylation of Rhodopsin. When [Ca2+]
drops as a consequence of illumination, Rec switches its conformation to a “tense”
state where the fatty acid is sequestered in an hydrophobic crevice, allowing Rec
to diffuse in the cytosol. The dissociation of the Rec-GRK1 complex triggers the
phosphorylation of Rhodopsin, leading to an increase of the affinity for Arrestin,
which then replaces the α-subunit of Transducin, ultimately leading to the shutting
down of the signal (Figure 3B).
FIGURE 1.6: Three dimensional structure of apo (left) [57] and Ca2+-loaded (right) [56]
myristoylated Recoverin. Protein backbone is represented as grey tubes, myristoyl group
is shown as red spheres, Ca2+ ions are shown as green spheres. The hydrophobic and
hydrophilic Solvent Accessible Surfaces are shown in transparency in gray and blue re-
spectively.
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While Rec has been found to play a role only in Cancer-associated Retinopathies
[58] and Recoverin-associated Retinopathies [59], it was tested as a prototypical
Ca2+-sensor protein for potential therapeutical applications of nanodevices [Paper
1] and for investigating the role of Mg2+ in the phototransduction cascade [Paper
4].
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1.1.5 Calmodulin
Calmodulin is a ubiquitous 17 kDa all-αhelix protein considered the ancestor of the
Calmodulin superfamily of Ca2+-sensor proteins [60]. CaM is able to selectively
recognize more than 300 different targets involved in several different biological
processes, such as ion channels regulation, protein folding, apoptosis, cell motility,
homeostasis and cytoskeleton development and functionality [61, 62]. Structural
architecture of CaM is composed by four Ca2+-binding EF-hand motifs arranged in
two globular lobes connected by a flexible linker [63] with different Ca2+-affinities,
leading to an apparent affinity of a low micromolar order, usually increasing in
the presence of a target protein[64]. In the absence of Ca2+ the two lobes acquire
a tightly packed conformation [65], upon Ca2+ binding CaM exhibits an elevated
degree of structural plasticity [66] making CaM, able to regulate different target
proteins with selective interaction modes [67, 68], at odds with the aforementioned
Ca2+ sensors Rec and GCAP1.
FIGURE 1.7: Three dimensional structure of apo (left) and Ca2+-bound (right) CaM,
secondary structure is represented in cartoon, Ca2+-ions are represented as red spheres,
N-term domain is colored in blue, C-term domain is in yellow, the linker region is in
green.
Recently, an increasing number of heterogeneous pathologies have been found to
be associated with CaM, spanning from cancer-related alterations of cell cycle and
proliferation[69], to neurodegenerative diseases like Alzheimer’s [70], to cardiovas-
cular diseases [71, 72, 73, 74], raising interest as a potential target for nanodevice-
mediated protein therapy.
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1.2 Nanomedical applications for protein therapy
Gene therapy is one of most promising approaches for treating genetic disorders,
but the difficulty of delivering and stably expressing the protein of interest, together
with the potential risk of recombination-related side effects, is one major drawback.
A safer alternative to this approach is the so called protein therapy, which consists
in the delivery of folded and functional proteins to specifically targeted tissues, in
order to replace the intracellular pool of mutated proteins which are the cause of
the pathological phenotype [75]. In this context, nanodevices are one of the most
promising tools thanks to their small size (<100 nm) and their high surface to vol-
ume ratio, which would allow high amounts of protein to be carried to a target
tissue, cell, or even organelle [76]. Furthermore, nanodevices offer high versatility
in terms of chemical composition, which allows these potential carriers to be specif-
ically engineered in order to increase target specificity or to acquire useful features
such as bioluminescence [77] and thermal sensitivity [78]. Several Ca2+-sensor pro-
teins have been found to be associated with inherited diseases, therefore different
biocompatible nanodevices, namely liposomes and CaF2 nanoparticles [79], have
been tested for their suitability as Ca2+-sensors carriers, by exploiting the physio-
logical behavior of these proteins for binding and release [Paper 1][Paper 2]. In-
deed liposomes with Rod-Outer-Segment like lipid composition were successfully
applied for the delivery of encapsulated Rec inside rod cells, [80], in addition these
liposomes were found to reversibly bind Rec on their surface presumably through
to the myristoyl switch mechanism [Paper 1]. On the other hand, CaM and Rec
were found to reversibly bind the matrix of lanthanide-doped, upconverting CaF2
NP [81], supposedly through the coordination of Ca2+ ions belonging to the lattice
by their EF-hands [Paper 1][Paper 2]. Binding is per se not sufficient for assess-
ing the suitability of nanodevices as protein carriers, as a major requirement for
this approach to be effective is the preservation of the native structure and function-
ality. Indeed, recent studies suggested that nanoparticle-bound proteins could be
subjected to significant structural changes [82, 83] or unfolding [84] upon binding,
which were found to be highly dependent on the chemical nature of the nanodevice
and on the protein system [Paper 1][Paper 2].
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Methods
2.1 Expression and purification of recombinant pro-
teins
Protein expression and purification is a necessary preliminary step of every in vitro
biochemical an biophysical study, as different amounts of pure protein are required
by different experimental techniques. Indeed, while some approaches like fluores-
cence spectroscopy or Surface Plasmon Resonance (SPR) need just few micrograms
of protein, others like Isothermal Titration Calorimetry (ITC) or Nuclear Magnetic
Resonance (NMR) employ several milligrams of sample, which have to possess a
high percentage of purity in order to provide accurate and reliable data. Nowa-
days it is possible to express proteins in prokaryotic systems like E. coli and B.
subtilis and eukaryotic systems like yeast or mammalian cells using recombinant
DNA technique, or in in vitro systems. Recombinant DNA approach, which con-
sists of the transformation of living systems using genetic material coming from
different living system, was employed for the expression in E. coli strain BL21
DE3 of the Ca2+-sensors studied in this thesis, namely CaM from A. thaliana and
Rec and GCAP1 from B. taurus. E. coli is the most popular system for the ex-
pression of recombinant proteins because of its simplicity of transformation, rapid
and low-cost growth [85, 86]. Moreover, the recent development of new bacterial
strains, plasmidic vectors and protein tags provided tools to overcome most of the
problems associated with recombinant protein expression, such as inclusion body
formation, post-translational modifications, protein toxicity and mRNA instability
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[85]. All previously presented Ca2+-sensors presented in this thesis were indeed
expressed recombinantly in E. coli BL21 DE3 strains transformed with different
pET vectors. These vectors contain IPTG-induced T7 promoter [87], by far the
best performing promoter with a recombinant protein expression up to 50% of to-
tal proteins [88], making T7-based pET vectors the most popular system used for
heterologous expression in E. coli [89]. Purification of recombinantly expressed
Ca2+-sensors was achieved through Fast protein liquid chromatography techniques,
which consist of the exploitation of biophysical properties of the proteins such as
hydrophobicity, charge, size or biorecognition, for binding and eluting from spe-
cific chromatographic columns [90] differing in their resin content. Indeed CaM
[91] and Rec [92] were purified through Hydrophobic Interaction Chromatography,
while GCAP1 was purified after a combination of Anionic Exchange and Size Ex-
clusion Chromatography [93].
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2.2 CD spectroscopy
Circular dichroism spectroscopy is a low-resolution technique employed in the in-
vestigation of the structural properties of biomolecules [94], based on the absorp-
tion of circularly polarized light. The difference between the clockwise (R) and
counter-clockwise (L) components of the circularly polarized light absorbed by chi-
ral centers results in an elliptically polarized light, which gives information about
the microenvironment of the chiral centers. CD spectroscopy can be proficiently
used to retrieve some structural information about proteins [95, 96], indeed proteins
have optically active chromophores such as the peptide bond, absorbing below 240
nm, aromatic sidechains, absorbing between 260 and 320 nm, and disulphide bonds
which absorb weakly around 260 nm. Moreover, ligands and cofactors can also ab-
sorb ranging from 300 nm to the near infrared region [97], therefore this technique
can be employed to investigate enzymatic reactions or conformational changes upon
ligand binding. Since absorption below 240 nm is due mainly to the peptide bond,
it is possible to obtain a fingerprint of the protein in terms of secondary structure
type and content, as each type of secondary structure has its own typical far UV CD
spectrum [Figure 2.1].
By deconvolving the far UV CD spectra is therefore possible to estimate the content
of each type of secondary structure, using a variety of algorithms like K2d [98],
CONTIN [99], and DICHROWEB [100, 101]. In the near UV region (260-320
nm) the three aromatic aminoacid sidechains are specifically absorbing at typical
wavelengths, indeed Trp shows an absorption peak close to 290 nm with fine struc-
ture spanning to 305 nm, Tyr residues absorb between 275 and 282 nm, while Phe
residues exhibit sharp bands with fine structure between 255 and 270 nm.
The signal arising from aromatic residues is greatly influenced by their number,
mobility, position and environment, providing a low-resolution fingerprint of the
protein that can be used for comparative studies. In addition, by monitoring vari-
ations of the CD signals upon titration with denaturing agents or by increasing the
temperature it is possible to quantitatively estimate the stability of the native pro-
tein. While the structural information retrieved by CD spectra is not comparable
to that of X-ray crystallography or NMR in terms of resolution, this technique is
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FIGURE 2.1: Examples of far UV CD spectra typical of α-helix (solid line), anti-parallel
β-sheet(long dashed line), type I β-turn (dotted line), extended 31-helix or poly (Pro) II
helix (cross dashed line), irregular structure (short dashed line), from [96]
FIGURE 2.2: Example of Near UV CD spectrum, from [96]
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far less demanding as far as measurement time and sample requirements are con-
cerned. Indeed, CD spectroscopy allows to perform a comprehensive study of the
structural features of a protein in less than 30 min, using roughly 1 mg of material
and without destroying the sample. All these features make CD spectroscopy quite
a useful technique when working with recombinant proteins which are difficult to
express and purify with a low yield, especially when used in combination with other
non-destructive techniques like Dynamic Light Scattering.
18 Chapter 2. Methods
2.3 Fluorescence spectroscopy
Fluorescence is a luminescent process in which molecules are able to emit light
upon excitation of the electronic states by external stimuli such as friction, chemical
agents or light absorption. Molecules have a ground electronic state, characterized
by a low energy, several excited electronic states at higher energies and many vibra-
tional states in between. Excited electronic states can be reached by electrons when
an external stimulus provides enough energy to fill the gap between the ground state
and the excited state. The promoted electron, though, loses vibrational energy after
collision with other molecules, reaching the lowest vibrational state of the excited
electronic state, then the molecule reverts to the ground electronic state by emitting
a photon [102]. The discovery of the fluorescence principle opened the door to a
plethora of widely applied and sophisticated approaches to study biological pro-
cesses. More specifically, this technique allowed to investigate the structure and
dynamics of nucleic acids [103, 104], proteins [105, 106], and their interaction with
other molecules such as substrates, cofactors and membranes. Proteins are ideal
candidates for fluorescence studies due to the presence of delocalized electrons in
the sidechain of aromatic residues Phe, Tyr and Trp, and the availability of several
small chemical dyes like Cyanine or Alexa specifically developed.
Although all aromatic residues could be in principle used as intrinsic fluorescent
probes, Trp is by far the most commonly used probe, as its indole group provides
the highest absorbance, with a peak near 280 nm, and emission between 310 and
350 nm. Being the rarest aromatic aminoacid due to the metabolic cost of its syn-
thesis [108], Trp fluorescence also provides somewhat detailed information of the
microenvironment of precise regions of the proteins. This can be used not only
to evaluate conformational changes [109] upon interaction with other molecular
partners [110], but also to investigate the folding state of the protein. Indeed,
like many other extrinsic fluorescent molecules, Trp residues are solvatochromic,
as their properties in terms of quantum yield and the position of the emission or
absorption bands strongly depends on their environment [111]. Denaturation or in-
creased exposure to a polar solvent due to structural change cause a bathochromic
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FIGURE 2.3: Fluorescence absorbance end emission spectra of aromatic aminoacids,
from [108]
(red) shift of the maximal emission, whereas membrane embedding, or more gener-
ally a tighter packing of hydrophobic interactions surrounding Trp residues generate
an hypsochromic (blue) shift to shorter wavelengths [112, 113]. Versatility is the
main quality of fluorescence spectroscopy studies, since the possibility to employ
either intrinsic or extrinsic fluorescent probes, combined with the investigation of
anisotropy, Forster Resonance Energy Transfer and solvatochromism effects, allows
the coverage of several structural aspects of biomolecules. In addition, fluorescence
studies can be performed not only at steady state, but also monitoring the time de-
pendence of fluorescence emission through lifetime and kinetic studies. Although
fluorescence techniques are noninvasive, they are sensitive to autofluorescence in-
terferences and each of the aforementioned approaches has different limitations.
For example, FRET is suitable only for investigating short-range phenomena, flu-
orescence anisotropy suitability is dependent on the lifetime of the dye and on the
properties of the proteic system studied, and intrinsic fluorescence measurements
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could have a low spatial resolution due to the presence of several Trp residues [114].
2.4. Dynamic Light Scattering 21
2.4 Dynamic Light Scattering
Dynamic Light Scattering (DLS) also known as Photon Correlation Spectroscopy or
Quasi-Elastic Light Scattering, is a widely used technique employed for the study
of the dynamics of particles undergoing Brownian motion in colloidal solutions
[115, 116]. DLS approach can therefore be applied for the estimation of the hy-
drodynamic properties of biomolecules like DNA [117], proteins [118, 119] and
any nanosized-particle [120]. When a coherent and monochromatic light beam is
shone onto a colloidal solution, where all particles are randomly moving according
to Brownian motion, each particle behaves as a secondary source as the light wave
gets scattered. The interference between the radiation scattered by the particles gen-
erates a time-fluctuating speckle pattern which depends on the diffusion coefficient
of the particles. Small particles diffuse in liquid medium faster than large particles,
resulting in more rapid fluctuations of the intensity of scattered light with respect
to the slow fluctuation exhibited by large particles. The DLS technique is substan-
tially based on the analysis of the fluctuations of the scattered intensity, which is
performed by processing the signal with the autocorrelation technique, hence the
synonym Photon Correlation Spectroscopy. Essentially, the correlation of the in-
tensity of the scattered signal is monitored at increasing time intervals, yielding the
autocorrelation function, which for a suspension of monodisperse, spherical par-
ticles, follows an exponential decay. The decay of the autocorrelation function is
strictly related to the diffusion coefficient of the particles in suspension, as larger
molecules have longer decay than smaller molecules. Therefore, using the Stokes-
Einstein equation it is possible to obtain the equivalent sphere radius of the particles,
which, for spherical particles, represents the hydrodynamic radius (R).
D =
kT
6piηR
(2.1)
The only method recommended by the international standard ISO 13321 [121] to
extract the particle size from DLS experiments performed on a population with a
monomodal Gaussian distribution of size, such as proteins or nanodevices, is the
22 Chapter 2. Methods
method of cumulants [122]. This method takes into account the mean and the vari-
ance of the population and allows to measure the polydispersity of the diffusion
coefficient of the population, represented as polydispersity index, which is used to
estimate the quality of the experimental sample object of the study.
FIGURE 2.4: Dynamic Light Scattering principle, from [116]
The main advantages of this technique are the limited experimental time and quan-
tity of sample, as a precise determination of the size of the particles can be achieved
in less than 1 hour with less than 1 mg of protein or nanodevices. On the other hand,
the sensitivity of the technique requires careful handling of the samples, which have
to be preferably filtered through 0.2 μm filter in order to remove dust particles or
oversize contaminants.
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2.5 Chelator assay
The estimation of the Ca2+ affinity of Ca2+-sensor protein ions can be achieved
through different approaches, one of the most common is Isothermal Titration Calorime-
try, based on the measurement of heat exchange upon ligand titration. This tech-
nique, though, can suffer from interferences due to the absorption or release of
heat as a consequence of conformational changes, as would be the case for Ca2+-
sensor proteins in which, by definition, Ca2+-binding is accompanied by structural
variations. Therefore, other direct binding methods such as Circular Dichroism or
fluorescence spectroscopy based titrations are more suitable for studying the Ca2+-
affinity of this family of proteins. Spectroscopy-based methods can give reliable
and accurate results only when the population of Ca2+-free and Ca2+-bound proteins
are significant, meaning that a protein concentration roughly equal to the dissocia-
tion constant is required. Nevertheless, spectroscopy-based direct binding methods
do not allow to estimate Ca2+ smaller than 1 μM, therefore, in order to estimate high
affinity constants, it is necessary to rely on other direct methods like Ca2+-selective
electrodes or measurement of bound 45Ca, or on indirect methods. The chelator
assay is one of the best performing indirect methods, and is based on the competi-
tion between a Ca2+-sensor protein and a chromophoric Ca2+-chelator [123] such as
quin-2, 5,5’Br2-BAPTA and 5N-BAPTA, whose fluorescence or absorbance strictly
depends on Ca2+-binding. The selectivity of Ca2+-binding by these chromophoric
chelators makes this technique particularly useful for studying NCS proteins like
GCAPs, whose Ca2+-affinity is affected by the presence of Mg2+ ions. While chela-
tor assay experiments are relatively simple to perform, their interpretation is not
trivial, as the estimation of macroscopic binding constants depends on the unravel-
ing of several microscopic binding constants. Fortunately, CaLigator software [124]
deals with the complexity of the system, leaving the user just with the determination
of the total concentration of Ca2+, protein and chelator in order to retrieve precise
macroscopic binding constants for all possible binding sites. The only limitation of
the method is that the affinity of each Ca2+ binding site has to be higher than that
of the chelator, which can be overcome by a suitable choice of the chromophoric
chelators, whose affinity span from low nanomolar to high micromolar range.
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2.6 Molecular Dynamics simulations
The knowledge about structural properties of a protein is fundamental for the under-
standing of its function, in this regard the contribute given by X-ray crystallography
and NMR spectroscopy has been invaluable. X-ray and NMR are, up to now, the
only methods able to provide structural information at atomistic resolution, but the
dynamic properties of the proteins of interest still remain largely unknown. In-
deed, X-ray crystallography depicts only a frozen state of the protein, while NMR
requires high protein concentration and sometimes not physiological experimen-
tal conditions. The progress in informatics, both in terms of computational re-
sources and programming skills, led to the development of Molecular Dynamics
(MD) simulations [125, 126], a method previously applied in theoretical physics
and material science, to fill the lack of experimental tools for the investigation of
biomolecules dynamics. This technique is able to combine both quantum mechan-
ics and classical mechanics to monitor protein folding [127], and time evolution of
biomolecules such as DNA, proteins and membranes [128] over relatively long time
frames [129]. Pure quantum mechanics simulations are in principle the most accu-
rate way to reproduce enzymatic reactions and biomolecules dynamics, but they
are still computationally very demanding, therefore classical mechanics turned out
to be a fair compromise between accuracy and feasibility, at least when dealing
with proteins structural behavior. In classical MD simulations the trajectories of all
atoms are calculated solving Newton’s equations of motion, where forces acting on
the particles and their potential energies are numerically calculated using molecular
mechanics force fields. These force fields are empirical potentials consisting of a
summation of bonded and non-bonded pair forces which represent approximations
of quantum-mechanical effects through classical mechanics laws. Indeed stretch-
ing and bending of covalent interactions are modeled according to Hooke’s law,
torsional angles are modeled using a periodic function, electrostatics is represented
by point charge Coulomb interactions, van der Waals interactions are approximated
with the Lennard-Jones potential. Several programs dedicated to MD simulations
like GROMACS [130], CHARMM [131] and AMBER [132] have their own force
fields, which usually differ in the parametrization of the interactions and/or in the
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specificity for biomolecules. Once the force field has been chosen and a three-
dimensional structure of the protein is available, the workflow of MD simulations
is well defined.
FIGURE 2.5: Molecular Dynamics simulations workflow
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Unfortunately, MD simulations are very sensitive to the several initial parameters,
such as structure, computational architecture, thermostatic and barometric controls,
which make them intrinsically non reproducible. However, this obstacle can be
overcome by running different replicas, whose consistency and reproducibility need
to be assessed using Principal Component Analysis based approaches [133] such as
cosine content [134] and Root-Mean Square Inner Product [135]. Consistent and
exhaustive MD trajectories carry a huge amount of structural and energetic infor-
mation representing several possible conformations of the simulated protein, which
can be analyzed at different levels of accuracy and complexity. Among the most ba-
sic analyses that can be performed on a MD trajectory there are Root Mean Square
Deviation and Root Mean Square Fluctuation (time-averaged RMSD) of α-carbons,
which represent the global structural stability and the local flexibility, respectively.
Another popular and useful analysis of MD trajectory is the estimation of the Sol-
vent Accessible Surface of the protein or of specific residues, which represent the
envelope of the center of a spherical molecule of water on the van der Waals surface.
These indexes are indeed very informative for some Ca2+-sensor proteins like CaM
or Rec, which undergo major structural rearrangements upon Ca2+-binding, while
dynamical conformational studies of GCAP1 require more sophisticated approaches
like, for example, the Protein Structure Network approach [136], to unveil the con-
nection between GCAP1 subtle conformational changes and its regulation modes.
MD simulations are a powerful tool for the investigation of protein dynamics and
are also employed to refine or validate molecular restraints of NMR and X-ray struc-
tures, on which they strictly depend. The advantage over these techniques lies in
the uniqueness of the dynamical information produced by MD simulations, which
can be also considered as a disadvantage, as no experimental way of validating this
information is yet available.
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2.7 Protein Structure Network
Protein Structure Network (PSN) [137, 138] is a recent approach combining struc-
tural biology and network concepts, in which proteins are represented as graphs
where residues are nodes and interactions between residues are edges. Such net-
works can be generated on crystallographic or NMR structures using geometrical
constraints, indeed H-bond, electrostatic and hydrophobic interactions require par-
ticular distances and/or angles in order to occur. These PSN, though, are generated
only on static structures or on a limited set of conformations derived from NMR
experiments, lacking therefore of information about protein dynamics provided by
MD simulations. Pyinteraph [139] revealed itself a valuable tool for combining
protein dynamics and PSN, allowing not only to include dynamic information into
PSN, but also providing quantitative tools for the evaluation of the persistence of
each interaction. The size of the largest hydrophobic cluster of interaction is the
most restrictive criterion for the evaluation [137] of the persistence threshold that
can be used to refine PSN in order to include only persistent interactions. Once the
PSN generated by persistent interactions has been created, the topological analy-
sis of such PSN allows to identify the most connected amino acids in the network
(hubs), which play a key role in maintaining the correct topology and, if mutated,
are most likely to perturb global structure and functionality. Moreover, the PSN
paradigm can be proficiently adopted to identify intramolecular communication
pathways between distant regions of the protein, underlying allosteric mechanisms
[140, 141] connected to protein dynamics. In order for a pathway between residues
A and B to be significant for the sake of information transfer, the communication
between them has to be robust, which means, according to the parsimony princi-
ple, that they are connected by a large number of shortest paths made by persistent
interactions. Therefore, to investigate the preferential intramolecular communica-
tion routes between two residues belonging, for example, to a Ca2+-binding site and
target interface residue, we created the Communication Robustness (CR) index, de-
fined as follows:
CR =
σAB · l
pT
(2.2)
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Where σAB is the number of shortest path of length l and pT is the persistence
threshold previously used to generate the PSN. PSN analysis and CR index have
been successfully employed to discover preferential communication routes in dif-
ferent regulatory states of GCAP1 as reported in Paper 9, but this approach can be
virtually extended to any other Ca2+-sensor protein.
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Introduction to the papers
This thesis work is composed by nine papers attached in appendix. Here is a brief
summary of the results and the conclusions of each paper.
3.1 Paper 1: Nanodevice-induced conformational and
functional changes in a prototypical calcium sen-
sor protein.
Marino V, Astegno A, Pedroni M, Piccinelli F, Dell’Orco D. Nanoscale. 2014 Jan
7; 6(1):412-23. doi: 10.1039/c3nr04978g.
(published before the PhD period)
Nanodevices are one of the most promising tools for targeted protein therapy, since
their high surface to volume ratio would allow to deliver high amounts of protein.
Here we tested the suitability of liposomes and lanthanide-doped upconverting CaF2
NP as nanocarriers of the prototypical NCS Rec. I performed all the experiments
of this project as part of my Master Degree in Bioinformatics and Medical Biotech-
nology and in the following 9 months of internship. To prove the suitability of
the nanodevices we had to assess the binding and the functionality of Rec while
bound on the surface of the nanodevices, and in order to do so we used DLS, lim-
ited proteolysis, CD and fluorescence spectroscopy. We found that Rec was able
to reversibly bind CaF2 NP, probably via EF-hand motifs, and liposomes upon ex-
trusion of the myristoyl group, even though the reversibility was more effective for
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the latter. While liposomes preserved the structural features of Rec, allowing the
triggering of the physiological Ca2+-dependent myristoyl-switch, NP significantly
perturbed the secondary and tertiary structure of Rec as well as its thermal stabil-
ity, forcing Rec to acquire a conformation which impaired its capability to act as
a Ca2+-sensor protein. CaF2 NP were therefore proven not to be suitable as Rec
carriers, at odds with liposomes which fully preserved all physiological features of
the NCS.
3.2. Paper 2: Structural plasticity of calmodulin on the surface of CaF2
nanoparticles preserves its biological function.
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3.2 Paper 2: Structural plasticity of calmodulin on
the surface of CaF2 nanoparticles preserves its bi-
ological function.
Astegno A, Maresi E, Marino V, Dominici P, Pedroni M, Piccinelli F, Dell’Orco D.
Nanoscale. 2014 Dec 21; 6(24):15037-47. doi: 10.1039/c4nr04368e.
Following the proof of concept presented in Paper 1, we tested the suitability of
the same lanthanide-doped upconverting CaF2 NP as carrier of the ubiquitous Ca
2+-
sensor protein CaM. By means of DLS we were able to prove that also CaM was
able to bind the NP with an ITC-estimated stoichiometric ratio of 1 NP: 120 CaM,
consistent with the number of possible binding sites (144) on the surface of the NP
assessed by geometrical approximations. My contribution to this project consisted
of the experimental planning and the performing of the DLS and CD experiments.
CD spectra showed that NP-bound CaM acquired a Ca2+-bound like secondary and
tertiary structure, meaning that the NP binding mode was presumably the same as
the Ca2+-binding mode, that is via the EF-hands motifs. Therefore, for a better un-
derstanding of the EF-hands involved in Ca2+-binding and conformational changes
upon NP interaction, we generated the double mutant E105Q-E141Q knocking out
the Ca2+-binding capability of EF3 and EF4. The lack of conformational changes
detected upon NP or Ca2+ binding allowed us to identify the N-lobe, constituted
by EF1 and EF2, as responsible for the physiological structural variations asso-
ciated with Ca2+-sensing. We also tested whether NP-bound CaM exhibited any
residual capability of binding the target peptide from Gad1, such possibility was
confirmed by CD spectroscopy, which highlighted that peptide binding was also
Ca2+-dependent. Finally we tested the residual functionality by enzymatic assay
with Gad1, which was completely preserved as shown by the full activation of the
enzyme, therefore proving the suitability of CaF2 NP as carriers of CaM, at odds
with what was reported for Rec in Paper 1. In conclusion, CaF2 NP applicability
as Ca2+-sensors carriers was found to be dependent on the structural flexibility of
the proteins. Indeed, the same structural plasticity which allows the recognition and
32 Chapter 3. Introduction to the papers
the regulation of several targets by CaM, compared to the single target of Rec, is
probably the cause of the difference in the behavior of the two Ca2+-sensors upon
interaction with the NP.
3.3. Paper 3: Conformational changes in calcium-sensor proteins under molecular
crowding conditions.
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3.3 Paper 3: Conformational changes in calcium-sensor
proteins under molecular crowding conditions.
Sulmann S, Dell’Orco D, Marino V, Behnen P, Koch KW. Chemistry. 2014 May
26; 20(22):6756-62. doi: 10.1002/chem.201402146.
In this study we assessed by DLS and SEC the Ca2+-induced variations of the hydro-
dynamic properties of several Ca2+-sensor proteins, and compared them with Ca2+-
dependent SPR signals in order to discriminate different conformational changes.
In detail we investigated the conformational changes of the ubiquitous Ca2+-sensor
CaM, and Troponin C, which is involved in Ca2+-mediated muscle contraction.
In addition, we studied two NCS involved in phototransduction, that is three dif-
ferent variants of Rec, namely non-myristoylated (nmRec), myristoylated (mRec)
and myristoylated without the C-terminal region (mRec 2-190) and five variants of
GCAP1, namely non-myristoylated (nmGCAP1), myristoylated (mGCAP1) and its
retinal dystrophy-related mutants D100E, L151F and E89K. This comparative anal-
ysis allowed the investigation of the role of the N-terminal myristoylation in modu-
lating the hydrodynamic variations of Rec and GCAP1 upon Ca2+-binding. More-
over, the analysis of the effects of the C-terminal fragment of Rec and the point
mutations of GCAP1 provided a comparative assessment of the sensitivity of the
three experimental approaches. Indeed, while all three techniques measure the rear-
rangement of the water molecules belonging to the hydration shell of the proteins,
DLS and SEC are solution techniques. The dextran-coated SPR chips instead mimic
the physiological molecular crowding, which might affect structural and dynamical
properties of protein hydration shell. For this project I performed DLS measure-
ments and the relative data analysis, which highlighted a decrease of hydrodynamic
diameter upon Ca2+-binding for TnC, mGCAP1 and nmRec, or an increase, as was
the case for CaM, mRec and nmGCAP1. These variations reflect the differences
in hydrophobicity exhibited, for example, by apo and Ca2+-bound Rec, where the
increased exposure of hydrophobic surfaces upon Ca2+-binding causes major rear-
rangements of the hydration shell. Interestingly, the presence of post-translational
myristoylation had an opposite effect on the Ca2+-dependent hydrodynamic size
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variation of the two NCS Rec and GCAP1. By analyzing SPR, DLS and SEC mea-
surements we could conclude that the change in the refractive index measured by
SPR clearly correlated with the absolute value of the variation in the hydrodynamic
size of the proteins. Moreover, this technique allowed to discriminate even small
differences caused by point mutations in mGCAP1, providing further evidence of
the sensibility of the approach and a fingerprint profile for each protein in conditions
comparable to the physiological molecular crowding.
3.4. Paper 4: Structural effects of Mg2+ on the regulatory states of three neuronal
calcium sensors operating in vertebrate phototransduction.
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3.4 Paper 4: Structural effects of Mg2+ on the reg-
ulatory states of three neuronal calcium sensors
operating in vertebrate phototransduction.
Marino V, Sulmann S, Koch KW, Dell’Orco D. Biochim Biophys Acta. 2015 Sep;
1853(9):2055-65. doi: 10.1016/j.bbamcr.2014.10.026.
Mg2+ is a divalent cation present in its free form at a concentration around 1 mM
in photoreceptor cells [15] and it is involved in the regulation of several enzymes
as well as a cofactor for ATP and GTP. The lack of major variations in the concen-
tration of Mg2+ in photoreceptor cells led to the conclusion that it was not directly
involved in the regulation of phototransduction cascade. NCS proteins though, are
in principle capable to bind Mg2+ ions via the Ca2+-binding EF-hands, especially
when their Ca2+-affinity is in the micromolar range. Therefore, in this project we
investigated the effects that Mg2+ exerted on the structural properties of three NCS
involved in phototransduction, namely GCAP1, GCAP2 and Rec, by means of CD
and fluorescence spectroscopy, ITC and MD simulations. With the exception of
the ITC measurements, all experimental and computational data were collected
and analyzed by me. Rec was found to be slightly affected by Mg2+ in terms of
secondary and tertiary structure, its physiological myristoyl switch was shown not
to be triggered by Mg2+ ions, which in general mildly decreased the protein ther-
mal stability with respect to the apo form. The secondary and tertiary structure of
GCAP2 seemed to be affected by the presence of Mg2+, ITC measurements allowed
for the estimation of two binding sites, one with a physiologically relevant affinity
of 320 uM and the other with a non-physiological affinity of 4.4 mM, similarly to
what was previously reported for GCAP1. Nonetheless most of the investigations
we performed on GCAP2 were intrinsically non reproducible, therefore suggesting
that the role of the cation would be rather complex and possibly associated with
different oligomeric states of GCAP2. GCAP1 was the most Mg2+-affected NCS
of this study, as both secondary and tertiary structures underwent small but signif-
icant changes in the presence of Mg2+, which were known to be associated with
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the activating form of the target GC. MD simulations highlighted the necessity of
a Mg2+ ion in the EF2 motif for the stable and specific interaction with the target
GC. Moreover they allowed us to identify a sequence of events that have to occur
in order for GCAP1 to switch from the inhibiting to the activator state, namely the
release of Ca2+ from EF4, the Ca2+/Mg2+ exchange in EF2 and the release of Ca2+
from EF3.
3.5. Paper 5: Differential Nanosecond Protein Dynamics in Homologous Calcium
Sensors.
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3.5 Paper 5: Differential Nanosecond Protein Dynam-
ics in Homologous Calcium Sensors.
Robin J, Brauer J, Sulmann S, Marino V, Dell’Orco D, Lienau C, Koch KW. ACS
Chem Biol. 2015 Oct 16; 10(10):2344-52. doi: 10.1021/acschembio.5b00278.
GCAPs are able to specifically change conformation according to different Ca2+
concentrations triggering their switch from inhibitor to activator of the target GC.
Here we studied the conformational dynamics of GCAP1 using the same approach
that was successfully applied to investigate GCAP2 [142], that is time-resolved
fluorescence spectroscopy. GCAP1 has 4 Cys residues located in different spatial
regions, C18 and C29 belong to the entering helix of EF1 and are situated at the
beginning and the end of the helix respectively, C106 is part of the Ca2+-binding
loop of EF3 and C125 lies in the loop connecting EF3 and EF4. To investigate
in detail selected regions of the molecule, all but one Cys residues were mutated
to Ala (CAAA, ACAA, AACA, AAAC), then the only remaining Cys residue was
labelled with the fluorescent dye Alexa647 and subjected to the fluorescence stud-
ies. Fluorescence decay and anisotropy highlighted that C106 was the the most
ion-affected residue in terms of increased lifetime and rotational correlation time.
This implied a higher solvent exposure of C106 upon Ca2+ or Mg2+ dissociation,
which was supported by the analysis of the diffusional dye motion. I collaborated
to this project by running and analyzing all-atom Molecular Dynamics simulations
in order to gain structural insights into the regions where the dye, which was not
part of the simulations, would have been covalently bound. The increase of the
distance between D168 and R178 (Figure 5), belonging respectively to the N-lobe
(EF1 and EF2) and C-lobe (EF3 and EF4) highlighted a divergent motion of the
lobes upon Ca2+-binding. In addition, we identified three ideal planes representing
EF1, EF3 and EF4 and monitored the amplitude of the angles between EF1-EF4
and EF3-EF4, resulting in a decrease of both angles upon Ca2+-binding. Simulation
derived data resulted to be in line with the experimentally deduced “twisted accor-
dion” model of conformational dynamics, where Ca2+ induced the approach of two
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lobes accompanied by the outward movement of the EF3 loop . This led to the con-
clusion that despite high structural similarity, NCS proteins are able to specifically
recognize and regulate their target also thanks to peculiar protein dynamics.
3.6. Paper 6: Impact of cone dystrophy-related mutations in GCAP1 on a kinetic
model of phototransduction.
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3.6 Paper 6: Impact of cone dystrophy-related muta-
tions in GCAP1 on a kinetic model of phototrans-
duction.
Dell’Orco D, Sulmann S, Zägel P, Marino V, Koch KW. Cell Mol Life Sci. 2014
Oct; 71(19):3829-40. doi: 10.1007/s00018-014-1593-4.
In this study we investigated the effects that four GCAP1 mutants associated to
Cone and Cone-Rod Dystrophies, namely E89K, D100E, L151F and G159V ex-
erted on the structure and the functionality of the proteins, by means of CD spec-
troscopy, ITC and enzymatic assays. The experimental enzymatic parameters were
then implemented in a previously published model of phototransduction in order to
both predict the kinetics of the photoresponse in rod cells and to analyze the contri-
bution of the other Ca2+-sensor GCAP2 in shaping the cGMP synthesis. My contri-
bution to this project consisted of the characterization of these mutants in terms of
secondary and tertiary structure and their thermal stability, which were assessed by
CD spectroscopy. All but E89K mutant showed small but significative differences
in the CD spectra, both in the near and the far UV regions, in particular in the Ca2+
bound forms. E89K mutant instead exhibited major differences in the tertiary struc-
ture and a slight decrease of the thermal stability in the absence of Ca2+. All data
presented here allowed us to conclude that these mutants had a decreased catalytic
efficiency with respect to that of the wild type, similarly to the Y99C mutant, for
which electrophysiological recordings were available [55]. Therefore we were able
to conclude that our photoresponse simulations were in line with experimental data,
moreover we found a compensatory effect of GCAP2 in the regulation of the target
GC, in line with the Ca2+-relay model [35].
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3.7 Paper 7: Two retinal dystrophy-associated mis-
sense mutations in GUCA1A with distinct molec-
ular properties result in a similar aberrant regu-
lation of the retinal guanylate cyclase.
Marino V, Scholten A, Koch KW, Dell’Orco D. Hum Mol Genet. 2015 Dec 1;
24(23):6653-66. doi: 10.1093/hmg/ddv370.
Here we presented a thorough characterization of the two recently found GCAP1
mutants I107T and L84F in spanish patients affected by Cone, Cone-Rod andMacu-
lar dystrophies, in terms of structure, thermal stability, Ca2+ affinity and functional-
ity. These variants, which caused similar clinical phenotype, are in close proximity
in terms of primary structure, but they belong to different lobes, indeed L84F is lo-
cated at the end of the exiting helix of EF2, while I107T is a part of the Ca2+-binding
loop of EF3. With the exception of the enzymatic assays, all the experimental and
computational data were collected and analyzed by me. CD spectroscopy high-
lighted a wild type-like secondary and tertiary structure for I107T, similar to those
of the variants studied in Paper 6, while L84F exhibited a significantly different
tertiary structure in the absence and in the presence of Ca2+ or Mg2+. Both mutants
showed three-phase thermal denaturation profiles in the absence of Ca2+ with de-
creased thermal stability with respect to the wild type, accompanied by an increase
of the thermal stability in the Ca2+-bound form, which was more pronounced for
the L84F variation. Intrinsic Trp fluorescence approach was employed for the esti-
mation of Ca2+ and Mg2+ affinity, highlighting that both mutants exhibited the same
wild type-like biphasic behavior when switching from the apo to the Ca2+-bound
form. Interestingly, L84F variant showed that it could bind two Mg2+ ions at phys-
iological Mg2+ concentration. While I107T showed a decreased Ca2+ affinity with
respect to the wild type, similarly to most dystrophy related mutants [50], L84F
surprisingly exhibited a wild-type like Ca2+ affinity and a positive cooperativity of
binding in the presence of Mg2+. Indeed it was possible to fit data from the chelator
assay with a 2 or 3 binding site model without major differences in the macroscopic
3.7. Paper 7: Two retinal dystrophy-associated missense mutations in GUCA1A
with distinct molecular properties result in a similar aberrant regulation of the
retinal guanylate cyclase.
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binding constants, suggesting that probably EF2 was occupied by a Mg2+ ion and
that Ca2+-binding to EF3 increased Ca2+-affinity in EF4. Molecular Dynamics sim-
ulations provided some mechanistic insights into the experimental evidences, high-
lighting that the higher thermal stability of the L84F variant was probably due to
a tighter packing of the myristoyl moiety in the hydrophobic cleft, as shown by its
lower solvent exposure. Moreover the EF3 Ca2+-coordinating residues were found
to be significantly less flexible in L84F mutant than the wild type in the Ca2+-bound
form, suggesting a long range intramolecular communication pathway between the
myristoyl group and the C-lobe, in line with the previously described "myristoyl-
tug" mechanism [39]. This suggested a deeper computational investigation of long-
range allosteric mechanisms in GCAP1, which was performed in Paper 9. Despite
all these structural and Ca2+-affinity differences, both mutants exhibited functional
features common to all other retinal dystrophy-related GCAP1 mutants and leading
to a constitutive activation of the target GC. In conclusion, our data suggested that
the alteration of intra-intermolecular communication mechanisms, rather than just
the decreased Ca2+ affinity, could be responsible for the dysregulation of the GC by
GCAP1 mutants associated with retinal dystrophies.
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3.8 Paper 8: Dysfunction of cGMP signalling in pho-
toreceptors by a macular dystrophy-related mu-
tation in the calcium sensor GCAP1.
Vocke F, Weisschuh N, Marino V, Malfatti S, Jacobson SG, Reiff CM, Dell’Orco
D, Koch KW. Hum Mol Genet. 2016 Dec 26. doi: 10.1093/hmg/ddw374.
In the last number of years an increasing number of retinal dystrophy-related GCAP1
mutants have been discovered. Here is the biochemical and biophysical character-
ization of the most recently identified L176F mutant by means of CD and fluores-
cence spectroscopy, DLS, enzymatic and chelator assays and Molecular Dynamics
simulations. My contribution to this project consisted in the design and planning
of CD and DLS experiments, as well as the running and analysis of MD simula-
tions. Like the L84F mutant presented in Paper 7, L176F also didn’t show any
perturbations in its Ca2+-affinity compared to the wild type, while it exhibited dif-
ferent tertiary structure, an increase in the hydrodynamic radius upon Ca2+ binding,
higher affinity for the target GC and the highest activity of all mutants studied so
far. The reason for this could be found in the intrinsic Trp fluorescence Mg2+ titra-
tions, which showed 10 fold higher affinity for Mg2+ with respect to the wild type,
meaning that probably this variant could bind 2 Mg2+ ions. To furtherly investi-
gate this aspect we compared the trajectories resulting from MD simulations of the
Ca2+-loaded state as well as one/two Mg2+ ion-bound state of wild type GCAP1
and L176F variant. Results showed that not only the L176F variant was struc-
turally more rigid than the wild type with two Mg2+ ions bound in EF2 and EF3,
but also that the mutation had long-range allosteric effects on the distal EF4, which
could explain the constitutive activation of the GC, at odds with the majority of the
dystrophy-related variants, whose pathological mechanism was supposed to depend
on the decreased Ca2+ affinity.
3.9. Paper 9: Allosteric communication pathways routed by Ca2+/Mg2+ exchange
in GCAP1 selectively switch target regulation modes.
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3.9 Paper 9: Allosteric communication pathways routed
by Ca2+/Mg2+ exchange in GCAP1 selectively switch
target regulation modes.
Marino V, Dell’Orco D. Sci Rep. 2016 Oct 14; 6:34277. doi: 10.1038/srep34277.
In this study we tried to shed some light on the mechanisms that allow GCAP1
to switch from activator to inhibitor of the target GC upon Mg2+/Ca2+ exchange by
running and analyzing five replicas of 200 ns all-atom Molecular Dynamics simula-
tions. We therefore simulated the Ca2+-loaded inhibiting state and the two possible
activator states with Mg2+ bound to EF2 or EF2 and EF3, both with and without N-
terminal myristoylation. In order to exhaustively sample the conformational space
explored by MD simulations, we employed Principal Component Analysis (PCA)-
based indexes to check the reproducibility and the consistency between replicas,
such as cosine content, Root Mean Square Inner Product and PCA projections. All
these combined indexes allowed us to consider the five replicas as one single 1 us
consistent trajectory, which was then subjected to an analysis of the persistence of
the noncovalent interactions between residues to generate a single Protein Structure
Network (PSN) for each state representing the dynamic structural behavior. We then
performed network analysis on each PSN to identify key residues with a high num-
ber of persistent interactions, finding that some hub residues like D100 or I143 were
associated with retinal dystrophies mutations. To identify the preferential commu-
nication routes between EF-hands and the putative interface with the target GC, we
created the Communication Robustness (CR) index that took into account the per-
sistence threshold that generated the PSN, the number and the lenght of the shortest
paths connecting selected residues according to the parsimony principle. The CR
analysis was then performed on the residues of the putative GCAP1-GC interface
and the representative Glu residues of each EF hand, finding that E38 and C29 were
the most robustly communicating residues of the interface in specific states. We also
analyzed the most probable pathways connecting the aforementioned residues with
the EF-representative Glu residues using the Selective Betweenness index, which
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allowed to highlight of specific intramolecular communication routes depending on
the loading state of each EF-hand. Since the myristoyl group was found not to
have many persistent interactions, we applied the CR criterion between the three
functional EF-hands and compared the myristoylated and non myristoylated forms,
finding that the acylic group was required in order to maintain the allosteric com-
munication between EF2 and EF4, in line with the "myristoyl tug" mechanism [39].
In conclusion, our computational approach allowed us to understand that the switch
between inhibitor and activator form of GCAP1 depended not only on the loading
state of the EF-hands, but also on the intramolecular communication routes that
transfer the information to the GCAP1-GC interface. Moreover, the identification
of some hub residues as target of pathological mutations suggested that the dysreg-
ulation of the target GC could be due to the perturbation of the PSN, and therefore,
of the communication routes. This led to the conclusion that this approach could
be applied also to other NCS proteins to unveil intramolecular, and possibly inter-
molecular communication pathways.
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Conclusions
This thesis work combined experimental and computational techniques to investi-
gate different aspects of structure-function relationship of Ca2+-sensor proteins. In
detail, the NCS GCAP1 was extensively studied both in health and disease condi-
tions, from different standpoints: Paper 4 deals with the structural determinants of
the switch between its regulatory modes associated with Mg2+ and Ca2+ exchange
and with the conformational effects of Mg2+ on other two NCS, namely GCAP2
and Rec. In Paper 5 the Ca2+/Mg2+ exchange of GCAP1 was investigated in terms
of protein dynamics leading to the conformational switch from inhibitor to activator
of the target GC. The structural and functional effects exerted by GCAP1 point mu-
tations associated with retinal dystrophies are the subject of Paper 6, Paper 7 and
Paper 8. In particular, results from Paper 7 and Paper 8 highlighted a new perspec-
tive in GCAP1 pathological variants, that is that the molecular mechanism leading
to the disease is not necessarily correlated to the decreased Ca2+-affinity exhibited
by some disease associated variants, but rather to the alteration of the intramolec-
ular communication routes. This suggested the application of the PSN paradigm
to MD simulations of GCAP1 as explained in Paper 9, in which the analysis of
intramolecular communication pathways from the ion-binding sites to the target in-
terface revealed long range allosteric communication routes specifically exhibited
by the target-inhibiting and target-activating states. Paper 3 is a comparative study
of SEC, DLS and SPR techniques to investigate differences in hydrodynamic prop-
erties due to conformational changes upon Ca2+-binding exhibited by Ca2+-sensors,
among which CaM, GCAP2 and different variants of GCAP1 and Rec. In this
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work the sensitivity of SPR in detecting Ca2+-induced conformational changes un-
der molecular crowding conditions was assessed, indeed this approach has been
proved to be able to discriminate even small conformational differences such as
those associated with GCAP1 physiological states and its pathological mutants. Fi-
nally, Paper 1 and Paper 2 involve the suitability of liposome-based and CaF2 NP-
based nanodevices as Ca2+-sensors carriers for potential nanomedical applications.
Results from Paper 1 show that liposomes preserved Rec physiological structural
properties, while CaF2 NP alter Rec conformation, impairing its Ca
2+-sensing abil-
ity. On the other hand, Paper 2 suggests that the same CaF2 NP preserve both
CaM structure and functionality in terms of the ability to bind and regulate Gad tar-
get. Taken together, these papers indicate that CaF2 exert protein-specific effects on
Ca2+-sensors, therefore suggesting further investigations. In conclusion, the com-
bination of experimental and computational techniques provides a powerful frame-
work for the investigation of structure/function relationship of Ca2+-sensor proteins.
Such approaches revealed themselves particularly useful for gaining multiscale in-
sights into the molecular mechanisms leading to physiological processes, as well
as their dysregulation associated to single residue mutations. Indeed, the biochemi-
cal and biophysical characterization of several GCAP1 variants highlighted similar
clinical phenotypes in spite of different molecular properties, suggesting an asso-
ciation with the alteration of the intramolecular communication network. In this
respect, the future application of the computational approach presented in Paper 9
to GCAP1 variants may be helpful in identifying common patterns between dys-
functional communication networks. This could potentially provide the structural
information needed to design compounds interfering with the inter/intramolecular
interaction network of GCAP1, in order to restore the physiological regulation of
the target enzyme GC.
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Nanodevice-induced conformational and
functional changes in a prototypical calcium sensor
protein†
Valerio Marino,a Alessandra Astegno,b Marco Pedroni,bc Fabio Piccinellibc
and Daniele Dell’Orco*ad
Calcium (Ca2+) plays a major role in a variety of cellular processes. Fine changes in its concentration are
detected by calcium sensor proteins, which adopt speciﬁc conformations to regulate their molecular
targets. Here, two distinct nanodevices were probed as biocompatible carriers of Ca2+-sensors and the
structural and functional eﬀects of protein–nanodevice interactions were investigated. The prototypical
Ca2+-sensor recoverin (Rec) was incubated with 20–25 nm CaF2 nanoparticles (NPs) and 70–80 nm
liposomes with lipid composition similar to that found in photoreceptor cells. Circular dichroism and
ﬂuorescence spectroscopy were used to characterize changes in the protein secondary and tertiary
structure and in thermal stability upon interaction with the nanodevice, both in the presence and in the
absence of free Ca2+. Variations in the hydrodynamic diameter of the complex were measured by
dynamic light scattering and the residual capability of the protein to act as a Ca2+-sensor in the presence
of NPs was estimated spectroscopically. The conformation, thermal stability and Ca2+-sensing capability
of Rec were all signiﬁcantly aﬀected by the presence of NPs, while liposomes did not signiﬁcantly
perturb Rec conformation and function, allowing reversible binding. NP-bound Rec maintained an all-
helical fold but showed lower thermal stability and high cooperativity of unfolding. Our analysis can be
proﬁciently used to validate the biocompatibility of other nanodevices intended for biomedical
applications involving Ca2+-sensors.
Introduction
Calcium (Ca2+) triggers and regulates a broad variety of cellular
and physiological processes and acts as an important second
messenger in many biochemical pathways.1 The detection of
Ca2+ is performed by sensor proteins, which adopt specic
conformations in response to ne changes in intracellular
[Ca2+].2 Among Ca2+-sensor proteins, neuronal calcium sensors
(NCS) are mostly localized in the neuronal tissue, although their
expression has been detected also in other tissues.3,4 A proto-
typical NCS is recoverin (Rec), a sensor belonging to the EF-
hand superfamily, which is involved in the regulation of the
biochemical events occurring in photoreceptor cells upon light
exposure. The post-translational myristoylation at the N-
terminus allows Rec to act as a regulator of the signalling
cascade as [Ca2+] drops during the phototransduction
process.5,6 Specically, the binding of Ca2+ triggers the protein
structural transition from a “tense” (T), compact conformation
in which the myristoyl group is sequestered in a hydrophobic
pocket to a “relaxed” (R), more extended conformation, in
which the myristoyl moiety is solvent-exposed (Fig. 1). Exposure
of the myristic group is accompanied by an overall augmented
hydrophobicity of the protein surface and provides an anchor
that binds Rec to the photoreceptor disc membranes, thus
permitting the regulation of the rhodopsin kinase activity.5,7
This switch mechanism constitutes a functional hallmark for
myristoylated Rec (mRec) and the physico-chemical details have
long been investigated.7,8 Interestingly, mRec binds two Ca2+
ions with moderate aﬃnity (apparent KD  17–18 mM),
9,10 while
the non-myristoylated variant (nmRec) has two binding sites
with signicantly higher aﬃnity (KD1¼ 0.11 mM, KD2¼ 6.9 mM).
9
It is well established that distortion in the cell Ca2+-homeo-
stasis may lead to severe diseases. In particular, hereditary cone
dystrophies represent a severe class of disorders that correlate
with mutations in genes coding for NCS proteins, which can
eventually lead to impaired vision and blindness.11–15 In order to
rescue the physiological levels of second messengers including
Ca2+, a novel approach could be the direct delivery of well-
dened and precisely structured proteins into the cell to
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replace the dysfunctional protein, hence avoiding some of the
potential problems of gene therapy. Ideally, the means of
delivery should minimally perturb the proteins to be carried in
order to keep them fully functional. For the sake of protein
delivery, nanodevices (NDs) may oﬀer unique opportunities in
that the high surface to volume ratio would ensure high
amounts of protein carried by devices of relatively small
volumes. It is however fundamental to assess the eﬀects that the
ND exerts on the protein conformation and function upon
interaction. Indeed, very recent lines of evidence suggest that
nanoparticles (NPs) may lead to signicant structural changes
and even unfolding of proteins bound to the particle
surface.16–19
Among the most promising nanoscale devices for nano-
medicine purposes, lanthanide-doped upconverting NPs have
raised considerable attention in the last few years because of
their capacity to be multiphoton-excited with near infra-red
(NIR) light and generate emission at higher energies spanning
the UV to the NIR, a feature that can be exploited in a variety of
bioimaging and biomedical goals.20–26 Particularly promising
are CaF2 NPs,
27 which can be synthesized by a single-step
hydrothermal method and coated by citrate, thus ensuring
appropriate dispersion in water environments.28 In particular,
CaF2 NPs doped with luminescent lanthanide ions can be used
as multifunctional nanoprobes for highly penetrating uores-
cence, which can be exploited together with the uorescence
thermal sensitivity property.29 Moreover, they showed no
toxicity in tests performed with HeLa cells, thus setting the
basis for biocompatible carrier systems that can conveniently
exploit the upconversion phenomenon.29
In this work, we explored the possibility to use CaF2 NPs and
lipid nanovesicles as convenient carriers of Ca2+ sensors for
biomedical purposes. We investigated the eﬀects that the
interaction with the ND exerted on the structural and functional
properties of both mRec and nmRec and evaluated the residual
capability of the protein to act as a Ca2+-sensor in the presence
of the ND. Our results show that CaF2 NPs signicantly alter the
structural and functional properties of both mRec and nmRec,
which signicantly decrease their sensitivity to free Ca2+. The
interaction between the protein and the particles is not medi-
ated by the citrate coating NPs, thus suggesting a direct
electrostatic interaction that alters the size of the protein as well
as its secondary and tertiary structures. NP-bound mRec and
nmRec showed a signicantly lower thermal stability and the
unfolding prole was found to be highly cooperative, indepen-
dent of the presence of free Ca2+. Liposomes on the other hand
did not signicantly perturb protein secondary and tertiary
structures, and the capability to work as a Ca2+-sensor in their
presence was preserved.
The partial reversibility of binding to CaF2 NPs observed for
mRec and the specic conformational features observed
suggest that the interaction with the particle surface induces a
structure that is signicantly diﬀerent from the respective
equivalent in solution. While Ca2+-sensing is greatly altered, the
novel conformation is completely folded and perhaps associ-
ated with novel functions to be explored in future studies.
Results and discussion
Ca2+-dependent structural changes in myristoylated and non-
myristoylated Rec
Binding of two Ca2+ ions to mRec showed distinct spectroscopic
features, which represent the hallmarks of the myristoyl-switch
mechanism. Far UV-CD spectra showed the typical pattern of an
all-a protein, with two minima at 208 and 222 nm (Fig. 2A). In
line with previous ndings,30 we observed that the binding of
Ca2+ leads to a signicant decrease of the minimum at 222 nm
with substantially unaltered intensity at 208 nm, thus causing
the q222/q208 ratio to switch from 0.77 in the apo-form to 0.87 in
the Ca2+-bound form (Table 1). CD spectroscopy in the near UV
region allows monitoring of the asymmetric environment of the
aromatic residues, which was observed to signicantly change
upon Ca2+-binding in the case of mRec (Fig. 2B).
As observed in previous studies,31 metal binding caused the
ellipticity to drastically decrease mostly in the tyrosine (Tyr) and
tryptophan (Trp; W) bands, while only a minor change was
observed in the phenylalanine (Phe) region. The uorescence
spectrum (Fig. 2C) arising mostly from the intrinsic uores-
cence of three Trp residues (W31, W104 and W156) showed a 7
nm red-shi (329 nm to 336 nm) of the maximum wavelength
(Table 1) and a moderate quenching of the signal, as already
found in previous studies.32 This is in line with the increased
Fig. 1 Three-dimensional structure of myristoylated recoverin in its Ca2+-free (left) and Ca2+-bound (right) forms, corresponding to the T and R
states, respectively. The backbone is represented by gray cartoon tubes, the myristic moiety by green spheres, and the two Ca2+ ions by red
spheres. The three Trp residues are represented by purple sticks and labeled, while the molecular surface is shown in transparency. Solvent-
accessible surface areas (ASA) for each Trp in the absence and in the presence of Ca2+ are: W31 (49.4 A˚2 to 58.6 A˚2); W104 (0 A˚2 to 12.6 A˚2); W156
(2.6 A˚2 to 33.3 A˚2); structural data are from NMR average structures (left: PDB entry 1IKU; right: PDB entry 1JSA).
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solvent-exposure of hydrophobic residues upon occurrence of
the myristoyl switch during the Ca2+-binding process, in
particular structural data conrm that all three Trp residues
(W31, W104 and W156) become signicantly exposed (Fig. 1).
The signicant variations observed in mRec conformation upon
saturation with Ca2+ were conrmed also by dynamic light
scattering (DLS) measurements (Fig. S1A;† see also Table 2 and
Fig. 4D and E), which revealed a 0.3 nm increase in the
hydrodynamic diameter. The overall increase in mRec hydro-
dynamic size was postulated earlier7 and appears to be in line
with the radius of gyration and solvent-accessible surface area
as determined by comparing the average NMR structures of the
apo8 and Ca2+-bound5 forms. Overall, our spectroscopic data are
consistent with a signicant conformational change in mRec
secondary and tertiary structures upon Ca2+-binding, compat-
ible with the myristoyl switch mechanism.
The non-myristoylated form of the same protein (nmRec)
showed diﬀerent spectroscopical features (Fig. 2). While the
overall fold is clearly all-a, in this case both minima detected by
far UV-CD spectroscopy (Fig. 2D) at 208 and 222 nm became
more negative upon Ca2+-binding, leading to a less pronounced
variation in the q222/q208 ratio, which switched from 0.83 in the
apo-form to 0.88 in the Ca2+-bound form (Table 1). The overall
diﬀerent spectral shape of the Ca2+-bound form compared to
mRec was previously observed in other NCS that do not undergo
a myristoyl switch,12,30 and can be attributed to an increased
compactness of the protein in the presence of Ca2+.12 Along the
same line, the variation in the tertiary structure was less
prominent for nmRec (Fig. 2E) compared to mRec (Fig. 2B), and
the changes mostly concerned the Trp and Tyr regions. Diﬀer-
ences were detected also in the Trp-uorescence spectrum
(Fig. 2F and Table 1), which showed a modest (1 nm) red-shi
Fig. 2 Structural changes occurring in mRec and nmRec upon binding of Ca2+ and upon interaction with CaF2 NPs. All measurements were
performed at T¼ 25 C in 5mM Tris–HCl pH 7.5, 150mM KCl buﬀer. (a) Far-UV CD spectra of 6.3 mMmRec in the presence of equal amounts (46
mM) of saturating EGTA or Ca2+, both isolated and incubated with 1 mgmL1 CaF2 NPs. (b) Near-UV CD spectra of 31.4 mMmRec in the presence
of equal amounts (230 mM) of saturating EGTA or Ca2+, both isolated and incubated with 5 mg mL1 CaF2 NPs. (c) Intrinsic Trp ﬂuorescence
emission spectrum (lexc ¼ 290 nm) of 0.78 mM mRec in the presence of equal amounts (5.8 mM) of saturating EGTA or Ca
2+, both isolated and
incubated with 125 mg mL1 CaF2 NPs. (d) Far-UV CD spectra of 5.8 mM nmRec in the presence of equal amounts (46 mM) of saturating EGTA or
Ca2+, both isolated and incubated with 1 mg mL1 CaF2 NPs. (e) Near-UV CD spectra of 29.3 mM nmRec in the presence of equal amounts (230
mM) of saturating EGTA or Ca2+, both isolated and incubated with 5 mg mL1 CaF2 NPs. (f) Intrinsic Trp ﬂuorescence emission spectrum (lexc ¼
290 nm) of 0.73 mM nmRec in the presence of equal amounts (5.8 mM) of saturating EGTA or Ca2+, both isolated and incubated with 125 mg mL1
CaF2 NPs. The q222/q208 ratio for all forms and the wavelengths of maximal emission are reported in Table 1.
Table 1 Biophysical parameters of mRec and nmRec in the absence and in the presence of nanodevices (LP stands for ROS-like liposomes)
+EGTA +Ca2+
q222/q208
a (n) Tm
b (C) Hc
c
lmax u
d (nm) q222/q208 (n) Tm (
C) Hc lmax u (nm)
mRec 0.77 (5) 73.1 15.0 329 0.87 (5) 78.8 10.7 336
nmRec 0.83 (5) 73.8 7.8 338 0.88 (5) 79.4 11.5 339
NP + mRec 0.91 (5) 66.4 21.9 336 0.91 (5) 65.4 23.9 336
NP + nmRec 0.90 (5) 68.6 19.4 339 0.92 (5) 68.1 19.2 339
LP + mRec 0.77 (5) — — 330 0.92 (5) — — 338
LP + nmRec 0.84 (5) — — 339 0.92 (5) — — 340
a Ratio between ellipticity at 222 and 208 nm; n stands for number of replicates in each experiment. b Melting temperature obtained by tting the
experimental curve to a 4 parameter Hill sigmoid (see eqn (1) in Methods). c Hill coeﬃcient. d Wavelength at which uorescence emission is
maximal upon excitation at l ¼ 290 nm.
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and an increase of intensity in the presence of saturating Ca2+,
substantially in line with previous ndings.32 Interestingly, DLS
measurements showed the co-presence of two populations, a
monomeric form with hydrodynamic diameter decreasing upon
Ca2+-binding (0.27 nm, see Table 2 and Fig. S1C†) and a
higher order oligomer likely comprising 5–7 units that behaved
independent of Ca2+. While intensity peaks corresponding to
higher order oligomers were detected both for mRec and nmRec
in DLS experiments, their eﬀective weight on the photon
correlation signal is modest due to the 1/d6 scaling of scattered
light intensity. Indeed, according to number and volume
distributions of the same molecular species only monomeric
forms were detected (data not shown). Thus, we may conclude
that mRec and nmRec behave in an opposite way upon binding
of Ca2+, the latter decreasing its hydrodynamic size at variance
with the rst one. An opposite behaviour of the two Rec variants
was similarly found in a very recent study using surface plas-
mon resonance.33
Eﬀects of CaF2 nanoparticles on Rec structure and stability
The same spectroscopic characterization performed with iso-
lated proteins was done in the presence of CaF2 NPs. Working
with a suitable NP concentration is necessary to distinguish
between spectroscopic signals arising from the unbound
proteins and those relative to NP-bound ones. According to a
simple geometric model of Rec–NP interaction (see Methods
and ESI†) we calculated the maximum number of bound Rec for
a 30 nm diameter NP to be 244, thus aer xing the NP
concentration we kept the corresponding protein concentration
below this theoretical maximum in all the experiments, working
under conditions at which the signal arising from the protein
was clearly detectable.
Interestingly, the structural features of mRec signicantly
changed in the presence of NPs (Fig. 2). The presence of satu-
rating free Ca2+ led to lower dichroism in the far UV-CD region
(Fig. 2A), at odds with the isolated protein and likely indicative
of a loss of protein compactness upon interaction with the NP.
The spectrum however showed a very similar shape for NP-
bound mRec independent of the presence of free Ca2+, as
quantitatively demonstrated by the same q222/q208 ratio (0.91 in
both cases, Table 1). This value is similar to that observed for
the Ca2+-bound form of both mRec and nmRec (0.88, Table 1).
Thus, the secondary-structural features in the presence of NPs
are incompatible with those typical of the myristoyl switch,
although under every tested condition the protein clearly
showed a characteristic all-a folding. Along the same line, near
UV-CD spectra in the presence of CaF2 NPs showed a tertiary
structure hallmark signicantly diﬀerent from that of the iso-
lated protein. In detail, while the Trp region was very similar to
that of the apo mRec (Fig. 2B), Tyr and Phe bands showed a
remarkable diﬀerence in their ne structure and increased
signal. The tertiary structure appeared to be less aﬀected by the
presence of saturating free Ca2+ compared to the isolated
protein and overall, the presence of CaF2 NPs yielded more
prominent diﬀerences in the spectrum of Ca2+-bound forms.
Since the CaF2 NPs used in this study were coated with
citrate, we further tested whether the interaction was mediated
by citrate rather than occurring through the CaF2 matrix. The
presence of K–citrate even at high concentration did not prevent
the occurrence of the myristoyl switch (Fig. S2A†), moreover the
q222/q208 ratio and the near-UV spectra (Fig. S2B and Table S1†)
were all very similar to those of mRec in the absence of citrate
(see Fig. 2A and B). The citrate coating therefore did not perturb
the interaction of Rec with the NP, and was probably fully
replaced by the protein milieu.
Very minor diﬀerences were detected in the intrinsic Trp
uorescence spectra (Fig. 2C) in the presence and in the
absence of Ca2+. A hardly detectable blue shi of the maximum
wavelength was observed upon saturation with Ca2+ and
comparison with the unbound protein highlighted a quenching
of the signal and a microenvironment of Trp residues similar to
that of the Ca2+-bound isolated protein (lmax ¼ 336 nm, Table
1). DLS experiments showed that mRec binds NPs both in the
presence and in the absence of free Ca2+, and the changes in the
hydrodynamic diameter of the NP–protein complex were 2.6 nm
and 1.7 nm respectively (see Table 2, Fig. S1B,† 4D and E).
Similar to mRec, incubating nmRec with CaF2 NPs led to
signicant structural changes. The secondary structure of NP-
bound nmRec was comparable to the unbound condition
(Fig. 2D) although a lower dichroism signal is likely indicative of
decreased compactness. Similar q222/q208 ratios were observed
in the absence (0.90) and in the presence (0.92) of Ca2+ (Table 1),
thus indicating a very similar secondary structure compared to
the myristoylated form when bound to the NP surface. Also
similar to mRec, ellipticity in the near-UV range substantially
increased in the presence of NPs (Fig. 2E) showing minor
diﬀerences in the Trp bands and small but signicant diﬀer-
ences in the Phe and Tyr regions. The intrinsic Trp uorescence
spectrum (Fig. 2F) was virtually identical in the presence or in
the absence of saturating Ca2+ and beside a very minor increase
in uorescence intensity in the presence of saturating Ca2+, no
shi in the maximum wavelength was observed (Table 1). DLS
experiments showed that also nmRec binds NPs both in the
presence and in the absence of free Ca2+, and changes in the
hydrodynamic diameter of the NP–protein complex were more
Table 2 Hydrodynamic diameter measurements by dynamic light
scattering. d: hydrodynamic diameter, s: standard error, n: number of
repetitions, pdI: polydispersity index
+ EGTA + Ca2+
d 	 s (nm) (n) pdI d 	 s (nm) (n) pdI
mRec 5.22 	 0.02 (20) 0.43 5.52 	 0.02 (19) 0.37
nmRec 5.57 	 0.06 (12) 0.51 5.3 	 0.08 (13) 0.49
CaF2 NP 25.4 	 0.2 (15) 0.08 27.61 	 0.17 (15) 0.14
LPa (mRec) 71.6 	 0.7 (6) 0.14 72.3 	 0.7 (8) 0.12
LPb (nmRec) 78.6 	 0.5 (10) 0.08 78.0 	 0.5 (10) 0.08
NP + mRec 28.0 	 0.2 (19) 0.13 29.29 	 0.17 (18) 0.13
NP + nmRec 28.9 	 0.2 (21) 0.17 32.7 	 0.3 (20) 0.16
LP + mRec 74.2 	 2.5 (7) 0.21 77.4 	 0.6 (8) 0.11
LP + nmRec 78.9 	 0.8 (8) 0.08 79.1 	 0.6 (8) 0.08
a Liposomes used in experiments with mRec. b Liposomes used in
experiments with nmRec.
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signicant compared to the myristoylated variant (3.5 nm and
5.1 nm, respectively; see Table 2, Fig. S1D,† 4D and E).
Overall, these ndings suggest that the interaction with CaF2
NPs causes dramatic changes in the secondary and tertiary
structures of bothmRec and nmRec. In particular, our data clearly
show that the myristoyl switch does not occur in the presence of
CaF2 NPs. It is worth noting that the interaction occurs under all
the tested conditions, as proved by: (a) the spectroscopic evidence,
which ensures the presence of onlyminimal amounts of unbound
protein, and (b) the size determination by DLS, which shows
that the thickness of the protein coating on the NP varies between
1.7 nm and 5.1 nm (Table 2), depending on the protein and the
presence or absence of free Ca2+.
Further information as to the structural features of NP-
bound Rec was obtained by limited proteolysis experiments.
Limited proteolysis is a useful tool for detecting protein exi-
bility,34 since the sensitivity to protease digestion diﬀers
signicantly between folded regions and unfolded regions, such
as exible loops. Even for proteins with known structures,
limited proteolysis can provide important information about
folding intermediates.35 The presence or absence of a bound
ligand can aﬀect the susceptibility of a protein segment to
proteases, thus resulting in either increased or decreased
accessibility. Limited proteolysis has been applied to investigate
both the structural eﬀects induced by the binding of small
ligands such as Ca2+ ions36 as well as changes in protein
structure and dynamics upon binding to nanoparticles.16 The
proteolysis patterns of mRec and nmRec in the absence and in
the presence of NPs are shown in Fig. 3A.
Tryptic treatment with 2 mM Ca2+ (lanes 1 and 2) and 2 mM
EGTA (lanes 5 and 6) led to diﬀerent digestion proles for mRec
and nmRec; such a treatment was more eﬀective on nmRec. In
particular, in the presence of 2 mM EGTA (lanes 5 and 6) nmRec
became very sensitive to trypsin digestion, leading to the accu-
mulation of a 15 kDa fragment, while mRec proteolysis was
appreciably slowed down and no lower molecular mass frag-
ments were detected by SDS-PAGE. This could indicate that
exposed sites in the non-myristoylated protein are more pro-
tected in the myristoylated one. In the presence of NPs the
electrophoretic patterns of both nmRec and mRec were char-
acterized by the prevalence of a band with a very high molecular
weight, most likely representing protein–NP complexes, with
only a faint band corresponding to the full length Rec. Under
these conditions the digestion proles of nmRec and mRec are
identical both with Ca2+ (lanes 3 and 4) and EGTA (lanes 7 and
8), supporting our previous conclusion that CaF2 NPs inhibit
the occurrence of the myristoyl-switch of mRec under the
investigated conditions. Proteins are probably “spread” on the
surface of the NP, thus exposing hydrophobic residues in a Ca2+-
independent manner. Moreover, while the presence of NPs
seems to be ineﬀective in mRec proteolysis, it apparently
protects nmRec from proteases in the presence of EGTA. In
particular, for nmRec mixed with particles, only one protein
band was visible with no accumulation of the 15 kDa tryptic
fragment (lanes 6 versus lanes 8), indicating that sites exposed
in the free protein are protected in the NP-bound protein.
The biophysical analysis was completed by the comparison
of the thermal denaturation proles of isolated proteins and
Fig. 3 Analysis of limited proteolysis patterns and thermal denaturation proﬁles of mRec and nmRec in the presence and in the absence of CaF2
NPs. (a) Left: limited proteolysis of mRec in the presence of 2 mM CaCl2 or 2 mM EGTA: undigested (lanes 1 and 5), digested by TPCK–trypsin
1 : 100 (lanes 2 and 6), undigested in the presence of NPs (mRec–NP 200 : 1) (lanes 3 and 7), digested by TPCK–trypsin 1 : 100 in the presence of
NPs (mRec–NP 200 : 1) (lanes 4 and 8). Lane (M) is the protein ladder. Right: identical analysis for nmRec. (b) Thermal denaturation proﬁles of6
mM mRec (left) and nmRec (right) in the presence of equal amounts (46 mM) of EGTA or Ca2+, both with or without incubation with 1 mg mL1
CaF2 NPs. Thermal denaturation was followed by monitoring the ellipticity signal at 208 nm over the 20–96
C temperature range. Quantitative
data obtained by ﬁtting the experimental curve to a sigmoidal function are reported in Table 1.
416 | Nanoscale, 2014, 6, 412–423 This journal is © The Royal Society of Chemistry 2014
Nanoscale Paper
NP–protein complexes in the presence and in the absence of
Ca2+ (Fig. 3B), obtained by heating the system up to 96 C.
Thermal denaturation proles of mRec (Fig. 3B) presented a
typical sigmoidal shape which was satisfactorily tted by a Hill
function (see Methods and ESI†). The melting temperature
increased by about 5.7 C upon binding of Ca2+, indicative of the
typical stabilizing eﬀect of the cation. This value is in partial
disagreement with the results reported by Permyakov et al.31,
who measured by thermal scanning microcalorimetry an
increase of 15 C. The diﬀerent technique employed for scan-
ning as well as the overall conditions might partially explain
such discrepancy. The melting process showed higher cooper-
ativity in the apo-form (Table 1), and far UV-CD spectra recorded
aer cooling down the denatured sample to 25 C showed a
minimal residual structure both in the presence and in the
absence of Ca2+, however the typical secondary structure was
lost (results not shown). Very interestingly, incubation with
CaF2 NPs led to signicantly diﬀerent thermal denaturation
proles (Fig. 3B). Thermal stability turned out to be indepen-
dent of the presence of free Ca2+ and about 7 C lower compared
to the isolated protein in the absence of Ca2+, respectively 13 C
lower in the presence of Ca2+ (Fig. 3B and Table 1). Moreover,
the unfolding process occurred with remarkably higher coop-
erativity (Table 1). A similar result was observed for nmRec
(Fig. 3B and Table 1). Here as well Ca2+ increased the thermal
stability of the unbound protein, but the presence of CaF2 NPs
led to highly cooperative unfolding proles which were
substantially identical to one another, independent of the
presence of free Ca2+. The NP–protein complex was slightly
more stable (DTm  2–3
C) in the case of nmRec compared to
mRec (Table 1). The fact that for both mRec and nmRec the Hill
coeﬃcient was signicantly higher in the presence of NPs
suggests that the structure of the NP-bound protein is less
“conformationally dynamic” compared to the equivalent in
solution, and the thermal denaturation process indeed spans a
narrower range of conformational states resulting in a highly
cooperative transition.
Eﬀects of CaF2 nanoparticles on Rec Ca
2+-sensing
We further investigated whether the binding of Rec to CaF2 NPs
was reversible, that is, if the protein could be released from the
particle surface in the presence of saturating free Ca2+ or in its
complete absence. Fig. 4A–C show the results of our DLS
experiments, in which injections of small volumes of saturating
Ca2+ and/or EGTA were performed in pre-incubated mixtures of
protein and ND. Interestingly, the binding of mRec to the NP
was found to be only partially reversible (Fig. 4A): injection of
saturating Ca2+ followed by injection of saturating EGTA led to a
modest change in hydrodynamic diameter (0.5 nm), which is
however lower compared to the change induced in the NP–
mRec complex by the presence of Ca2+ (1.3 nm). Unlike mRec,
nmRec resulted to be more tightly bound to the NP’s surface
(Fig. 4B): in fact, the same procedure did not lead to a decrease
of the hydrodynamic diameter aer the second injection, but it
rather caused a further increase of the overall size (+0.6 nm). We
point out that from our DLS data it is not possible to clearly
distinguish between variations in the hydrodynamic diameter
solely due to changes in conformation of the bound protein and
changes due to a shied equilibrium between bound and
Fig. 4 Results from dynamic light scattering experiments. (a–c) Reversibility tests for Rec-ND binding monitored by DLS. Plots are reported as
size distributions for each complex. (a) Size proﬁles for 1 mg mL1 CaF2 NPs incubated with 8 mMmRec in the presence of 100 mM EGTA (black
line) and after two subsequent injections leading to 233 mM free Ca2+ (red line) and 222 mMEGTA (blue line). (b) Same conditions as in (a) obtained
for nmRec. (c) Size proﬁles for 20 nM ROS-like liposomes (70 nm diameter) in the presence of 240 mM free Ca2+ (black line), incubated with 27
mM mRec (red line) and after injection leading to 1 mM EGTA (blue line). (d–e) Hydrodynamic diameter measurements of proteins, NDs and
protein–ND complexes and dependence on free Ca2+. (d) Hydrodynamic diameter measured by DLS in the presence of saturating EGTA (left)
and saturating Ca2+ (right); bars stand for standard errors. (e) Eﬀects of free Ca2+ on the size of proteins and protein–ND complexes as measured
by Dd ¼ dCa
2+
 dEGTA. Error bars report on errors calculated by error propagation procedures, LP stands for ROS-like liposomes.
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unbound proteins. The signicantly diﬀerent behaviour
observed by DLS for mRec (Fig. 4A) and nmRec (Fig. 4B) in
contrast with the similar spectroscopic features of the NP-
bound proteins (Fig. 3) suggests that the binding mechanism
is strictly protein-dependent, and the myristoyl moiety plays a
signicant role in allowing binding/release of the NCS from the
NP’s surface.
While informative as to the general behaviour of NP–Rec
complexes in the presence of saturating Ca2+ as well as in its
complete absence, in an “on–oﬀ” fashion, DLS experiments did
not thoroughly probe the residual capability of mRec/nmRec to
act as NCSs in the presence of the NP. We therefore performed
Ca2+ titrations in the nM to mM range and monitored the
intrinsic Trp uorescence of the protein in the presence and in
the absence of CaF2 NPs (Fig. 5). Fluorescence emission at the
wavelength corresponding to the maximum intensity at low
Ca2+ (Flmax) from mRec showed a typical sigmoidal trend
(Fig. 5A), and reached its half-maximal value (KappD ) at 40.9 mM
[Ca2+]. This value is higher compared to the apparent aﬃnity for
Ca2+ of mRec (18 mM (ref. 9 and 10)), which is reasonable since
rather than directly studying the binding process we monitored
the eﬀect of Ca2+-binding on the protein conformation, ulti-
mately responsible for the uorescence signal.
The same reasoning applies to nmRec (Fig. 5B), for which
KappD ¼ 22.1 mM, higher than the apparent aﬃnity for Ca
2+ (KD1¼
0.11 mM, KD2 ¼ 6.9 mM).
9 It is worth noting that, while for mRec
Flmax decreased with increasing [Ca2+], in line with the
augmented hydrophobicity of the Ca2+-bound protein, the
opposite trend was observed for nmRec, thus Flmax increased
with increasing [Ca2+]. This is in line with previous reports.7,8,33
Incubating mRec and nmRec with CaF2 NPs resulted in very
diﬀerent trends for Flmax. Neither form of the protein was able to
respond normally to Ca2+ and remained “blocked” up to high
concentrations ([Ca2+] > 200 mM; Fig. 5A and B). Aer the pro-
longed plateau, Flmax monotonically increased in both cases in a
similar manner, although at high [Ca2+] the change in Flmax was
more apparent for mRec than for nmRec (Fig. 5A and B).
Therefore, in the presence of NPs, the Ca2+-sensing capability of
both mRec and nmRec was highly compromised, suggesting
that both proteins were blocked in a specic conformation up to
relatively high [Ca2+], aer which proteins did partially respond
to Ca2+. The increase in uorescence emission at high concen-
trations of Ca2+ observed for mRec might reect the partial
release of the protein from the NP surface observed in DLS
experiments (Fig. 4A). Overall, this scenario appears fully
compatible with the previous evidence from spectroscopic, DLS
and limited proteolysis experiments.
Eﬀects of ROS-like liposomes on Rec structure and stability
We tested whether completely diﬀerent NDs exerted any struc-
tural and functional eﬀects on Rec by creating nanovesicles with
the same lipid composition as that found in rod-outer segment
(ROS) discs within vertebrate photoreceptors. Far UV-CD
spectra of mRec in the presence of 70 nm liposomes
(Fig. S5A†) were very similar to those of the unbound protein
(Fig. 2A), as shown by comparable q222/q208 ratios observed in
the absence (0.77) and in the presence (0.92) of saturating Ca2+
(Table 1). Despite the noise due to the comparable size of the
liposomes and the wavelength of the incident light, near UV-CD
spectra (Fig. S5B†) were also very similar to those of the
unbound protein, except for minor diﬀerences in the ne
structure observed for the Tyr and Trp bands. Fluorescence
spectra also showed high similarity with respect to the isolated
protein, and a 8 nm red-shi accompanied by intensity
quenching was observed in this case too (Fig. S5C†), although
both maxima were slightly red-shied. Interestingly, DLS
experiments proved that mRec-bound liposomes in the pres-
ence of saturating Ca2+ (Fig. 4C and Table 2) led to a 5.2 nm
Fig. 5 Ca2+-sensing capability of Rec in the presence and in the
absence of CaF2 NPs. Titration experiments were performed in the 27
nM to 980 mM [Ca2+] range by monitoring the intrinsic Trp ﬂuores-
cence emission (lexc¼ 295 nm in all the experiments). (a) Ca
2+ titration
of 0.8 mM mRec isolated (full circles) and incubated with 135 mg mL1
CaF2 NPs (empty circles). Fluorescence emission (F
lmax) was monitored
at lem ¼ 329 nm for the unbound protein and at lem ¼ 336 nm in the
presence of CaF2 NPs. Four replicates were accumulated and results
are shown as average 	 standard deviation. Data points collected for
the unbound protein were ﬁtted according to a Hill function leading to
K
app
D ¼ 40.9 mM and a Hill coeﬃcient H ¼ 2.8. (b) Ca
2+-titration of 0.8
mM nmRec isolated (full circles) and incubated with 135 mg mL1 CaF2
NPs (empty circles). Maximum ﬂuorescence emission was monitored
at lem ¼ 338 nm for the unbound protein and at lem ¼ 339 nm in the
presence of CaF2 NPs. Four replicates were accumulated and results
are shown as average 	 standard deviation. Data points collected for
the unbound protein were ﬁtted according to a Hill function leading to
K
app
D ¼ 22.1 mM and a Hill coeﬃcient H ¼ 2.5.
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increase in the size of the complex, which was almost
completely reversible upon addition of saturating EGTA
(Fig. 4C). In the absence of Ca2+ (i.e. 240 mMEGTA), however, the
size of the complex did not signicantly change within the
experimental error (Table 2), compatible with a very low
propensity of apo mRec to bind liposomes. The situation was
slightly diﬀerent for nmRec, as the presence of ROS-like lipo-
somes did not signicantly alter the secondary structure
(Fig. S5D†), thus resulting in similar q222/q208 ratios as those of
the unbound protein (0.84 in the absence and 0.92 in the
presence of saturating Ca2+, Table 1), while slight changes in
optical activity were observed in the near UV range (Fig. S5E†),
where ne spectral structures appeared corresponding to all
three aromatic bands, both in the presence and in the absence
of saturating Ca2+. On the other hand, the behaviour compa-
rable to that of the unbound protein was observed in the
intrinsic Trp uorescence emission (Fig. S5F†), the main
diﬀerences being a 1 nm instead of 2 nm red-shi and a more
prominent increase of intensity.
The observed diﬀerences are not likely to be due to a stable
binding between nmRec and liposomes, as DLS experiments
could not detect any signicant variation of the hydrodynamic
size of the liposomes in the presence of proteins, independent
of the presence of saturating EGTA or Ca2+ (Table 2 and
Fig. S3†). They are likely due to excluded volume eﬀects and a
balance between long-range electrostatic eﬀects induced by
liposomes and transient contacts between the protein and the
liposome surface.
Overall, these results show that ROS-like liposomes work
as suitable “anchors” for Ca2+-bound mRec, which mimic
biological membranes and unlike CaF2 NPs do not prevent
the protein from functioning as a NCS via the myristoyl
switch mechanism. This interpretation seems to be
completely in line with previous ndings.37 In this respect,
liposomes could be used as suitable carriers for mRec in a
biological context. On the other hand, nmRec did not show
signicant interactions with the liposomes under the tested
conditions.
Fig. 6 Schematic representation of the interaction between mRec and liposomes (top) and CaF2 NPs (bottom). On the left is depicted the
situation at low free Ca2+, while on the right that at saturating Ca2+. Top: the protein (green cartoon) is free in solution in its apo T-state and does
not interact with the liposome. When Ca2+ increases and binds to mRec (right: red spheres represent Ca2+ ions) the myristic group (magenta) is
exposed and serves as an anchor to bind to the liposome surface. The process is fully reversible. Bottom: in the presence of CaF2 NPs, mRec
binds tightly to the particle surface independent of free Ca2+, adopting a new conformation (blue cartoons) that diﬀers from both the T and R
one, and which does not respond to free Ca2+. Only the unbound protein responds normally and may undergo the T to R reversible transition.
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Free Ca2+-dependence of ND-Rec hydrodynamic size
In this work we investigated the interaction of Rec in both its
myristoylated and non-myristoylated forms with two signi-
cantly diﬀerent types of NDs, namely CaF2 NPs and liposomes
with a ROS-like lipid composition. We found that the interac-
tion generally depends on both the presence of post-
translational modication in the protein and the presence or
absence of free Ca2+ in solution. Fig. 4D–E summarize the
results obtained by DLS (Table 2): mRec, whose size increased
by 0.3 nm upon Ca2+ binding (Fig. 4D), apparently binds CaF2
NPs independent of the presence of free Ca2+ in solution as
clearly shown by the increase in the hydrodynamic diameter of
the complex observed both in the presence of Ca2+ and EGTA
(Table 2). The increase in size though depends on the free Ca2+,
being 2.6 nm in the absence of Ca2+, and 1.7 nm increase in the
presence of free Ca2+ in solution. In contrast, nmRec decreased
in size by 0.3 nm upon Ca2+ binding, however when it was
incubated with CaF2 NPs, it increased the hydrodynamic
diameter of the particles by 3.5 nm in the absence of free Ca2+
and by 5.1 nm in the presence of free Ca2+ in solution. Inter-
estingly, free Ca2+ aﬀects the hydrodynamic size of the protein–
ND complex in a protein-specic way (Fig. 4E). High free Ca2+
led to signicantly thicker coating of CaF2 NPs by nmRec
compared to mRec, as clearly assessed by comparing the
diﬀerence in the hydrodynamic diameter (Dd¼ dCa
2+
 dEGTA) of
the NP–protein complex in the presence of Ca2+ and in the
presence of EGTA (Dd ¼ 3.8 nm for nmRec and 1.3 nm for
mRec; Fig. 4E). It is unclear whether this is due to a higher
propensity of nmRec to form aggregates already in solution (see
Fig. S1A†) or, more likely, to a not well-dened surface
phenomenon involving the coating by multiple protein layers.
A diﬀerent situation was observed when proteins were
incubated with ROS-like liposomes. While no signicant inter-
action with nmRec was observed either in the presence or in
the absence of free Ca2+ (Fig. 4E, S3† and Table 2), incubation
with mRec at high free Ca2+ increased the hydrodynamic
diameter of the liposomes by 3.2 nm (Fig. 4E). In the absence
of free Ca2+, however, the hydrodynamic diameter showed
high variance (Table 2 and Fig. 4E) indicative of a more poly-
disperse suspension (Table 2). Overall, this is compatible with a
stabilizing eﬀect of free Ca2+ on liposome–mRec interaction,
which is reected by the signicantly lower polydispersity index
(Table 2).
Conclusion
Our data show that both CaF2 NPs and liposomes interact with
mRec and nmRec, however the interaction strongly depends on
the specic ND. Fig. 6 schematically summarizes our ndings
onmRec. In the absence of free Ca2+ (Fig. 6, top le), most of the
protein is present in solution in its apo-form (T), and does not
interact with the vesicle. Under conditions of saturating Ca2+
however, the myristoyl switch mechanism occurs, thus leading
to the Ca2+-bound form (R) and to the exposure of the myristic
group, which allows the protein to stably bind to the liposome
surface. The extent of binding is directly regulated by the fully
preserved capability of mRec to detect Ca2+, and the association
process can be reversed if the free Ca2+ is chelated (see Fig. 4).
A completely diﬀerent scenario applies to the molecular
process in the presence of CaF2 NPs (Fig. 6, bottom). Upon
incubation with particles, mRec sticks to the NP surface
adopting a conformation (blue cartoons in Fig. 6) that diﬀers
from both the R and T ones. This tight interaction prevents
mRec from functioning as a Ca2+ sensor, at least up to high Ca2+
concentrations (see Fig. 5). However, the NP-bound protein is
not unfolded at all. It rather adopts a new, highly helical
conformation that exposes hydrophobic residues in a manner
that partly resembles the R-form, and the binding is partially
reversible. A similar scheme applies to nmRec in the presence of
CaF2 NPs, but the interaction with CaF2 NPs appears even
tighter and irreversible. Moreover, no signicant interaction
occurs with liposomes.
In conclusion, liposomes could be used as suitable surface
carriers of mRec in a biological context to preserve the protein
structure and functional properties. On the other hand, CaF2
NPs seem to induce a diﬀerent conformation to the protein,
stabilizing a state that is greatly independent of the levels of free
Ca2+ and suggesting a direct interaction between the Ca2+-
binding motifs of the protein and the CaF2 matrix, which seems
to be the case both for mRec and nmRec. The specic mode of
interaction is currently unknown, and together with the novel
biological functions, it will be the object of future studies.
Experimental
Protein expression and purication
Myristoylated and nonmyristoylated Rec were expressed essen-
tially as reported,10,38 with some modications elucidated in the
ESI.†
Nanoparticle synthesis, structural and spectroscopic
characterization
The synthesis procedure of lanthanide doped CaF2 NPs was
similar to the method developed by some of us.29 Details are
provided in the ESI.†
Preparation of liposomes
Liposomes were prepared as described previously10 and is
reported in the ESI.†
Limited proteolysis
26.5 mg of nmRec or mRec were mixed with nanoparticles (Rec–
NP 200 : 1) in 5 mM Tris–HCl pH 7.5, 150 mM KCl, 1 mM DTT
and 2 mM CaCl2 or 2 mM EGTA and incubated for 1 h at 25
C.
Particle–protein mixtures were treated with TPCK–trypsin
1 : 100 (w/w). For each protein a control sample without any
protease was studied in parallel. Aer 30 minutes the digestion
reaction was stopped by rapid addition of reducing sample
buﬀer and boiling for 5 min. Then, proteolysis pattern was
visualized by SDS-PAGE on a 15% gel and Coomassie blue
staining.
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Dynamic light scattering experiments
DLS measurements were performed with a Zetasizer Nano-S
(Malvern Instruments) using a polystyrene low volume dispos-
able sizing cuvette (ZEN0112). Viscosity and refractive index
were set to be 0.8872 cP and 1.330 (default values for water), the
temperature was set to 25 C with 2 min equilibration time. The
measurement angle was 173 backscatter and the analysis
model was set to multiple narrow modes. For each measure-
ment a minimum of 7 determinations were performed, each
consisting of 13–15 repetitions. Buﬀers (5 mM Tris–HCl, 150
mM KCl pH ¼ 7.5, adjusted with CaCl2 or EGTA), were ltered
through a Jet Biolm 0.22 mm membrane, while protein-only
solutions were ltered through an Anotop 10 lter (Whatman,
0.02 mm).
Circular dichroism spectroscopy and thermal denaturation
proles
Circular dichroism (CD) spectroscopy studies were performed
with a Jasco V-710 spectropolarimeter equipped with a Peltier
type thermostatted cell holder. Both near-UV (250–320 nm) and
far-UV spectra (200–250 nm) were recorded at 25 C at a scan
rate of 50 nm min1, a bandwidth of 1 nm and an integration
time of 4 s. Five spectra accumulations were averaged for each
sample, and the spectrum of the buﬀer (with or without NP or
liposomes) was considered as a blank and subtracted. For
recording far-UV spectra the protein concentration was 5–7 mM
in 0.1 cm cuvettes, while for near-UV spectra it was 29–32 mM in
1 cm cuvettes. Far-UV spectra were recorded in the presence of
either 45–50 mM EGTA or Ca2+ while near-UV spectra were
recorded in the presence of either 230 mM EGTA or Ca2+.
Thermal denaturation of Rec both isolated and in the pres-
ence of CaF2 NPs was monitored between 20
C and 96 C using
the same conditions and concentration range as for the far-UV
spectra measurements. The ellipticity signal at 208 nm (q208)
was recorded at a scan rate of 1C min1 and a response time of
4 s, using a 0.1 cm quartz cuvette. Thermally denatured samples
were cooled down to 25 C and, aer 5–15 min, a far-UV CD
spectrum was recorded to check for residual structures (results
not shown).
The analysis of thermal denaturation curves was performed
for each sample assuming a two-state transition process. By
monitoring q208 as a function of the temperature it was possible
to quantitatively describe the fraction of folded and unfolded
protein under diﬀerent conditions. No complete unfolding was
achieved for Rec under any experimental condition, as shown by
the residual CD signal aer thermal denaturation. Data were
tted according to two functions, one accounting for the vari-
ation of the Gibbs free energy (see ref. 12, results not shown),
and another one consisting of a 4-parameter Hill sigmoid:
y ¼ bn þ
jbn  bujT
H
Tm
H þ TH
(1)
where bn is the baseline value (q208) of the native protein, bu is
the baseline value of the unfolded protein, T is the temperature,
H is the Hill coeﬃcient and Tm is the melting temperature.
Results from the two tting procedures were comparable in
terms of Tm and eqn (1) was used throughout this work for
quantitative comparisons.
Fluorescence spectroscopy and Ca2+-titrations
The emission uorescence spectra were recorded between 300
and 380 nm at 25 C in 1 cm quartz cuvette using a Jasco FP-750
spectrouorimeter, aer excitation at 290 nm, at a scan rate of
60 nm min1. The excitation and emission bandwidth were set
to 5 nm. The collected data were obtained by subtracting the
signal of NPs or liposomes to an average of three accumula-
tions. The protein concentration for all uorescence spectra
measurements was 1 mM in the presence of 6 mM EGTA or
Ca2+.
Ca2+ buﬀers used in uorescence titration experiments were
prepared as described previously.39 The solutions used for the
uorescence titration experiments were: (1) carefully decalcied
5 mM Tris–HCl 150 mM KCl pH ¼ 7.5; (2) CaCl2 at variable
concentrations; and (3) 1 mM EGTA, whose pH was adjusted to
7.5 by addition of KOH. Free Ca2+ concentration for each titra-
tion point was calculated according to the Ca–EGTA NIST so-
ware (http://www.maxchelator.stanford.edu/CaEGTA-NIST.htm),
by xing T ¼ 25 C, pH ¼ 7.5 and ionic strength ¼ 0.15 M. By
mixing the three solutions, the nal Ca2+ concentration for each
point was varied in the 27 nM to 980 mM range. In each titration
experiment the protein concentration was 0.8 mM while that of
NPs was 135 mg mL1. Ca2+ titration experiments were performed
by monitoring the maximal Trp uorescence emission (lex ¼
295 nm) at the lowest free Ca2+ concentration (27 nM), which is
expected to change according to the increasing saturation of the
protein by Ca2+. The corresponding lmax values in every case are
reported in Fig. 6.
Estimation of the size-dependent protein coverage of the ND
surface and concentration adjustments
The maximum number of proteins bound to each ND depends
on the total surface accessible to proteins and on the fraction of
the ND surface occupied by a bound protein. Based on the
simplest geometric model of interaction and considering all the
objects as rigid spheres, themaximal stoichiometric protein–NP
ratio to ensure a minimal presence of unbound proteins in
solution is:
NmaxRec ¼
4pðrND þ rRecÞ
2
prRec2
(2)
where NmaxRec is the maximum number of Rec molecules that can
occupy the surface of the ND, rND is the radius of the ND and
rRec is the radius of Rec. In other words, the geometric problem
is that of occupying the augmented surface area of a sphere by
NmaxRec circles, each of area prRec
2.
Also, assuming that the density of CaF2 NPs is equal to that
of bulk CaF2 (r ¼ 3.18 g cm
3), the molecular weight of CaF2
NPs (NP in eqn (3)) was calculated as follows:
MWNP ¼
4prNP
3
3
rCaF2NA (3)
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For example, in the presence of NPs of 30 nm diameter,
NmaxRec ¼ 244 and the molecular weight of CaF2 NPs is 27 
 10
6 g
mol1. For near UV CD spectra with a reasonable signal-to-noise
ratio, approximately 30 mM (0.7 mg mL1) Rec is required, so
that 0.12 mM is the concentration of saturating CaF2NPs (3.2 mg
mL1) that, under the maximal binding geometric assumption,
guarantees to keep the amount of free Rec low.
Liposomes diﬀer from NPs in terms of geometrical proper-
ties, as the former can be modeled as a spherical bilayer of
thickness h whereas the latter can be modeled as a full sphere.
The molecular weight of lipids making the ROS-like liposomes
(MWROS¼ 756.725 Da) was calculated using a weighted mean of
the molecular weight of each lipid (MWPC ¼ 790.2 Da, MWPE ¼
748.1 Da, MWPS¼ 814.1 Da, MWCho¼ 386.7 Da). The number of
lipid molecules in a unilamellar liposome is given by:
Ntot ¼
4p

d
2
 2
þ 4p

d
2
 h
 2
a
(4)
where d is the diameter of the liposome, h is the thickness of the
bilayer (5 nm) and a is the head group area of a lipid molecule.
Assuming that the head group area of the ROS-like lipid mixture
is equal to that of PC (0.71 nm2), the molar concentration of
liposomes that can be obtained when rehydrating a certain
amount of lipids in a specic volume of aqueous buﬀer (clipid in
mg mL1) is:
MLP ¼
clipid
NtotMWROS
(5)
Thus, if 2 mg lipids are rehydrated in 2.6 mL aqueous buﬀer,
the molar concentration MLP of liposomes expected is 20 nM.
Knowing theMLP allows the determination of the stoichiometric
relationship between liposomes and dissolved Rec, under the
assumption of maximal geometric binding. The maximum
number of Rec bound to 80 nm liposomes is NmaxRec ¼ 1471 (see
eqn (2)), therefore the maximum concentration of Rec bound to
a suspension of 0.77 mg mL1 liposomes is 29.4 mM. Since the
hydrodynamic diameter of liposomes varied between 70 and 80
nm, in order to ensure stoichiometric excess of protein binding
sites on ROS-like liposomes over free, unbound Rec, 0.77 mg
mL1 liposomes and 25 mM Rec concentration were chosen for
DLS and near UV spectra measurements, whereas a 1 : 5 dilu-
tion was chosen for recording far UV spectra (0.15 mg mL1 LP
and 5 mM Rec) and a 1 : 80 dilution was chosen for recording
uorescence spectra (0.18 mg mL1 LP and 0.3 mM Rec).
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Structural plasticity of calmodulin on the
surface of CaF2 nanoparticles preserves its
biological function†
Alessandra Astegno,*a Elena Maresi,a Valerio Marino,b Paola Dominici,a
Marco Pedroni,a Fabio Piccinellia and Daniele Dell’Orco*b
Nanoparticles are increasingly used in biomedical applications and are especially attractive as biocompati-
ble and biodegradable protein delivery systems. Herein, the interaction between biocompatible 25 nm
CaF2 nanoparticles and the ubiquitous calcium sensor calmodulin has been investigated in order to
assess the potential of these particles to serve as suitable surface protein carriers. Calmodulin is a multi-
functional messenger protein that activates a wide variety of signaling pathways in eukaryotic cells by
changing its conformation in a calcium-dependent manner. Isothermal titration calorimetry and circular
dichroism studies have shown that the interaction between calmodulin and CaF2 nanoparticles occurs
with physiologically relevant aﬃnity and that the binding process is fully reversible, occurring without sig-
niﬁcant alterations in protein secondary and tertiary structures. Experiments performed with a mutant
form of calmodulin having an impaired Ca2+-binding ability in the C-terminal lobe suggest that the
EF-hand Ca2+-binding motifs are directly involved in the binding of calmodulin to the CaF2 matrix. The
residual capability of nanoparticle-bound calmodulin to function as a calcium sensor protein, binding to
and altering the activity of a target protein, was successfully probed by biochemical assays. Even if
eﬃciently carried by CaF2 nanoparticles, calmodulin may dissociate, thus retaining the ability to bind the
peptide encompassing the putative C-terminal calmodulin-binding domain of glutamate decarboxylase
and activate the enzyme. We conclude that the high ﬂexibility and structural plasticity of calmodulin are
responsible for the preservation of its function when bound in high amounts to a nanoparticle surface.
Introduction
Calcium (Ca2+) is a ubiquitous intracellular messenger respon-
sible for controlling numerous cellular processes in a wide
range of organisms.1 Cells respond to an extra-cellular stimu-
lus by a transient change in intracellular Ca2+ concentration
which, in turn, is sensed by an array of Ca2+-binding proteins
or Ca2+-sensors that are able to adapt their shape so as to
recognize their molecular partners.2 Among these, calmodulin
(CaM) is probably the most prototypical member, which acts
as a Ca2+ messenger in all eukaryotic cells, recognizing more
than 300 diﬀerent protein partners involved in various funda-
mental biological mechanisms3,4 such as cell motility, cyto-
skeleton architecture and function, growth, proliferation,
metabolic homeostasis, ion transport, protein folding, and
apoptosis. CaM is a small (∼17 kDa), highly conserved, acidic
protein with two globular domains (N- and C-domains or
lobes) connected by a flexible spacer.5 Each domain contains a
pair of Ca2+-binding motifs called EF-hands and binds two
Ca2+ ions in a cooperative manner. The apparent aﬃnity of
CaM for Ca2+ is in the range of 10−6–10−7 M and can increase
in the presence of the target protein.6 Notably, the N- and C-
lobes diﬀer in their aﬃnity for Ca2+, showing an apparent Kd
of approximately 10 μM and 1 μM, respectively,7,8 and adopt
diﬀerent conformations depending on the presence of Ca2+. In
the absence of Ca2+, the two lobes adopt a closed confor-
mation formed by a bundle of helices that are packed against
each other, and most of the hydrophobic residues are shielded
from the solvent.9 Ca2+ binding to each globular domain leads
to substantial alterations in the interhelical angles within the
EF-hands to produce a more open conformation.10 This results
in the exposure of hydrophobic sites that bind to and activate
a large number of target proteins. CaM displays a high degree
of conformational plasticity, both at the level of individual
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and figures. See DOI: 10.1039/c4nr04368e
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amino acid side chains and of the orientation of entire
domains, allowing for target proteins to evolve specific
modes of CaM interaction and regulation during Ca2+
sensing.11,12
In the last few years, the central role of CaM and diﬀerent
Ca2+/CaM-dependent systems in controlling several physiologi-
cal processes and disease-associated conditions has clearly
emerged. Altered CaM-dependent cell cycle regulation and
proliferation have been described in tumor cells, and targeting
of CaM and/or CaM-dependent systems has been considered
a valid strategy for therapeutic intervention in cancer.13 More-
over, recently discovered CaM point mutations associated with
arrhythmogenic human pathologies14 and the recent finding
that CaM levels are significantly increased in Alzheimer’s
disease15 suggest that several physiological conditions and dis-
eases other than cancer may involve Ca2+/CaM messenger
systems, thus highlighting the importance of CaM as a target
for new therapeutic approaches.
As one of the developing areas of nanomedicine, increasing
interest has been dedicated to nanoparticle (NP) systems as
carriers for protein delivery. NPs are expected to oﬀer several
advantages over more traditional devices, such as improved
protein stability, protection from proteases, cell targeting, and
bioavailability. Moreover, nanodevices are small enough to
enter almost all areas of the body, including cells and orga-
nelles, potentially leading to a new approach to medicine.16
Our group has previously investigated the possibility to use
CaF2 NPs as suitable carriers of Ca
2+-sensor proteins, analyz-
ing the interaction between the prototypical neuronal calcium
sensor recoverin and the nanodevices.17 CaF2 NPs are easily
obtained by means of a straightforward synthetic protocol and
were found to be biocompatible, showing no evidence of tox-
icity in experiments performed on HeLa and mesenchymal
cells.18 Moreover, CaF2 NPs doped with suitable trivalent rare
earth ions are eﬃcient luminescent nano-probes, a feature
that could be conveniently exploited for various bioimaging
applications.18
CaF2 NPs were found to significantly alter the structural
and functional properties of recoverin and decrease its
sensitivity to free Ca2+, thus suggesting novel biological func-
tions induced by the particle. These novel features seem to be
related to the nature of these particles, which are constituted
by a CaF2 matrix that could be specifically recognized by the
Ca2+-sensor protein.
In order to devise a carrier system with broad biomedical or
biotechnological applicability, it is important that surface-
bound proteins retain their structural and functional pro-
perties. In this work, the suitability of CaF2 NPs as nano-
carriers of a model Ca2+-sensor protein, namely the calmodulin
isoform 1 (CaM1) from A. thaliana, has been investigated. For
this purpose, as a direct probe of the biological functionality
of the CaM–NP complex, the pyridoxal 5-phosphate (PLP)-
dependent enzyme glutamate decarboxylase (Gad1) was used,
which catalyzes the α-decarboxylation of L-glutamate to
γ-aminobutyrate (GABA). A unique feature of plant Gad is the
presence of a CaM-binding domain at its C-terminus, making
it the best characterized metabolic enzyme regulated by Ca2+/
CaM in plants.
In this work, it was found that the binding of CaM1 to CaF2
NPs is fully reversible and occurs with physiologically-relevant
aﬃnity. Using site-specific mutagenesis, we investigated the
role of EF-hand motifs as possible sites for CaM1–NP inter-
action, and the eﬀect of NPs on the Gad1–CaM1 complex
activity and spectral properties has been evaluated.
Results and discussion
To investigate the interaction between CaM1 and NPs and its
eﬀect on Gad1 activation, the recombinant protein corres-
ponding to CaM1, which represents the canonical CaM
isoform, was utilized. The primary structure of A. thaliana
CaM1 is highly conserved among plant CaMs identified in
Hordeum vulgare, Medicago sativa, and Petunia hybrida, as well
as very similar to those found in mammals (89% identity to
vertebrate CaMs). Moreover, the canonical 12-amino acid loop
of the CaM EF-hand motif, which binds Ca2+ with a pentago-
nal bipyramidal geometry including seven coordination sites,
is strongly conserved (Fig. 1a and b). This conservation
between plant and animal CaMs is not surprising since CaM is
thought to be essential for eukaryotic cell function. A major
diﬀerence in the primary structure with mammalian CaMs is
the presence in plant CaMs of a cysteine residue at position
seven in the 12-amino acid loop of the first EF-hand.
The synthesized CaF2 NPs possess the fluorite-like crystal
structure. They crystallize with a cubic structure of 5.46 Å unit
cell length.19 Each Ca2+ ion is surrounded by eight fluoride
anions (as depicted in Fig. 1c for the red colored Ca2+ ion) and
each fluoride anion is surrounded by four Ca2+ ions. Within
the unit cell there are four Ca2+ and eight F− ions and the dis-
tance between two nearest neighbour Ca2+ ions is 3.86 Å. As
the CaF2 NPs are capped with the citrate anion, several Ca
2+
ions on the surface of the material are bound both to the
fluoride anions and to the carboxylic group of the capping
agent.
Thermodynamics of CaM1–NP interaction
Isothermal titration calorimetry (ITC) was used to investigate
the aﬃnity and thermodynamic parameters that accompany
the binding of CaM1 to NPs. Raw data of CaM1-binding to
CaF2 NPs at 25 °C are shown in Fig. 2. The subsequent
addition of CaM1 to CaF2 NPs results in a pattern of exother-
mic binding spikes, characterized by the thermodynamic para-
meters shown in Table 1. The exothermicity of calorimetry
peaks is believed to be due to the strong interaction between
NPs and the protein. The data fitted well to a single process.
Thus, interprotein interaction is not involved in binding and
protein association appears to occur without any significant
degree of cooperativity. The association constant was esti-
mated to be ∼4.9 × 105 M−1, corresponding to an apparent
aﬃnity of ∼2 μM. The binding of CaM1 to NPs appears to be
an enthalpically driven process, with the large, favorable value
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of the ΔH term that dominates over ΔS, thus suggesting that
polar interactions are primarily responsible for CaM1–NP
binding. The complete saturation of heat signal was observed
at a CaM1 to NP molar ratio of ∼120, which is consistent with
the theoretical maximum number of bound CaM1 of ∼144 for
a ∼25 nm diameter NP obtained by a previously described17
simple geometric model of CaM1–NP interaction, where all
objects are considered to be rigid spheres.
The parameter values obtained from the fitting process
were only marginally aﬀected by subtraction of the blank titra-
tion (CaM1 into buﬀer), and the reported values are without
subtraction as the total concentration of CaM1 in the blank
titration does not correspond to the free concentration of
CaM1 obtained in the particle-binding experiments.
Ca2+-dependent structural changes in CaM1 in the presence
and absence of NPs
The shape of the far-UV CD spectrum (250–200 nm) of CaM1
from A. thaliana is very similar to that of bovine CaM for both
the Ca2+-free (apo) and Ca2+-saturated (holo) forms20,21
(Fig. 3a). This indicates that the overall secondary structure
content of the two CaMs is very similar, which is expected
given the very high sequence identity between the two pro-
teins. The far-UV CD spectra of both the apo- and holo-forms
have two minima at 208 and 222 nm indicating that the
protein contains substantial α-helical structure. In the pres-
ence of saturating concentrations of Ca2+, a major confor-
mational change takes place causing an increase in the
negative bands at 208 and 222 nm leading to a switch in the
θ222/θ208 ratio from 0.91 in the apo-form to 0.94 in the Ca
2+-
bound form (Table 2). In the literature, this change has been
explained as an increase in the α-helical content, due to re-
orientation/distortion of the α-helices22 or a change in protein
compactness upon Ca2+ binding.23 The latter suggestion is
Fig. 1 Structural details of CaM1 from A. thaliana and of CaF2 NPs. (a) Cartoon representation superimposed in transparency to the molecular
surface representation highlights the typical architecture of CaM. The N-term lobe is shown in light orange, the linker region in light green, and the
C-terminal lobe in light blue. The four Ca2+ ions, each bound to an EF-hand motif, are represented by red spheres while the unique Tyr residue
(Y139) is represented by magenta sticks. (b) Close-up of the coordination of two Ca2+ ions (red spheres) at the C-terminal domain by ﬁve oxygens
from carboxylic groups of acidic residues in each EF-hand motif (represented by sticks), a backbone carbonyl oxygen (represented by sticks) and a
water molecule (not shown). The two Glu residues providing bidentate ligands and the target of mutagenesis (E105 and E141) are shown in yellow,
and Tyr139 is represented by magenta sticks. Secondary structure elements from the C-terminal domain are represented by gray cartoons, while the
visible portion of the linker region is represented by light green cartoons. (c) Detail of the CaF2 unit cell: for the red colored Ca
2+ ion the full coordi-
nation environment is shown. The ﬁgure was prepared with the software PyMol (The PyMOL Molecular Graphics System, Version 1.5.0.4,
Schrödinger, LLC (a and b)) and the Mercury computer program for crystal structure visualisation, provided by CCDC (c).
Fig. 2 ITC data for CaM1 in solution with CaF2 NPs in decalciﬁed 5 mM
Tris-HCl and 150 mM KCl, pH 7.5, at 25 °C. The particle concentration in
the cell (0.2 mL) was 240 nM, and the protein concentration in the
syringe was 190 μM. The upper panel shows the raw data, and the
bottom panel shows the plot of heat ﬂow per mole of titrant (CaM1)
versus the molar ratio (CaM1 : NP) at each injection together with a ﬁt
using a one-site binding model.
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consistent with NMR data comparing apo- and holo-CaM,
showing that the α-helical contents of the two states are
similar.10 It is also compatible with recent surface plasmon
resonance studies24 that showed variations in the compactness
of CaM upon Ca2+ binding.
Thermal denaturation of CaM1 was further investigated by
ramping the temperature from 20 °C to 96 °C at a rate of 1 °C
min−1 and monitoring the ellipticity signal at 208 nm (θ208).
Under these conditions, apo-CaM1 is denatured at 60 °C and
above. As already reported in ref. 25 addition of Ca2+ leads to
stabilization of the structure of CaM1 where even at 90 °C,
the protein retains evidence of a partially folded state
(see Fig. S1†). Interestingly, incubation with CaF2 NPs yielded
thermal denaturation profiles that were very similar to one
another independent of the presence of free Ca2+ and to the
isolated protein profile in the presence of Ca2+ (Fig. S1†).
Fig. 3b shows the near-UV CD spectra of CaM1 in the apo-
form and in the presence of added Ca2+. CD spectroscopy in
the near-UV region (320–250 nm) allows monitoring the asym-
metric environment of aromatic residues, which was observed
to change significantly upon Ca2+-binding. A. thaliana CaM1
contains no tryptophan, nine phenylalanine residues, and a
single tyrosine, which lies at position 139 in the “loop” of
Ca2+-binding site 4 (Fig. 1).
Fig. 3 Far- and near-UV CD spectra of CaM1 in the presence and absence of CaF2 NPs. All measurements were performed at 25 °C in 5 mM Tris-
HCl, pH 7.5, and 150 mM KCl buﬀer. (a) and (c) Far-UV CD spectra of 12 μM CaM1 in the presence of 1 mM Ca2+ or 1 mM EGTA, alone (a) and incu-
bated (c) with 1.4 mg mL−1 CaF2 NPs. (b) and (d) Near-UV CD spectra of 60 μM CaM1 in the presence of 1 mM Ca
2+, or 1 mM and 5 mM EGTA alone
(b) and incubated (d) with 7 mg mL−1 CaF2 NPs.
Table 2 The θ222/θ208 ratio of CaM1 in the absence and presence of
NPs
θ208 (mdeg) θ222 (mdeg) θ222/θ208
CaM1 −29.23 −26.67 0.91
CaM1 + Ca2+ −30.39 −28.50 0.94
NP + CaM1 −30.56 −28.82 0.94
NP + CaM1 + Ca2+ −30.44 −28.43 0.93
NP + CaM1 + EGTA −28.00 −25.48 0.91
Table 1 Thermodynamics parameters involved in the binding between CaM1 and CaF2 NPs, derived from ITC measurements
a
KA
(105 M−1)
ΔH
(kcal mol−1) Stoichiometry
ΔS (cal
mol−1 K−1)
ΔG° (kcal
mol−1) n
CaM1 : NPs 4.9 ± 0.5 −21.72 ± 5.39 28.29 ± 3.61 −47.77 ± 18.97 −7.76 ± 0.06 6
aWeighted average and standard deviations are from nmeasurements. The ΔS and the ΔG° values were calculated from ΔH − TΔS = −RT ln KA.
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As observed for other CaMs,26 the prominent decrease in
ellipticity at 262 and 268 nm upon Ca2+ binding, as well as the
shoulder at 255 nm, is attributed to phenylalanine residues
that are equally distributed in the N (5) and C (4) domains.
The broad unresolved negative band above 273 nm in the Ca2+-
saturated protein can be attributed to the single tyrosine
residue in the C-terminal half of the molecule. Metal binding
causes a sign inversion of the dichroic signal previously
observed also in Neurospora CaM,27 spinach CaM,28 zucchini
CaM,29 and Drosophila melanogaster CaM,26 which all possess
only one tyrosine residue. In the presence of EGTA, both near-
and far-UV CD spectra of CaM1 were identical to that of apo-
CaM1, confirming the high level of both protein and buﬀer
decalcification (data not shown).
Far- and near-UV CD spectroscopy was also used to deter-
mine whether the same structural changes occurred upon
CaM1–NP interaction (Fig. 3c and d). In the far-UV, CD spectra
are more negative in the presence of NPs and become almost
indistinguishable in shape and intensity from those of the
Ca2+-saturated free protein (see Fig. 3a). The spectra showed a
very similar shape for NP-bound CaM1, independently of the
presence of free Ca2+, as quantitatively demonstrated by the
same θ222/θ208 ratio (0.94 versus 0.93 respectively, Table 2). This
value is identical to that observed for the Ca2+-bound form of
CaM1 (0.94, Table 2). Thus, NPs induced the protein to
acquire a Ca2+ like conformation. Interestingly, upon removal
of free calcium by EGTA, the spectrum showed a shape that
was very similar to that of Ca2+-free CaM1, as is evident from
the identical θ222/θ208 ratio (0.91 in both cases, Table 2). This
suggests that the binding of CaM1 to NPs, both in the pres-
ence and absence of Ca2+, is almost completely reversible
upon addition of saturating concentrations of EGTA. Reversi-
bility of the association between CaM1 and NPs was further
demonstrated by dynamic light scattering (DLS) experiments
in the presence of saturating concentrations of Ca2+ and EGTA
(Fig. S2†).
Along the same lines, near-UV CD spectra in the presence
of CaF2 NPs were very similar to those of the Ca
2+-bound
protein, and upon addition of EGTA a behavior comparable to
that of the apo-protein was observed (Fig. 3d). We used 5 mM
EGTA for the near-UV spectra to maintain the same excess of
EGTA over CaM1 used in the far-UV experiments (∼83-fold
excess). All these data seem to suggest that the interaction
between the CaF2 matrix and CaM1 is mediated by the same
CaM1 Ca2+-binding sites involved in the binding of free Ca2+
ions to the unbound protein.
Role of C-terminal domain Ca2+ binding sites in CaM1–NP
interactions
To investigate whether EF-hand motifs are directly involved in
the binding of CaM1 to CaF2 NPs, a CaM1 mutant was pre-
pared with a Ca2+ binding capacity limited to the N-lobe by
substituting the negatively charged glutamate residues at posi-
tion 12 (Glu105 and Glu141) in both the EF-hand motifs at the
C-terminal domain to neutral glutamine residues. Sequence
comparisons of EF-hand Ca2+-binding sites from other pro-
teins reveal that the glutamate at position 12 is one of the
most conserved residues within the EF-hand motif.30 The carb-
oxylate group of this residue is unique as it provides two
ligands for the Ca2+ ion, suggesting a critical role in Ca2+-
binding (Fig. 1). It was decided to remove the Ca2+ binding
sites at the C-terminal domain, since in mammalian CaM1
Ca2+-binding aﬃnities are diﬀerent for the N- and C-terminal
lobes, with the latter having a 3- to 10-fold higher aﬃnity for
Ca2+. The residual capability of the mutant protein to interact
with NPs was further probed by CD spectroscopy. Interestingly,
the spectra of the isolated mutant did not show the Ca2+
induced changes in the near-UV region typical of the wild-type
(wt) protein. Indeed, when treated with the same amount of
Ca2+ and EGTA used for the wt, the CaM1 variant exhibited CD
spectra that were identical both in shape and intensity
(Fig. 4a). Moreover, in the presence of NPs the near-UV spectra
were very similar to those of the protein in the absence of NPs,
both with saturating concentrations of Ca2+ and EGTA
(Fig. 4b). Taken together, this suggests that there is a direct
interaction between the Ca2+-binding motifs of the protein and
the CaF2 matrix. However, the absence of significant variations
in the CD spectra of the mutant in the absence and presence
of NPs can be ascribed to either a weaker interaction between
the mutant protein and the NP compared to the wt protein, to
Fig. 4 Near-UV CD spectra of CaM1 EE105-141QQ double mutant. Near-UV CD spectra of 60 μM CaM1 mutant in the presence of 1 mM Ca2+ or
1 mM EGTA alone (a) and incubated (b) with 7 mg mL−1 CaF2 NPs.
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a minor conformational change in the tertiary structure of
the mutant upon Ca2+-binding, or both. ITC data (Fig. S3†)
support the former hypothesis, as addition of the CaM1
mutant to CaF2 NPs under the same experimental conditions
used for the wt protein (see Fig. 2) exhibited a profile that was
not ascribable to a binding event in terms of both heat change
and signal intensity.
The high aﬃnity of CaM1 for the CaF2 NPs may be partly
explained by the high local concentration of the Ca2+ ion
(∼41 M, within the crystal, see Supplementary methods in
ESI†). Presumably, upon interaction between CaM1 and CaF2
NPs, the capping agent is replaced by the donating groups of
the protein. This hypothesis is supported by our previous
study, in which the same type of NPs were shown to bind reco-
verin despite the presence of citrate as a capping agent.17 In
particular, the geometric environment of the Ca2+ ions on the
surface, involved in the bond with CaM1, should be consti-
tuted by several donating oxygen atoms from the residues of
the EF-hand motif and by several fluoride anions from the
fluorite matrix.
Binding of CaM1 to Gad1 CaM binding domain (CBD) peptide
Since Gad1 is a CaM-binding protein, comparing the capacity
of CaM1 to interact with Gad1 binding domain (CBD) in the
presence and absence of NPs would be informative regarding
the residual ability of NP-bound CaM1 to bind to its target.
The ability of CaM1 to bind the Gad1 CBD was thus assessed
by CD spectroscopy. Previous small-angle X-ray scattering
(SAXS) analysis demonstrated a 1 : 2 CaM1 : peptide stoichi-
ometry for the interaction,31 and the binding of the CBD
peptide to CaM1 in the presence of Ca2+ was thus investigated
under the same conditions.
It has been established that CaM-binding peptides adopt
an amphipathic helix conformation when binding to Ca2+-
saturated CaM1.32–34 As shown in Fig. 5, the far-UV CD
spectrum of the isolated CBD peptide in the presence of Ca2+
suggests that the peptide was not folded in a distinct structure
(Fig. 5a). When the peptide was incubated with CaM1,
however, the interaction led to significant structural rearrange-
ments of both CBD and CaM1 (Fig. 5a and Table 3). An
intense dichroic signal with two negative peaks at 208 and
222 nm was observed (Fig. 5a, green line), suggesting that
upon interaction with CaM1 the peptide adopted the typical
α-helical conformation observed with other interacting
peptides. Interestingly, the intensity of the signal arising
from CaM1 also increased upon interaction with the peptide
(Fig. 5a, red line, and Table 3), indicating that a helical fold
with increased ellipticity distinguished the formation of the
Fig. 5 Far- and near-UV CD spectra of CaM1, CBD peptide and CaM1–CBD complex in the presence of Ca2+ with and without CaF2 NPs. All
measurements were performed at 25 °C in 5 mM Tris-HCl, pH 7.5, and 150 mM KCl buﬀer. (a) and (b) Far-UV CD spectra of 12 μM CaM1 and 24 μM
peptide in the presence of 1 mM Ca2+, alone (a) and incubated (b) with 1.4 mg mL−1 CaF2 NPs. (c) and (d) Near-UV CD spectra of 60 μM CaM1 and
120 μM peptide in the presence of 1 mM Ca2+, alone (c) and incubated (d) with 7 mg mL−1 CaF2 NPs.
Paper Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2014
P
u
b
li
sh
ed
 o
n
 1
3
 O
ct
o
b
er
 2
0
1
4
. 
D
o
w
n
lo
ad
ed
 b
y
 I
n
st
it
u
t 
n
at
io
n
al
e 
d
e 
la
 r
ec
h
er
ch
e 
sc
ie
n
ti
fi
q
u
e 
(I
N
R
S
) 
o
n
 0
5
/1
1
/2
0
1
4
 1
4
:1
0
:0
2
. 
View Article Online
complex as compared to individual spectra of CaM and CBD.
Moreover, the shape of the spectra referring to the complex
also diﬀered from that of the individual components, as
demonstrated by the θ222/θ208 ratio, which for CaM1 increased
from 0.94 (Table 2) to 0.98 (Table 3) in the presence of the
CBD peptide and Ca2+, approaching the ∼1.02 values observed
for coiled-coil motifs.35,36 Such a value was fully reached for
the spectra obtained by subtracting: (i) the spectrum of the
CaM1 alone from that in complex with CBD peptide (Fig. 5a,
green line; θ222/θ208 = 1.13, Table 3); (ii) the spectrum of CBD
peptide alone from that in complex with CaM1 (Fig. 5a, red
line; θ222/θ208 = 1.03, Table 3). Thus, the binding between
CaM1 and the CBD peptide induced a tight interaction
between the constituting α-helices, which in certain regions
may coil together like the strands of a rope. It should be
noticed that the same experiments performed in the absence
of free Ca2+ led to similar results, with lower spectral intensi-
ties (Table 3), indicating a substantial role of free Ca2+ in facili-
tating and stabilizing the interaction between CaM1 and the
CBD peptide (Fig. S4†). Indeed, we cannot exclude that resus-
pension of lyophilized peptides induced a small but signifi-
cant contamination with free Ca2+.
Results from near-UV CD spectroscopy are in agreement
with those in the far-UV (Fig. 5c). The CBD peptide, either in
the presence or absence of Ca2+, did not show a well defined
tertiary structure (green and pink curves); however, when the
peptide was incubated with CaM1 the interaction became
apparent even in the absence of Ca2+ or in the presence of a
small contamination with Ca2+ induced by the resuspension of
lyophilized peptides. The complex showed a conformation
(dark blue curve) similar to that of the Ca2+/CaM1 (red curve),
with appreciable diﬀerences ascribable to the band of Tyr139.
When saturating Ca2+ was added, drastic changes over the
entire spectral range were clearly detected (cyan curve), imply-
ing important conformational changes involving both the
phenylalanine and tyrosine bands, as suggested by the signifi-
cantly increased signal and the onset of finer band structure,
especially in the region around Tyr139.
The same experiments were performed in the presence of
NPs (Fig. 5b and d). Overall, the results obtained in the far-UV
region were similar to those obtained in the absence of NPs
and in the presence of saturating Ca2+ (compare Fig. 5a and b).
Considering the spectral shape and intensity, the presence of
NPs was found to mimic that of free Ca2+, as almost identical
intensities and θ222/θ208 ratios were obtained, compared to
those in the absence of NPs but in the presence of saturating
free Ca2+ (Table 3). Moreover, adding saturating Ca2+ to the
suspension in the presence of NPs aﬀected neither the inten-
sity nor the shape of any spectra (Table 3).
Interesting results were obtained from CD spectroscopy in
the near-UV region when the interactions between CaM1 and
the CBD peptide were investigated in the presence of NPs
(Fig. 5d). When no free Ca2+ was added to the suspension, a
large dichroic signal was observed with local maxima that only
partly reflected those observed in other cases (dark blue line).
This suggests that at low Ca2+ the peptide might interact with
CaM1 and/or the NP, resulting in an overall diﬀerent tertiary
structure, at least considering the local environment of phenyl-
alanine residues and that of Tyr139. However, in the presence
of saturating free Ca2+ the spectrum (green line) was similar to
that observed in the absence of NPs (black dashed line in
Fig. 5d or cyan line in Fig. 5c), and specific features of the
spectral pattern such as a local maximum at 290 nm were
clearly present.
Overall, results from CD experiments suggest a virtually
complete capability of CaM1 to bind the CBD peptide even
when bound to NPs, and to undergo the required confor-
mational switches that are triggered or enhanced by free Ca2+
in a structurally correct and reversible manner.
Eﬀect of NPs on Gad1 activity and spectral properties
CD experiments in the presence of Gad1 CBD provide infor-
mation about the ability of both NP-bound and unbound
CaM1 to bind the target in the presence of saturating Ca2+.
However, they cannot thoroughly probe the residual capability
of CaM1 to act as a sensor protein that transduces Ca2+ signals
by binding to and altering the activity/function of a target
protein. To investigate this aspect, Gad1 activity was measured
in the presence of CaM1–NP complexes. Gad1 is a cytosolic
enzyme that exhibits a dual regulation: pH regulation, with a
maximum activity at pH 5.8, and a Ca2+/CaM1 activation at
neutral pH. We tested Gad1’s ability to perform a decarboxyla-
tion reaction in the presence of CaM1 and NPs at pH 7.5,
where it is influenced mostly by CaM1.31 Interestingly, at this
pH, CaM1 previously incubated with NPs is still able to cause
Gad1 activation in a similar manner to the eﬀect observed in
the absence of NPs and restores an activity profile comparable
to that of the Gad1–CaM1 complex. In particular, as shown in
Fig. 6a, in the presence of NPs the enzyme retains about 70%
of its activity.
Ca2+/CaM1 also has a clear impact on the spectral pro-
perties of Gad1. The UV-Vis spectrum of Gad1 displays charac-
teristic absorption bands with maxima at 415 and 338 nm,
which are attributed to the ketoenamine and enolimine forms
of the Schiﬀ base, respectively,31 and whose relative intensities
depend on pH: the 338 nm band increases with increasing pH,
Table 3 The θ222/θ208 ratio of CaM1 in the presence and absence of
CBD and NPs
θ208
(mdeg)
θ222
(mdeg)
θ222/
θ208
CaM1 + CBD −52.85 −49.95 0.94
CaM1 + CBD + Ca2+ −56.11 −55.31 0.98
(CaM1 + CBD) − CBD −47.70 −47.30 0.99
(CaM1 + CBD + Ca2+) − (CBD + Ca2+) −51.24 −52.87 1.03
(CaM1 + CBD) − CaM1 −12.56 −13.19 1.05
(CaM1 + CBD + Ca2+) − (CaM1 + Ca2+) −14.15 −15.97 1.13
NP + CaM1 + CBD −55.55 −54.58 0.98
NP + CaM1 + CBD + Ca2+ −55.16 −54.30 0.98
(NP + CaM1 + CBD) − (NP + CBD) −50.95 −52.41 1.03
(NP + CaM1 + CBD + Ca2+) − (NP + CBD + Ca2+) −50.98 −52.37 1.03
(NP + CaM1 + CBD) − (NP + CaM1) −13.25 −15.24 1.15
(NP + CaM1 + CBD + Ca2+) − (NP + CaM1 + Ca2+) −12.89 −15.01 1.16
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while the 415 nm band decreases. Ca2+/CaM1-binding essen-
tially abolishes the pH-dependence in the UV-Vis spectrum:
the 338 nm species is strongly reduced, while the protonated
Schiﬀ base (415 nm) is enhanced compared to unbound Gad1.
In order to determine the impact of NPs on the spectral pro-
perties of Gad1, we monitored the spectral behavior of the
enzyme after NPs-CaM1 binding. After subtraction of the con-
tribution of CaF2 NPs, which show a modest absorption band
around 330 nm, Gad1 spectra in the presence of Ca2+/CaM1
are still characterized by a lack of interconversion of the two
tautomers, indicating that CaM1 after interaction with NPs is
able to move into solution, bind Gad1 at its CaM binding
domain, and aﬀect the tautomeric equilibrium of the internal
aldimine, as in the absence of NPs (Fig. 6b).
Conclusions
Taken together, our data revealed that, upon NPs interaction,
CaM1 retains an almost complete functionality, being able to
both bind the peptide encompassing the putative C-terminal
CBD of Gad1 and to activate the Gad1 protein. Thus, the capa-
bility of the protein to work as a Ca2+ sensor, recognizing and
activating its biological target, is fully preserved in the pres-
ence of CaF2 NPs, which seem to represent suitable surface
carriers for this protein, likely due to the high structural plas-
ticity of CaM1. The apparent protein aﬃnity towards nano-
particle surfaces (Kd ∼ 2 μM) is lower compared to the value of the
dissociation constant of the Gad1–CaM1 complex (Kd ∼
0.1 μM) previously reported,31 pointing to a very tight binding
of the three CaM molecules to the Gad1 hexamer. Thus, after
interaction with NPs, it is reasonable to conclude that CaM1 is
able to dissociate, move into solution and activate the Gad1
enzyme. Furthermore, the fact that both interactions (NPs–
CaM1 and CaM1–Gad1) are characterized by aﬃnity constants
with physiological relevance makes the system of great interest
for diﬀerent biotechnological and biomedical applications.
Experimental
Protein preparation and peptide synthesis
CaM1 from Arabidopsis thaliana was expressed and purified as
described previously31 with some modifications elucidated in
the ESI.†
The recombinant mutant carrying various E to Q substi-
tutions was generated based on the sequence alignment of
CaM1 with human, bovine and other plant CaMs. The EE105-
141QQ mutant form of CaM1 was made from the wt construct
pET12b-AtCaM1 using the QuikChange® site-directed muta-
genesis kit (Agilent Technologies) following the manufac-
turer’s protocols. The kit employs double-stranded DNA as a
template, two complementary oligonucleotide primers con-
taining the desired mutation, and DpnI endonuclease to digest
the parental DNA template. The coding region of the mutated
plasmid was verified by DNA sequencing. E. coli strain BL21
(DE3) cells were transformed and used for expression. The con-
ditions for expression and purification of the mutant were as
described for the wt protein.31 Purified CaM1 EE105-141QQ
mutant was at least 95% pure with an estimated molecular
mass of 17 kDa based on SDS-PAGE analysis.
Purified wt and mutant proteins were dialyzed against
decalcified NH4HCO3 buﬀer, lyophilized, and stored at −80 °C
until use.
The 32 amino acid polypeptide encompassing the putative
C-terminal CaM-binding domain of Gad1 (CBD) was chemi-
cally synthesized by GenScript Corporation. The sequence was
as follows: VTVKKSDIDKQRDIITGWKKFVADRKKTSGIC. The
peptide was 93.6% pure as determined by high pressure liquid
chromatography. The concentration of the peptide was deter-
mined from the calculated molar extinction coeﬃcient (ε280 =
5500 M−1 cm−1, http://web.expasy.org/protparam/).
Building a homology model of CaM1 from A. thaliana
The homology model of the Ca2+-bound CaM1 from A. thaliana
was built using the SWISS-MODEL Homology Modeling server
Fig. 6 Eﬀects of CaF2 NPs on the Gad1–Ca
2+/CaM1 complex activity and spectral properties. (a) GABA formation as a function of CaM1 concen-
trations in the presence and absence of CaF2 NPs. Gad1 activity assays were performed in a solution containing 25 mM MES, 25 mM MOPS, 150 mM
NaCl, and 2 mM CaCl2 at pH 7.5 in the absence (black squares) and presence (red circles) of 0.13 mg mL
−1 CaF2 NPs. 100 mM L-glutamate, 0.6 μg of
Gad1, and the indicated concentration of CaM1 were used for each assay. (b) Absorbance spectra were recorded in 25 mM MES, 25 mM MOPS,
150 mM NaCl, and 2 mM CaCl2 at pH 7.5 for Gad1 and Gad1–Ca
2+/CaM1 complex in the presence and absence of 1.4 mg mL−1 NPs.
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(swissmodel.expasy.org).37,38 The best template chosen for the
modeling was CaM from potato (PCM6, PDB entry: 1rfj; resolu-
tion: 2.0 Å39), sharing a ∼96% sequence identity with CaM1
from A. thaliana and likewise harboring a tyrosine residue at
position 138. The Global Model Quality Estimation (GMQE)
index was 0.97, indicating a high reliability for the homology
model, also confirmed by the satisfactory values of the four
structural descriptors (torsion angles, all atom and C-beta
interactions, solvation potential) making up the QMEAN
potential scoring function.
Nanoparticle synthesis and decalcification
The synthesis of CaF2 NPs was performed as previously
described.17,18 The suspension of NPs in the working buﬀer
(5 mM Tris-HCl, pH 7.5, 150 mM KCl) was highly mono-
disperse with 24.9 ± 0.4 nm average diameter for the NPs, as
probed by dynamic light scattering as described previously.17
A 15 mg mL−1 stock NPs solution was prepared in decalcified
water. The complete decalcification of NPs was achieved by
stirring the solution overnight in the presence of a dialysis
membrane tube containing the chelating ion exchange resin
Chelex®100 (BioRad).
Estimate of size-dependent protein coverage of the NP surface
and concentration adjustments
The evaluation of the maximum number of CaM1 bound to
CaF2 NPs was done as previously reported by our group.
17 In
the presence of NPs with a diameter of 25 nm, the theoretical
maximum number of bound CaM1 is ∼144. Details are pro-
vided in the ESI.†
Dynamic light scattering experiments
DLS measurements were performed as reported in the ESI.†
Isothermal titration calorimetry
Calorimetric measurements were performed using a TA iso-
thermal titration microcalorimeter (TA Instruments). CaM1
was titrated into suspended NPs at 25 °C. For a typical
NP–CaM1 titration, 0.24 μM NPs were placed in the reaction
cell (200 μL). The protein was dissolved to 190 μM, corres-
ponding to 3.2 mg mL−1, in decalcified 5 mM Tris-HCl, pH
7.5, 150 mM KCl. This protein concentration was chosen
because in CaM1 solutions above 4 mg mL−1, CaM1 exists as
dimers due to the formation of inter-chain disulfide bonds
involving a cysteine residue at position 27. For titration exper-
iments, 1.5 μL of CaM1 solution was injected into the reaction
cell at 300 s intervals, with a total number of 34 injections,
which were found to be suﬃcient to obtain complete binding
curves. The pH of the protein solution was adjusted to match
the pH of the particle solution (pH 7.5). Particle and protein
solutions were equilibrated to 25 °C and degassed prior to
each titration. The reference cell was filled with water during
all titration experiments and the NP suspension in the sample
cell was constantly stirred at 250 rpm. Calorimetric curves
provide a correlation between thermal flow involved in each
injection and time. Positive peaks stand for endothermic reac-
tions and negative peaks stand for exothermic reactions. From
the known concentrations of the protein and particles, the
stoichiometry, aﬃnity, and enthalpy changes upon binding
were derived by fitting the data to a one-site binding model
using the software NanoAnalyze (TA Instruments). In order to
determine the heat of dilution, CaM1 at the same concen-
tration as in the particle-binding experiments was titrated into
the buﬀer.
Spectroscopic measurements
Absorption spectra were obtained with a Jasco-V560 UV-Vis
spectrophotometer using 4 μM Gad1 in 25 mM MES, 25 mM
MOPS, 150 mM NaCl, 2 mM CaCl2 without CaM1 or with
12 μM CaM1 in the presence and absence of 1.4 mg mL−1 NPs.
CD measurements were obtained using a Jasco J-710
spectropolarimeter at 25 °C in a buﬀer solution containing
5 mM Tris-HCl, pH 7.5, and 150 mM KCl. Both near-UV
(250–320 nm) and far-UV spectra (200–250 nm) were recorded
at a scan rate of 50 nm min−1, a bandwidth of 1 nm, and an
integration time of 4 s. Five spectra accumulations were aver-
aged for each sample, and the spectrum of the buﬀer (with
or without NPs) was considered as blank and subtracted. For
far-UV spectra, the protein concentration was 12 μM in 0.1 cm
cuvettes, while for near-UV spectra it was 60–65 μM in 1 cm
cuvettes.
CD spectra of the CaM1–peptide complex were obtained
using a protein : peptide ratio of 1 : 2. In particular, for far-UV
spectra 12 μM CaM1 and 24 μM peptide were used, while for
near-UV spectra 60 μM CaM1 and 120 μM peptide were mixed
in 5 mM Tris-HCl, pH 7.5, containing 150 mM KCl.
Thermal denaturation experiments were carried out as
reported in ESI.†
Gad1 activity assay
Enzyme activity assays were done as described previously40
with slight modifications. Briefly, Gad1 reactions were per-
formed at 30 °C using 100 mM L-glutamate as a substrate in
25 mM MES, 25 mM MOPS, 150 mM NaCl, 2 mM CaCl2
without CaM1 or with various concentrations of CaM1 (from 5
nM to 1 μM) in the absence and presence of NPs, at pH 7.5.
GABA produced by the Gad1 reaction was estimated using a
GABASE (Sigma) coupled reaction, which produces NADPH.
The NADPH concentration was calculated from the absorbance
at 340 nm, using a molar extinction coeﬃcient εNADPH = 6220
M−1 cm−1. The GABASE reaction mix contains 1 mM α-keto-
glutarate, 1 mM NADP, 1 mM DTT, and 0.6 U GABASE in 0.1 M
Hepes buﬀer, pH 8.6.
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Conformational Changes in Calcium-Sensor Proteins under
Molecular Crowding Conditions
Stefan Sulmann,[a] Daniele Dell’Orco,[b] Valerio Marino,[b] Petra Behnen,[c] and Karl-
Wilhelm Koch*[a]
Abstract: Fundamental components of signaling pathways
are switch modes in key proteins that control start, duration,
and ending of diverse signal transduction events. A large
group of switch proteins are Ca2+ sensors, which undergo
conformational changes in response to oscillating intracellu-
lar Ca2+ concentrations. Here we use dynamic light scatter-
ing and a recently developed approach based on surface
plasmon resonance to compare the protein dynamics of a di-
verse set of prototypical Ca2+-binding proteins including
calmodulin, troponin C, recoverin, and guanylate cyclase-ac-
tivating protein. Surface plasmon resonance biosensor tech-
nology allows monitoring conformational changes under
molecular crowding conditions, yielding for each Ca2+
-sensor protein a fingerprint profile that reflects different hy-
drodynamic properties under changing Ca2+ conditions and
is extremely sensitive to even fine alterations induced by
point mutations. We see, for example, a correlation between
surface plasmon resonance, dynamic light scattering, and
size-exclusion chromatography data. Thus, changes in pro-
tein conformation correlate not only with the hydrodynamic
size, but also with a rearrangement of the protein hydration
shell and a change of the dielectric constant of water or of
the protein–water interface. Our study provides insight into
how rather small signaling proteins that have very similar
three-dimensional folding patterns differ in their Ca2+-occu-
pied functional state under crowding conditions.
Introduction
Conformational transitions in proteins control the on and off
modes of cellular responses in a very precise manner. These
conformational changes can be induced, for example, by small
organic ligands, protein–protein interactions, or second mes-
sengers like Ca2+ . The versatile action of Ca2+ is based on the
operation of hundreds of different Ca2+-sensor proteins that
detect changes in intracellular Ca2+ , thereby switching into
a mode of controlling the function of a target protein.[1] Often,
one Ca2+-sensor protein can regulate different targets, among
which the most prominent example is probably calmodulin
(CaM), a member of the superfamily of EF-hand Ca2+-binding
proteins. CaM exhibits a kind of conformational plasticity,
meaning it is able to control different target protein function
by adopting a fitting conformation for a specific target struc-
ture.[2, 3] A similar task is probably performed by neuronal Ca2+
-sensor (NCS) proteins, a subgroup of the EF-hand superfami-
ly.[4, 5] However, despite their rather similar three-dimensional
folding, each member of this group may regulate only a few
or just one target out of a large diversity of different proteins.
For example, rod and cone cells of the vertebrate retina specif-
ically express Ca2+-sensors like recoverin[5] and guanylate cy-
clase-activating protein 1 (GCAP1),[6–8] of which the latter regu-
lates the activity of sensory membrane guanylate cyclases.
Considering the conformational variety of one small Ca2+
sensor like CaM[2, 3] on the one hand and the similar general
folding of NCS proteins[4,5] on the other poses the following
questions. Which conformational changes control the on and
off states of a particular Ca2+ sensor? How do these states
differ in proteins of the same subgroup or between mutants
and the corresponding wild type?
Fluorescence, circular dichroism, and NMR spectroscopy
have been widely employed among other methods to detect
conformational changes in proteins. A more recent rather inno-
vative approach was to use the surface plasmon resonance
(SPR) phenomenon for the detection of conformational transi-
tions. Two different experimental procedures have mainly been
tested so far. Localized SPR (LSPR)[9, 10] employs silver or gold
nanoparticles coated with the protein under study. Commercial
SPR sensors use dextran-coated gold surfaces with covalently
and non-covalently attached proteins. By using the latter ap-
proach conformational changes have been detected in en-
zymes, redox proteins, and Ca2+-binding proteins.[11–17] Further-
more, coupled plasmon-waveguide resonance spectroscopy,
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a technique related to SPR, has been employed to study con-
formational changes in G protein-coupled receptors.[18,19] It has
been argued that the rather long (ca. 200 nm) decay length of
the electromagnetic field in commercially available SPR sensor
chips, such as CM5 supplied by Biacore, dramatically reduces
the sensitivity to small refractive index changes occurring close
to the sensor surface,[10] thus making the much shorter (ca.
5 nm) decay length in LSPR systems more appropriate for de-
tecting a conformational change of an adsorbed protein on its
surface. However, SPR responses obtained with proteins immo-
bilized on dextran-coated sensor chips have been clearly corre-
lated with conformational changes using appropriate con-
trols.[11–19] Artefact signals were excluded in a recent study that
compares Ca2+-induced conformational changes in the neuro-
nal Ca2+-sensor protein recoverin with a specifically designed
recoverin mutant, which does not undergo a Ca2+-triggered
conformational change.[16] We noticed that increasing the Ca2+
concentration ([Ca2+]) into the millimolar range leads to dex-
tran matrix effects on the sensor chip surface independent of
the immobilized protein.[16] This study was more recently ex-
tended by comparing different Ca2+-sensor proteins under ex-
perimental conditions, in which the influence of ionic strength,
divalent cations, and different sensor chip surfaces was
tested.[17] This SPR-based approach allows us to investigate
Ca2+-induced conformational changes in a working range of
physiologically relevant free [Ca2+] , thereby distinguishing
non-specific matrix effects from protein-derived signals in a set-
ting of precisely defined parameters. A further advantage of
our method is that it uses a commercial SPR device and
a sensor chip, which provides four flow cells to immobilize and
investigate up to three proteins and one control surface under
identical buffer flow and sample injections.[16,17]
It has been suggested that the solvent around the immobi-
lized protein rearranges during a conformational transition, es-
pecially when a significant variation in the hydrophobicity of
the solvent-exposed protein surface occurs, thus leading to
changes in the dielectric milieu of the whole flow cell of the
sensor chip.[11,13,14, 16,17]
Based on previous and present observations we sought to
discriminate different forms of conformational changes in a set
of Ca2+-sensor proteins. For this purpose we determined the
Ca2+-dependent changes in the hydrodynamic properties of
Ca2+-sensor proteins and compared them with Ca2+-induced
SPR responses. Our results confirm that the SPR-based ap-
proach is extremely sensitive to even fine alterations induced
by mutations in the conformational switch of Ca2+-sensor pro-
teins. The signal depends not only on the change in hydrody-
namic protein size upon Ca2+-binding, but likely reflects a dif-
ferent hydration structure, which can be significantly affected
in the crowding conditions occurring on the sensor chip.
Results
Ca2+-induced changes in hydrodynamic volume
First, we investigated Ca2+-dependent changes in the hydrody-
namic radius of Ca2+-sensor proteins that are known to differ
significantly in their conformational transitions. For this pur-
pose we determined the hydrodynamic diameter (d in nm) of
several Ca2+-sensor proteins by dynamic light scattering (DLS)
in the presence and absence of Ca2+ , of which representative
results are displayed in Figure 1 for CaMS17C, a mutant of myris-
toylated recoverin (mRec2–190),[20,21] myristoylated GCAP1
(mGCAP1) and troponin C (TnC). These measurements showed
a size distribution of light scattering intensity resulting in one
peak of high intensity (peak 1) and one of lower intensity
(peak 2). However, one exception was observed in the case of
TnC, for which the intensity of peak 2 was higher (see also fur-
ther below). Determination of hydrodynamic diameters re-
vealed for Ca2+-free proteins the following d values (Table 1):
4.97 (CaMS17C), 5.53 (mRec2–190), 7.5 (mGCAP1), and 7.88 nm
(TnC). Adding saturating Ca2+ caused a shift of peak 1 to either
higher (CaMS17C, mRec2–190) or lower d values (mGCAP1, TnC) in-
dicating a Ca2+-induced change of the hydrodynamic volume.
The same set of measurements was performed with wild type
myristoylated (m) and nonmyristoylated (nm) recoverin, and
with several point mutants of GCAP1 known to cause retinal
cone-rod dystrophies[22–24] (Table 1).
In order to compare the changes in d among all tested Ca2+
-sensor proteins in relative and not in absolute terms, we eval-
uated our data by calculating the relative change Dd/dEGTA (Dd
is defined as the diameter in the presence of Ca2+ minus that
in the presence of EGTA (dCa2+-dEGTA)). Values for Dd/dEGTA of 5.7
and 14.7% were found for recoverin and CaM, respectively
Figure 1. Determination of hydrodynamic diameters of Ca2+-sensor proteins
by dynamic light scattering. All measurements were performed at T=25 8C
in 5 mm Tris/HCl pH 7.5, 150 mm KCl buffer. Black solid lines refer to meas-
urements in the presence of saturating EGTA, while dashed lines to saturat-
ing Ca2+ conditions. Size distributions of: 26 mm mRec2–190 in the presence of
240 mm EGTA and 260 mm Ca2+ (upper left) ; 55 mm TnC in the presence of
equal amounts (1.5 mm) of saturating EGTA or Ca2+ (upper right) ; 187 mm
CaMS17C in the presence of 4 mm EGTA and 5 mm Ca2+ (lower left) ; 60 mm
mGCAP1 in the presence of equal amounts (1.5 mm) of saturating EGTA or
Ca2+ . Data obtained by DLS measurements reporting the intensity of scat-
tered light as% of the total area.
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(Table 1). Deletion of twelve amino acids at the C-terminus of
recoverin in the mutant Rec2–190 diminished the Ca2+-depen-
dent change in d yielding a Dd/dEGTA=2.3%, which is consis-
tent with previous reports identifying this region as Ca2+-sensi-
tive control module.[20,21] Changes in TnC were also large, but
with an inverted sign of Dd/dEGTA (18.3%).
GCAP1 is an NCS protein like recoverin, but does not show
a large rearrangement of its myristoyl group.[25] Interestingly, it
also displayed a pronounced change in d (Dd/dEGTA=10.3%).
Wild type (WT) GCAP1 was further compared with several of its
single-point mutants known to cause retinal cone-rod dystro-
phies.[22–24] Ca2+-saturated GCAP1 mutants had a d value of
around 7 nm, which is not much different to that of WT. How-
ever, the relative changes Dd/dEGTA showed a larger variation
yielding 5.6% for L151F, 7.2% for E89 K and 13.8% for
D100E (Table 1).
Intensity peaks corresponding to higher order oligomers
were detected for each protein, and they were particular ap-
parent for TnC. Their effective weight on the photon correla-
tion signal is, however, modest due to the 1/d6 scaling of scat-
tered light intensity. Monitoring number and volume distribu-
tions of the same molecular species in fact confirmed that
monomers were the most populated species in each case.
DLS measurements confirmed that all tested Ca2+-sensor
proteins undergo significant Ca2+-induced changes in their hy-
drodynamic volume. However, the relative changes expressed
in Dd/dEGTA are rather different among the proteins and even
became visible among myristoylated and nonmyristoylated
protein forms. Ca2+-induced changes in WT recoverin and WT
GCAP1 led to significant Dd and Dd/dEGTA values, but sign in-
version occurred when a myristoyl group was posttranslational
attached to the protein (Table 1).
Detection of Ca2+-switch
modes by an SPR biosensor
An alternative approach to
detect differences in Ca2+-in-
duced protein dynamics had
previously been reported for re-
coverin, CaM, GCAP1, and
GCAP2 using SPR.[16,17] Therefore,
we hypothesized that the di-
verse switch modes of Ca2+
-sensor proteins, which we ob-
served by dynamic light scatter-
ing, can also be detected using
the SPR approach and we in-
cluded in the present study Ca2+
titrations with TnC, mRec2–190
and the GCAP1 mutants E89K,
D100E, L151F, and G159V
(Figure 2). TnC on the chip sur-
face reacted to increasing [Ca2+]
with responses of increasing am-
plitudes reaching saturation at
>30 mm Ca2+ (Figure 2, upper
panel). A similar Ca2+ sensitivity
was observed with the recoverin mutant Rec2–190 (Figure 2,
lower panel), which was almost identical to previously deter-
mined values of the wild type (Table 2). However, the maximal
amplitudes that were reached at the end of the titrations were
Table 1. Dynamic light scattering measurements of Ca2+-sensor proteins. Determination of the hydrodynamic
diameter d from peaks 1 and 2 ( standard error=s/N1/2 ; N is the number of repetitions; d was determined in
the presence or absence of Ca2+ . Dd [nm] is the difference dCadEGTA (propagation of errors= (s1
2+s2
2)1/2.
CaM was the S17C-mutant.[17] . Wild type recoverin is abbreviated Rec.
Protein [nm] d (peak 1)
[nm]
d (peak 2)
[nm]
N Dd
[nm]
Dd/dEGTA
[%]
TnC (EGTA) 7.880.11 61.782.80 21 1.440.30 18.3
TnC (Ca2+) 6.440.06 60.224.20 21
CaM (EGTA) 4.970.01 62.145.50 25 +0.730.03 +14.7
CaM (Ca2+) 5.700.03 25
mRec2–190 (EGTA) 5.530.05 23 +0.130.06 +2.3
mRec2–190 (Ca2+) 5.660.02 26
mRec (EGTA) 5.220.02 79.9111.10 20 +0.300.03 +5.7
mRec (Ca2+) 5.520.02 78.605.20 19
nmRec (EGTA) 5.570.06 37.431.57 12 0.230.10 4
nmRec (Ca2+) 5.340.08 36.181.50 13
mGCAP1 (EGTA) 7.50.2 20 0.80.2 10.3
mGCAP1 (Ca2+) 6.690.04 26
D100E (EGTA) 7.820.12 21 1.080.14 13.8
D100E (Ca2+) 6.740.07 29.483.34 18
L151F (EGTA) 7.500.11 26.824.60 27 0.420.19 5.6
L151F (Ca2+) 7.080.15 26.656.50 20
E89K (EGTA) 8.300.09 4417 21 0.60.1 7.2
E89K (Ca2+) 7.700.09 40.4013.38 25
nmGCAP1 (EGTA) 6.250.05 23 +0.510.09 +8.2
nmGCAP1 (Ca2+) 6.760.07 26
Figure 2. SPR responses of Ca2+-sensor proteins at increasing free [Ca2+] .
Examples of sensorgrams obtained upon Ca2+ titrations (left panel). The re-
sponse amplitude at the end of each Ca2+ injection is plotted as a function
of Ca2+ (right panel ; the error bars represent the SD). Sensorgrams were ob-
tained for TnC and the myristoylated recoverin mutant Rec2–190. Data fitting
by a Hill sigmoidal curve resulted in KSPR1=2=11.50.3 mm for TnC (n=5) and
a KSPR1=2=4.900.02 mm (n=8) for Rec
2–190.
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dramatically different between TnC and Rec2–190 (Table 2). This
was partly due to differences in immobilization density, which
was in all tests much lower for TnC than for all recoverin forms
(see the Experimental Section and below). Additionally, differ-
ences in the structure and dynamics of the protein hydration
shell contribute to the observed effects (see also the Discus-
sion section). Mutants of GCAP1 also showed a characteristic
response pattern (Figure 3) allowing the determination of the
[Ca2+] at which the increase in response amplitude is half max-
imal (KSPR1=2 in Table 2). The K
SPR
1=2 of the GCAP1 mutants was shift-
ed to higher [Ca2+] , indicating a decrease in Ca2+-binding af-
finity, which is in agreement with previous results that these
cone-rod dystrophy related mutations cause a change in Ca2+
sensitivity.[23,24] The experiments were also performed in the
presence of physiological levels of free magnesium. The pres-
ence of 1 mmMg2+ during the Ca2+-titrations had mainly two
effects; it decreased the response amplitudes and increased
the KSPR1=2 of both WT and mutant GCAP1 (Figure 3 and Table 2).
Thus, the Ca2+ titrations displayed two main features that
were characteristic for each protein: the KSPR1=2 and different am-
plitudes that were reached at saturating [Ca2+] (Figures 2 and
3).
The response amplitudes of the titration series at saturating
Ca2+ were normalized to the amount of immobilized protein
and were defined as normalized RUmax (Table 2). It became
clear that response amplitudes were highly dependent on the
type of protein as well as on the immobilization technique.
However, a different chemistry of coupling does not signifi-
cantly affect the KSPR1=2, instead it results in important variation of
response amplitudes reached at the end of each analyte injec-
tion.[16] Therefore we compared quantitatively the results from
the three techniques employed in this work on a series of
GCAP1 mutants, which were all immobilized by means of
amine coupling at similar amounts on the sensor chip surface.
We point out that detecting subtle variations in the conforma-
tional properties of proteins differing from one another only
by a single-point mutation represents a proof of the sensitivity
of the approach. Figure 4 reports the results of quantitative
comparisons. The SPR signal clearly correlates with the change
Table 2. SPR-based detection of conformational changes expressed in
half-maximal values of response amplitudes and normalized RUmax values.
CaM was the S17C-mutant.[17]
Protein Divalent
cations
KSPR1=2
[mm]
Normalized
RUmax
TnC Ca2+ 11.50.3 10.20.5
mRec2–190 Ca2+ 4.900.02 39.90.9
mGCAP1[a] Ca2+ 19.70.8 2.30.1
Ca2+ +Mg2+ 25.41.2 1.00.1
mE89K Ca2+ 30.81.4 1.80.1
Ca2+ +Mg2+ 59.90.7 1.50.1
mD100E Ca2+ 20.90.3 2.60.1
Ca2+ +Mg2+ 45.80.7 1.50.1
mL151F Ca2+ 31.60.6 1.90.1
Ca2+ +Mg2+ 52.41.4 1.10.1
mG159V Ca2+ 24.01.1 2.00.1
Ca2+ +Mg2+ 79.42.3 1.10.1
CaMa Ca2+ 5.700.03 11.70.1
Ca2+ +Mg2+ 17.20.4 6.60.1
mGCAP2[a] Ca2+ 24.90.2 3.60.3
Ca2+ +Mg2+ 37.70.5 2.00.1
mRec[a] Ca2+ 5.00.2 36.30.3
Ca2+ +Mg2+ 5.20.1 19.50.1
[a] See reference [17] .
Figure 3. Sensorgrams obtained for myristoylated GCAP1 mutants E89K,
D100E, L151F and G159V. Sensorgrams are on the left panel, evaluation of
data without Mg2+ (*) and in the presence of 1 mm free Mg2+ (*) is shown
on the right panel. Data fitting by a Hill sigmoidal curve resulted in the fol-
lowing values of KSPR1=2 (in brackets): E89K (30.81.4 mm ; n=4); D100E
(20.90.3 mm, n=3), L151F (31.60.6 mm, n=4), G159V (24.1.1 mm, n=3).
Values of KSPR1=2 in the presence of 1 mmMg
2+ were: E89K (59.90.7 mm ;
n=6); D100E (45.80.7 mm, n=5), L151F (52.41.4 mm, n=6), G159V
(79.42.3 mm, n=4). Error bars represent the standard deviation.
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in hydrodynamic radius as detected both by size exclusion
chromatography (SEC) (R2=0.83) and DLS (R2=0.88), thus con-
firming that the signal originates from changes in hydrody-
namic properties of the protein upon Ca2+ binding.
Discussion
Ca2+-sensor proteins like recoverin and CaM undergo extensive
changes in their three-dimensional structure upon Ca2+ bind-
ing[2, 3, 5] and thereby switch between on and off modes. Multi-
functional Ca2+ sensors like CaM, however, can operate in
more complex ways by, for example, controlling target func-
tion in Ca2+-bound and Ca2+-free states.[1–3] In the present
work, we investigated how protein parameters like size and hy-
drodynamic volume change, when a Ca2+ sensor is switching
between Ca2+-bound and Ca2+-free states. Large structural
changes in recoverin and CaM were mirrored in significant
changes of their hydrodynamic diameters (Table 1). Further, we
employed classical techniques like DLS and SEC, which provid-
ed us with a data set that for each protein gave a fingerprint
profile reflecting different hydrodynamic properties. For exam-
ple, CaM and TnC showed among all tested Ca2+-sensor pro-
teins the largest differences in size (Ca2+-free versus Ca2+
-bound), and SPR confirmed these important variations. How-
ever, a clear mismatch was observed for recoverin and its trun-
cated mutant Rec2–190, for which relative changes in size deter-
mined by DLS differed significantly from each other, and were
less prominent compared to CaM and TnC, (Table 1), at odds
with determinations by SPR (Figure 2, Table 2). On the other
hand, when the same set of GCAP1 mutant was similarly com-
pared, DLS, SEC, and SPR showed consistent results (Figure 4).
Where does this discrepancy originate from? We previously an-
alyzed[16] the available structural data on recoverin and postu-
lated that the significant increase in hydrophobicity upon Ca2+
binding would reflect on the structure of the hydration shell,
and consequently on the refractive index of the protein–water
dielectric milieu, which is the physical signal detected by SPR
instruments. It is in fact known that, owing to the lack of hy-
drogen bonds, water molecules near hydrophobic surfaces
behave different from bulk water.[26] The different properties of
hydration water in terms of local density reflect in a different
dielectric constant and eventually refractive index, which is its
square root. This is, however, true for both proteins in solution,
like in SEC and DLS experiments, and those immobilized on
the SPR sensor chip. What is significantly different in the two
situations is the molecular crowding, which is definitely higher
in the SPR conditions and might affect differently the structure
and dynamics of the hydration shell.[26]
Physiological protein solutions in a cellular environment are
highly concentrated (up to 400 gL1) filling 5–40% of the total
cell volume.[27] As we have pointed out in a recent publication
the SPR approach for detecting conformational changes relies
on a high amount of immobilized protein in a dextran-like
mesh.[17] Therefore, it differs from the “canonical” use of the
SPR technology (particularly the Biacore system), in which low
immobilization levels on the sensor chip surface should be
achieved in order to obtain reliable kinetic constants.[28] How-
ever, it was not the aim of the present study to extract kinetic
constants from the sensorgrams. Instead we have a high densi-
ty of proteins covalently attached to a 100 nm dextran layer
mimicking crowding effects, for which inert synthetic polymers
including dextran are often used.[29,30]
The Ca2+-dependent changes of CaM in the presence of
crowding reagents differ significantly from those of the diluted
protein solution.[31] Our results here indicate that this conclu-
sion might be true for a variety of different sensor proteins
pointing to a more general principle. However, the parameter
KSPR1=2 that we determined here is different from apparent KD
values for direct Ca2+ binding to recoverin[16,20,21] and GCAP1
forms[24, 32] or values that describe the [Ca2+] , at which a biologi-
Figure 4. Comparison of normalized RUmax values and differences in Stokes
radii (jDrStokes j = j r
EGTA
Stokesr
Ca2þ
Stokes j) for the series of mGCAP1 variants. The upper
panel shows the normalized values of RUmax obtained from Ca
2+ titration
series as seen in Figure 2 for myristoylated GCAP1 WT and the mutants
E89K, D100E, L151F, and G159V. Differences in Stokes radii were obtained
both from analytical size exclusion chromatography (mid panel) and dynam-
ic light scattering (see Table 1), and the absolute value of the variation line-
arly correlates with RUmax in both cases (lower panel : *:SEC data set
(R2=0.83) ; &: DLS data set (R2=0.88)).
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cal regulatory effect is halfmaximal (IC50, EC50).
[4–8,20–23,25] In our
previous work[17] we related apparent KD values of Ca
2+ bind-
ing to KSPR1=2 by the equation K
app
D =KccK
SPR
1=2, in which Kcc is
a unitless quantity defined as conformational change contribu-
tion. Thus, the empirical parameter KSPR1=2 is a useful tool to de-
scribe a concerted binding-conformational switch, either
among different, but related, proteins or under conditions that
influence conformational transitions.[17]
Then, how can SPR signals of increasing amplitudes at in-
creasing [Ca2+] be interpreted? SPR signals originate from
changes in the refractive index close to the sensor surface and
the refractive index equals the square root of the dielectric
constant of the medium and of the soluble compounds. Al-
though the dextran–protein compartment on the surface of
the sensor chip is in an aqueous environment the relative die-
lectric constant of water in a crowded protein environment is
lower than e=80, the value in bulk solution. In our SPR experi-
ments the volume fraction of the immobilized protein is
around 0.2 (Supporting Information) and under these condi-
tions the e of water decreases to about 60.[26] The maximal am-
plitudes that we observed in different Ca2+-sensor proteins are
between 10 and 300 RU, which correspond to a relative
change[33] in bulk refractive index of 105 to 3104. The rela-
tive change Der in dielectric constant of the aqueous protein–
dextran compartment corresponds to 3.2103 and 1.7102,
respectively. Thus, the Ca2+-induced conformational changes
for proteins like recoverin as detected by SPR are accompanied
by an approximately fivefold higher change in dielectric con-
stant compared to GCAP1 variants, higher than the relative
change attributed to water when passing from bulk to
a highly crowded environment. We therefore conclude that
the changes in protein conformation correlate with a rearrange-
ment of both the hydration shell and the hydrodynamic pro-
tein properties (see above). We further conclude that the posi-
tive SPR amplitudes during a Ca2+ titration originate from an
increase of the dielectric constant of water or of the protein–
water interface. Thus, it would reflect a less “crowded” state in
the dextran matrix, when Ca2+ is bound to Ca2+-sensor pro-
teins like recoverin, GCAPs, and CaM. If this hypothesis is true,
one should find conditions under which Ca2+ titrations result
in negative SPR amplitudes. In fact, we observed in a previous
paper[17] that the nonmyristoylated forms of recoverin and
GCAP1 exhibited negative amplitudes indicating a kind of re-
verse process with a lowering of e (water). This observation
would also be consistent with our dynamic light scattering
measurements, during which changes in hydrodynamic diame-
ter and Dd/dEGTA occurred with sign inversion. Indeed, when
taken as absolute values, changes in hydrodynamic radii as de-
tected by SEC and DLS significantly correlate with changes in
SPR signals (Figure 4).
Conclusion
We determined physicochemical properties for a set of Ca2+
-sensor proteins that regulate the activity of various target pro-
teins like kinases, cyclases, and ion channels. They operate by
performing Ca2+-induced switches between on and off states
that are triggered by incremental changes of Ca2+ , which are
significant for cellular processes. We here show that these Ca2+
sensors exhibit different responses to changing [Ca2+] in com-
bination with the surrounding water shell. In particular, we
were able to correlate data from the SPR biosensor approach,
dynamic light scattering, and size exclusion chromatography
experiments. Thereby, we obtained characteristic fingerprint
profiles relevant for the proteins under conditions of molecular
crowding.
Experimental Section
Preparation of protein samples, buffers and calcium stocks
Wild type and mutant forms of recoverin and GCAP1 were hetero-
logously expressed in E. coli and purified to homogeneity as de-
scribed previously.[20–24] The recoverin mutant mRec2–190 was a var-
iant of myristoylated recoverin that lacks 12 residues at the C-ter-
minus.[20,21] Preparation and use of CaMS17C in SPR experiments con-
taining a Cys at position 17 have been described previously.[17]
Samples used in this work were a kind gift of Prof. Sara Linse (Uni-
versity of Lund, Sweden). Troponin C (TnC) was commercially ob-
tained from Apollo Scientific Ltd. , Stockport, UK.
For SPR experiments, we used the SPR running buffer consisting of
5 mm Tris/HCl pH 7.5, 150 mm KCl. For removing Ca2+ contami-
nants the buffer was applied on a Chelex 100 resin column (Bio-
rad) with a flow rate of 3 mLmin1. Treatment of the Chelex resin
before use was exactly as described previously.[16,17] The remaining
concentration of Ca2+ in the buffer after decalcification was mea-
sured by withdrawing a small volume and by performing a BAPTA
absorption assay as described.[17] It was found to range between
0.11 and 0.20 mm. For the Ca2+ titration experiments we used CaCl2
of the highest grade available, dissolved it in the decalcified buffer
to a final concentration of 46 mm. This Ca2+ stock solution was
used to obtain Ca2+ stocks of lower concentration by subsequent
dilutions to the following final concentrations used in SPR experi-
ments (injections in Figure 2): 0.4, 0.7, 0.9, 1.1, 1.6, 2.5, 4.8, 14, 37,
46.2 mm. All buffers were filtered (0.22 mm) and degassed for at
least 1 h before use. For SPR runs Tween20 was added at a final
concentration of 0.005% (v/v).
Dynamic light scattering
DLS measurements were performed with a Zetasizer Nano-S (Mal-
vern Instruments) using a polystyrene, low-volume, disposable,
sizing cuvette (ZEN0112). Viscosity and refractive index were set to
0.8872 cP and 1.330 (default values for water), temperature was set
to 25 8C with 2 min equilibration time. The measurement angle
was 1738 backscatter and the analysis model was set to multiple
narrow modes. For each measurement a minimum of 12 determi-
nations were performed, each consisting of 13–15 repetitions. Buf-
fers (5 mm Tris-HCl, 150 mm KCl, pH 7.5, adjusted with saturating
levels of CaCl2 or EGTA), were filtered through a Jet Biofilm
0.22 mm membrane, while protein-only solutions were filtered
through an Anotop 10 filter (Whatman, 0.02 mm).
SPR experiments and data analysis
A Biacore2000 surface plasmon resonance instrument (GE Health-
care) was employed for detecting conformational changes in Ca2+
-sensor proteins upon injections of Ca2+ . Proteins were immobi-
lized at high surface densities on commercial CM5 sensor chips (GE
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Healthcare, Uppsala, Sweden). Changes in resonance units (RU)
after immobilization are at 2000–9000 RU (1000 RU correspond to
1 ng protein per mm2).[33] Typical immobilization densities were
2 ngmm2 (TnC), 7 ngmm2 (GCAP1 forms), 8 ngmm2
(CaMS17C) and 9 ngmm2 (recoverin forms). CaMS17C and recoverin
forms were immobilized by means of thiol coupling, GCAP1 forms
by means of amine coupling. Details about general performance of
SPR experiments, of Ca2+ titrations, and data evaluation have been
described,[16,17] but a brief summary is given in the following. Ca2+
solutions of increasing free [Ca2+] were injected for 2 min into SPR
running buffer (see above). Control injections over a blank surface
were done in parallel and were subtracted from sensorgrams ob-
tained with protein coated surfaces. The response amplitude of
each Ca2+ injection was determined by measuring the difference
between RU at start and end of the corresponding Ca2+ injection
yielding Ca2+ titration series. Plotting the response amplitude as
a function of Ca2+ yields the [Ca2+] , at which the response ampli-
tude is half maximal (KSPR1=2) as described in detail before.
[17] Maximal
amplitudes of Ca2+ titration series were divided by the amount of
immobilized protein yielding normalized RUmax values.
Analytical size exclusion chromatography
Ca2+-sensor proteins were analyzed by size exclusion chromatogra-
phy using a Bio-Sept SEC2000 column (2504 mm, Phenomenex,
Aschaffenburg, Germany). Standard proteins for calibration were
bovine serum albumin (66 kDa, Stokes radius 35.5 ), ovalbumin
(43 kDa, Stokes radius 30.5 ), carboanhydrase (30 kDa, Stokes
radius 23.6 ), myoglobin (17.8 kDa, Stokes radius 20.2 ), and ribo-
nuclease (13.7 kDa, Stokes radius 16.4 ). Buffer used in chroma-
tography was the SPR running buffer (s. above) with either 1 mm
CaCl2 or 1 mm EGTA added. The protein (50 to 150 mg) was applied
on the column and the elution profile was recorded at 280 nm.
Elution volumes Ve of Ca
2+-sensor proteins were determined at
high and low [Ca2+] and the distribution coefficient KAV was calcu-
lated according to KAV= (VeV0)/(VtV0), in which Vt is the total
column volume and V0 is the void volume. Stokes radii were deter-
mined from a calibration plot of log Stokes radius versus KAV from
4–9 different chromatography runs.
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The effects of physiological concentration of magnesium on the switch states of the neuronal calcium sensor
proteins recoverin, GCAP1 andGCAP2were investigated. Isothermal titration calorimetrywas applied for binding
studies. Circular dichroism spectroscopywas used to characterize protein thermal stability, secondary and tertia-
ry structure in conditions of high and low [Ca2+], mimicking respectively the dark-adapted and light-exposed
photoreceptor states during the phototransduction cascade. Further, molecular dynamics (MD) simulations
were run to investigate the dynamical structural properties of GCAP1 in its activator, inhibitor and putative
transitory states.
Our results conﬁrmed that Mg2+ is unable to trigger the typical Ca2+-induced conformational change of
recoverin (myristoyl switch) while it decreases its thermal stability. Interestingly, Mg2+ seems to affect the
conformation of GCAP2 both at high and low [Ca2+], however the variations are more substantial for
myristoylated GCAP2 in the absence of Ca2+. GCAP1 is responsive to Mg2+ only in its low [Ca2+] state and
Mg2+-GCAP1 tertiary structure slightly differs from both apo and Ca2+-bound states. Finally, MD simulations
suggest that the GCAP1 state harboring one Mg2+ ion bound to EF2 acquires structural characteristics that are
thought to be relevant for the activation of the guanylate cyclase. Moreover, all the putative Mg2+-bound states
of myristoylated GCAP1 are structurally less ﬂexible than Ca2+-bound states. GCAP1 acquires a more compact
tertiary structure that is less accessible to the solvent, thereby inducing a different conformation to themyristoyl
moiety, whichmight be crucial for the activation of the guanylate cyclase. This article is part of a Special Issue en-
titled: 13th European Symposium on Calcium.
© 2014 Elsevier B.V. All rights reserved.
1. Introduction
Calcium (Ca2+) plays a crucial role as a secondmessenger in rod and
cone photoreceptor cells where, depending on the species, its concen-
tration drops from ~250–800 nM to ~20–100 nM during the activation
of the phototransduction cascade [1,2]. Being directly involved in
negative feedback mechanisms, Ca2+ permits the regulation of light-
sensitivity in photoreceptors and allows the typical adaption mecha-
nisms observed under different light regimes [3–6]. Subtle changes in
[Ca2+] are detected by neuronal calcium sensor (NCS) proteins belong-
ing to the EF-hand superfamily, which precisely regulate the enzymatic
activity of their targets [7,8], by adopting speciﬁc conformations in
response to Ca2+-binding. Among NCS proteins, recoverin (Rec) exerts
its regulatory properties on the activity of rhodopsin kinase by
exploiting a mechanism known as myristoyl switch. Recoverin triggers
from a “tense” (T), compact conformation in which, at low [Ca2+] the
post-translationally-bound myristoyl group is buried in a hydrophobic
pocket to a more “relaxed” (R), extended conformation in which, at
high [Ca2+] the myristic moiety is solvent-exposed and more likely
anchored to disk membranes [9,10]. Unlike Rec, the NCS guanylate
cyclase-activating proteins 1 and 2 (GCAP1, GCAP2) do not undergo a
myristoyl switch mechanism, but operate in a calcium-relay system
[3] to make gradual responses to small changes in [Ca2+], which results
in a ﬁne-tuned control of the activities of photoreceptor speciﬁc sensory
membrane bound guanylate cyclases (which for reasons of simplicity
we will refer in the text to a singular GC), speciﬁcally inhibiting the
enzyme responsible for the synthesis of cyclic GMP (cGMP) at high
[Ca2+], and stimulating it at low [Ca2+] [4,11].
While it is well established that Ca2+ plays a major role in many
biochemical processes underlying the phototransduction cascade, the
role of magnesium (Mg2+), another divalent cation present at much
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higher concentration in both rod and cone outer and inner segments is
less well understood. Mg2+ is an important cofactor for the fundamen-
tal nucleosides triphosphate ATP and GTP and a large number of
enzymes appear to be regulated by Mg2+ in conditions that match the
large physiological concentrations observed in tissues and cells [12]. In
photoreceptor cells, [Mg2+] stabilizes at relatively high values
(~1 mM), independent of signiﬁcant variations of pH, Ca2+ and Na+,
leading to the conclusion that unlike Ca2+ it does not participate in
the dynamic regulation of phototransduction [13]. It is however
known that EF-hand motifs that bind Ca2+ via an ideal pentagonal
bipyramid geometry consisting of six oxygen atoms from carboxyl and
carbonyl groups of the protein and an oxygen atom from a water mole-
cule, may also bind Mg2+ in the same binding sites, though via an
octahedral geometry [14]. The lack of a bidentate coordination usually
provided by a Glu residue in the case of Ca2+ binding results in a
monodentate coordination, overall leading to six rather than seven
oxygen ligands in the case of Mg2+. Depending on their speciﬁc afﬁnity
for Ca2+, which may vary from 10−9M to 10−6M, Ca2+-binding sites
usually bind Mg2+ ions four to ﬁve orders of magnitude less strongly,
thus making it particularly difﬁcult to measure the dissociation
constants [15]. Moreover, the radius of a hydrated Mg2+ ion is ~400-
fold larger compared to the dehydrated one, while that of Ca2+
increases ~25-fold upon hydration. As a consequence, Mg2+ cannot be
easily stripped of its hydration shell, and despite the similar chemical
reactivity and charge the two cations show often very different
biochemical behaviors [16]. Establishing general principles to quantify
Mg2+ competition for Ca2+-binding sites is therefore not trivial, as
each binding site, and eventually each protein may behave differently,
depending on the relative afﬁnity for the cations and their local
concentrations.
In the last years a number of exhaustive biochemical and biophysical
investigations have revealed that free Mg2+ is important for the activa-
tion of GC by GCAP1. Mg2+ seems to bind to apo-GCAP1withmoderate
afﬁnity [17,18] and the apo form of GCAP1 seems not to exist physiolog-
ically, nor to be able to activate GC or colocalize with it in experiments
with cells [19]. Previous studies on Rec suggest that Mg2+ does not
inﬂuence the knownmyristoyl switch mechanism [20], but no dedicat-
ed structural study was performed so far. Finally, while a Ca2+/Mg2+
exchange mechanism of general validity for GCAP-mediated activation
of GC was proposed [21] based on the evidence that GCAP2 is also
functionally affected by Mg2+ [17,22], to our knowledge the structural
effects of Mg2+ on GCAP2 have never been experimentally studied so
far, nor has the afﬁnity for binding been estimated.
In this work we present a comparative analysis of the structural
effects of Mg2+ on the regulatory states of Rec, GCAP1 and GCAP2 by
focusing on conditions of high and very low Ca2+, thus mimicking
dark-adapted and illuminated photoreceptor cells. We measured
variations of secondary and tertiary structure in different conditions,
including the presence and absence of the post-translational
myristoylation of the NCS proteins at the N-terminal. For myristoylated
GCAP1 (mGCAP1), we performed comparative molecular dynamics
simulations of the activating, inhibitory and putative transitory states,
highlighting important dynamical features, which might be critical for
switching between different regulatory states.
2. Material and methods
2.1. Protein expression and puriﬁcation
Proteins were heterologously expressed in Escherichia coli and
puriﬁed by hydrophobic interaction chromatography (myristoylated
and non-myristoylated Rec (m/nmRec); see Refs. [23,24] for details)
or by size exclusion chromatography and anion-exchange chromatog-
raphy (m/nmGCAP1; see ref. [25] for details; m/nmGCAP2 see [26] for
details). Protein sample purity was veriﬁed by SDS-PAGE. Protein buffer
was exchanged with decalciﬁed NH4HCO3, and samples were then
concentrated, lyophilized and stored at−80 °C until use.
2.2. Circular dichroism spectroscopy and thermal denaturation studies
Circular dichroism (CD) spectroscopy studies were performed with
a Jasco V-710 spectropolarimeter equipped with a Peltier type
thermostated cell holder, using quartz cuvettes with path length of
1 cm for near UV spectra (250–320 nm) and 0.1 cm for far UV spectra
(200–250 nm). Both near UV and far UV spectra were recorded at
37 °C at a scan rate of 50 nm min−1, with a bandwidth of 1 nm and
an integration time of 4 s. For each spectrum ﬁve accumulations were
averaged and the spectrum of the buffer was recorded before each set
of measurements and subtracted. For far UV spectra protein concentra-
tionwas 8–10 μM for Rec, 17–20 μM for GCAP2 and 8–13 μM for GCAP1,
while for near UV spectra it was respectively 15–20 μM, 40–42 μM and
26–52 μM. All experiments were performed in 5 mM Tris–HCl pH 7.5,
150 mM KCl, and 2 mM DTT.
Both far UV and near UV spectrawere recorded: i) in the presence of
10-fold excess EGTA with respect to protein concentration; ii) after the
addition of 1 mM MgCl2 or 2-fold excess CaCl2 with respect to the
concentration of EGTA; and iii) after the addition of the other salt not
added in the previous step. Thermal denaturation of all proteins was
monitored between 20 °C and 96 °C in the same conditions as for far
UV spectra, as far as protein, EGTA, CaCl2 and MgCl2 concentrations
are concerned. The ellipticity signal at 208 nm (θ208) was recorded at
a scan rate of 1 °Cmin−1 and a response time of 4 s. The thermal dena-
turation analysis was performed assuming a two-state transition pro-
cess, where the θ208 signal recorded as a function of temperature
represents the fraction of folded andpartly unfolded protein.Whenpos-
sible, thermal denaturation curves were ﬁtted to a 4-parameter Hill sig-
moid and a value for themelting temperaturewas estimated, otherwise
a minimum value of transition temperature evaluation was estimated.
The equation for the ﬁtting curve was:
y ¼ bn þ
bn−buj jT
H
THm þ T
H
where bn is the baseline value (θ208) of the native protein, bu is the
baseline value of the partly unfolded protein, T is the temperature, H is
the Hill coefﬁcient and Tm is the melting temperature.
2.3. Mg2+-GCAP2 titrations monitored by intrinsic ﬂuorescence
spectroscopy
Protein sampleswere excited at 290 nmwavelength, while emission
ﬂuorescence spectra were recorded between 300 and 380 nm at 25 °C
in 1 cm quartz cuvette using a Jasco FP-750 spectroﬂuorimeter, where
the scan ratewas set to 60nmmin−1 and excitation and emission band-
width was set to 5 nm. Mg2+ buffers used for ﬂuorescence titration
experiments were prepared using 5 mM Tris–HCl pH 7.5, 150 mM KCl,
100 mM EGTA and MgCl2 at variable concentrations, everything was
dissolved in or diluted with the aforementioned Tris–HCl buffer. Free
Mg2+ concentration for each titration point was calculated according
to the Ca-Mg-ATP-EGTA Calculator software using NIST database
(http://maxchelator.stanford.edu/CaMgATPEGTA-NIST.htm) by ﬁxing
T = 25 °C, pH = 7.5, and ionic strength = 0.15 M. By mixing these
solutions, the ﬁnal free Mg2+ concentration was varied in the 9.8 μM–
29.9 mM range. Protein concentration was ~0.8 μM for each titration
point. After recording three accumulations of the spectrum in the
presence of 100 μM EGTA, only the intensity at the wavelength
corresponding to the maximum intensity of ﬂuorescence emission of
the apo spectrum was monitored for the other titration points, which
was expected to change according to Mg2+-binding.
2056 V. Marino et al. / Biochimica et Biophysica Acta 1853 (2015) 2055–2065
2.4. Isothermal titration calorimetry
Mg2+ binding to apo-GCAP2 was monitored by isothermal titration
calorimetry (ITC) as described earlier [27]. In brief we used an VP-ITC
instrument from Microcal (Northampton, MA, USA) at T = 25 °C, and
the decalciﬁed GCAP2 form was present in the recording cell at 3.6–
14 μM concentration in the same decalciﬁed Tris buffer (5 mM Tris–
HCl pH = 7.5, 150 mM KCl) used for the CD studies. The titration was
performed by subsequential injections of 3–5 μL 10 mM MgCl2 into
the recording cell. Remaining Ca2+ impurities in the decalciﬁed Tris
buffer were determined by a BAPTA absorption assay and ranged from
10 to 13 nM.
Best ﬁtting results of the ITC data were obtained by a sequential two
site binding model implemented in the Origin 7 software package
(Microcal), providing apparent dissociation constants (KD) and enthal-
py changes (ΔH) upon magnesium binding.
2.5. Molecular dynamics simulations
A homology model of human mGCAP1 was built using the three-
dimensional structure of chicken mGCAP1 in its Ca2+-bound form as
template [28], according to a procedure elucidated in a previous work
[29]. All simulation states were modeled either by removing Ca2+ ions
from each respective EF-hand binding site or by substitution with a
Mg2+ ion, thus obtaining the states shown in Fig. 5. In particular, we
prepared starting structures corresponding to: i) two GC-activating
states (oneMg2+ ion bound to EF2, the other EF-hands accommodating
no ion; indicated from now on as EF2Mg
2+
; another one accommodating
two Mg2+ ions, EF2Mg
2+
EF3Mg
2+
); ii) two possible transitory states
(EF2Mg
2+
EF3Ca
2+
and EF2Ca
2+
EF3Ca
2+
); iii) the GC inhibiting state
(EF2Ca
2+
EF3Ca
2+
EF4Ca
2+
); and iv) two hypothetical, presumably non
physiological states (apo protein and EF2Mg
2+
EF3Mg
2+
EF4Mg
2+
).
MD simulations of all seven systems were performed using
GROMACS 4.6.3 simulation package [30], with the CHARMM27 all-
atom force ﬁeld [31,32]. CHARMM27 parameters for describing the
post-translational myristoylation were generated manually, and are
available upon request for academic use. Periodic Boundary Conditions
(PBC)were applied using a dodecahedral box as the cell unit and choos-
ing 12 Å as minimum distance between the protein and the box
boundaries. Water model TIP3P was used to describe the solvent.
Depending on the number of cations bound to the protein, a variable
number of Mg2+ ions was added in the solvation box in order to set
the concentration of Mg2+ ions to 1 mM and to neutralize the system,
together with 29 K+ and 29 Cl− ions, which were added to adjust the
salt concentration to 150 mM while keeping the system neutral. In
detail, the systems included: 32,610 total atoms for the apo form
(9853 water molecules, 6 Mg2+ counterions), 32,619 total atoms for
EF2Mg
2+
(9856 water molecules, 5 Mg2+ counterions), 32,622 total
atoms for EF2Mg
2+
EF3Mg
2+
(9857 water molecules, 4 Mg2+ counter-
ions), 32,622 total atoms for EF2Mg
2+
EF3Ca
2+
(9857 water molecules, 4
Mg2+ counterions), 32,628 total atoms for EF2Mg
2+
EF3Mg
2+
EF4Mg
2+
(9859 water molecules, 3 Mg2+ counterions), 32,622 total atoms for
EF2Ca
2+
EF3Ca
2+
(9857 water molecules, 4 Mg2+ counterions) and
32,628 total atoms for EF2Ca
2+
EF3Ca
2+
EF4Ca
2+
(9859 water molecules,
3 Mg2+ counterions).
All structures were subjected to energy minimization, ﬁrst with the
steepest descent (Fmax = 1000 kJ mol
−1 nm−1) and then with the
conjugate gradients algorithm (Fmax= 500 kJ mol
−1 nm−1), keeping
the position of the backbone atoms and cations bound to the protein
restricted in both cases. The system was then equilibrated at 310 K for
2 ns of backbone position-restrained MD simulations and then at
310 K for 2 ns of unrestricted MD simulations. V-rescale thermostat
[33] was used to keep the system temperature ﬁxed at 310 K, by using
a coupling constant τt of 0.1 ps. The Particle Mesh Ewald (PME) [34]
method was employed to calculate electrostatic interactions. Short
range attractive and repulsive interactions were computed using a
Lennard-Jones potential with a cutoff of 12 Å. LINCS algorithm [35]
was used to constrain all but water molecules bond length, allowing
for an integration time step of 2 fs by the leap-frog algorithm. After
equilibration the system underwent 200 ns unrestrained isothermal-
isobaric (NPT ensemble; T = 310 K, P = 1 atm)MD simulation. System
pressure was set to 1 atm using the Berendsen weak coupling
algorithm [36] with a coupling constant τp of 1 ps.
2.6. Analysis of MD trajectories
Generated MD trajectories were subjected to different analyses. The
surface accessible surface area (SASA) and the root-mean square
deviation (RMSD) were calculated over the 200 ns trajectory, the latter
being referred to each structure after the 4 ns equilibration. The intrinsic
ﬂexibility of the system was evaluated by computing the root mean
squared ﬂuctuation (RMSF) for each amino acid, in the time frame of
the simulation, deﬁned as time averaged-RMSD:
RMSFi ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
T
XT
t j¼1
ri t j
" #
−rre fi
$$$
$$$2
vuut
where T is the 200 nsMD time frame and ri (tj) and ri
ref represent the co-
ordinates of the Cα atom of residue i at the time tj and after 4 ns equili-
bration, respectively.
RMSD and RMSF analyseswere applied only on alpha carbons, while
the SASA was calculated on the entire protein.
All analyses were performed using Wordom software [37,38].
Smoothing of the RMSD and SASA plots as a function of time was
performed with the smoothing function within the SigmaPlot 12
package, by using the running average module with 10,000 intervals
averaging 2000 points each, corresponding to one tenth of the points
in the original dataset. Raw data for RMSD and SASA are reported
without smoothing in Supplementary Figs. S2 and S3, respectively.
Table 1
Structural and biophysical properties of Rec, GCAP1 and GCAP2 in different conditions.
Protein Apo Mg2+ Mg2+ + Ca2+ Ca2+ Ca2+ + Mg2+
θ222/θ208 Tm θ222/θ208 Tm θ222/θ208 Tm θ222/θ208 Tm θ222/θ208 Tm
mRec 0.77 73.1a 0.76 68.8 0.87 76.5 0.86 78.8a 0.88 76.5
nmRec 0.85 73.8a 0.86 68.8 0.90 86.0 0.90 79.4a 0.90 86.0
mGCAP1 0.88 50.1b 0.90 51.5 0.91 NDc 0.91 N70b 0.92 NDc
nmGCAP1 0.88 42.7b 0.91 54.5 0.92 NDc 0.93 N60b 0.91 NDc
mGCAP2 0.89 NDc 0.87 NDc 0.90 NDc 0.89 NDc 0.89 NDc
nmGCAP2 0.90 92.1 0.90 N96 0.88 NDc 0.86 NDc 0.87 NDc
a Data from ref. [39].
b Data from ref. [29].
c Fit not possible.
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3. Results and discussion
3.1. Comparative analysis of the structural effects of Mg2+ on the neuronal
calcium sensor proteins
In order to test whether the sequence of binding events of the
different cations (Ca2+ and/or Mg2+) matters for achieving the speciﬁc
protein structures, for all three NCS proteins analyzed and both for their
myristoylated and non-myristoylated forms we recorded CD spectra in
the far and in the near UV after each of the following steps: i) starting
from the apo protein (saturating [EGTA]); ii) addition of either
1mMMg2+ or saturating Ca2+; and iii) inverting the order of the cation
additions described in the previous point. Results are reported in the
following ﬁgures, while a summary of the results obtained for far UV
spectroscopy and thermal stability is reported in Table 1.
3.2. Effects ofMg2+ on the secondary and tertiary structure of Rec and on its
thermal stability
The addition of saturating Ca2+ to apo-nmRec caused a typical
increase in ellipticity (more negative signal, Fig. 1a), which was
observed in earlier studies [39]. When Mg2+ was added to nmRec
after Ca2+ saturation, a slight decrease in ellipticity was observed in
the far UV (Fig. 1a), but no signiﬁcant change was observed in protein
tertiary structure, as demonstrated by the substantially overlapped
spectra in the near UV region (compare green and red curves in
Fig. 1b), which describe the local asymmetric environment of aromatic
residues known to be especially sensitive to protein tertiary structure.
Interestingly, when Mg2+was added to apo-nmRec, a signiﬁcant
increase in ellipticity was observed both in the far (Fig. 1c) and in the
near UV spectra (Fig. 1d), especially in the dichroic bands of Phe
and Tyr residues, suggesting that the protein might bind Mg2+ in
these conditions. However, when Ca2+ was added on the top
(Mg2++Ca2+), the spectra became undistinguishable from the ones
obtained in the reverse order (compare green lines in Fig. 1b and d).
Thermal denaturation studies showed that theMg2+-bound form of
nmRec in the absence of Ca2+ is less stable than the apo form (Tm
apo=
73.8 °C; Tm
Mg2+ = 68.8 °C; see Fig. S1 and Table 1). However, when
Ca2+ was added at a saturating level after previous incubation with
Mg2+, we observed an increase in stability with respect to the one in
the presence of saturating Ca2+ only (Tm
Mg2+/Ca2+= 86.0 °C, Tm
Ca2+ =
79.4 °C, Table 1). Therefore, the structural effect of Mg2+ on nmRec is
mostly a mild destabilization of the apo form but a major stabilization
of the Ca2+-bound form.
We observed some similar behavior for the myristoylated form of
Rec (mRec) (Fig. 1, Table 1). Indeed, the spectral properties of mRec
appeared to be only slightly affected by Mg2+, both when starting
from the apo and the Ca2+-saturated form. Fig. 1e and g shows that
the overall effect of Mg2+ is dampening the intensity of both the apo
and Ca2+-bound CD spectra in the far UV, but no signiﬁcant perturba-
tion of the spectral shape was observed either in the far or near UV
(Table 1), indicative of an overall good preservation of both the second-
ary and the tertiary structure. In line with these structural ﬁndings,
Mg2+ destabilized both apo and Ca2+-bound mRec, with a more
prominent effect on the apo form (Tm
apo = 73.1 °C; Tm
Mg2+ = 68.8 °C;
Tm
Ca2+= 78.8 °C; Tm
Mg2+/Ca2+= 76.5 °C, see Table 1).
In conclusion, these observations are in linewith previous work [20]
showing that Mg2+may bind Rec, but it does not trigger the conforma-
tional switch, probably because the monodentate, six-coordinate
structure of Mg2+-bound EF-hands in the protein does not allow the
myristic moiety to move out of the hydrophobic cleft where it is buried.
3.3. Effects of Mg2+ on the secondary and tertiary structure of GCAP1 and
on its thermal stability
While the main effect of Mg2+ on the far UV CD spectra of Ca2+-
bound nmGCAP1 was a mild dampening in the intensity of the spec-
trum (Fig. 2a), apo-nmGCAP1 far UV spectra showed appreciable
changes uponMg2+ binding (Fig. 2c and Table 1), consistentwith slight
changes in the secondary structure or protein compactness. The molar
ratio θ222/θ208, which describes quantitatively the spectral shape of all-
α helix proteins, indeed increased from 0.88 to 0.91 (Table 1). Interest-
ingly, while the θ222/θ208 ratio in the presence of both Mg
2+ and Ca2+
substantially did not depend on the order by which the incubation
was performed, the Ca2+-bound form in the absence of Mg2+ showed
a ratio (0.93) slightly higher than all other cases (Table 1). Near UV
Fig. 1. Structural changes occurring in recoverin upon binding of Ca2+ andMg2+. All measurements were performed at T=37 °C in 5mMTris–HCl pH7.5, 150mMKCl, 2mMDTT buffer.
(a) Far UVCD spectra of 9.8 μMnmRec in the presence of 200 μMEGTA (black), 200 μMfree Ca2+ (red) and after addition of 1mMMg2+ (green). (b) Near UVCD spectra of 20.4 μMnmRec
in the presence of 250 μMEGTA (black), 250 μM free Ca2+ (red) and after addition of 1mMMg2+ (green). (c) Far UV CD spectra of 9.8 μMnmRec in the presence of 200 μMEGTA (black),
1mMMg2+ (blue) and after addition of 200 μMfree Ca2+ (green). (d)NearUVCD spectra of 20.4 μMnmRec in the presence of 250 μMEGTA (black), 1mMMg2+ (blue) and after addition
of 250 μM free Ca2+ (green). (e) Far UV CD spectra of 8.1 μMmRec in the presence of 200 μMEGTA (black), 200 μM free Ca2+ (red) and after addition of 1mMMg2+ (green). (f) Near UV
CD spectra of 17.2 μMmRec in thepresence of 250 μMEGTA(black), 250 μMfree Ca2+ (red) and after addition of 1mMMg2+ (green). (g) FarUVCD spectra of 8.1 μMmRec in thepresence
of 200 μMEGTA (black), 1 mMMg2+ (blue) and after addition of 200 μM free Ca2+ (green). (h) Near UV CD spectra of 17.2 μMmRec in the presence of 250 μMEGTA (black), 1 mMMg2+
(blue) and after addition of 250 μM free Ca2+ (green).
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spectra of Ca2+-bound nmGCAP1 showed only very minor variations
upon the addition of Mg2+ (Fig. 2b), in particular in the ﬁne structure
of the Phe region, which could however be attributed to instabilities of
the signal due to protein ﬂexibility.
Interestingly, in line with what we observed for the secondary
structure, binding of Mg2+ to apo-nmGCAP1 caused more pronounced
alterations of the near UV CD spectra, extending from the Phe to the
Trp bands (Fig. 2d). Upon the addition of saturating Ca2+ however,
the spectrum became almost undistinguishable from the one obtained
the other way around (adding Mg2+ ﬁrst and then saturating with
Ca2+; compare green curves in Fig. 2b and d). In conclusion, in the
apo form of nmGCAP1 or at conditions of very low Ca2+, Mg2+ affects
both the secondary and the tertiary structure, but it has substantially
no effect on the Ca2+-bound form. This also reﬂects on the increased
thermal stability of the Mg2+-bound form of nmGCAP1 versus the apo
form (Tm
apo = 42.7, Tm
Mg2+ = 54.5, Table 1), substantially in line with
what was determined by Lim et al. with differential scanning calorime-
try [18]. No estimate of Tm
Mg2+/Ca2+ was possible from the thermal
denaturation curves (see Fig. S1), as the denaturation proﬁle was
apparently monotonic up to ~90 °C.
A slightly different situationwas observed formGCAP1. The addition
of 1 mM Mg2+ to Ca2+-saturated mGCAP1 resulted in a signiﬁcant
Fig. 2. Structural changes occurring in GCAP1 upon binding of Ca2+ and Mg2+. All measurements were performed at T = 37 °C in 5 mM Tris–HCl pH 7.5, 150 mM KCl, 2 mM DTT buffer.
(a) Far UV CD spectra of 13 μM nmGCAP1 in the presence of 200 μM EGTA (black), 400 μM free Ca2+ (red) and after addition of 1 mMMg2+ (green). (b) Near UV CD spectra of 52 μM
nmGCAP1 in the presence of 625 μM EGTA (black), 1.35 mM free Ca2+ (red) and after addition of 1 mM Mg2+ (green). (c) Far UV CD spectra of 13 μM nmGCAP1 in the presence of
200 μM EGTA (black), 1 mM Mg2+ (blue) and after addition of 400 μM free Ca2+ (green). (d) Near UV CD spectra of 52 μM nmGCAP1 in the presence of 625 μM EGTA (black),
1 mM Mg2+ (blue) and after addition of 1.35 mM free Ca2+ (green). (e) Far UV CD spectra of 13 μM mGCAP1 in the presence of 200 μM EGTA (black), 200 μM free Ca2+ (red) and
after addition of 1 mM Mg2+ (green). (f) Near UV CD spectra of 26 μMmGCAP1 in the presence of 400 μM EGTA (black), 400 μM free Ca2+ (red) and after addition of 1 mM Mg2+
(green). (g) Far UV CD spectra of 13 μMmGCAP1 in the presence of 200 μM EGTA (black), 1 mMMg2+ (blue) and after addition of 200 μM free Ca2+ (green). (h) Near UV CD spectra
of 26 μMmGCAP1 in the presence of 400 μM EGTA (black), 1 mMMg2+ (blue) and after addition of 400 μM free Ca2+ (green).
Fig. 3. Structural changes occurring in GCAP2 upon binding of Ca2+ and Mg2+. All measurements were performed at T = 37 °C in 5 mM Tris–HCl pH 7.5, 150 mM KCl, 2 mM DTT buffer.
(a) Far UV CD spectra of 19 μM nmGCAP2 in the presence of 300 μM EGTA (black), 300 μM free Ca2+ (red) and after addition of 1 mMMg2+ (green). (b) Near UV CD spectra of 42 μM
nmGCAP2 in the presence of 600 μM EGTA (black), 1.4 mM free Ca2+ (red) and after addition of 1 mM Mg2+ (green). (c) Far UV CD spectra of 19 μM nmGCAP2 in the presence of
300 μM EGTA (black), 1 mM Mg2+ (blue) and after addition of 300 μM free Ca2+ (green). (d) Near UV CD spectra of 42 μM nmGCAP2 in the presence of 600 μM EGTA (black),
1 mMMg2+ (blue) and after addition of 1.4 mM free Ca2+ (green). (e) Far UV CD spectra of 19 μMmGCAP2 in the presence of 300 μM EGTA (black), 300 μM free Ca2+ (red) and after
addition of 1 mMMg2+ (green). (f) Near UV CD spectra of 42 μMmGCAP2 in the presence of 600 μM EGTA (black), 1.4 mM free Ca2+ (red) and after addition of 1 mMMg2+ (green).
(g) Far UV CD spectra of 19 μMmGCAP2 in the presence of 300 μM EGTA (black), 1 mMMg2+ (blue) and after addition of 300 μM free Ca2+ (green). (h) Near UV CD spectra of 42 μM
mGCAP2 in the presence of 600 μM EGTA (black), 1 mMMg2+ (blue) and after addition of 1.4 mM free Ca2+ (green).
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dampening of the far UV CD spectra (Fig. 1e), but the spectral shape did
not change signiﬁcantly (θ222/θ208= 0.91 versus 0.92, Table 1). In line
with this observation, in the near UV range the addition of Mg2+ did
not affect at all the spectral properties of Ca2+-saturated mGCAP1 in
any of the typical aromatic bands (Fig. 1f).
When Mg2+ was added to apo-mGCAP1, the intensity of the
spectrum did not signiﬁcantly change, although the shape changed in
a similar manner compared to the non-myristoylated form (Table 1).
Spectral alterations were observed also in the near UV range (Fig. 1h),
especially in the Tyr and partially in the Trp band. However, also for
mGCAP1 the spectra obtained by adding ﬁrst Ca2+ and then Mg2+, or
the other way around were substantially indistinguishable from one
another (compare green curves in Fig. 2f and h). Thus, at high Ca2+
the presence of Mg2+ does not inﬂuence the structural properties of
either the myristoylated and non-myristoylated forms of GCAP1.
The presence of Mg2+ slightly stabilized mGCAP1 secondary
structure (Tm
apo= 50.1 °C, Tm
Mg2+= 51.5 °C, Table 1), but no conclusion
could be drawn as to the comparison between the Ca2+-bound form
and the same in the presence of Mg2+, since both transitions were not
complete at 95 °C (Fig. S1, Table 1: Tm
Ca2+
N 70, Tm
Mg2+/Ca2+
N 70 °C).
3.4. Effects of Mg2+ on the secondary and tertiary structure of GCAP2 and
on its thermal stability
The structural behavior of nmGCAP2 in the presence of physiological
Mg2+ signiﬁcantly differed from that observed with GCAP1. No differ-
ence was detected in intensity and shape of the far UV CD spectra
when Mg2+ was added to the apo-nmGCAP2 (Fig. 3c) or to the Ca2+-
saturated form (Fig. 3a), which is reﬂected by the identical θ222/θ208
ratios in the two cases (0.90 and 0.86, respectively; see Table 1). This
might suggest that no Mg2+-binding occurs. However, the presence of
Mg2+ slightly inﬂuenced the environment of aromatic residues, both
with or without Ca2+-saturating levels (Fig. 3b and d), as proven by
small but signiﬁcant alterations of the near UV ﬁne spectra. Surprisingly,
the effect was more apparent when Mg2+ was added after Ca2+-
saturating levels (Fig. 3b), where differences could be appreciated in
the Phe and Tyr bands.
From the analysis of thermal denaturation curves it was not possible
to assess a value for the melting temperature for any of the tested case,
since no transition apparently occurred at T b 96 °C (Fig. S1).
Similar to what we observed for the non-myristoylated form,
addition of Mg2+ to the Ca2+-saturated mGCAP2 did not perturb its
secondary structure, as demonstrated by the overlapped far UV CD
spectra (Fig. 3e, compare green and red curves), which was quantita-
tively conﬁrmed by the identical (0.89) θ222/θ208 ratios (Table 1). Also
in this case however, the tertiary structure appeared to be somewhat
sensitive toMg2+, even after saturationwith Ca2+ (Fig. 3f), as indicated
by spectral changes and a decrease in intensity of the dichroic bands of
Phe and Tyr residues. Interestingly and at odds with the non-
myristoylated form, Mg2+ slightly perturbed the far UV CD spectrum
of apo-mGCAP2 (Fig. 3g), with the θ222/θ208 ratios shifting from 0.89
to 0.87 (Table 1), but adding saturating Ca2+ restored the original
spectral shape and intensity (Fig. 3g and Table 1; compare green curves
in Fig. 3e and g). However, the tertiary structure resulted to be far less
affected by Mg2+ when starting from the apo form of mGCAP2
(Fig. 3h), and saturating with Ca2+ restored a similar Ca2++Mg2+
spectrum (see Fig. 3f for comparison). Also formGCAP2, no clear conclu-
sion as to the role of Mg2+ in stabilizing each structural state could be
drawn from the analysis of thermal denaturation proﬁles because no
transition was visible in any case (Fig. S1). The only appreciable
difference was the thermal denaturation proﬁle of mGCAP2 in the sole
presence of Mg2+, which compared to the non-myristoylated form,
seems to start a transition earlier, thus suggesting a lower thermal
stability (Fig. S1).
In conclusion, results from CD spectroscopy for m/nmGCAP2
signiﬁcantly differ from those for GCAP1 and suggest that Mg2+might
bind to GCAP2 with different afﬁnity and/or dynamics than it does to
GCAP1. The binding might however be speciﬁc for different activation
states of the calcium sensor. In particular, we could observe the follow-
ing: i) for nmGCAP2, if the binding occurred, it would affect only the
local environment of its aromatic residues, mostly and surprisingly at
high [Ca2+]; ii) for mGCAP2, results from far UV CD suggest that the
binding might occur in the condition of low Ca2+, however this would
leave the tertiary structure substantially unperturbed; and iii) for
mGCAP2, results from near UV CD suggest that the local environment
of its aromatic residues is inﬂuenced by physiological Mg2+ even after
saturation with Ca2+.
While the conclusions from our CD spectroscopy analysis of GCAP1
are substantially in line with what is known as to the role of Mg2+
interacting with the NCS, and are compatible with deﬁned structural
consequences of a pure binding process, results for GCAP2 seem intrin-
sically hard to interpret, and somewhat contradictory. Overall, the data
are not feasible for an interpretation based on a pure binding process,
and in fact they raise some questions. Is GCAP2 binding Mg2+ depend-
ing on the presence of themyristoyl moiety? Does the putative binding
occur even in the presence of saturating Ca2+, thus presumably in other
binding sites than those highly speciﬁc for Ca2+? We tried to answer
some of these questions by further focusing on the putative interaction
of GCAP2 with Mg2+.
3.5. Biophysical studies of the interaction between myristoylated/non-
myristoylated GCAP2 and Mg2+
In order to quantitatively investigate the binding of Mg2+ to GCAP2,
we performed ITC experiments starting from conditions of carefully
decalciﬁed proteins and buffers. While for nmGCAP2 the pattern of
heat pulses observed in all the titration experiments was incompatible
with a binding process (results not shown), only in 4 out of 15
experiments performed with mGCAP2 the observed pattern was
Fig. 4. Example of Mg2+-mGCAP2 binding curve monitored by ITC. The upper part shows
theheat pulse obtained by the injection 5 μL 10mMMgCl2 in 14 μMmGCAP2 indecalciﬁed
Tris buffer. The lowerpart displays the resulting enthalpy changeas a function of themolar
ratio of Mg2+ and mGCAP2 and the ﬁtting curve.
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ascribable to a binding process. An example of successful titration is
reported in Fig. 4, and a summary of the obtained thermodynamic
parameters is shown in Table 2. Fitting the data to a sequential two-
site binding model led to a physiologically relevant afﬁnity (320 μM)
for the ﬁrst binding site and a non-physiological (4.4 mM) afﬁnity for
the second, lowest afﬁnity binding site, similarly to what has been
previously obtained by Lim et al. [18] for GCAP1.While the four success-
ful titrations were per se reproducible and compatible with an exother-
mic process, we stress that in themajority of the other cases and in spite
of the same experimental conditions and protein samples used in
repeated experiments, no speciﬁc binding pattern could be obtained,
thus pointing to a phenomenon thatmight be intrinsically poorly repro-
ducible. Indeed, when we tried an alternative approach to detect Mg2+
binding to GCAP2 by performing titration experiments using the intrin-
sic Trp ﬂuorescence of the protein with the same setup previously used
for GCAP1 [17], we could neither observe a reproducible pattern for
mGCAP2 nor for nmGCAP2 (results not shown).
Overall, our results clearly showed that the structural effects of
Mg2+ on GCAP2 and the binding mode signiﬁcantly differ from what
has been so far observed for GCAP1. In particular, under the tested
conditions it has been especially difﬁcult to measure binding constants
for Mg2+, as some other process not occurring for GCAP1 seems to
interfere with the putative binding of Mg2+. One possibility to explain
our data is that GCAP2 may be dimeric independent of the Ca2+ levels
[40]. In particular, the observation that in the apo form GCAP2 is more
ﬂexible [40] may explain, at least partly, why the observed changes in
far UV CD spectra (Fig. 3g) could be ascribed to the binding of Mg2+.
However, it could well be that even slight changes in the amount of
cations as well as in protein concentration lead to different populations
of monomers vs. dimers, which would complicate the interpretation of
ITC and ﬂuorescence data. Another possible phenomenon interfering
with our titration experiments could be the different behavior of the
myristoyl moiety in mGCAP2. Like in GCAP1, the acylic group does not
extrude totally in a myristoyl switch fashion [41], however and at
odds with GCAP1 it seems to be rather exposed to the solvent in both
apo and Ca2+ states [42] and more sensitive to the external environ-
ment, as seen in experiments with membranes and micelles [43]. This
could also partially contribute to the complex behavior observed in
our experiments.
3.6. Molecular dynamics simulations of different regulatory states of
myristoylated GCAP1
3.6.1. Diverse GC activating and inhibitory states of mGCAP1
While it is generally established that the fully Ca2+-loaded state of
GCAP1 is responsible for themaximal inhibition of theGC target, several
recent lines of evidence showed that, when Ca2+ concentration drops to
lower values (20–50 nM) as a consequence of photoreceptor illumina-
tion, it is a speciﬁc Mg2+-bound form of GCAP1 rather than its apo
state, that triggers the activation of GC [17,19,21]. In different studies,
Peshenko et al. measured by ﬂuorescence spectroscopy a moderate
afﬁnity of GCAP1 for Mg2+ (~0.25 mM), which was shown not to
depend signiﬁcantly on the presence of myristoylation [17,44]. The
binding was also conﬁrmed by ITC experiments performed by the
same authors, although the detected afﬁnity for the only physiologically
relevant binding constantwas lower (~0.7mM) [18]. These quantitative
data confer reliability to the hypothesis that, at least one EF-hand in
GCAP1 may be occupied by Mg2+, when [Ca2+] is signiﬁcantly low. By
means of exhaustive mutational analysis and functional assays the
same group demonstrated that the metal-free state of EF3, supposedly
the lower afﬁnity binding site for Mg2+, reduced the efﬁciency of GC
binding and activation, thus leading to the conclusion that the binding
of a cation to EF3 seems necessary for reaching the proper functional
state of the target enzyme [19,45].
By making use of the knowledge arising from these previous studies
we set up 200 ns MD simulations of mGCAP1 in seven different states,
reported in Fig. 5. We simulated the states corresponding to low
[Ca2+] and light-exposed conditions, where EF2 is necessarily occupied
by Mg2+, which was predicted to be bound to EF3 as well in order to
activate the GC efﬁciently [21]. We also simulated the dark-adapted
state that inhibits GC, in which EF2, EF3 and EF4 are all occupied by
Ca2+ [21] and built models for intermediate, transitory states, in
which Ca2+ has dissociated from the lowest afﬁnity site EF4, and EF2
is either still occupied by a Ca2+ or a Mg2+ ion. Finally, for the sake of
comparison of structure dynamics, we simulated two putative states:
one in which no EF-hand is occupied by any cation (apo), and the
other one where all three EF-hands are ideally occupied by Mg2+ ions.
Neither of these states is likely to be physiologically relevant, as in the
ﬁrst case it was demonstrated by comprehensive mutagenesis experi-
ments that GCAP1mutants that do not bind Ca2+ andMg2+ are incapa-
ble of activating GC [46]; on the other hand, the rather low afﬁnity of
GCAP1 for Mg2+ compared to the ~1 mM intracellular concentration
together with the competition for Ca2+ makes it rather unlikely that
more than two binding sites are ever occupied by Mg2+ even in the
total absence of Ca2+.
In the following paragraphs, we shall present the results of MD
simulations of diverse GCAP1 states by ﬁrst comparing the structure of
each state after 4 ns equilibration with that of the apo form, in which
no EF-hand is occupied by any cation, and then describing the structural
features observed in the 200 ns MD production phase.
3.6.2. General structural properties of mGCAP1 states after equilibration
The comparison of seven mGCAP1 states before the production
phase of MD simulations conﬁrmed that important structural
differences that distinguish speciﬁc states with respect to the putative
apo form already manifest in the equilibration phase. As a clarifying
example, Fig. 6 reports on the comparison between the equilibrated
structures (after 4 ns) of apo-mGCAP1 and the fully Ca2+-loaded state
EF2Ca2+ EF3Ca2+ EF4Ca2+ (holo). In apo-mGCAP1 all EF-hands were in
an “open” conformation, resulting in an overall higher accessibility to
Table 2
Thermodynamic parameters for Mg2+ binding to mGCAP2.
KD
1/mM KD
2/mM ΔH1/kcal mol−1 ΔH2/kcal mol−1
0.32 ± 0.20 4.4 ± 2.3 −4.6 ± 3.5 −2.7 ± 35.6
Fig. 5. Regulatory states of mGCAP1 simulated in 200 nsmolecular dynamics simulations.
Each of the cation-binding EF-hand is indicated. Writing in italics refers to a binding site
occupied by either a Ca2+ (red sphere) or Mg2+ (green sphere) ion. The schematic
positioning of each state refers to the light conditions and the relative intracellular levels
of Ca2+, represented at the top of the ﬁgure.
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the solvent as compared to the holo-mGCAP1. The fully Ca2+-loaded
state appeared indeed more compact already at the beginning of the
MD production phase. After the equilibration phase, the myristoyl
group in apo-mGCAP1 was bent at C5, to tighten the interaction with
key hydrophobic residues, among which Phe 43, Leu 45, Phe 63 and
Leu 80, and marginally Tyr 76. A similar bent conformation was
observed for the myristic group in holo-mGCAP1, although the motion
of the N-terminal loop toward the protein interior in the holo form
signiﬁcantly reduced the interaction with Phe 63, while maintaining
the other hydrophobic interactions substantially unaltered (Fig. 6).
3.6.3. Structural dynamics of putative GC-activating states over 200 ns
simulations
The 119–132 loop interconnecting EF3 with EF4 (represented in
gray in Fig. 6) was generally highly ﬂexible in the tested states, as
reﬂected by the high RMSF values found for this structural region over
200 ns (Fig. 7b). Moreover, in some of the tested states the 120–125
strand of this loop acquired a localα-helix conformation, which showed
a transient behavior. In contrast to other states however, in the apo-
mGCAP1 the loop was found to be rather stable and the local helix
conformation persisted over the 200 ns simulation. Another peculiar
feature of the apo state was a conserved pair of H-bonds between the
backbone groups NH of Ile 107 and C_O of Leu 151 and NH of Leu
153 and C_O of Gly 105, which created a short antiparallel β-sheet
stable during the 200 ns simulation, which contributed to maintain
EF3 and EF4 in an open conformation. Interestingly, both residues Ile
107 and Leu 151 have been found to be mutated respectively in Thr
and Phe in patients suffering from cone dystrophy [47,48]. Another
similarly short β-sheet was observed between EF1 and EF2, which how-
ever was not stable during the production phase. The hydrophobic
interactions stabilizing the myristoyl moiety were generally conserved.
When all the EF-hands were virtually occupied by a Mg2+ ion (EF2Mg
2+
EF3Mg
2+
EF4Mg
2+
) the Cα-RMSD calculated with respect to the apo form
after the 4 ns equilibration was 3.4 Å, the highest in the whole series of
GCAP1 simulated states. An apparent difference was the kink of the
myristoyl group at C10, due to the hydrophobic interaction with Leu
80, but structural differences were generally spread over the whole
tertiary structure, especially at the EF3 motif and 119–132 loop. Overall
the EF2Mg
2+
EF3Mg
2+
EF4Mg
2+
form was the most dynamically compact
one in the series, as clearly shown by the lowest SASA proﬁle (Fig. 7
and Fig. S3). After the ﬁrst 50 ns dynamics production the structure
was signiﬁcantly stable, and even the highly dynamic 119–132 loop
showed only minor rearrangement as compared to other cases. With
respect to the equilibrated structure, main differences concerned only
the EF3 loop and the conformation of the myristoyl moiety, likely due
to an outward rigid displacement of the C-terminal helix.
3.6.4. Structural dynamics ofmore realistic GC-activating states over 200 ns
simulations
The structure of mGCAP1 with one Mg2+ bound to EF2 (EF2Mg
2+
)
after equilibration was signiﬁcantly different from the apo form, with
a Cα-RMSDof 2.8 Å. The EF2 loop (64–76),whichwas in anopen confor-
mation in the apo form, became now properly closed to bind a Mg2+
cation. The myristoyl group was still involved in interactions with Phe
43 and Leu 45 with the same orientation as in the apo form, while Phe
63 acquired a different conformation, resulting in a weaker interaction,
similar towhat was observed for the holo form. New stabilizing interac-
tions involved Val 83 and Leu 176. The main structural difference with
apo-mGCAP1 in the N-term domain was a different inclination and
orientation of the entering helix (helix E) in the EF2 motif. Signiﬁcant
variations were observed also in the C-term domain, where helices
had generally undergone rigid motions and the 119–132 loop showed
a signiﬁcantly different conformation.
During the course of the 200 ns simulation the structure of EF2Mg
2+
mGCAP1 was overall fairly stable when compared to all other GCAP1
states, which is reﬂected by the stable and lowest Cα-RMSD proﬁle
(Fig. 7a). Even the 119–132 region was rather stable, as shown in
Fig. 7b. The most ﬂexible region was the 142–148 stretch (Fig. 7b),
which corresponds to the E-helix and the loop of EF4. The formation
of the transient helix in the 119–132 loop connecting EF3 and EF4 was
also observed. Interestingly, due to the fact that residues 2–8 (N-termi-
nus) tend to close toward the protein core, in line with the decrease in
the overall SASA (Fig. 7c) the myristic moiety became kinked at the
level of C4, acquiring a novel L-shaped conformation that was fairly
stable in the simulated time course. Overall, the SASA proﬁle conﬁrmed
that after approximately 40 ns the EF2Mg
2+
mGCAP1 structure, like all
the other Mg2+-only-bound cases, acquired an overall conformation
less solvent-exposed compared to the tested Ca2+-bound forms
(Fig. 7c).
The other mGCAP1 state hypothesized to be relevant for GC activa-
tion, in which two Mg2+ ions are bound respectively to EF2 and EF3
(EF2Mg
2+
EF3Mg
2+
) showed a 3.2 Å Cα-RMSD compared to apo
mGCAP1, which became 1.9 Å when compared to EF2Mg
2+
. Comparison
with the EF2Mg
2+
state highlighted, as the main difference, a higher
ﬂexibility of the 119–132 region in the time course of the 200 ns-
simulation (Fig. 7b), otherwise a rather similar conformation was
observed. In line with what was observed in the EF2Mg
2+
form, the
SASA stabilized after ~80 ns to an average value that was lower com-
pared to the Ca2+-bound forms. The acyl chain of the myristoyl group
in some of the frames kinked around C7 and was stabilized by interac-
tions with Phe 63, Trp 21 and Val 83. Moreover, the simulation showed
a rotation of themyristoyl group around C1 leading to an L-shaped con-
formation, which was however signiﬁcantly less stable than the one
observed for EF2Mg
2+
.
Fig. 6. Cartoon structural model of mGCAP1 in the apo form (left), and in the fully Ca2+-loaded form (right) after 4 ns equilibration in all-atomMD simulations. The EF1motive is yellow,
EF2 green, EF3 orange and EF4 violet blue. Loops interconnecting EF-hand motifs are colored gray, while the N-term and the C-term are colored pale pink and pale cyan, respectively. The
myristoyl moiety is represented by purple sticks. Themain residues interactingwithmyristoyl are also represented by sticks, labeled and colored according to the structural elements they
belong to. The SASA, shown in transparency, is 10,606 Å2 for the apo form and 10,043 Å2 for the Ca2+-bound form.
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Overall, the conformation of EF2 and EF3 was in a closed form, very
similar to that of EF2Mg
2+
, even though the latter had noMg2+ bound to
EF3. This seems to support the idea that binding of Mg2+ to EF3 is not
essential to properly structure the EF3 loop and make GCAP1 switch
to its GC activating state, although the ion occupancy of EF3 seems to
be a functional requirement [19,45].
3.6.5. Structural dynamics of putative GCAP1 transitory states over 200 ns
simulations
The mGCAP1 state with one Mg2+ ion bound to EF2 and one Ca2+
ion bound to EF3 (EF2Mg
2+
EF3Ca
2+
) showed a signiﬁcant Cα-RMSD
(2.8 Å) compared to the apo state already after equilibration. The
myristoyl moiety was kinked at C4 and C8, overall inducing an S-
shape in the acylic chain after equilibration. During the 200 ns MD pro-
duction themyristoylmoietywas rather ﬂexible, with kinksmaintained
at C7/C8, and some extended conformations observed in some frames.
The 119–132 loop was quite ﬂexible over the simulated time frame,
while peculiar features of this state were: i) the short helix at the C-
terminus, which closed up toward the protein interior right after the
equilibration phase, and stabilized there for the whole MD production;
ii) the appearance of another ﬂexible region, namely the loop 142–149
associated to EF4; and iii) helix E in EF1 was observed to oscillate in a
rigid fashion around a rather stable average position. These structural
features resulted in a 2.3 Å RMSD value after the 200 nsMD production
as compared to the GC activating state EF2Mg
2+
(Fig. 8).
Rather different structural features characterized the other putative
state of mGCAP1, namely that with two Ca2+ ions bound to EF2 and EF3
(EF2Ca
2+
EF3Ca
2+
). The ﬁrst difference appeared clearly after equilibra-
tion, as the Cα-RMSD (3.5 Å) compared to apo form was signiﬁcantly
higher than that calculated with respect to EF2Mg
2+
EF3Ca
2+
(2.3 Å),
which maintained rather similar even at the end of 200 ns simulations
(2.1 Å; Fig. 8). Binding of Ca2+ to both EF-hands constrained the confor-
mation of the relative loops and made the two EF-hands interact more
tightly with one another, with far reaching effects on thewhole tertiary
structure. Indeed, the time course of the Cα-RMSD increased monoton-
ically (Fig. 7a), and reached the highest values in thewhole set of tested
Fig. 7. Structural descriptors of mGCAP1 dynamical features calculated on the trajectories
obtained by 200 ns all-atom molecular dynamics simulations. All ﬁgures have the same
legend: apo black, EF2Mg
2+
red, EF2Mg
2+
EF3Mg
2+
green, EF2Mg
2+
EF3Ca
2+
blue, EF2Mg
2+
EF3Mg
2+
EF4Mg
2+
cyan, EF2Ca
2+
EF3Ca
2+
pink, EF2Ca
2+
EF3Ca
2+
EF4Ca
2+
gray. (a) Smoothed
curves describing the time evolution over 200 ns of the Cα-RMSD calculated with respect
to the relative equilibrated structure (for raw data see Fig. S2). (b) RMSF of Cα atoms for
each amino acid calculatedwith respect to the equilibrated structure. (c) Smoothed curves
describing the time evolution over 200 ns of the SASA for eachmGCAP1 state (for rawdata
see Fig. S3).
Fig. 8. Structural representation of the transition from inhibitor to activator state of
mGCAP1. Left: front view, right: side view, rotated π/2 counter-clockwise. EF2Ca
2+
EF3Ca
2+
EF4Ca
2+
inhibitor state is colored in gray, EF2Ca
2+
EF3Ca
2+
transition state is pink,
EF2Mg
2+
EF3Ca
2+
transition state is blue and EF2Mg
2+
activator state is red. α-Helices are
represented as cylinders, β-sheets are represented by arrows, the myristoyl group is
represented by sticks and Mg2+ and Ca2+ ions are represented by green and red spheres,
respectively. Each structure represents the ﬁnal frame after 200 ns MD simulations. Cα-
RMSD values for the overlapped structures are respectively 2.8 Å (top), 2.1 Å (middle)
and 2.3 Å (bottom).
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states, suggesting that this state of mGCAP1 is indeed rather unstable,
and may precede EF2Mg
2+
EF3Ca
2+
in the time course of GCAP1 switch
from GC inhibitory to activating states.
Peculiar features in the binding pocket of the myristoyl moiety were
observed. The myristoyl group did not interact anymore with Leu 176
but was stabilized by interactions with Leu 80 and Tyr 76 which, com-
pared to other cases, showed here a stronger interaction with the acylic
chain. Interestingly, the Cα-RMSD calculatedwith respect to the EF2
Mg2+
EF3Mg
2+
form was 2.1 Å after equilibration, and the structures were in-
deed rather similar, except for the highlyﬂexible interconnecting region
119–132 and the conformation of EF-4 at the level of the 142–148
region (E-helix and loop). Nonetheless, the EF2Ca
2+
EF3Ca
2+
form showed
overall high local ﬂexibilities compared to the all other forms in several
structural regions, as clearly shown by the RMSF plots (Fig. 7b). This is
presumably due to the fact that this transitory state serves indeed to
induce to the GC the transition from inhibitor to activator states, there-
fore an overall ﬂexibility may be necessary. Among themost prominent
collectivemotions occurring during the course of the 200ns dynamics, a
slight outward tilt of helix E in EF3was observed, aswell as a rotation of
the ψ angle between the peptide bond involving the myristoyl moiety
and that of Gly 2, a feature already observed after equilibration.
The SASA proﬁle (Fig. 7c) highlighted already after 80 ns a higher expo-
sition to the solvent compared to all other forms with only Mg2+ ions
bound.
3.6.6. Structural dynamics of the GC inhibiting state over 200 ns simulations
The structure of the Ca2+-saturated, holo-mGCAP1, correspond-
ing to the GC-inhibitory state (EF2Ca
2+
EF3Ca
2+
EF4Ca
2+
) showed a
Cα-RMSD of 2.7 Å with respect to the apo form after equilibration.
Major differences concerned the structure of all three EF-hand
calcium-binding loops, as already described in Section 3.6.2 (see
Fig. 6). The Cα-RMSD with respect to the EF2
Ca2+ EF3Ca
2+
state after
4 ns equilibration was 2.3 Å, mostly ascribable to differences in the
ﬂexible interconnecting loop 119–132 and EF4, as expected consid-
ering that EF4 is the binding site with the lowest afﬁnity for Ca2+
[18,29]. However, the structural difference increased in the time
course of MD simulations, resulting in a 2.8 Å RMSD after the produc-
tion phase (Fig. 8).
Analysis of MD simulations over the 200 ns showed signiﬁcant var-
iations in theN-terminal part, especially in the2–8 strand,which caused
signiﬁcant changes in the amplitude of the O_C–C1–C2 dihedral angle
in the myristoyl moiety, which remained stable in the 50–200 ns time
frame.
Interestingly, despite the Cα-RMSD increased monotonically up to
~100 ns, reaching values among the higher ones within the tested set
of mGCAP1 states (Fig. 7a), it then stabilized to values lower than
those of the apo, EF2Ca
2+
EF3Ca
2+
, EF2Mg
2+
EF3Mg
2+
and EF2Mg
2+
EF3Ca
2+
states although the SASA (Fig. 7c)was higher than the respective values
for these states, except for EF2Ca
2+
EF3Ca
2+
.
3.6.7. General conclusions from MD simulations: essential structural
features for switching between different mGCAP1 regulatory states
Results from our MD simulations provide a structural interpretation
that is missing so far. For instance, it provides an explanation why at
least one Mg2+ ion has to be bound to mGCAP1 in order to switch to
its activating state. Indeed, when Mg2+ is bound to EF2, structures are
characterized by a more compact conformation, with reduced SASA
compared to the inhibitory state (see Fig. 7c). The analysis also suggests
another reason for apo-mGCAP1 not to exist physiologically, namely
that it is characterized by high solvent accessibility (Fig. 7c) and too
many regions of high ﬂexibility (Fig. 7b). Such a state would very likely
interfere with the stable and site-directed targeting to the GC. The ﬁnal
conformation of the myristoyl moiety is similar in both Mg2+-bound
activating states (EF2Mg
2+
and EF2Mg
2+
EF3Mg
2+
), and signiﬁcantly differs
from that of the transitory and inhibitory states.
Exchanging Mg2+ for Ca2+ in EF2 seems also a crucial step in deﬁn-
ing the transitory state, in order to drive mGCAP1 toward its fully
activating state. It is in fact apparent fromMD simulations that the tran-
sitory state with two Ca2+ ions bound is structurally far less stable and
compact than the one with one Mg2+ and one Ca2+ ion bound (Fig. 7).
While our data are in agreementwithMg2+ beingbound to EF2 in order
to achieve structural features allowing the activation of the GC [21], re-
sults fromMD simulations suggest that the binding of Mg2+ also to EF3
would cause an extreme ﬂexibility of the 119–132 loop, and a general
higher ﬂexibility compared to the case in which the EF3 site is empty
(Fig. 7a and b). On the other hand, it has been previously demonstrated
that binding of a cation to EF2 is crucial for GCAP1 attachment toGC, and
that in EF3 it is in fact less critical, although it enhances the efﬁciency of
the GCAP1 docking on the target enzyme [19] and its maximal stimula-
tion [45]. The overall moderate afﬁnity of GCAP1 for Mg2+ would still
allow an occupancy of EF2 by Mg2+ of about 55% and of EF3 of about
33% in the absence of competition with Ca2+ (see Supplementary Infor-
mation). Moreover, the binding of GCAP1 to the GC target might stabi-
lize its structure and reduce the intrinsic ﬂexibility, therefore the
results from our MD simulations appear substantially in line with the
current model of Mg2+/Ca2+ exchange in the regulation of GC by
GCAP1 [21].
Finally, it is worth noting that besides the intrinsic differences in
structural features typical of eachGCAP1 regulatory state, no occurrence
of dramatic conformational changes was observed in our MD simula-
tions, the overall Cα-RMSD never exceeding 4 Å (Fig. 7). This ﬁnding is
in line with a very recent work by Lim et al. [49], in which a mutant of
GCAP1 lacking Ca2+ binding in EF4 and thus mimicking the transition
to the activating state was found to have similar NMR backbone
chemical shifts compared to wild type Ca2+-saturated GCAP1, thus
suggesting the absence of dramatic conformational changes.
A graphical summary of the dynamical features of mGCAP1
switching from the GC inhibitory state to the GC activating form is
reported in Fig. 8. The ﬁgure shows a snapshot of the regulatory states
after 200 ns MD simulations, in their transition toward the activating
state, upon release of Ca2+ ions from the three EF-hands, and
replacement with a Mg2+ ion in EF2.
4. Conclusions
By using different biophysical techniques we demonstrated that the
structural effects of physiological Mg2+ on the regulatory state strongly
depend on the speciﬁc neuronal calcium sensor. While Rec in its
myristoylated form constituting the physiological condition is only
slightly affected by Mg2+ in terms of protein structure and stability,
GCAP1 and GCAP2 are both signiﬁcantly affected. In particular, our
results conﬁrm that the GC activating state of GCAP1 requires the
presence of at least a Mg2+ ion bound to the EF2 motif, a result consis-
tent with previous biochemical investigations [45]. MD simulations
further suggest a sequence of dynamical events that accompany the
switch of mGCAP1 from its GC inhibitory to its activator state, which
include: i) the release of a Ca2+ ion bound to EF4; ii) the Mg2+/Ca2+
ion exchange in EF2; iii) and the release of a Ca2+ ion bound to EF3.
These events accompany the structural transition toward a rather
compact state, in which themyristoyl moiety shows a certain ﬂexibility,
and is eventually stabilized in a conformation that differs signiﬁcantly
from that of the holo, inhibitory state. It will be interesting to further
investigate, whether the transition does strengthen and/or stabilize
the interaction with the target GC.
The structural behavior of nm/mGCAP2 in the presence of Mg2+
appears signiﬁcantly different from that of GCAP1, and overall rather
complex. While our data clearly show that Mg2+ does exert an effect
on the structure of both GC-activating and inhibitory states, it likely af-
fects speciﬁc oligomeric states of GCAP2, perhaps inﬂuencing the
environment of the myristic moiety in ways yet to be clariﬁed in future
studies.
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ABSTRACT: Shaping the temporal response of photo-
receptors is facilitated by a well-balanced second messenger
cascade, in which two neuronal Ca2+-sensor proteins operate in
a sequential relay mechanism. Although they share structurally
similar sensing units, they diﬀerentially activate the same target
protein. Here, as a prototypical case in Ca2+-mediated signal
processing, we investigate diﬀerential cellular responsiveness in
protein conformational dynamics on a nanosecond time scale.
For this, we have site-speciﬁcally labeled cysteine residues in
guanylate cyclase-activating protein GCAP1 by the ﬂuorescent
dye Alexa647 and probed its local environment via time-resolved ﬂuorescence spectroscopy. Fluorescence lifetime and rotational
anisotropy measurements reveal a distinct structural movement of the polypeptide chain around position 106 upon release of
Ca2+. This is supported by analyzing the diﬀusional dye motion in a wobbling-in-a-cone model and by molecular dynamics
simulations. We conclude that GCAP1 and its cellular cognate GCAP2 operate by distinctly diﬀerent switching mechanisms
despite their high structural homology.
S patial and temporal variations in intracellular Ca2+ signalsare key phenomena in physiological processes like, for
example, fertilization, apoptosis, muscle contraction, and
sensory perception.1−3 A general open question in Ca2+-
mediated signal processing is how physiological speciﬁcity is
achieved by unique forms of target interaction and activation.
For example, the ubiquitous Ca2+ sensor calmodulin can adopt
diﬀerent three-dimensional structures depending on target
binding,2 whereas members of the neuronal Ca2+ sensor (NCS)
protein family share common structural features like EF-hand
Ca2+-binding sites but are more speciﬁc in target regulation.3
However, all these signaling pathways have in common that a
Ca2+-induced conformational change in the speciﬁc Ca2+ sensor
triggers subsequent protein−protein interaction modes and
diﬀerent target regulatory features.
Photoreceptor cells are remarkable single photon detectors,
in which Ca2+ transport and Ca2+-sensor systems fulﬁll key
functions for temporally precise responses. Utilizing the second
messengers cGMP and Ca2+, these cells respond to changing
light conditions on a millisecond time scale.4 Negative feedback
loops further control and shape photoreceptor responses,
thereby involving NCS proteins like guanylate cyclase-
activating proteins (GCAP) that target membrane guanylate
cyclases.5−7 GCAPs harbor three functional EF-hands and
operate in a Ca2+-relay mode fashion in photoreceptor cells,8−10
which is evident by diﬀerences in Ca2+-sensing and catalytic
eﬃciency of target regulation,8−16 electrophysiological record-
ings,9,17 and computational modeling.18
The response to ﬂuctuating Ca2+-concentrations by GCAPs
is assumed to be mediated by conformational changes.11−16 For
GCAP2, this conformational change was found, in an earlier
time-resolved ﬂuorescence study, to reﬂect a piston-like
movement19 of the α-helix situated between positions C111
and C131. This raises the interesting question of whether the
structurally related GCAP1 protein undergoes a similar or even
identical conformational transition, even though it diﬀers
signiﬁcantly in its Ca2+-signaling properties. Speciﬁcally, one
may ask whether these functional diﬀerences are already
manifesting in early stages of Ca2+-controlled protein dynamics.
Previous studies of GCAP1 did not yet conclusively address
those questions. Static studies of tryptophan ﬂuorescence
quantum yield and Ca2+-induced modiﬁcations of cysteines
showed conformational transitions without, however, providing
insight into structural dynamics.14,23,24 An amide hydrogen−
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deuterium exchange study indicated movements of the N-
terminal and C-terminal fragment upon Ca2+-dissociation.25
Employing a GCAP1 mutant with an inactive EF-hand 4 in an
NMR spectroscopy approach suggested a remote control
mechanism, in which EF-hand 4 inﬂuences EF-hand 1 for
switching the protein form the activator to the inhibitor
state.26,27
Here, we study the conformational dynamics of GCAP1 by
time-resolved ﬂuorescence spectroscopy. Mutants of GCAP1
were expressed with all but one of its four cysteine residues
replaced, checked for functionality, and then site-speciﬁcally
labeled with the ﬂuorescent dye Alexa647. The local environ-
ment of the dye was probed by time-resolved ﬂuorescence
spectroscopy in the apo-state and with either Ca2+ or Mg2+
bound to the protein. A major conformation rearrangement of
the polypeptide chain around amino acid position 106 is
revealed upon release of Ca2+. These results are supported by a
wobbling-in-a-cone model analysis and by molecular dynamics
simulations, which overall suggest distinctly diﬀerent switching
mechanisms for GCAP1 and GCAP2 upon Ca2+ release.
■ RESULTS AND DISCUSSION
Biochemical Properties of Labeled GCAP1 Mutants.
Native GCAP1 contains four cysteine residues at positions C18,
C29, C125, and C106 (Figure 1a). In previous work we
constructed and thoroughly analyzed the biochemical proper-
ties of isolated cysteine mutants of nonmyristoylated (nmyr)
GCAP1 revealing that all mutants are functional.22 In the
present work, nmyr and myristoylated (myr) mutants with one
C left were expressed in E. coli, puriﬁed, and biochemically
analyzed. The remaining cysteine in mutants annotated CAAA
(C18), ACAA (C29), AACA (C106), and AAAC (C125)
allowed site-speciﬁc labeling with the ﬂuorescent dye Alexa647
(see Table 1). Degree of myristoylation was high for all
mutants as routinely observed for wildtype GCAP1 (88 to
95%). Labeling with Alexa647 was also successful for all
mutants yielding (84 to 95%), except for nmyrC125 and
myrC125, where 78% and 63% were obtained, respectively.
Attachment of Alexa647 did not impair the Ca2+-sensitive
activating properties of GCAP1, since all labeled GCAP1 forms
activated native rod outer segment guanylate cyclase 1 (ROS-
GC1) with similar IC50 values, i.e. deﬁning the free Ca
2+
concentration of half-maximum guanylate cyclase activation
(Figure 1b). In addition, we labeled nmyrGCAP1 variants and
determined their Ca2+-sensitive activation proﬁles. All curves
were similar but shifted to slightly higher free Ca2+-
concentrations (Supporting Information Figure S1). This
diﬀerence between the myristoylated and nonmyristoylated
form is a characteristic feature of wildtype GCAP17,27 and
demonstrates that mutants labeled with Alexa647 undergo the
critical Ca2+-dependent conformational changes in a nearly
identical manner as the nonlabeled wildtype protein and,
therefore, are well suited for subsequent ﬂuorescence studies.
Fluorescence Lifetime. For each mutant, the ﬂuorescence
lifetime was measured for the Ca2+-bound, the Mg2+-bound, a
mixed Ca2+/Mg2+ bound, and the apo-state of the protein. A
representative ﬂuorescence decay curve is displayed in Figure
2a showing ﬂuorescence decay of myrC106 in the presence of
Ca2+ (green curve) or EGTA (red curve) and the instrument
response function (blue curve). A biexponential ﬁt results in
equally distributed residuals, indicating a good agreement with
the experimental data.
Such an acceptable biexponential modeling was observed for
all mutants when assuming a fast component ranging from 0.6
to 1.2 ns and a slow component ranging from 1.3 to 2.0 ns.
Typically, the amplitude of the slow component exceeded that
of the fast component by a factor of 3. Therefore, a summary of
deduced lifetimes for the dominating slow component τ1 is
given in Figure 2b, exhibiting similar features for both
myristoylated and nonmyristoylated mutants. Speciﬁcally,
ﬂuorescence lifetimes diﬀered signiﬁcantly among cysteine
positions. The longest ﬂuorescent lifetimes were observed for
the dye at positions C18 and C29 located in the interior of the
protein. In contrast, the ﬂuorescence lifetime was shortest for
Figure 1. (a) Three-dimensional structural model of GCAP1. The position of each cysteine is highlighted. The myristoyl group (yellow) is layered in
a hydrophobic crevice, and the three functional EF-hand motifs have each a bound Ca2+ (magenta). (b) Ca2+-sensitive activation of ROS-GC1 by
myristoylated GCAP1 mutants as indicated. The IC50 values are the following (three to four data sets): 336 nM (Alexa647-labeled CAAA), 529 nM
(Alexa647-labeled ACAA), 832 nM (Alexa647-labeled AACA), and 659 nM (Alexa647-labeled AAAC).
Table 1. Labelling of Myristoylated and Non-myristoylated
GCAP Mutants with Alexa647-C2-maleimidea
myr GCAP nonmyr GCAP
degree of myristoylation
(%)
degree of labeling
(%)
degree of labeling
(%)
CAAA 91.4 90.2 84.5
ACAA 91.0 88.5 89.8
AACA 87.8 95.2 94.9
AAAC 95.1 78.5 63.5
aThe degree of myistoylation for the D6S mutants was determined by
rp-HPLC.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.5b00278
ACS Chem. Biol. 2015, 10, 2344−2352
2345
the positions C106 and C125 corresponding to regions exposed
to the solvent.
Most prominently, binding of either Ca2+, Mg2+, or a mixture
thereof did hardly aﬀect the ﬂuorescence lifetimes. In stark
contrast, in the apo-state, i.e. in the presence of the chelating
agent EGTA, the ﬂuorescence lifetime of the dye increased
signiﬁcantly at each of the dye positions. This increase in
ﬂuorescence lifetime is most pronounced for dye labeling at
C106. Here, lifetime increases by more than 30% from 1.4 ns
with either Ca2+ or Mg2+ bound to 1.8 ns in the apo-state of the
myristoylated protein.
Fluorescence Anisotropy. Similarly, the ﬂuorescence
anisotropy was measured for each of the eight mutants in
each of the four cation conﬁgurations. A representative
anisotropy decay curve is shown in Figure 3a for myrC18 in
the presence of Ca2+ (green curve) or for the apo-state (red
curve). Again, a biexponential model gives a statistical
distribution of residuals indicating a good agreement with the
experimental data for the ﬂuorescence anisotropy of the
protein−dye complex. Therefore, we can identify two distinct
two rotational correlation times, which can be distinguished
into a fast component ranging from 0.43 to 0.82 ns for all
mutants and a slow component ranging from 19 to 43 ns for
the mutants C18 and C29 with the dye located in the interior
of the protein−dye complex. For the mutants C106 and C125
with the dye facing the exterior of the protein, the rotational
correlation times of the protein−dye complex greatly exceeded
the ﬂuorescence lifetime and only lower limits of several
hundreds of nanoseconds could be estimated (results not
shown).
For the mutant C18, the slow component is shown in Figure
3b for all cation conﬁgurations. In the myristoylated protein, we
ﬁnd similar rotational correlation times from 27 to 33 ns in the
case of Ca2+ or Mg2+ binding and a slight increase to 43 ns in
the apo-state. Under all conditions, the rotational correlation
time of the nonmyristoylated protein is signiﬁcantly faster than
in the myristoylated case, and again the correlation time in the
Figure 2. (a) Representative ﬂuorescence decay curves of the mutant myrC106 in the apo (red) and Ca2+ bound (green) state and corresponding
residuals for biexponentially ﬁtted curves (black). The instrument response function (IRF) is shown in blue. (b) Summary of the high amplitude
lifetime component for all mutants. Each section corresponds to one mutant, either myristoylated (red) or nonmyristoylated (blue), in all cation
conﬁgurations. Each data point corresponds to the weighted average of 10 measurements with a weighted ﬁtting error <5 ps. Error bars are smaller
than the data point symbols.
Figure 3. (a) Representative anisotropy decay curves of mutant myrC18 in the apo (red) and Ca2+ bound (green) state and corresponding residuals
for biexponentially ﬁtted curves (black). (b) Summary of the slow rotational correlation time component for the mutant C18, either myristoylated
(red) or nonmyristoylated (blue), in all cation conﬁgurations. Each data point corresponds to the weighted average of 10 measurements with
weighted ﬁtting errors ranging from 0.33 to 4.0 ns, depending on excess of rotational correlation time over ﬂuorescence lifetime.
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apo-state is slightly longer than in the case of Ca2+ or Mg2+
binding.
Change in Local Environment of the Dye. The
ﬂuorescence lifetime τ of a dye is related to the local viscosity
η of its environment via τ ∝ ηβ, where β is a positive number.28
In the interior of the protein, the diﬀusive rotational motion of
the dye is constrained, and the local viscosity of the
environment therefore is large. This gives rise to a
comparatively long ﬂuorescence lifetime. In contrast, an
exposure of the dye to the solvent buﬀer will reduce the local
viscosity and hence ﬂuorescence lifetime. The observed
pronounced increase in ﬂuorescence lifetime of the dye in
the apo-state therefore necessarily reﬂects a tighter conﬁnement
of the dye in the interior of the protein than in the Ca2+- or
Mg2+-bound state and thus indicates that the loop region
around position C106 moves toward the interior of the protein,
when GCAP1 releases its Ca2+.
Motional Restriction by Wobbling-in-a-Cone. This
local movement at position C106 is further supported by
analyzing the diﬀusional dye motion in a phenomenological
wobbling-in-a-cone model (see Figure 4).19,29−31 This model
separates a rapid diﬀusive rotational motion of the dye within
its local environment from the much slower global rotational
motion of the protein−dye complex and hence naturally
accounts for the two distinct decay times in the experimentally
measured anisotropy curves. The geometric constraint of the
dye motion due to the surface of the protein is taken into
account by restricting the dye rotation to the interior of a cone
with semicone angle
θ = + + −−
−⎛
⎝
⎜
⎜
⎛
⎝
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⎞
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Here, the amplitudes of the fast and slow components, rD and
rG, are the amplitudes of the fast and slow components of the
anisotropy decay.
An analysis of our experimental data within the framework of
this model suggests that at dye position C106 this semicone
angle decreases markedly from 41° in the Ca2+-bound state to
32° in the apo-state of the myristoylated protein. Clearly, a dye
closer to the interior of the protein should be more restricted in
its motion than a dye more exposed to the solvent. Therefore,
the analysis of both our ﬂuorescence and anisotropy measure-
ments strongly indicates a movement of the loop region around
position C106 toward the interior of the protein, when GCAP1
releases its Ca2+. Rebinding of Ca2+ or Mg2+ reverses this
movement. This is consistent with the notion that the binding
of cations to an EF hand loop, where C106 is located, results in
a structural transition from an open conformation in the apo-
state to a more closed conformation in the case of cation
binding. When switching from open to closed conformation, a
covalently bound dye molecule would therefore necessarily
move outward with respect to the protein interior.
In contrast, the diﬀusional dye motion is similar in all cation
conﬁgurations of the mutant C18 but diﬀers strongly between
the myristoylated and nonmyristoylated form. The distance
between the cysteine sulfur in C18 and the end-standing carbon
of the myristoyl group is ∼1.03 nm and is located at the end of
the hydrophobic crevice harboring the fatty acyl chain. One
would expect a larger semicone angle due to larger spatial
freedom, if the myristoyl group is missing. However, we deduce
a reduction in the semicone angle from 26° in the myristoylated
protein to 15° in the nonmyristoylated protein, which is
accompanied by an increase in lifetime by ∼0.1 ns (Figure 2b).
This indicates a movement of the region around C18 into the
hydrophobic pocket, thereby constraining its circular move-
ment.
Global Rotation of the Protein−Dye Complex. Our
anisotropy measurements further indicate that the local
conformational change upon release of Ca2+ or Mg2+ at
position C106 results in an increase in the slow, global
rotational correlation time ϕG, which is directly related to the
hydrodynamic radius rst of the protein by the Stokes−Einstein−
Debye equation
ϕ =
πηr
k T
4
3
st
G
3
B
Here, kBT is the Boltzmann factor and η = 1 mNs/m
2 is the
viscosity of water at a temperature T = 293.15 K. In our
measurements, we necessarily probe the rotational motion of
the protein−dye complex. To extract information on the
rotational correlation time of the unlabeled protein, the
presence of the dye molecule must not enlarge the hydro-
dynamics radius of the protein. This requirement is met for a
dye located in the interior of the protein, i.e. for a motionally
restricted dye showing the longest ﬂuorescence lifetimes. From
our ﬂuorescence lifetime measurements, the most suitable
mutant to probe the rotational correlation time of GCAP1 is
C18. The increase in rotational correlation time from 27 ns
(Ca2+-bound) to 43 ns (apo) therefore corresponds to an
increase in hydrodynamic radius from rst = 2.98 ± 0.05 nm
(Ca2+-bound) to rst = 3.48 ± 0.10 nm (apo). This global
enlargement of the mutated protein upon release of Ca2+ agrees
with dynamic light scattering measurements on myristoylated,
wild type GCAP1,32 in which the hydrodynamic radius was
determined as rst = 3.35 ± 0.02 nm for the Ca
2+-bound state
and rst = 3.75 ± 0.10 nm for the apo-state.
Molecular Dynamics Simulations. To gain further
structural insights into the local movement at position C106,
as compared to the global enlargement of the protein observed
Figure 4. Semicone angle obtained from a wobbling-in-a-cone model
for mutants C18 and C106, either myristoylated (red) or non-
myristoylated (blue), in all cation conﬁgurations. Each data point
corresponds to the weighted average of 10 evaluations with weighted
errors ranging from 0.15° to 0.57°. Error bars are smaller than the data
point symbols.
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upon Ca2+ and/or Mg2+ release, we analyzed the results from a
previous 200 ns molecular dynamics (MD) study33 of
myristoylated GCAP1 in the light of the time-resolved
ﬂuorescence measurements presented here (Figure 5).
Although the dye was not explicitly included in MD
simulations, the biochemical assays performed in this study
(Figure 1b) suggest that the dye exerts only minimal
perturbations to the GCAP1 structure/function.
The analysis of MD trajectories focused on selected regions
representative for those structural elements, in which the dye
was experimentally bound as a probe for the structural
dynamics. At the same time, it allowed us to assess global
dynamical properties of the GCAP1 tertiary structure, which is
characterized by two lobes, each consisting of two EF-hand
regions (EF1−EF2 and EF3−EF4).20
The distance between these lobes is well represented by the
distance between the Cα atoms of D168 and R178, which are
both located in the C-terminal region, but in the two diﬀerent
lobes. As D168 and R178 form a salt bridge, this distance
remains nearly constant at 1.03 ± 0.02 nm in the apo-state
(Figure 5b) but is dynamically disturbed upon Ca2+ (∼32% salt
bridge presence) or Mg2+ binding (∼72% salt bridge presence)
increasing the distance to 1.38 ± 0.07 nm and 1.31 ± 0.04 nm,
respectively. In consequence, formation of the salt bridge in the
apo-state enables the protein to open up near the Ca2+-binding
sites, which should be accompanied by an increased separation
between the EF-hands.
To elucidate this feature the EF-hand motifs are conveniently
represented by planes, which stand at an angle with respect to
each other. For example, EF1 and EF4 are nearly parallel in the
Ca2+ and Mg2+ bound state (6.8 ± 0.9°) but are signiﬁcantly
tilted (19.5 ± 1.8°) against each other in the apo-state.
Similarly, the angle between EF3 and EF4 increases from 23.3
± 1.7° in the Ca2+ bound state to 34.8 ± 0.8° in the apo-state
(Figure 5c,d).
Therefore, molecular dynamics simulations point to two
main reorganizing movements in the GCAP1 structure during
the transition from the cation-bound to the apo-state:
decreasing the distance between the two lobes by forming a
salt bridge and a concomitant slight but signiﬁcant expulsion of
the EF4 region with respect to other regions (EF1 and EF3).
These parallel movements lead to a slight increase in the radius
of gyration of the protein in the apo-state (1.711 ± 0.009 nm)
as compared to the Ca2+-bound state (1.68 ± 0.01 nm) and to
an overall more important increase in the hydrodynamic
volume of GCAP1, which is in agreement with previous
theoretical33 and experimental32 observations. Additionally, the
increased angles between the EF-hand motifs upon release of
Ca2+ open a cavity for the loop region around position C106 to
move toward the interior of GCAP1. Pictorially, this dynamic
process can be illustrated as a “twisted accordion”-like
movement.
The large-scale motions described above are in fact in line
with principal component analysis (PCA) performed on the
whole 200 ns MD trajectory. Analysis of the ﬁrst two principal
components (PCs) describing the large-scale movements
indeed shows that, in the apo-state, EF1, EF2, EF3, and C-
and N-termini move in a concerted fashion along the direction
Figure 5. Structural descriptors of myrGCAP1 dynamical features calculated on the trajectories obtained by carrying out 200 ns all-atom molecular
dynamics simulations. (a) Cartoon structural model of myrGCAP1 in the Ca2+-bound form with the myristoyl moiety (orange), cysteine side chains
(yellow), Ca2+ ions (green), as well as Cα atoms of key residues belonging to EF1 (blue), EF3 (red), EF4 (purple), and deﬁning the distance
between the N- and C-terminal domains (cyan). (b) Evolution of the distance between Cα of D168 and R178: apo (red), Mg
2+-EF2 (blue), Ca2+-
loaded (green). (c) Evolution of the angle between EF1 and EF4: apo (red), Mg2+-EF2 (blue), Ca2+-loaded (green). (d) Evolution of the angle
between EF3 and EF4: apo (red), Mg2+-EF2 (blue), Ca2+-loaded (green).
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of the ﬁrst PC (Supporting Information Figure S2). Projection
of the concerted trajectories over the second PC of the apo-
state suggests that the loop connecting EF1 and EF2 as well as
the highly ﬂexible 121−133 region and the loops of EF-hands 2,
3, and 4 are collectively moving along the same direction,
orthogonal to that deﬁned by the ﬁrst PC, which is substantially
in line with the “twisted accordion” model described above. On
the other hand, the ﬁrst two PCs describing large scale motions
of the Ca2+-bound state of GCAP1 show a concerted motion of
the C- and N-termini and of the highly ﬂexible 121−133 loop,
while the movement along the longitudinal axis of the
“accordion” is much less pronounced.
Summary and Conclusions. In conclusion, our model of a
twisted accordion-like movement for GCAP1 upon a changing
Ca2+ concentration distinctly contrasts the piston-like move-
ment deduced from a previous time-resolved ﬂuorescence study
on its structurally similar cognate GCAP2 (see Figure 6 for a
comparison).18 Recently, another pair of related NCS proteins,
NCS-1 and calneuron-1, was found to diﬀerentially modulate
by selective Ca2+ sensing a signaling pathway involving the
heterodimeric adenosine/dopamine receptor.34 Thus, our
results constitute an example of a more general concept
beyond retina speciﬁc Ca2+ sensors. Previously, the variability of
target recognition and regulation by NCS proteins despite their
structural similarities has been related in the past to diﬀerences
in the number and location of Ca2+-binding sites, in surface
charge distribution, and in Ca2+-sensitive dimeriza-
tion.2,8−11,32,35 Here, we present a new concept, in which
diﬀerential cellular responsiveness mediated by two structurally
similar proteins is directly mirrored by a diﬀerence in protein
conformational dynamics, which tunes their physiological
speciﬁcity.
■ METHODS
Cloning of GCAP1 Cysteine Mutants. The cloning of the single
cysteine mutants of bovine GCAP1, in which three cysteine residues
are replaced by alanine, namely C18AAA, AC29AA, AAC106A, and
AAAC125, was described in detail before.22 To facilitate myristoylation
of GCAP1 variants at the N-terminus, an additional point mutation at
position 6 (D6S) is necessary for creating a consensus sequence for
the yeast N-myristoyltransferase (NMT). It was shown earlier that this
point mutation has virtually no eﬀect on the biochemical and
biophysical properties of wildtype GCAP1.36 Accordingly, we prepared
the D6S mutants employing the following primers 5′-AAACAT-
ATGGGGAACATTATGTCCGGTAAGTCG-3′ and 3′-TTTGAA-
TTCTCAGCCGTCGGCCTCCGC-5′ and used the respective
cysteine mutant as a template. The ampliﬁed PCR product was cut
with NdeI and NheI and ligated in an analogous treated template clone.
All sequences were veriﬁed by DNA sequencing (LGC Genomics).
Expression and Puriﬁcation of GCAP1, Wild-Type, and
Cysteine Mutants. GCAP1 mutants were overexpressed in BL21
E. coli cells as described before.8,15,22 In order to myristoylate GCAP1,
mutants cells were cotransformed with the plasmid pBB131 containing
a gene for the yeast (S. cerevisiae) NMT. After cell lysis, the
myristoylated and nonmyristoylated GCAP1 mutants were isolated
from the insoluble fraction.8,15,22 Brieﬂy, the insoluble material was
homogenized in 6 M guanidinium hydrochloride and afterward
dialyzed against Tris-buﬀer (20 mM Tris-HCl, 150 mM NaCl, 1 mM
DTT pH 7.5). Prior to chromatographic steps, the volume of the
protein solution was reduced by ammonium sulfate precipitation.
Subsequently, the protein was resolved and applied onto a size
exclusion column (Superdex 75, GE Healthcare) equilibrated in Tris-
buﬀer. Fractions containing the respective GCAP form were further
puriﬁed with an anion exchange column (HiLoad 26/10 Q Sepharose;
GE Healthcare) equilibrated in Tris-buﬀer with 2 mM EGTA.
Chromatography was performed with a gradient of 200−550 mM
NaCl in 40 mL.
The purity of the obtained GCAP forms was veriﬁed by sodium
dodecyl-sulfate polyacrylamide gel electrophoresis. The myristoylation
degree of the D6S mutants was determined by a reversed phase HPLC
on a silica based C-18 column (Luna 5 μm C18, Phenomenex).37
Labeling with the Fluorescent Dye Alexa647 and Validation
of Protein Function. GCAP1 mutants with one reactive cysteine
were labeled with the ﬂuorescent dye Alexa647-C2-maleimide (Life
Technologies) using the following protocol: the respective lyophilized
GCAP1 form was dissolved in 10 mM Hepes-KOH pH 7.0 to a ﬁnal
concentration of 30 μM. The Alexa647 dye was added in 5-fold molar
excess in a ﬁnal volume of 0.5 mL. The reaction mixture was incubated
for 1−3 h in a light-protected vial at room temperature, before the
reaction was terminated by adding 2 mM DTT.
Removal of the excessive dye was done by passing the reaction
mixture over a NAP5 column (GE Healthcare) equilibrated in
ﬂuorescence buﬀer (125 mM NaCl, 25 mM Tris-HCl pH 7.4). If
excessive dye was still present, it was removed by dialysis against the
same buﬀer.
For the calculation of the labeling eﬃciency, the concentration of
the bound dye was determined by UV−VIS spectrophotometry at 650
nm (ε = 265 000 M−1 cm−1) and the protein concentration by the
Coomassie Blue assay.
A critical point for further use of ﬂuorescence labeled mutants was
the ability to regulate the target guanylate cyclase ROS-GC1. For this
purpose, we isolated membranes from bovine rod outer segments,7,8
providing us with a native ROS-GC1 source. The cyclase activity was
determined as a function of free [Ca2+] exactly as described before.
Fluorescence Lifetime Measurement. Fluorescence lifetime
measurements were performed by time-correlated single photon
counting (TCSPC). A pulsed diode laser (PicoQuant, LDH 8−1−060
with PDL 800) operating at a repetition rate of 6 MHz provided 50 ps
pulses centered at 656 nm and at an average power < 5 μW. Vertically
polarized laser pulses were weakly focused into a microcuvette.
Emitted ﬂuorescence light was collected and focused by a glass
objective (Nikon, NA = 0.7) onto an avalanche photodiode (ID
Quantique 100).
Figure 6. Comparison of the three-dimensional structures of GCAP1 and GCAP2 showing distinctly diﬀerent switching mechanisms upon Ca2+
release. Structural model of GCAP2 is based on the NMR structure (PDB ID: 1JBA).21
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To avoid anisotropy eﬀects, all lifetime measurements were
performed under magic angle conditions (54.7°). Fluorescence
decay curves I(t) were collected with a timing resolution of 4 ps
(PicoQuant, PicoHarp 300) and ﬁtted with the software FluoFit
(PicoQuant) to an exponential decay model by reconvolution:
∫ ∑= ′ ′ ′τ
−∞ =
− −
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Here, Ai denotes the amplitude of the decay component with
ﬂuorescence lifetime τi.
The instrument response function (IRF) was recorded with
excitation light scattered from diluted milk and found to have a full
width at half-maximum (fwhm) of about 100 ps.
Our setup yielded a monoexponential decay for free oxazine 1.
However, a biexponential decay was observed for free Alexa647, which
we attribute to a low but nonzero probability for the dye to take an
alternative conﬁguration due to its chemical structure. Reference
measurements of free Alexa647 in the presence of Ca2+, Mg2+, or the
chelating agent EGTA used for the apo-state measurements yielded no
change in ﬂuorescence lifetime.
For each of the four mutants, either myristoylated or non-
myristoylated, and in each of the four cation conﬁgurations, we
carried out 10 measurements and calculated the weighted mean x ̅ =
(Σwixi)/(Σwi) with wi = 1/(Δxi)
2 and the overall error as Δx = [1/
(Σwi)]
1/2.
Fluorescence Anisotropy Measurement. For ﬂuorescence
anisotropy measurements, the intensity of ﬂuorescence emission
with a polarization component parallel, I∥(t), and perpendicular, I⊥(t),
to the vertically polarized excitation light was measured. The
ﬂuorescence anisotropy r(t) is then deﬁned as
=
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Here, an instrument parameter G corrects for biased polarization
detection eﬃciency and was found to be G = (∫ IHV(t) dt/∫ IHH(t) dt)
= 0.95 for our setup.
Anisotropy decay curves were ﬁtted with the software FluoFit
(PicoQuant) to an exponential decay model
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Here, ri denotes the amplitude of the decay component with rotational
correlation time ϕi and r∞ is the steady state anisotropy.
Similar to the lifetime measurements, we carried out 10 measure-
ments for both I∥(t) and I⊥(t), for all mutants and in all conﬁgurations,
and calculated the weighted mean accordingly.
Molecular Dynamics Simulations. Molecular dynamics simu-
lations were set up as previously described33 using as a starting
structure the homology model of human mGCAP1 built using Ca2+-
bound chicken mGCAP120 as a template (PDB ID: 2R2I), according
to a procedure previously elucidated.12 Simulated states were modeled
either by removing Ca2+ ions from all three EF-hand binding sites
(apo) or by removing Ca2+ ions from EF3 and EF4 and substitution
with a Mg2+ ion in EF2 (Mg2+-EF2).
MD simulations were performed using the GROMACS 4.6.3
simulation package,38 with the CHARMM27 all-atom force ﬁeld.39,40
Structures were subjected to energy minimization, 4 ns equilibration,
and 200 ns MD production with an integration time step of 2 fs. See
ref 33 for details. Values reported for distances and angles are mean
values ± standard deviations calculated over the last 10 ns of MD
production.
Analysis of MD Trajectories. MD trajectories generated in
Marino et al.33 were subjected to diﬀerent analyses. The distance
between the centers of mass of Cα of D168 (belonging to the EF3−
EF4 lobe) and R178 (belonging to the EF1−EF2 lobe) was calculated
over the 200 ns MD time frame with the g_dist function implemented
in the GROMACS simulation package. The angles between the versors
orthogonal to the planes cutting EF1 (represented by Cα Ca
2+
’s of
W21, E38 and R40), EF3 (represented by Cα’s of Y95, K97 and I115),
and EF4 (represented by Cα’s of T136, E154 and G159) were
calculated over the 200 ns MD time frame with the g_sgangle function
implemented in the GROMACS simulation package, which is based
on the equation cos = ·̂ ̂̂EF EF n n1 4 1 4 and cos = · ̂̂̂EF EF n n3 4 3 4.
Smoothing of distance and angle data plots was performed with the
smoothing function within the SigmaPlot 12 package, by using the
running average module with 10 000 intervals averaging 200 points
each, corresponding to one-hundredth of the points in the original
data set (2 ns frequency).
Principal component analysis was performed using the pca module
of the Wordom software41 by computing progressive comparisons
every 10 ns. Radius of gyration measurement calculated on all protein
atoms was performed using the rgyr module of the Wordom software.
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a significant rearrangement of the aromatic residues upon 
binding of Ca2+. To gain insight into the dynamic changes 
of cyclic GMP levels in a photoreceptor cell, we incorpo-
rated parameters describing the regulation of target gua-
nylate cyclase by GCAP1 mutants into a comprehensive 
kinetic model of phototransduction. Modeling led us to 
conclude that the contribution of GCAP1 to the dynamic 
synthesis of cyclic GMP in rod cells would depend on the 
expression level of the wild-type form. Although the syn-
thesis rate controlled by GCAP1 remains at a constant 
level, in the case of high expression levels of cone-dystro-
phy GCAP1 mutants it would not contribute at all to shap-
ing the cGMP rate, which becomes dynamically regulated 
solely by the other present Ca2+-sensor GCAP2.
Keywords Guanylate cyclase · GCAP · Retinal 
dystrophy · Phototransduction · Kinetic modeling
Introduction
Inherited retinal dystrophies are very often caused by an 
imbalance of Ca2+- and cGMP homeostasis. These two 
second messengers operate in rod and cone photoreceptor 
cells to control their excitation by light and their adapta-
tion to different light intensities [1, 2]. While the pho-
totransduction cascade in rod and cone cells leads to the 
light-induced hydrolysis of cGMP, closure of cyclic nucle-
otide-gated (CNG) channels and hyperpolarization of the 
cell, the cytoplasmic concentration of Ca2+ ([Ca2+]) is 
indirectly controlled by light: Ca2+ flows into the cell by 
open CNG channels, and is extruded via a Na+/Ca2+, K+-
exchanger. Light-triggered closure of CNG channels stops 
the influx of Ca2+, but extrusion via the exchanger leads to 
a decrease in [Ca2+]. By these two mechanisms, [Ca2+] is 
Abstract Cone dystrophy-related mutations in guanylate 
cyclase-activating protein 1 (GCAP1) are known to cause 
severe disturbance of their Ca2+-sensing properties affect-
ing also their regulatory modes. However, crucial biochem-
ical properties of mutant GCAP1 forms have not been fully 
elucidated and regulatory parameters of GCAP1 mutants 
have not been considered within the context of a com-
prehensive description of the phototransduction cascade 
kinetics. We investigated therefore the structure–function 
relationships of four dystrophy-relevant point mutations in 
GCAP1 harboring the following amino acid substitutions: 
E89K, D100E, L151F, and G159V. All mutations decrease 
the catalytic efficiency in regulating the target guanylate 
cyclase and decrease the affinity of Ca2+-binding in at least 
one, but in most cases two EF-hand Ca2+-binding sites. 
Although the wild type and mutants of GCAP1 displayed 
large differences in Ca2+-binding and regulation, circu-
lar dichroism (CD) spectroscopy revealed that all proteins 
preserved an intact secondary and tertiary structure with 
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strictly controlled over a rather narrow range being several 
hundred nanomolar Ca2+ in the dark and going down to 
below 100 nM in the light [1, 2]. Ca2+-sensor proteins like 
calmodulin, recoverin, and the guanylate cyclase-activating 
proteins (GCAPs) detect in photoreceptors these changes in 
[Ca2+] and respond by controlling the activity of target pro-
teins involving the CNG channel, rhodopsin kinase GRK1, 
and membrane-bound guanylate cyclases, respectively 
[3–5].
Mutations in the guanylate cyclase signaling complex 
correlate for example with retinal diseases like Leber con-
genital amaurosis and cone-rod dystrophies and are linked 
to mutations in the genes GUCY2D and GUCA1A cod-
ing for photoreceptor guanylate cyclase 1 (ROS-GC1) and 
GCAP1, respectively [6, 7]. GCAPs can respond to incre-
mental changes in [Ca2+] and work in a relay mode fashion 
[8–11]. Most GCAP1 mutations found in patients suffer-
ing from retinal dystrophies exhibit a more or less severe 
disturbance in their Ca2+-sensing properties, resulting in 
constitutively active GCAP1 forms under physiological 
conditions [12–16]. Thus, they maintain the cyclase con-
stitutively active over the range of [Ca2+], in which they 
normally switch between activating and inhibiting regula-
tory modes. We have recently investigated in more detail 
the structural and functional properties of four mutants 
(E89K, D100E, L151F, G159F) that have some common 
properties that are shared by other mutant GCAP1 forms. 
For example, they are located in the domains consisting of 
the Ca2+-binding motifs EF-hand 3 and 4 (for a structural 
model see figures in Refs. [7] and [16]), have a decreased 
thermal stability and display a significantly large shift in 
the IC50-value, the [Ca2+], at which the activation of the 
target ROS-GC is half maximal [15, 16]. Experimental 
work on transgenic mice further supports the notion that 
GCAP1 mutations that are linked to retinal dystrophies 
cause photoreceptor degeneration, probably by apoptotic 
processes [17, 18]. However, so far, the biochemical prop-
erties of mutant GCAP1 forms have not been considered in 
the context of the whole cascade, since they have not yet 
been integrated into a computational kinetic model of the 
phototransduction cascade [19–22].
Wild-type (WT) GCAPs are known to influence and 
regulate catalytic parameters like kcat/Km of the target ROS-
GCs [8]. In the present work, we determined therefore, 
how cone-dystrophy related mutants of GCAP1 influence 
parameters like kcat/Km. Further, using isothermal titration 
calorimetry (ITC) we determined thermodynamic param-
eters and constants for Ca2+-binding to GCAPs and relate 
them to the changes observed in the near UV circular 
dichroism (CD) spectra upon Ca2+-binding, which show 
tertiary structure rearrangement in each GCAP1 variant. 
Finally, the experimentally determined parameters describ-
ing the regulation of ROS-GC1 by GCAP1 at different 
[Ca2+] were incorporated into a comprehensive kinetic 
model of phototransduction [20–22], allowing the assess-
ment of how individual point mutations affect the signal-
ing pathway and the Ca2+-dependent GCAP relay system 
[23] as well as the overall cell photoresponse. Our results 
suggest that GCAP1 mutants perturb the shape of photore-
sponse, prolonging its duration, and increase its amplitude 
in each tested illumination condition. Interestingly, the 
dysfunction of GCAP1 pathogenic forms is predicted to be 
partly compensated by the action of native GCAP2, which 
becomes dominant in shaping the dynamics of cGMP syn-
thesis upon light stimulation.
Materials and methods
Protein expression and purification
WT and mutants of GCAP1 were overexpressed in BL21 
E. coli cells as described previously and subsequently 
purified to homogeneity as outlined elsewhere [8, 15, 16]. 
Briefly, GCAP1-forms were extracted from inclusion bod-
ies by homogenization in 6 M guanidinium hydrochloride 
and dialyzed against 3 l of Tris buffer (20 mM Tris–HCl, 
150 mM NaCl, 1 mM DTT pH 7.5). After one buffer 
change, any remaining insoluble fractions were removed 
by centrifugation (100,000 × g for 30 min). GCAP vari-
ants in the resulting supernatant were purified in the pres-
ence of 1 mM EDTA or 2 mM EGTA by a combination 
of size exclusion and ion-exchange chromatography using 
a Superdex 75 column and a HiLoad 26/10 Q Sepharose, 
respectively (GE Healthcare, Germany).
Guanylate cyclase assay and kinetic analysis
For guanylate cyclase activity assays, we used washed 
bovine rod outer segment (ROS) membranes that were 
prepared from frozen bovine retinae as described [24]. 
These membranes are a source of intact and active outer-
segment guanylate cyclase type 1 (ROS-GC1 or RetGC1, 
GC-E). Membranes (corresponding to a content of 70 µg 
rhodopsin) were reconstituted with 10 µM of purified WT 
or mutant GCAP1. Guanylate cyclase activity was assayed 
at 2 mM EGTA (≤10 nM free [Ca2+]) as a function of the 
substrate Mg2+-GTP at a free [Mg2+] of 1 mM. Analysis 
of data was performed with SIGMA plot 10.0 software. A 
direct plot of activity versus [Mg2+-GTP] resulted in a sig-
moidal curve as observed previously [8], which indicates 
cooperative substrate binding. We analyzed the data fur-
ther by linearizing a corresponding Lineweaver–Burk plot 
[8] using a Hill coefficient n from a fit of the direct plot. 
Values of Vmax and Km were then determined from a plot 
of 1/V (reciprocal of guanylate cyclase activity) versus 1/
Author's personal copy
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[S]n (reciprocal of the substrate concentration raised to the 
power of n).
Isothermal titration calorimetry (ITC)
For ITC experiments, we used a VP-ITC instrument from 
MicroCal (Northampton, MA, USA) at T = 25 °C. Purified 
GCAP1 forms were present in the recording cell in titra-
tion buffer (5 mM Tris/HCl, pH = 7.5; 150 mM KCl) at 
10–30 µM and titrated with increasing CaCl2 concentra-
tions. All buffers were decalcified using a Chelex 100 resin 
column (Bio-Rad, Hercules, CA, USA) with a flow rate of 
3 ml/min as described [16]. CaCl2 was of the highest grade 
available and dissolved in the decalcified titration buffer to 
a final 1 M concentration and Ca2+ stocks were prepared 
by subsequent dilutions to final concentrations 0.5–2 mM. 
All buffers were filtered (0.22 µm) and degassed for at 
least 1 h before use.
CaCl2 in the titration buffer was placed in the microsy-
ringe chamber at 0.5–1 mM. Ca2+ titration was performed 
by subsequent injections of 5 µl Ca2+ solution into the 
recording cell keeping a time interval of 180 s between 
injections and an initial delay of 600 s after temperature 
equilibration. Control injections of Ca2+ into the decalci-
fied buffer without protein were also performed, but did 
not result in specific heat changes. The baselines of the 
raw data were automatically adjusted by Origin (Micro-
Cal) and the same software was employed for data analy-
sis and fitting. Optimal fitting results were obtained with a 
model assuming three binding sites for Ca2+ providing an 
estimate for KDapp and molar enthalpy (∆H) changes at the 
given temperature.
Circular dichroism (CD) spectroscopy and thermal 
denaturation studies
Circular dichroism spectroscopy studies were performed 
with a Jasco V-710 spectropolarimeter equipped with a Pel-
tier-type thermostated cell holder. Near-UV (250–320 nm) 
spectra were recorded at 25 °C at a scan rate of 50 nm/min, 
a bandwidth of 1 nm, and an integration time of 4 s. Protein 
concentration was in the 0.5–0.7 mg/ml range (22–35 µM) 
as measured by Bradford assay [25]. Spectra were recorded 
in a 1-cm cuvette at final 1 mM concentration of Ca2+ or 
EGTA. Five spectra accumulations were averaged for each 
sample, and the spectrum of the buffer was subtracted. 
Far-UV CD spectra were recorded for the myristoylated 
E89K variant between 200 and 250 nm, in the same con-
ditions as those described in [16]. Protein concentration 
was 21 µM in 0.1-cm cuvette, and spectra were recorded 
in the presence of either 200 µM EDTA or Ca2+. Spectra 
were recorded both at 25 and 37 °C, to directly compare 
the results with those of other mutants [15, 16]. Thermal 
denaturation studies of the E89K variant in the presence 
of Ca2+ or EDTA were performed in the 4–96 °C range. 
The ellipticity signal at 222 nm (θ222) was recorded at a 
scan rate of 1 °C/min and a response time of 16 s, using a 
0.1-cm quartz cuvette. Thermally denatured samples were 
cooled down to 25 and 4 °C and, after 5–15 min, a far-UV 
CD spectrum was recorded to check for residual structures. 
The analysis of thermal denaturation curves was performed 
for each sample assuming a two-state transition process, as 
previously described [16].
Computational kinetic model of cGMP synthesis 
and simulation of photoresponses
A previously developed mathematical model of phototrans-
duction in rod cells accounting for the comprehensive bio-
chemical mechanisms [19–22] was employed to simulate 
rod responses to flashes leading from 1.5 to 1,100 rho-
dopsin photoisomerizations. The model used in this work 
was originally developed for quantitative simulations of 
photoresponses from amphibian rod cells [19, 20] but it 
has been widely demonstrated that the model proved also 
able to predict with great accuracy the qualitative dynamics 
observed in mouse photoreceptors [20–22].
The synthesis of cGMP by ROS-GC1 was modeled 
according to the recently developed Ca2+-relay implemen-
tation [23]. In the current implementation, the cGMP syn-
thesis was specifically modeled as follows:
in which the first two terms represent the regulation by 
GCAP1 in its wild-type (first term) and mutated (second 
term) form, and the third one that by GCAP2. In order 
to simulate the autosomal dominant form of the disease, 
the expression of mutated GCAP1 was considered to be 
approximately half of the total protein expression. We 
further simulated a hypothetical (recessive) form (Online 
Resource 1), the first term in (1) was omitted and the 
weight of the second term was set to unity. In each term, 
the numerator is defined as the maximal activation of 
ROS-GC1:
in which βdark, the dark rate of cGMP synthesis, was set 
to 1.2 s−1, cGMPdark = 4 µM is the cGMP concentration 
in the dark, Ca2+dark = 0.6 µM is the concentration of free 
(1)
ab
d[cGMP]synth
dt
= 0.5 × amax1
1 +
(
Ca2+free
ICGCAP150
)h1 + 0.5
×
amutmax1
1 +
(
Ca2+free
ICGCAP1mut50
)h1mut + amax2
1 +
(
Ca2+free
ICGCAP250
)h2
(2)amax = βdarkcGMPdark
(
1 +
(
Ca2+dark
IC50
))h
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calcium in the dark, IC50 is the calcium concentration at 
which the synthesis of cGMP is half maximal and h is the 
Hill coefficient for the action of calcium on the cyclase rate 
via each specific GCAP protein. If no mutations were pre-
sent in GCAP1, then numerators would equal each other (a
max1 = amax2 = amax = 60 µM/s, see [23]), thus leading to 
the results discussed in the recent Ca-relay implementation 
model [23]. If, however, cone dystrophy-related mutations 
were present in GCAP1, amax1 would be affected, which is 
accounted for by amutmax1, as well as it would be the denomi-
nator of the first term in Eq. (1). Specifically, ICGCAP1mut50  
and h1mut were set to their relative values (-fold variation) 
compared to the wild type, according to the data in [16, 
26]. No changes were done to parameters determining the 
contribution to GC1 regulation by GCAP2. The model was 
implemented using SBTOOLBOX2 for MATLAB (http://
www.sbtoolbox2.org website) [20] and all numerical simu-
lations were carried out in this framework. Deterministic 
simulations were run from automatically generated and 
compiled C-code models, based on the CVODE integrator 
from SUNDIALS [27].
Results
Influence of GCAP1 mutants on enzyme catalysis
Mammalian GCAP1 and GCAP2 activate the target ROS-
GCs by increasing their catalytic efficiencies expressed in 
kcat/Km [8, 28]. Previous biochemical characterization of 
dystrophy-related GCAP1 mutants was mainly focused 
on their Ca2+-sensitive activation profiles and on Ca2+-
triggered changes in protein conformation, but these stud-
ies have not addressed questions concerning changes in 
catalytic efficiency. We determined the enzyme kinetics of 
ROS-GC1 in native bovine rod outer segments by varying 
the substrate Mg2+-GTP, but keeping the concentration of 
GCAP1 at a constant value of 10 µM GCAP1. The free 
[Ca2+] was set to 10−8 M. With WT GCAP1, we obtained a 
kcat/Km of 2 × 104 M−1 s−1 (Table 1) that was almost iden-
tical to our previously published value [8]. All four tested 
GCAP1 mutants decreased the catalytic efficiency, but to 
a different extent (Table 1). The largest effect was seen 
with D100E (~7-fold decrease) followed by E89K (~5-
fold), L151F, and G159V (~3-fold). The decrease is mainly 
caused by an increase of Km. Only E89K and D100E 
decreased slightly the kcat, whereas L151F and G159V even 
increased the kcat value. Binding of Mg2+-GTP and syn-
thesis of cGMP is known to occur in a cooperative fash-
ion. The mutations in GCAP1 had only a modest effect 
(decrease) on the Hill coefficient (Table 1).
Thermodynamic characterization of Ca2+ binding 
to GCAP1 mutants
ITC measurements were used to determine thermodynamic 
parameters of Ca2+ binding to WT and mutant forms of 
GCAP1. Representative examples of ITC titrations are shown 
in Fig. 1a–e for WT and four GCAP1 mutants. A compre-
hensive overview of all data is presented in Table 2. A com-
mon feature of nearly all GCAP1 forms was that the binding 
processes were exothermic in most cases, which is typically 
seen on negatively spiking heat pulses in the original record-
ing traces (Fig. 1, upper part of each panel). Only G159V 
displayed in all measurements small positive spikes at higher 
molar ratios of Ca2+ per protein indicating an endothermic 
binding process. Binding isotherms were obtained from the 
titration recordings by curve fitting using a sequential binding 
model with three different binding sites for Ca2+ (Fig. 1, lower 
part of each panel). WT GCAP1 is known to harbor three 
functional EF-hand Ca2+-binding sites of high, medium, and 
low affinity, which we could confirm by the fit of the experi-
mental data (KD1, KD2, KD3 in Table 2). GCAP1 mutants differed, 
however, in several aspects from the WT. They displayed 
lower affinities for Ca2+ in particular for KD2 and/or KD3, while 
the high affinity site remained nearly unchanged in all GCAP1 
forms showing a KD1 below 100 nM. The relative decrease in 
Ca2+ affinity in the mutants was highest in D100E (difference 
Table 1  Catalytic parameters of the activated state of native ROS-GC1
Assays were performed at constant concentrations of GCAP1 (10 µM) and free [Ca2+ ] (10−8 M) at varying concentrations of the substrate 
Mg2+-GTP. Values are the mean ± SD (three independent determinations). Two different Hill coefficients are listed, n was obtained from a sig-
moidal plot of activity versus [Mg2+-GTP], h represents the coefficient obtained from Ca2+-dependent activation curves. Values for IC50 and h 
were taken from Refs. [16, 26]
GCAP1  
form
Vmax (nmol × min−1  
per mg rhodopsin)
Km (mM) kcat (s−1) kcat/Km  
(103 M−1 s−1)
n IC50 (µM) h
WT 8.2 ± 1.7 0.14 ± 0.03 2.86 ± 0.58 20.42 ± 5.95 2.8 0.8 1.80
E89K 6.5 ± 0.3 0.52 ± 0.03 2.27 ± 0.12 4.37 ± 0.33 2.3 4.7 1.17
D100E 5.2 ± 0.2 0.61 ± 0.02 1.81 ± 0.07 2.97 ± 0.17 2.2 21.9 4.91
L151F 11.5 ± 0.4 0.60 ± 0.02 3.99 ± 0.14 6.65 ± 0.32 2.4 39.0 1.88
G159V 16.9 ± 1.1 0.82 ± 0.05 5.86 ± 0.38 7.15 ± 0.65 2 14.5 2.05
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Fig. 1  Ca2+ binding to GCAP1 WT and mutants. Representative 
ITC measurements of Ca2+ titrations with 23 µM WT GCAP1 (a) in 
comparison to mutants: 10 µM E89K (b), 19 µM D100E (c), 22 µM 
L151F (d), and 30 µM G159V (e) as indicated. Data were obtained by 
repetitive injections of CaCl2 into the protein solution. The upper part 
of each graphic shows the heat pulses obtained by injection of CaCl2, 
and the lower part shows the corresponding changes in enthalpy 
(kcal/mol of injectants). Data analysis by curve fitting yielded KD val-
ues of three binding sites and corresponding ∆H values, which are 
listed for several sets of experiments in Table 2
Table 2  Thermodynamics of Ca2+ binding to WT and mutant forms of GCAP1
Apparent dissociation constants KD and enthalpy changes were obtained from curve fitting
Rep number of repetitions
GCAP1 form Rep Dissociation constants KD (µM) Enthalpy change ∆H (kcal/mol)
KD1 KD2 KD3 ∆H1 ∆H2 ∆H3
WT 3 0.08 ± 0.007 0.29 ± 0.13 2.53 ± 0.19 −19.4 ± 0.2 −19.2 ± 0.4 −15.1 ± 0.4
E89K 4 0.085 ± 0.030 2.07 ± 1.18 25 ± 14 −18.7 ± 0.6 −10.7 ± 5.9 11.6 ± 6.5
D100E 2 0.031 ± 0.005 3.54 ± 0.60 144 ± 12 −18.7 ± 0.1 2.4 ± 0.4 3.4 ± 1.8
L151F 5 0.056 ± 0.024 0.40 ± 0.16 111 ± 67 −20.1 ± 0.5 0.4 ± 1.3 11.1 ± 3.7
G159V 3 0.098 ± 0.024 0.82 ± 0.11 2.19 ± 0.68 −14.4 ± 1.8 −19.3 ± 1.1 8.67 ± 1.04
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of constants KD2 and KD3 to the corresponding WT value was 
12- and 57-fold, respectively), while the mutant E89K showed 
a 7 to 10-fold decrease in affinities of these constants. In the 
mutant L151F only KD3 was affected (44-fold difference), 
whereas G159V displayed constants similar to the WT, only 
KD2 was 2.8-fold lower than the WT KD.
Binding of Ca2+ to the high affinity binding site (KD1) 
was exothermic for all GCAP1 forms with values for ∆H 
between −14.4 kcal/mol (G159V) and −19.4 kcal/mol 
(WT). In contrast, the low affinity KD3 values of all mutants 
corresponded to positive enthalpy changes between 3.4 kcal/
mol (D100E) and 11.6 kcal/mol (E89K). The medium affin-
ity binding site was exothermic for WT, E89K, and G159V, 
but endothermic for D100E and L151F (Table 2).
Structural effects of Ca2+ binding to GCAP1 mutants
Near-UV CD spectroscopy was used to assess the effects 
of Ca2+ binding on the tertiary structure of each GCAP1 
variant. For the wild-type GCAP1, the spectroscopic data 
showed a significant rearrangement of the aromatic resi-
dues upon binding of Ca2+, especially in the Phe and Tyr 
bands (Fig. 2), with a less prominent involvement of the Trp 
region. Saturation with Ca2+ revealed a higher dichroism 
compared to the apo-form and a fine structure in the Phe 
band with characteristic minima at 261 and 264 nm, while 
the trend was reversed in the Tyr–Trp regions, with a local 
maximum at 285 nm. Interestingly, in the absence of Ca2+ 
all GCAP1 variants except E89K showed similar spec-
tra compared to the wild type, suggesting that the tertiary 
structure of the apo-form is not significantly affected by 
the pathogenic mutations. However, the Ca2+-bound forms 
showed major differences in the Tyr–Trp regions, with 
a similar pattern but lower dichroic intensity in the Phe 
region. The 278–288-nm band switched from mostly nega-
tive to fully positive ellipticity, an effect particularly visible 
for the L151F and D100E mutants, and rather modest for 
the G159V variant. Thus, tertiary structure rearrangements 
concern mostly the Ca2+-bound forms of the mutants.
The E89K mutant showed a completely different near-
UV CD spectrum (Fig. 3a), both in the presence and in 
the absence of Ca2+. Strong positive ellipticity character-
ized both the EGTA and Ca2+-bound forms, suggesting 
that, at odds with all other mutants, the tertiary structure 
might be significantly different from that of the wild type 
already in the apo-form. Since this mutant in its myris-
toylated form was not fully characterized in earlier stud-
ies [16], we asked whether the secondary structure and 
the thermal stability would also significantly differ com-
pared to other mutants, therefore we repeated the same 
experiments performed earlier with the other GCAP1 
forms [16]. Far-UV CD spectroscopy (Fig. 3b) showed 
that, like the E89K non-myristoylated form [16], the 
myristoylated variant also has a typical all-α helical fold, 
which upon Ca2+ binding increased the relative elliptic-
ity at 222 nm by >22 %, thus showing full response to 
saturating Ca2+. Thermal denaturation profiles (Fig. 3c) 
could be fitted by the same model used for other GCAP1 
mutants, leading to a transition temperature of 37.3 °C in 
EDTA and approx 115 °C in the presence of saturating 
Fig. 2  Structural changes 
occurring in GCAP1 vari-
ants upon binding of Ca2+ 
at T = 25 °C, in 5 mM Tris/
HCl pH 7.5, 150 mM KCl 
buffer. Near-UV CD spectra of 
0.5–0.7 mg/ml GCAP1 were 
recorded in the presence of 
equal amounts (1 mM) of satu-
rating EGTA or CaCl2
Author's personal copy
3835Impact of cone-dystrophy related mutations in GCAP1
1 3
Ca2+. Calcium-saturated spectra recorded at 96 °C after 
thermal denaturation (Fig. 3d) showed that a significant 
portion of the secondary structure was retained; however, 
the spectra demonstrated a loss of α-helical content when 
compared to the ones recorded at 37 °C. Cooling back to 
4 °C led to further recovery of the signal, indicative of a 
partial recovery of secondary structure, but the spectral 
shape was still far from the native, purely α-helical one 
(Fig. 3d).
Effects of GCAP1 mutants on the kinetics 
of phototransduction
In order to explore the functional effects of cone dystro-
phy-related GCAP1 mutants on the whole phototransduc-
tion cascade, we used a recently developed comprehensive 
kinetic model of phototransduction in rod cells [20–22], in 
which the Ca2+-relay mechanism was implemented allow-
ing the separated contributions of GCAP1 and GCAP2 to 
the regulation of the ROS-GC1 activity to be monitored 
[23]. The functional effects of GCAP1 mutants on GC1 
activity as assessed by in vitro assays were explicitly con-
sidered here by setting kinetic constraints related to the 
experimental IC50 and h values, which were implemented 
directly in the Ca2+-relay model (see “Materials and 
methods”).
Figure 4 shows the simulation of typical photocurrents 
obtained for an amphibian rod stimulated by flashes of 
increasing intensities, from dim light conditions to saturat-
ing ones. A common feature observed for each mutant is the 
slight perturbation of photoresponse shapes, at each tested 
light intensity. The difference in the photoresponse kinet-
ics observed between wild-type rods and those expressing 
cone dystrophy-related GCAP1 forms is already apparent 
at dim light intensities leading to five photoisomerizations 
of rhodopsin. The superposition of simulated photocurrents 
(Fig. 4, last panel) highlights the most prominent effects, 
namely: (1) a higher response peak amplitude at each illu-
mination intensity; (2) the prolongation of the response 
duration, with a delay in the recovery time; (3) the post-
recovery stabilization at a lower current value, correspond-
ing to an increased dark current. These effects are relatively 
small in the implemented model that mimics data from 
dominant mutations in human, in which wild-type GCAP1 
accounts for ~50 % of the overall GCAP1 content. How-
ever, simulation of a hypothetical autosomal recessive form 
of the same mutants, thus leading to the complete absence 
of wild-type GCAP1 led to more significant effects (Online 
Fig. 3  Structural features of the E89K GCAP1 mutant. a Near-UV 
CD spectra recorded at 25 °C in 5 mM Tris/HCl pH 7.5, 150 mM 
KCl buffer, in the presence of equal amounts (1 mM) of saturating 
EGTA or Ca2+. b Far-UV CD spectra measured at T = 37 °C with 
21 µM protein in the presence of equal amounts (200 µM) of satu-
rating EDTA or CaCl2. c Thermal denaturation profile of 21 µM 
E89K-GCAP1 in the presence of equal amounts (200 µM) of EDTA 
or CaCl2, followed by monitoring the change in ellipticity signal at 
222 nm over the 20–96 °C temperature range. Curves obtained by fit-
ting to a quantitative model for a two-state transition are superposed 
to experimental points. d Far-UV CD spectra measured in the pres-
ence of saturating (200 µM) CaCl2 measured at T = 96 and 4 °C 
after thermal denaturation, as directly compared to spectra recorded 
at 37 °C
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Resource 1) with the onset of a “shoulder” at higher light 
intensities.
While present in each simulated GCAP1 mutant, these 
effects become more apparent for the variants in the follow-
ing order: E89K, G159V, L151F, D100E. It is worth notic-
ing that with respect to the nominal dark current initially 
set to 30.7 pA, the increase of dark current was similar 
for each mutant (+0.41 pA (E89K); +0.51 pA (G159V); 
+0.56 pA (L151F); +0.58 pA (D100E). However, in case 
of the sole expression of mutated GCAP1, e.g., in a hypo-
thetical recessive form of disease (Online Resource 1), the 
increase would be significantly stronger and differential 
for each mutant: +1.29 pA (E89K); +2.45 pA (G159V); 
+3.15 pA (L151F); +3.38 pA (D100E).
Since the kinetic computational model allows monitor-
ing individual reactions and molecular species within the 
simulated cascade, we sought to investigate the predicted 
dynamics for the rate of cGMP synthesis as determined by 
the sum of individual contributions by GCAP1, both in its 
wild-type and mutated forms, and GCAP2. Figure 5 shows 
the simulated curves for cGMP synthesis following a deliv-
ery of a light flash leading to 87 photoisomerizations.
While for wild-type GCAP1 both the absolute value 
and the shape of the cGMP rate are mostly determined by 
GCAP1, in the presence of ~50 % cone-dystrophy GCAP1 
mutants the shape of cGMP synthesis dynamic variation 
is also significantly determined by GCAP2. The effect is 
particular apparent in simulations of a hypothetical reces-
sive form of disease involving the same mutations (Online 
Resource 2). If no wild-type GCAP1 were present and the 
whole pool of GCAP1 were solely constituted by mutant 
proteins, in the cases of E89K and G159V mutants GCAP1 
would still play a role in shaping the rate of cGMP syn-
thesis, but by harboring the L151F or D100E mutation 
GCAP1 would not contribute at all to the dynamic synthe-
sis of cGMP, although it is still the determinant factor for 
setting the entity of the cGMP rate. Instead, the shape of 
the rate would be dynamically regulated solely by GCAP2. 
Hence, for these GCAP1 mutants, the protein apparently 
does not switch between its normal regulatory states.
Fig. 4  Simulated photocurrents of a rod photoreceptor stimulated 
by light of increasing intensity in the presence of ~50 % wild-type 
and ~50 % cone dystrophy-related GCAP1 variants, and wild-type 
GCAP2. The duration of each flash is 24 ms, and each stimulus leads 
to 1.5, 18, 87, 280, and 1,100 photoisomerizations of rhodopsin. In 
the last panel, superposition of simulated photoresponses correspond-
ing to wild-type and mutated GCAP1 variants to flashes leading to 5 
photoisomerization of rhodopsin is shown. The mathematical model 
used for the simulation is that reported in [23], with the Ca2+-relay 
model modified to include the parameters described in this work
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Discussion
A typical feature of GCAP1 mutations that are linked 
to cone-rod dystrophies is a change in the Ca2+-sensitive 
control of the target guanylate cyclase ROS-GC1, namely 
a shift in the Ca2+-dependent activation curve to higher 
Ca2+-concentrations (for review see [7]). This then creates 
a situation under which the cyclase is under control of a 
constitutively active GCAP1 leading to a constant rate of 
cGMP synthesis, and an unperturbed GCAP2, which is 
known to adjust the operating range of rods to high light 
intensities [29]. GCAP1, like other GCAP isoforms, har-
bors three functional EF-hand Ca2+-binding sites and the 
shift in Ca2+-sensitive regulation of ROS-GC appears to 
originate from a change in affinity of Ca2+ for the indi-
vidual EF-hands [30]. Lim et al. [31] assigned different 
affinities to the EF-hands in WT GCAP1 using ITC meas-
urements. The apparent dissociation constants we observed 
for WT GCAP1 (Table 2) are in good agreement with their 
published data resulting in two high affinity binding sites 
(KD1 and KD2 corresponding to EF-hand 3 and 4, respectively) 
and one site of lower affinity (KD3 in EF-hand 2). Our data 
are also consistent with our previous determinations of 
macroscopic Ca2+-binding constants using a competitive 
chromophoric Ca2+ chelator in a photometric assay, which, 
however, did not allow to assess potential contributions 
of the concerted conformational change upon Ca2+ bind-
ing [16]. Thus, the ITC measurements provided us with 
a reliable data set and showed that the high affinity site 
(KD1) remained nearly unchanged in comparison to the WT. 
More dramatic changes were observed for KD2 (in particu-
lar mutants E89K and D100E) and KD3 (particularly E89K, 
D100E, and L151F), which shifted to much higher values, 
indicating a decrease in affinity for Ca2+. Interestingly, the 
decrease in Ca2+ affinity did not lead to a loss in activating 
properties, but merely shifted the switching mode from an 
activator to an inhibitor state.
It is worth noting that the GCAP1 mutants exhibited far-
UV-CD spectra that showed the preservation of secondary 
structural features similar to the WT (Fig. 3 for E89K and 
Ref. [16]). Further, switching from Ca2+-saturated to Ca2+-
free GCAP1 forms caused different changes in the near-UV 
Fig. 5  Simulated time course of the synthesis of cGMP by GC in a 
rod cell under the Ca2+-mediated regulation by ~50 % wild-type and 
~50 % mutated GCAP1 and wild-type GCAP2 for a flash leading to 
87 photoisomerization of rhodopsin. Blue lines report on the contri-
bution of GCAP1 (both wild type and mutated) to the rate of cGMP 
synthesis, while red lines on that of GCAP2. The two contributions 
add up to form the overall rate (black line)
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spectra of all mutants (Fig. 2), but these changes indicated 
more subtle rearrangements in the vicinities of aromatic 
amino acid side chains of D100E, L151F, and G159V. Only 
E89K seemed to be an exception, since the near-UV spec-
tra showed a completely different profile, indicating a sig-
nificant structural change from the WT form. We propose 
that the E89K mutation in both myristoylated and non-
myristoylated GCAP1 leads to a misfolding of the protein, 
which could trigger photoreceptor cell death in ways not 
clarified yet.
Summarizing the results obtained with all other mutants, 
however, let us conclude that the main dystrophy-relevant 
aspect of the mutations does not originate from a struc-
tural instability or protein misfolding. Instead, it might 
be a direct consequence of the enzymatic and regulatory 
features.
This assumption was further confirmed by our stud-
ies on the catalytic efficiency. The two mammalian GCAPs 
(GCAP1 and 2) exhibit different regulatory properties includ-
ing differences in catalytic efficiency (kcat/Km) [8, 28]. Since 
this effect was found in previous work to be more pronounced 
in GCAP1 than in GCAP2, we reasoned that GCAP1 muta-
tions would affect kcat/Km in a previously unknown manner. 
Although the mutations led to lower catalytic efficiency, they 
did so by mixed effects having both consequences for Km 
(increase) and in some cases also for kcat (increase for L151F 
and G159V). It remains an open question, how these data on 
catalytic efficiency could contribute to the development of the 
retinal dystrophy, but since the decrease in kcat/Km is mainly 
governed by an increase in Km, fluctuations in the substrate 
Mg2+-GTP concentration could significantly disturb an effi-
cient cGMP synthesis by the following scenario: because the 
target ROS-GC1 would be constitutively activated by GCAP1 
mutants regardless of the cytoplasmic Ca2+-concentration, 
the turnover of GTP is expected to increase leading to a GTP 
drain. This would cause an imbalance of constant GTP sup-
ply via metabolic routes, at least transiently, affecting nega-
tively the catalytic efficiency. In turn, cGMP synthesis would 
decrease, but not in the precise time frame that is required for 
reliable photodetection.
In order to gain more insight into the cGMP synthe-
sis rate, when a photoreceptor cell expresses one of the 
GCAP1 mutants (in the presence of approximately 50 % of 
WT GCAP1 and the whole pool of WT GCAP2), we inte-
grated our experimental data on Ca2+-dependent ROS-GC1 
regulation by GCAP1 and GCAP2 into a kinetic model 
of phototransduction. Interestingly, the dynamic changes 
in cGMP synthesis rate became more pronounced the 
larger the changes of the biochemical properties of a par-
ticular GCAP1 mutant were, which is most significant for 
L151F and D100E (Figs. 4, 5). This effect seems to arise 
from the loss or reduction of any Ca2+-sensitive regulation 
of the GC by mutant GCAP1 under normal physiological 
Ca2+-concentrations, which by itself would lead to a con-
stant synthesis rate. Under conditions of constant illumina-
tion, when the synthesis rate is high, but at the same time 
less dynamically regulated, the substrate GTP concentra-
tion might also decline due to exhaustion of the cellular 
GTP pool. These fluctuations would then have an effect on 
the catalytic performance of the ROS-GC/GCAP complex 
(see above).
It is interesting to note that the perturbations of the pho-
totransduction kinetics observed in our simulations are in 
line with experimental data on transgenic mice expressing 
the Y99C mutation in GCAP1 also found in cone-dystrophy 
patients [17]. The Y99C variant showed similar biochemi-
cal features compared to the mutants analyzed here, and it 
constitutively activated the GC at physiological Ca2+, thus 
leading to an increase of free cGMP. In their electrophysi-
ological studies, Olshevskaya et al. [17] noticed an increase 
of dark current in the mutant mice, and a minor perturba-
tion of the photocurrents over a broad range of light stimuli 
ranging from single photon to saturating responses. The 
extent of the perturbation (increased amplitude and time-
to-peak for single photon response as well as the general 
prolongation of the light responses) was, however, found 
to depend on the expression level of mutant GCAP1 
over a background of wild-type GCAP1. Our computa-
tional model fully reproduces this behavior. The effects 
of mutants expressed in the presence of ~50 % wild-type 
GCAP1 led to significantly lower perturbation of the pho-
tocurrents (Fig. 4) compared to the simulated case of total 
absence of wild-type GCAP1 and its complete replacement 
by mutant variants (Online Resource 1), which in fact com-
pletely exclude the switch between activating and inhibi-
tory states. In the light of the Ca2+-relay model formerly 
implemented [23], we can now propose a mechanistic 
explanation of the changes to the Ca2+-dependent regu-
lation of GC activity in the presence of GCAP1 mutants, 
which would block the cyclase in a constitutively active 
state, and the co-presence of wild-type GCAP2. Under 
the conditions where one of the two GCAP regulators are 
blocked into a state where the switch cannot occur, the lack 
of its regulatory capability can be partially compensated by 
the activity of the other GCAP that, with its different Ca2+ 
sensitivity, is expected to slightly perturb the dynamics 
of cGMP synthesis with respect to the case in which both 
GCAPs are fully active in normal conditions. In the condi-
tions simulated here, as well as in the results reported on 
Y99C transgenic mice [17], both the presence of significant 
amount of normal GCAP1 and GCAP2 could compensate 
for the lack of GC regulation by mutated GCAP1 already 
at dimmer light intensities, thus contributing to the kinet-
ics of cGMP synthesis at times (and Ca2+ levels) normally 
regulated mostly by normal GCAP1, in line with the need 
for a system that makes gradual responses to small changes 
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in Ca2+, that is the Ca2+-relay model. In cases where wild-
type GCAP1 were totally absent and the cone dystrophy-
related variants were solely expressed, the compensa-
tory effect of GCAP2 would be even stronger (Figure S2 
in Online Resource). The mechanism could hence partly 
explain the significant differences observed in autosomal 
dominant and hypothetical recessive forms of disease. This 
postulated mechanism of needed compensation would also 
explain why in GCAP2 knockout mice [29] the perturba-
tion to the photoresponse kinetics were quantitatively very 
similar to those observed for Y99C-GCAP1 mice and in the 
present work.
In conclusion, our data suggest that the simultaneous 
presence of GCAP1 and GCAP2, acting in a synergic man-
ner in vivo, produces a different regulation of the cyclase 
than each type alone, and in cases where a GCAP has been 
genetically altered, a compensatory effect may occur dur-
ing the dynamics of the photoresponse that results in a 
less dramatic alteration of the photoresponses than what 
is expected by in vitro assays. However, even small altera-
tions of the Ca2+ and cGMP homeostasis in resting con-
ditions might be well sufficient to trigger the degenerative 
process in photoreceptors, thus being ultimately responsi-
ble for the onset of the disease.
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Abstract
Two recently identiﬁed missense mutations (p. L84F and p. I107T) in GUCA1A, the gene coding for guanylate cyclase (GC)-
activating protein 1 (GCAP1), lead to a phenotype ascribable to cone, cone-rod and macular dystrophies. Here, we present a
thorough biochemical and biophysical characterization of the mutant proteins and their distinct molecular features. I107T-
GCAP1has nearlywild-type-like protein secondaryand tertiary structures, and bindsCa2+with a >10-fold lower afﬁnity than the
wild-type. On the contrary, L84F-GCAP1 displays altered tertiary structure in bothGC-activating and inhibiting states, and awild
type-like apparent afﬁnity for Ca2+. The lattermutant also shows a signiﬁcantly high afﬁnity forMg2+, whichmight be important
for stabilizing the GC-activating state and inducing a cooperativemechanism for the binding of Ca2+, so far not been observed in
other GCAP1 variants. Moreover, the thermal stability of L84F-GCAP1 is particularly high in the Ca2+-bound, GC-inhibiting state.
Molecular dynamics simulations suggest that such enhanced stabilityarises fromadeeper burial of themyristoylmoietywithin
the EF1–EF2 domain. The simulations also support an allosteric mechanism connecting the myristoyl moiety to the highest-
afﬁnityCa2+ binding site EF3. In spite of their remarkably distinctmolecular features, bothmutants cause constitutive activation
of the target GC at physiological Ca2+. We conclude that the similar aberrant regulation of the target enzyme results from a
similar perturbation of the GCAP1–GC interaction, which may eventually cause dysregulation of both Ca2+ and cyclic GMP
homeostasis and result in retinal degeneration.
Introduction
Autosomal-dominant cone (COD) and cone-rod (CORD) dystro-
phies constitute particularly severe forms of inherited visual dis-
eases. The usually rapid clinical course leads to an initial
decrease in visual acuity, abnormal color vision, photophobia
anddecreased sensitivity in the central visualﬁeld, later followed
by progressive loss in peripheral vision and night blindness (1,2).
Most inherited retinal dystrophies are very often caused by an
imbalance of the homeostasis of the second messengers operat-
ing in rod and cone photoreceptor cells, namely Ca2+ and cyclic
GMP (cGMP). These important molecules control the kinetics of
photoreceptor light response and play a crucial role in light adap-
tation (3,4). Indeed, photoactivation of the visual pigment in
photoreceptors leads to the light-induced hydrolysis of cGMP,
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thereby causing the closure of cyclic nucleotide-gated channels;
these block the inﬂux of cations including Ca2+, and cause the hy-
perpolarization of the cell membrane. A second consequence of
illumination is a decrease in intracellular Ca2+due to the continu-
ous extrusion of the cation via a Na+/Ca2+, K+-exchanger.
Among other Ca2+-sensor proteins, guanylate cyclase-activat-
ing proteins (GCAPs) detect changes in Ca2+ concentration and re-
spond byadopting conformations that control the activity of their
target protein, the membrane-bound guanylate cyclases (GC). At
high [Ca2+], GCAPs inhibit the GC activity, thus ensuring basal le-
vels of cGMP; at low [Ca2+], after light activation of the photo-
transduction cascade, they switch to a GC-activating state,
which triggers the synthesis of cGMP and rapidly restores dark-
adapted conditions (5,6). As a result of the delicate interplay be-
tween Ca2+ and cGMP homeostasis, the concentration of Ca2+
during the phototransduction cascade is strictly controlled, and
ranges between several hundred nanomolar Ca2+ in the dark
down to below 100 n in the light (3,4).
GCAPs are sensor proteins able to bind up to three divalent
metal ions in their EF-hand motifs, namely EF2, EF3 and EF4.
They have been proven to be both Ca2+ and Mg2+ sensors, and
the Mg2+-bound form is implied in GC activation, while the Ca2+-
saturated form is necessary to fully inhibit the GC (5–9). The pres-
ence of various isoforms of GCAPs in photoreceptor cell types
seems to be justiﬁed by the fact that GCAPs can respond to incre-
mental changes in [Ca2+] andwork in a relaymode fashion (10–14).
To date, up to 12 missense mutations have been identiﬁed in
GUCA1A, the gene coding GCAP1, in patients suffering from retinal
disease, including COD, CORD and macular dystrophy (MACD)
(15,16). Biochemical investigations revealed that most of such
GCAP1 mutations exhibit a more or less severe disturbance in
their Ca2+-sensing properties, speciﬁcally, they maintain the GC
constitutively active over the physiological range of [Ca2+], in
which they normally switch between activating and inhibiting
regulatorymodes (17–21). The ﬁnal trigger of photoreceptor degen-
eration remains still unclear, although experiments performed on
transgenicmice suggest apoptosis as a possiblemechanism (22,23).
Among retinal dystrophy-related mutations in GUCA1A, two
(c.250C>T and c.320T>C) were very recently discovered in unre-
lated Spanish families affected by autosomal-dominant retinal
degeneration (16). The clinical phenotype was typically broad,
showing features of COD, CORD and MACD (16). The missense
mutations lead to amino acid substitutions that signiﬁcantly
modify the physico-chemical nature of the side chain, with pos-
sible consequent perturbation of the protein structure/function
relationship. Indeed, the c.250C>T mutation leads to the Leu 84
to Phe substitution (L84F-GCAP1), while c.320T>C leads to Ile
107 to Thr substitution (I107T-GCAP1), in the expressed protein.
The affected amino acid positions are in close vicinity at the
level of the primary structure, but are located in signiﬁcantly re-
mote regions of the GCAP1 tertiary structure (Fig. 1A). L84 is lo-
cated in the EF1–EF2 domain, at the end of the exiting helix
(αF2) of the EF2 motif. The region includes several important
hydrophobic residues that interact with the myristoyl moiety
post-translationally bound at the N-terminal (Fig. 1B), and the
neighbor residue K85 has been shown to be signiﬁcantly involved
in the binding interface with the GC (24,25). On the other hand,
I107 is located in the EF3 Ca2+ binding loop, although the residue
is not involved in direct Ca2+-coordination. The EF3–EF4 domain
has been deﬁned a ‘hot spot’ for retinal dystrophies (15), in that
many of the disease-associated mutations in GUCA1A codify for
residues located in this structural region (Fig. 1A, blue sticks).
The particularly broad phenotypical variety of these two
newly identiﬁed GUCA1A mutants includes MACD, which has
so far only been associated with the Y99C (26,27) and P50L (28)
substitutions. We therefore asked, whether L84F and I107T-
GCAP1 share commonmolecular features with other retinal dys-
trophy variants of GCAP1, or rather exhibit novel properties. We
performed a thorough biochemical and biophysical investigation
of the two mutants and found that, surprisingly, very different
molecular properties shown by the two mutants may result in
a similarly aberrant regulation of the target enzyme.
Results
Ca2+- and Mg2+-dependent structural changes and
protein thermal stability in I107T and L84F-GCAP1
monitored by circular dichroism spectroscopy
Circular dichroism (CD) spectroscopy was used to assess the po-
tential effects of the point mutations on both the secondary and
tertiary structure of I107T and L84F-GCAP1, in their GC-activating
Figure 1. Three-dimensional homologymodel of humanGCAP1. (A) Cartoon representation of the GCAP1overall fold. EF1 is colored in yellow, EF2 in green, EF3 in orange and
EF4 in light blue.N- andC-terminals are colored inpale greyand pale cyan, respectively, and themyristoyl group is represented by grey spheres. Calcium ions are represented
by red spheres, while residue targets of cone dystrophy-associatedmutations are shownby dark blue sticks. L84 and I107 are represented bymagenta sticks. (B) Details of the
region surrounding the myristoyl group. Hydrophobic residues showing persistent interactions with the myristoyl moiety are represented as sticks and labeled.
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and inhibiting states, corresponding to the Mg2+-bound and
Ca2+-bound conformations, respectively.
The apo form (EGTA) of I107T-GCAP1 (Fig. 2, upper left)
showed a near-UV CD spectrum similar to that of the wild-type
(7), though with a more pronounced negative dichroic band in
the Tyr-Trp region. The addition of Mg2+ lowered the intensity
of the spectrum and led to regions of positive dichroism (Fig. 2,
upper left). Following saturation with Ca2+, the spectrum yielded
a typical shape already observed for wild-type GCAP1 (7) and for
other COD-relatedmutants (29), with amutant-speciﬁc variation
in the amplitude of the positive Tyr band.
The binding of Ca2+ to apo I107T-GCAP1 caused signiﬁcant
variations in its tertiary structure, while the following addition
of Mg2+ did not signiﬁcantly perturb the near UV CD spectra
(Fig. 2, upper right), substantially in line with what was observed
for wild-type GCAP1 (7). The far UV CD spectra of I107T-GCAP1
(see Supplementary Material, Fig. S1, upper panels) showed the
typical all α-helix pattern, with a dampening of the signal of
the Mg2+-bound form compared with the apo form, but no
other alteration of the spectral shape as conﬁrmed by the identi-
cal ratio between the ellipticity values at 208 and 222 nm (Θ222/
Θ208 = 0.89; Table 1). A major increase in the signal after addition
of Ca2+ (see Supplementary Material, Fig. S1, upper left) and an
increase in Θ222/Θ208 (0.91) was observed, indicative of changes
in secondary structure and/or protein compactness (17).
Ca2+-bound I107T showed an increase in both the signal intensity
(see SupplementaryMaterial, Fig. S1, upper right) and in theΘ222/
Θ208 ratio (0.91; Table 1) comparedwith the apo form, with no sig-
niﬁcant differences upon Mg2+ addition.
Interestingly, a signiﬁcantly different tertiary structure was
observed for L84F-GCAP1 already in the apo form (Fig. 2, lower
left). Peculiar features were the positive dichroism in all the spec-
tral regions and the onset of a maximum in the Phe band, at
255 nm, which was previously observed only in ion-bound
Figure 2. Structural changes occurring in I107Tand L84FGCAP1 upon binding of Ca2+ andMg2+monitored by CD spectroscopy. Near UV spectrawere recorded at T = 37°C in
5 m Tris–HCl pH 7.5, 150 m KCl, 2 m DTT buffer. Upper panel, left: 25.3 µ I107T-GCAP1 in the presence of 400 µ EGTA (black, solid line), 1 mMg2+ (gray, solid line)
and after addition of 400 µ free Ca2+ (gray, dashed line); right: in the presence of 400 µ EGTA (black, solid line), 400 µ free Ca2+ (gray, solid line) and after addition of
1 m Mg2+ (gray, dashed line). Lower panel, left: 26 µ L84F-GCAP1 in the presence of 400 µ EGTA (black, solid line), 1 m Mg2+ (gray, solid line) and after addition of
400 µ free Ca2+ (gray, dashed line); right: in the presence of 400 µ EGTA (black, solid line), 400 µ free Ca2+ (gray, solid line) and after addition of 1 m Mg2+ (gray,
dashed line).
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wild-type GCAP1 (7). Mg2+-binding caused a small but signiﬁcant
conformational change in the Tyr band, and further addition of
Ca2+ changed the shape of the spectrum, particularly in the Phe
and Tyr bands (Fig. 2, lower left). The same kind of changes
were observed in Ca2+-bound L84F-GCAP1 (Fig. 2, lower right)
compared with the apo form, and the addition of Mg2+ after
Ca2+ did not signiﬁcantly alter the aromatic amino acid micro-
environment. As for the far UV spectra, Mg2+-binding slightly
lowered the signal at 208 nm, as shown by the increase in Θ222/
Θ208 from 0.90 to 0.94 (see Supplementary Material, Fig. S1,
lower left; Table 1), while addition of Ca2+ increased the signal
without altering the shape of the spectrum (Table 1). Ca2+-bind-
ing to the apo protein caused instead an increase in both the in-
tensity and the Θ222/Θ208 ratio to 0.92 (Table 1), while the addition
ofMg2+ resulted only in a small dampening of the signal (see Sup-
plementary Material, Fig. S1, lower right).
By taking advantage of the typical all-α architecture of both
GCAP1 variants, demonstrated by the far UV CD spectra in all
tested conditions, their thermal stability could be conveniently
monitored by following the ellipticity signal at 208 nm. Different-
ly from what observed for other COD/CORD-associated variants
(17), apo I107T-GCAP1 showed a three-phase thermal denatur-
ation proﬁle (Fig. 3A) with two apparent transitions at 42.0 and
91.5°C (Table 1). The binding of Mg2+ had a very mild effect on
the two transition temperatures (43.4 and 91.8°C, respectively)
while keeping the same unfolding pattern as the apo form. This
behavior also differs from wild-type GCAP1, which showed a typ-
ical two-phase transition pattern both in the apo and in the Mg2
+-bound forms, with melting temperatures of 50.1 and
51.5°C, respectively (7). Surprisingly, I107T-GCAP1 showed a
higher thermal stability in the presence of Ca2+ compared with
the wild-type (7) both in the absence (80.2 versus >70°C) and
in the presence (79.3 versus >70°C) of Mg2+, which slightly low-
ered the Tm (79.3 versus 80.2°C).
Thermal denaturation proﬁles for L84F-GCAP1 also showed
the same three-phase transitions for apo and Mg2+-bound
forms (Fig. 3B), with a clear transition at 38.2 and 42.2°C (Table 1),
respectively, and an only partly visible transition at >96°C. Ca2+
binding greatly increased the stability of L84F-GCAP1 both in
the absence (92.6°C) and in the presence of Mg2+ (91.9°C).
Intrinsic ﬂuorescence properties of I107T and
L84F-GCAP1
The ﬂuorescence properties of the two retinal dystrophy-related
GCAP1 mutants were compared with those of the wild-type in
conditionsmimicking dark-adapted (high [Ca2+]) and illuminated
(low [Ca2+]) photoreceptors. Intrinsic ﬂuorescence spectra of
wild-type GCAP1 (Fig. 4A) showed a major decrease (∼45%) of
the intensity upon Mg2+ binding to the apo form, together with
a small red shift in thewavelength of maximal intensity (342 ver-
sus 341 nm). Signiﬁcant increases in ﬂuorescence and red shift
(344 nm) were observed upon saturation with Ca2+. Apo I107-
GCAP1 also showed (Fig. 4B) quenching of the intrinsic ﬂuores-
cence upon Mg2+ binding, but to a lesser extent (∼10%), without
any shift in the maximum (341 nm, Table 1). Major quenching
was instead observed upon Ca2+ addition (∼50% with respect
to the apo form), which shifted the maximum of ﬂuorescence
toward higher wavelength (344 nm).
Table 1. Results from far UV CD spectroscopy, thermal denaturation
and ﬂuorescence spectroscopy
Θ222/Θ208
a Tm
b (°C) λmax ﬂuo
c (nm)
I107T
EGTA 0.89 42.0–91.5 341
Mg2+ 0.89 43.4–91.8 341
Mg2+ Ca2+d 0.91 79.3 344
Ca2+ 0.91 80.2 —
Ca2+ Mg2+d 0.91 — —
L84F
EGTA 0.90 38.2 to >96 341
Mg2+ 0.94 42.2 to >96 341
Mg2+ Ca2+ 0.94 91.9 342
Ca2+ 0.92 92.6 —
Ca2+ Mg2+ 0.92 — —
aRatio between ellipticity signal at λ = 222 and λ = 208 nm.
bMelting temperature obtained by ﬁtting the experimental curve to a four-
parameter Hill sigmoid.
cWavelength of maximal ﬂuorescence emission upon excitation at λ = 290 nm.
dLines labeled ‘Mg2+ Ca2+’ refer to experiments where Ca2+ was added after
saturating Mg2+, whereas cations were added in the opposite order in the ‘Ca2+
Mg2+’ cases.
Figure 3. Thermal denaturation proﬁles of I107T and L84F GCAP1 mutants in the
presence and in the absence of Ca2+ and Mg2+. (A) Thermal denaturation proﬁle of
∼6 µ I107T-GCAP1 in the presence of 200 µ EGTA (black triangles), 1 m Mg2+
(gray diamonds), 200 µ Ca2+ and 1 m Mg2+ (black squares) and 200 µ Ca2+
(gray circles). (B) Thermal denaturation proﬁle of ∼6 µ L84F-GCAP1 in the
presence of 200 µ EGTA (black triangles), 1 m Mg2+ (gray diamonds), 200 µ
Ca2+ and 1 m Mg2+ (black squares) and 200 µ Ca2+ (gray circles). Thermal
denaturation was followed by monitoring the ellipticity signal at 208 nm over
the 20–96°C temperature range. Quantitative data obtained by ﬁtting the
experimental values to a four-parameter Hill sigmoidal function are reported in
Table 1.
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L84F-GCAP1 exhibited a small quenching of ﬂuorescence
upon Mg2+ binding (∼10%) (Fig. 4C) with no shift of the maximum
(341 nm, Table 1), in a similar fashion to the I107T variant.
Interestingly, after Ca2+ addition, this mutant showed a smaller
red shift with respect to both wild-type and I107T-GCAP1
(342 nm), accompanied by an increase in ﬂuorescence intensity.
Monitoring Ca2+ and Mg2+ binding to I107T and
L84F-GCAP1
To investigate the origin of the distinct ﬂuorescence properties
observed for the two GCAP1 mutants in their different regulatory
states, wemonitored the binding of Ca2+ and Mg2+ to each variant
by two titration experiments. In a ﬁrst approach, Ca2+ titrations
were studied by monitoring spectroscopically the competition
with the 5,5′Br2-BAPTA chelator, both in the absence and in the
presence of physiological 1 m Mg2+. The working conditions
under which Ca2+ titrations were performed ensured robust and
reliable determinations in terms of protein stability and Ca2+ sat-
uration. Examples of titration curves are reported in Figure 5A
and B, and show very different patterns for I107T and L84F-
GCAP1. Data could be nicely ﬁtted by a two or three binding
sites model and the macroscopic binding constants were hence
determined (Table 2). Both variants bound Ca2+ with higher afﬁn-
ity with respect to the chelator (Fig. 5A and B) and the presence of
Mg2+ slightly lowered the apparent afﬁnity (Table 2). In detail, for
the I107T-GCAP1 variant, which carries a mutation in the EF3 Ca2+
binding motif, only the higher afﬁnity individual macroscopic
binding constants K1 and K2 were reasonably detectable, being
comparable to that of the chelator (log Kchelator = 5.6, KDchelator =
2.3 µ), while K3 was below the experimental detection limit.
Overall, this resulted in an apparent 2.5 µ afﬁnity in the absence
of Mg2+ and 2.8 µ in the presence of Mg2+, thus more than 10-
fold lower than that of the wild-type (31).
Surprisingly, L84F-GCAP1 showed a wild-type-like Ca2+ afﬁn-
ity in the absence of Mg2+ (KD
app = 0.15 versus 0.16 µ) and an
even higher afﬁnity in the presence of 1 m Mg2+ (KD
app = 0.39
versus 0.50 µ). The shape of the titration curve in the presence
of Mg2+ (Fig. 5B) showed a change in convexity typically observed
in protein systems that bind Ca2+ with a positive cooperativity
mechanism (30,32). Indeed, by assuming that one of the EF-
hand binding motifs was occupied by a Mg2+ ion, ﬁtting the ex-
perimental data to a two-binding site mechanism (Table 2) led
to substantially unaltered values for the macroscopic association
constants (logK1 and logK2) (Table 2), suggesting that the Ca
2+ af-
ﬁnity for the second binding site increases as a consequence of
the binding of a Ca2+ ion to the ﬁrst binding site. It is worthwhile
to notice that both wild-type and all other cone-dystrophy-
related GCAP1 variants investigated to date with this method
showed a sequential Ca2+ binding mechanism, without apparent
cooperativity (17).
In a different titration experiment, we monitored the intrinsic
Trp ﬂuorescence of each variant upon titration with Ca2+ and
Mg2+. Ca2+ ﬂuorescence titration measurements for L84F-GCAP1
(Fig. 5C) showed a wild-type-like biphasic behavior in the physio-
logical range of Ca2+ (0.1–0.6 µ) and in the whole tested range,
with a minimum around 100 n, in line with a previous work
(8). Moreover, consistent with the ﬂuorescence spectra and at
odds with the wild-type, L84F-GCAP1 showed an increase in
ﬂuorescence emission intensity in Ca2+-saturating conditions
with respect to the apo form. Interestingly, also I107T-GCAP1
showed an overall decrease in ﬂuorescence intensity when
switching between apo and Ca2+-saturated forms and a biphasic
conformational change, yet limited to the physiological range—a
feature shown also by G159V-GCAP1 (19).
Mg2+ ﬂuorescence titration for L84F-GCAP1 (Fig. 5D) showed
an overall decreasing pattern, in line with ﬂuorescence spectra,
Figure 4. Fluorescence spectra of GCAP1 variants. Fluorescence emission spectra
(λex = 290 nm)were recorded at T = 25°C in 5 mTris–HCl pH7.5, 150 mKCl, 1 m
DTT buffer. (A) Intrinsic Trp ﬂuorescence emission spectrum of ∼8 µ wild-type
GCAP1 in the presence of 1 m EGTA (black, solid line), after addition of 1 mMg2+
(gray, solid line), after further addition of 1 m free Ca2+ (gray, dashed line). (B)
Intrinsic Trp ﬂuorescence emission spectrum of ∼8 µ I107T-GCAP1 in the
presence of 1 m EGTA (black, solid line), after addition of 1 m Mg2+ (gray,
solid line), after further addition of 1 m free Ca2+ (gray, dashed line). (C)
Intrinsic Trp ﬂuorescence emission spectrum of ∼8 µ L84F-GCAP1 in the
presence of 1 m EGTA (black, solid line), after addition of 1 m Mg2+ (gray,
solid line), after further addition of 1 m free Ca2+ (gray, dashed line). The
wavelengths of maximal emission are reported in Table 1.
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Figure 5. Ca2+ and Mg2+ titrations of I107T and L84F-GCAP1 mutants obtained by absorption and ﬂuorescence spectroscopies. All experiments were performed at T = 25°C
in 5 mTris–HCl pH 7.5, 150 mKCl, 1 mDTTbuffer. (A) Ca2+ titration curves obtained byabsorption spectroscopy in the absence ofMg2+. Experimental points for I107T-
GCAP1 (black circles) and for L84F-GCAP1 (gray diamonds) are shown together with the optimal curve by computer ﬁtting (black and gray solid lines, respectively) and the
theoretical (simulated) curve for the titration in the sole presence of the chelator (gray dashed line). (B) Ca2+ titration curves obtained by absorption spectroscopy in the
presence of 1 mMg2+, experimental points for I107T-GCAP1 (black circles) and for L84F-GCAP1 (gray diamonds) are shown together with the optimal curve by computer
ﬁtting (black and gray solid lines, respectively) and the theoretical (simulated) curve for the titration in the sole presence of the chelator (gray dashed line). The curves
include dilution effects upon titration. The axes have been normalized as elucidated in the Materials and Methods section. (C) Ca2+ titration monitored by ﬂuorescence
spectroscopy of ∼0.7 µ I107T-GCAP1 (black line and circles) and of L84F-GCAP1 (gray line and diamonds) performed in the 2 n–100 µ range. (D) Mg2+ titration
monitored by ﬂuorescence spectroscopy of ∼0.7 µ I107T-GCAP1 (black line and circles) and of L84F-GCAP1 (gray line and diamonds) performed in the 9 µ–10 m
range. Titration experiments were performed by exciting Trp residues (λex = 290 nm) and monitoring the intrinsic Trp ﬂuorescence emission at λem = 340 nm. Three to
four replicates were accumulated and results are shown as average ± standard deviation.
Table 2. Results of Ca2+ binding and guanylate cyclase assay experiments
log K1
a log K2
a log K3
a KD
app (µ)b IC50 (µ)
c EC50 (n)
d X-folde
Wt 7.1 ± 0.9f 6.5 ± 0.8f 6.1 ± 0.5f 0.16f 0.24 ± 0.01 61 ± 32 33x
Wt Mg2+ 6.7 ± 0.8f 5.9 ± 0.1f 6.1 ± 1.0f 0.50f — — —
I107T 5.82 ± 0.14 (5.79 ± 0.11) 5.4 ± 0.3 (5.4 ± 0.3) 1.94 ± 1.91 2.5 (2.6) 7.5 ± 3.8 39 ± 26 17.5x
I107T Mg2+ 5.987 ± 0.002 (5.98 ± 0.04) 5.1 ± 0.5 (5.2 ± 0.4) 1.5 ± 1.1 2.8 (2.7) — — —
L84F 6.98 ± 0.04 6.68 ± 0.14 4.72 ± 0.17 0.15 1.8 ± 0.5 49 ± 17 10.5x
L84F Mg2+ 6.24 ± 0.08 (6.2 ± 0.3) 6.58 ± 0.03 (6.5 ± 0.3) 4.90 ± 0.15 0.39 (0.43) — — —
aDecimal logarithm of macroscopic binding constants for each Ca2+ binding site obtained by ﬁtting experimental data to a model with three (or two, text in italics,
in paraentheses) binding sites with the software CaLigator (30); errors represent standard deviation of at least three repetitions.
bApparent afﬁnity obtained by averaging the signiﬁcant macroscopic binding constants, see the Materials and methods section.
cIC50 is the Ca
2+ concentration at which the GC activity is half maximal; standard errors estimated from ﬁtting.
dEC50 is the concentration of GCAP1 at which the GC activity is half maximal; standard errors estimated from ﬁtting.
eX-fold activation is expressed as GCmax−GCmin divided by GCmin.
fData from (31).
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but also aminimumat around 80 µ, whichmight possibly imply
that a Mg2+ ion is bound to the protein with signiﬁcant afﬁnity in
the absence of Ca2+. I107T-GCAP1 exhibited a monophasic de-
creasing ﬂuorescence behavior, in line with ﬂuorescence spectra.
Experimental points could also be ﬁtted to a four-parameter Hill
sigmoid, with estimated transition concentrations of 3.6 m for
I107T-GCAP1 and 1.1 m for L84F-GCAP1.
Structural insights from molecular dynamics simulation
The biophysical data presented above could not completely clar-
ify some important mechanistic aspects as to the speciﬁc struc-
tural features of I107T and L84F-GCAP1 variants, which confer
distinct molecular hallmarks to each mutant. In particular, the
following aspects remained somewhat unclear: (i) I107T-GCAP1
may bind only two, and not three, Ca2+ ions in physiological con-
ditions corresponding to dark-adapted photoreceptors, i.e. high
intracellular Ca2+; (ii) Mg2+ could bind to L84F-GCAP1, presumably
to EF2 and most likely to EF3 as well, with higher afﬁnity com-
pared with the wild-type. On the other hand, the data collected
in this study indicate that the Mg2+-EF2 form of I107T-GCAP1
(EF2Mg2+ I107T-GCAP1) corresponding to the GC-activating state,
as well as the Ca2+-saturated form of L84F-GCAP1 (EF2Ca2+
EF3Ca2+ EF4Ca2+ L84F-GCAP1), corresponding to its GC-inhibiting
state, may indeed be of physiological relevance. We therefore
ran 150 ns all-atom molecular dynamics (MD) simulations for
each variant only in these latter states, and compared the results
with those of the same states for the wild-type, investigated in a
previous study (7).
EF2Mg2+ I107T-GCAP1 was overall less structurally stable and
more ﬂexible than the wild-type, as clearly demonstrated by
the higher α-carbon root mean-square deviation (RMSD) plot
(see Supplementary Material, Fig. S2A) and root-mean square
ﬂuctuation (RMSF) per residue (see Supplementary Material,
Fig. S2C). Signiﬁcantly, higher ﬂexibility was particularly appar-
ent in the 95–105 and 115–135 regions, corresponding to the EF3
entering helix (αE3) and Ca2+ binding loop, and the linker region
between EF3 and EF4, including portions of αF3 and αE4 (see Sup-
plementary Material, Fig. S2C). On the contrary, the structure of
EF2Ca2+ EF3Ca2+ EF4Ca2+ L84F-GCAP1 was signiﬁcantly more stable
(see Supplementary Material, Fig. S2B) and less ﬂexible (see Sup-
plementary Material, Fig. S2D) than that of the wild-type in the
same time frame, which is in line with the high thermal stability
of this variant.
Interestingly, in the time course of 150 ns, the two GCAP1 mu-
tants also showed distinct dynamical features in the structural
region constituting the highest-afﬁnity Ca2+ binding site EF3, fun-
damental for keeping the GC inhibiting state (9,33). Indeed, by
monitoring for each mutant and for the wild-type, the RMSD of
the EF3 Ca2+-coordinating residues D100, N104 and E111 (see
Supplementary Material, Fig. S3A, left panel), we found: (i) a sig-
niﬁcantly higher ﬂexibility of the three residues for EF2Mg2+
I107T-GCAP1 when compared with the EF2Mg2+ wild-type (see
Supplementary Material, Fig. S3B, left column); (ii) a signiﬁcantly
lower ﬂexibility of the same residues for EF2Ca2+EF3Ca2+EF4Ca2+
L84F-GCAP1 with respect to the Ca2+-saturated wild type (see
Supplementary Material, Fig. S3B, right column). While such ef-
fects were expected for the I107T mutation that is located in
EF3, the decrease in ﬂexibility of the Ca2+-saturated L84F mutant
came as a surprise and can be interpreted as long-range struc-
tural effects originating in EF3.
In order to get some further insight into the high stability of
L84F-GCAP1, we analyzed the persistency of hydrophobic inter-
actions with the myristoyl group by computing the percentage
of frames along the 150 ns simulation, in which the distance be-
tween the centers of mass of hydrophobic residues and the myr-
istoyl group was smaller than 5.5 Å (see Fig. 1B for a snapshot of
such hydrophobic residues). Results for EF2Ca2+EF3Ca2+EF4Ca2+
L84F-GCAP1 showed a signiﬁcantly increased persistence of
hydrophobic interactions with the myristoyl group (Fig. 6C) com-
pared with the wild-type protein for most of the residues in-
volved, namely L13, F43, L45, L176 and I179. M59 and L183 did
not show signiﬁcant variations and V180 was the only residue
with decreased persistence of hydrophobic interactions. The sig-
niﬁcantly tighter packingofhydrophobic residues around themyr-
istoyl group appears to be of particular importance for the sake of
keeping the myristoyl moiety buried within the EF1–EF2 domain
(see Supplementary Material, Movies S1 and S2). In particular,
the interactions involving F43 (∼80% of persistence) and L13
(∼28% of persistence) became stronger as the two residues dynam-
icallymoved signiﬁcantly closer to one another comparedwith the
wild-type case (see Supplementary Material, Fig. S3A, right panel,
representing the distance between the Cβ of the 43 and 84 resi-
dues). Overall, this reﬂects a remarkable decrease in solvent ac-
cessible surface for the myristoyl group (Fig. 6D) compared with
the wild-type case, along the whole simulated time frame.
At variance with this behavior, in EF2Mg2+ I107T-GCAP1
(Fig. 6A), L13, L45, I179, V180 and L183 had considerably less
persistent hydrophobic interactions with the myristoyl moiety
compared with the wild-type, while F43, M59 and L176 had a
more persistent interaction with the acyl group. A more loosely
packed myristoyl group with respect to the wild-type case was
also shown by a small increase in solvent accessibility (Fig. 6B)
and high structural ﬂuctuations (see Supplementary Material,
Fig. S2C).
Hydrodynamic properties and oligomeric state of I107T
and L84F-GCAP1
Dynamic light scattering (DLS) measurements were performed to
assess the hydrodynamic properties of the two GCAP1 variants in
their speciﬁc GC-activating and inhibiting states. I107T-GCAP1
(see Supplementary Material, Fig. S4A) showed a slight increase
in the hydrodynamic diameter upon binding of Mg2+ [d = (7.94 ±
0.11) versus (7.65 ± 0.06) nm, see Supplementary Material,
Table S1], while Ca2+ binding decreased the diameter to
6.79 ± 0.01 nm. No time-dependent aggregation was observed in
all the investigated conditions as shown by the mean count
rate stably ranging between 210 and 230 kcps. The reduction in
the size of the mutant is in line with the behavior of the wild-
type andof other COD-relatedGCAP1mutants (34). Size exclusion
chromatography (SEC) measurements for the same mutant (see
Supplementary Material, Fig. S5) resulted in a hydrodynamic
diameter of 6.6 nm for the apo form (see SupplementaryMaterial,
Table S1), which decreased to 6.0 nm upon Mg2+ binding and
underwent a further shrinking upon Ca2+ binding to 5.8 nm,
with a Ca2+-dependent increase in dimerization from 2 ± 1% to
13 ± 2% with respect to the apo form (see Supplementary Mater-
ial, Table S1).
DLS measurements of L84F-GCAP1 (see Supplementary Ma-
terial, Fig. S4B) could not provide a deﬁnitive estimate for the
hydrodynamic size in the absence of Ca2+ due to the presence
of low-order oligomers, which affect the correlation signal. This
GCAP1 variant exhibited, in the apo form, a clear time-dependent
aggregation over the course of 350 min (see Supplementary Ma-
terial, Fig. S4C), with an increasing count rate from 160 to
275 kcps. The aggregation propensity was somewhat impaired
by Mg2+ binding, with a count rate between 160 and 180, and
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even reversed by Ca2+ binding, which decreased the count rate
from 160–200 to 95–100 kcps. The presence of Ca2+ allowed also
a more realistic estimation of the L84F-GCAP1 monomer hydro-
dynamic diameter, which resulted 8.41 ± 0.04 nm when 1 m
Mg2+ was already present in solution, or 8.53 ± 0.04 nm when
Mg2+ was added to Ca2+-bound L84F-GCAP1. SEC measurements
showed a different behavior for L84F-GCAP1 (see Supplementary
Material, Fig. S5). Indeed, the estimated size for the monomer in
the apo form was 6.4 nm (see Supplementary Material, Table S1),
which decreased upon Mg2+ binding to 5.8 nm but increased
again to 6.4 nm upon Ca2+ binding. All L84F samples though
showed a higher percentage of aggregates (∼14–19%) than
I107T-GCAP1, and 6–7% dimers in solution, which may explain
the partial discrepancy with the DLS determinations. In sum-
mary, both DLS and SEC experiments conﬁrmed that in the
physiologically relevant states (Mg2+-bound and Ca2+-bound),
both mutants are essentially monomers.
Regulation of the guanylate cyclase activity by I107T and
L84F-GCAP1
GCAP1 is the physiological Ca2+-sensor regulating GC activity in
mammalian rod and cone cells. Its regulating properties are
characterized by two values: the EC50 is the concentration of
GCAP1 at which the activation of the target GC is half-maximal;
the IC50-value is the free Ca
2+-concentration at which the GC ac-
tivity is half-maximal in the presence of saturating GCAP1 con-
centration. We determined these values for the GCAP1 variants
that were investigated in this study. The EC50-values did not dif-
fer signiﬁcantly among all tested GCAPs revealing 49 ± 17 n for
L84F, 39 ± 26 n for I107T and 61 ± 32 n for wild type (Fig. 7B
and Table 2). These parameters indicate that the apparent afﬁn-
ity of GCAP1 for the target GCwasnot disturbed or changed by the
point mutations. However, large differences were found for the
IC50-values (Fig. 7A; Table 2): while the wild-type activated GC
with an IC50 of 0.24 μM (X-fold activation was 33-fold), activation
by the mutants was shifted to higher free Ca2+ (IC50 = 1.8 μM for
L84F and IC50 = 7.5 µ for I107T, Table 2). The X-fold activation
was also lower, reaching only 10.5-fold for L84F and 17.5-fold
for I107T.
Discussion
The analysis of biochemical and biophysical properties of COD-
and CORD-related GCAP1 mutants previously performed by
Figure 6. Intramolecular interactions and solvent accessibility of the myristoyl moiety monitored by MD simulations. (A) Histograms representing the persistence of
intramolecular hydrophobic interactions with the myristoyl group for EF2Mg2+ wild-type GCAP1 (black) and EF2Mg2+ I107T-GCAP1 (gray) over the 150 ns simulation time
frame. (B) Time evolution over 150 ns of the SASA for EF2Mg2+ wild-type GCAP1 (black) and EF2Mg2+ I107T-GCAP1 (gray). (C) Histograms representing the persistence of
intramolecular hydrophobic interactions with the myristoyl group for EF2Ca2+EF3Ca2+EF4Ca2+ wild-type GCAP1 (black) and EF2Ca2+EF3Ca2+EF4Ca2+L84F-GCAP1 (gray). (D)
Time evolution over 150 ns of the SASA for EF2Ca2+EF3Ca2+EF4Ca2+ wild-type GCAP1 (black) and EF2Ca2+EF3Ca2+EF4Ca2+ L84F-GCAP1 (gray). Persistence has been
calculated as the percentage of frames, for which the distance between the center of mass of the myristoyl group and the hydrophobic side chains was lower than 5.5 Å.
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some of us (17,19,29) highlighted common hallmarks, which al-
lowed a clear distinction between the wild-type and the patho-
logic variants. These include minor structural changes (17,29), a
generally lower thermal stability (17), signiﬁcantly reduced afﬁn-
ity for Ca2+ (17,29), alteration in the hydrodynamic properties (34)
and in ﬂuorescence emission (19). From a functional viewpoint,
signiﬁcantly increased IC50 values leading to constitutive activa-
tion of the GC at physiological Ca2+ were observed for all the mu-
tants investigated so far by us and by others, with less signiﬁcant
—if present at all—alterations in the EC50 values (15).
The study presented here extends the molecular character-
ization of disease-associated missense mutations found in
GUCA1A to the biochemical and biophysical analysis of the pro-
teins expressed by two genemutations recently found in Spanish
families (16). The newly identiﬁed L84F and I107T-GCAP1 var-
iants showed a rather heterogeneous clinical phenotype (16)
ascribable to COD, CORD and MACD, similar to those previously
observed for Y99C and P50L-GCAP1 (26,28). We asked whether
the expressed proteins showed molecular features in common
with the previously characterized GCAP1 mutants. Surprisingly,
we found that this is not the case for both the variants.
CD spectroscopy showed that, while both GCAP1 variants are
clearly folded in a typical predominantly α-helix architecture (see
Supplementary Material, Fig. S1), I107T-GCAP1 is characterized
by a tertiary structure and a conformational transition pattern
(Fig. 2) similar to that recently observed for D100E, L151F and
G159V (29). Instead, L84F-GCAP1 showed slight but signiﬁcant al-
terations in its tertiary structure in both the GC-inhibiting and ac-
tivating states (Fig. 2). Moreover, the secondary structure and the
protein compactness for L84F-GCAP1 appeared to be related to
the sequence of cation binding events, as reﬂected by the differ-
entΘ222/Θ208 ratios obtained in the Mg
2+ and Ca2+-saturating con-
ditions, depending on the order of cation saturation (Table 1 and
see Supplementary Material, Fig. S1). A peculiar feature of the
newly investigated mutants is that, while they both showed a
10–12°C lower thermal stability than the wild-type in the Mg2+
bound/GC-activating state (Fig. 3 and Table 1) (7,17), they dis-
played higher stability in the presence of saturating Ca2+ (GC-in-
hibiting state), a phenomenon that was particularly apparent for
L84F, resulting in the most stable form of GCAP1 observed so far.
Distinct behaviors were also observed by analyzing the ﬂuor-
escence emission of the two GCAP1 variants, which reﬂects dif-
ferent conformational and hydrophobicity properties following
cation binding (Figs 4 and 5). Both forms showed a dynamically
changing, Ca2+-dependent emission pattern in the 100–600 n
physiological range of Ca2+, indicating the operation as Ca2+ sen-
sors. However, the two mutants showed opposite trends, result-
ing in a maximum for L84F and a minimum for I107T at ∼200 n
Ca2+ (Fig. 5D). It is worth noticing that the Ca2+-titration ﬂuores-
cence pattern shown by I107T-GCAP1 lacked the typical biphasic
behavior that is observed for the wild-type. However, this lack
was observed earlier in other COD mutants (19), while L84F-
GCAP1 displayed a unique and opposite trend, with enhanced in-
tensity of ﬂuorescence in conditions of saturating Ca2+. Results
from titrations with Mg2+ also signiﬁcantly differed for the two
mutants. While I107T-GCAP1 showed a pattern compatible with
awild-type like, relatively lowafﬁnity for Mg2+ (8,35), L84F-GCAP1
proved to switch its conformation in the physiological range
of Mg2+ (1 m), hence suggesting a more prominent role for this
cation in regulating its function (Fig. 5D).
Ca2+-titration experiments in competition with a chromo-
phoric chelator also highlighted remarkable differences among
the two mutants. I107T-GCAP1 showed, with respect to the
wild-type (17,31), decreased macroscopic association constants
for each EF-hand (Table 2), both in the presence and in the ab-
sence of physiological Mg2+, consistent with a ∼10-fold reduction
in apparent afﬁnity for Ca2+. Data ﬁtting to a two-site binding
model further suggest that the binding of a Ca2+ ion might be
compromised for this mutant. This trend is substantially in line
with what was observed previously with the COD/CORD-asso-
ciated mutants E89K, D100E, L151F and G159V (17). On the con-
trary, titrations for L84F-GCAP1 showed a very different pattern,
with a wild-type-like distribution of macroscopic association
constants, at least for the higher afﬁnity binding sites, and an
overall comparable apparent afﬁnity for Ca2+ (Table 2). Interest-
ingly, titration experiments performed in the presence of physio-
logical Mg2+ resulted in a less prominent decrease in apparent
afﬁnity compared with the wild-type [see Table 2 and (31)].
Data ﬁtting to a three-site binding model points to a positive co-
operativity mechanism, in which the binding of a Ca2+ ion to a
Figure 7. Photoreceptor guanylate cyclase 1 (ROS-GC1) regulation by wild-type and mutant GCAP1. (A) Washed bovine photoreceptor membranes containing ROS-GC1
were reconstituted with 5 µ GCAP1 wild-type or mutants between 0.0017 and 1000 µ free Ca2+. Activation was half maximal (IC50) at 0.24 µ (wt), 1.8 µ (L84F) or
7.5 µ (I107T) free Ca2+. (B) ROS-GC1 activity as a function of the GCAP1 concentration at 0.0017 µ free Ca2+. Activation was half maximal (EC50) at 61 n (wt), 49 n
(L84F) or 39 n (I107T). In both cases, ROS-GC1 activity was estimated at 30°C in nmol cGMP min−1 mg−1 rhodopsin from the data obtained from at least three
independent experiments. Error bars indicate the standard deviation.
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ﬁrst binding site increased the afﬁnity for the second (Table 2).
Notably, this proposed mechanism is consistent also with a
two-site Ca2+-binding model (Table 2), i.e. if one of the EF-
hands were occupied by Mg2+ under physiological conditions,
the binding of Ca2+ could still occur with positive cooperativity.
MD simulations were run to unveil mutant-speciﬁc structural
features and helped explaining their distinct properties. For
instance, they highlighted a signiﬁcantly higher ﬂexibility for
I107T-GCAP1 when compared with the wild-type, in the EF2Mg2+-
bound form (see Supplementary Material, Fig. S2A and C),
which is particularly apparent in the EF3–EF4 domain. On the
contrary, in the Ca2+-saturated state, L84Fwas signiﬁcantly stable
in all structural regions (see SupplementaryMaterial, Fig. S2B and
D) including the 120–135 region connecting EF3 and EF4, which
has been shown to be highly dynamic in wild-type GCAP1 (7).
Structural differences between the two mutants in the vicin-
ity of the myristoyl group became also visible by MD simulations.
In the L84F mutant, the myristoyl moiety was found to be deeply
buried in the cleft formed by the EF2 and EF3 motives (Fig. 6D),
and most of the hydrophobic residues that interact with the
acyl group, in particular, F43, L13 and L45 (Fig. 1B), were found
to maintain signiﬁcantly more persistent interactions compared
with the wild-type, in the simulated time frame (Fig. 6C). This
was not the case for the Mg2+-bound I107T-GCAP1, in which the
myristoyl moiety appeared more loosely packed than in thewild-
type (Fig. 6B), as further demonstrated by the generally less per-
sistent hydrophobic interactions (Fig. 6A).
Finally, MD simulations permitted us to explain possible
functional consequence for the pathological mutants. The EF3
Ca2+-coordinating residues D100, N104 and E111 were found to
be more dynamical in the Mg2+-bound I107T-GCAP1 than in the
wild-type (see Supplementary Material, Fig. S3B, left column),
which is not surprising considering the location of the substitu-
tion in the EF3 loop (Fig. 1A). However, the same residues were
signiﬁcantly less ﬂexible in the L84F-GCAP1 variant than in the
wild-type in the presence of saturating Ca2+ (see Supplementary
Material, Fig. S3B, right column). The remote distance of L84F to
the EF3 Ca2+-binding loop implies an intra-molecular communi-
cation pathway that connects the region of the myristoyl group
and the EF3 binding motif, which occurs via an allosteric mech-
anism. Such intra-molecular communication may be related to
the one observed between the same region and EF4 in myristoy-
lated wild-type GCAP1, and is involved in the recently proposed
calcium-myristoyl ‘tug’-mechanism for tuning Ca2+ sensitivity
and interaction with the GC target (36).
In spite of their remarkably distinct biochemical and biophys-
ical properties, I107T and L84F-GCAP1 showed rather similar
functional properties, in terms of aberrant regulation of the GC
target. They both led to constitutive activation of the target en-
zyme at physiological Ca2+ (Fig. 7 and Table 2), reﬂected by the
7.5-fold higher IC50 value for L84F and the ∼31-fold higher IC50
for I107T. In line with other COD/CORD-associated GCAP1 mu-
tants (17), no signiﬁcant correlation exists between the apparent
afﬁnity for Ca2+ of the GCAP1 variant and the corresponding IC50
values (Table 2). This apparently surprising evidencemight be ex-
plained by the fact that the IC50 values summarize a rather com-
plex series of events, including the replacement of cations in the
GC-bound GCAP1 and the concerted conformational change
transferred to the target, as well as the rearrangement of the
GC dimer interface. Interestingly, the concerted action of these
sequential steps is mirrored in the extremely high cooperativity
of GC activation (37), although Ca2+ binding to isolated GCAP1
per se occurs generally without cooperativity (17). Indeed,
GCAP1 might display different Ca2+ afﬁnities when GCAP1 is
bound to the GC, pointing to a very complex regulation of the
GC–GCAP1 complex. As proven recently by some of us (38),
when GC variants carrying mutations in its dimerization domain
are incubated with wild-type GCAP1, a signiﬁcant shift in Ca2+-
sensitivity is observed. Although GC is per se not a Ca2+-sensing
unit, it seems to integrate and process information regarding
Ca2+ sensing by GCAP1. Similar phenomena are observed in
other Ca2+-sensor systems, for example, for the ubiquitous pro-
tein calmodulin, which changes its afﬁnity for Ca2+ when
bound to the several physiological targets (39).
In terms of target functionality, both GCAP1 mutants showed
remarkably decreased activation of the target GC (10.5× in the
case of L84F, 17.5× in the case of I107T, versus 33× in the case of
the wild-type). However, the EC50 values for the two mutants
were relatively similar to those of thewild-type (Table 2), suggest-
ing that the interaction between GCAP1 and GC may occur for the
mutants with similar afﬁnity as for the wild-type under physio-
logical conditions.
A previous bioinformatic analysis (16) led to a proposal about
the pathological mechanisms underlying the altered function of
the two GCAP1 mutants. For I107T, perturbation of protein sec-
ondary (and eventually tertiary) structure was predicted,
together with similar effects predicted for previously character-
ized COD/CORD-associated mutants (15). Since the same bio-
informatic approach led to the prediction of no structural
alteration for L84F, the authors hypothesized that the nucleotidic
mutation c.250C>Tmay disrupt a splicing enhancer and/or create
a splicing silencer (16), so that the ﬁnal cause for diseasewould in
that case be haploinsufﬁciency. Our data however suggest a dif-
ferent scenario. Indeed, the thorough biochemical and biophysic-
al characterization performed here highlighted for I107T-GCAP1
very minor structural alterations with respect to the wild-type,
in line with what we previously observed for the D100E, L151F
and G159V COD/CORD-associated mutants (17,29,34). On the
contrary, and at odds with the result of previous bioinformatic
predictions (16), signiﬁcant structural effects among retinal-
disease-related GCAP1 mutants were indeed observed for L84F-
GCAP1. Although our data cannot completely exclude the
haploinsufﬁciency hypothesis, they rather strongly point to
the autosomal-dominant nature of the disease for both of the
expressed mutants. The observation that both I107T and L84F-
GCAP1 lead to similar perturbation of target regulation, causing
the constitutive activation of GC, suggests a similarly altered
inter-molecular communication mechanism, which is described
for nearly all the retinal-dystrophy GCAP1 mutants investigated
so far (15). In light of the calcium-relay model (11), GCAPs that
are unaffected by mutations, like GCAP2 in rods, may partly com-
pensate for the dysfunction of the mutated GCAP1, thereby still
allowing almost normal visual capabilities. In the long run, how-
ever, the photoreceptor would undergo a detrimental alteration
of Ca2+ and cGMP homeostasis, thus triggering cell death. An im-
portant goal of future studies will be to understand in molecular
detail, how remarkably distinct molecular features of GCAP1 var-
iants exert a common regulatory effect on the target enzyme,
thus leading to its aberrant regulation.
Materials and Methods
Materials
Tris (hydroxymethyl) aminomethane (Tris), 3-(N-morpholino)
propanesulfonic acid (Mops), CaCl2, MgCl2, NaCl, KCl, EGTA and
DTT were purchased from Sigma Aldrich or Carl Roth and were
of the highest grade available.
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Methods
Cloning of L84F and I107-GCAP1 mutants
The novel sequence variants c.320T>C (p.Ile107Thr) and
c.250C>T (p.Leu84Phe) were introduced by PCR site-directed in
vitro mutagenesis (primers available upon request). The ampli-
ﬁed PCR product was cut with NdeI and NheI and ligated into
the expression vector pET11-bGCAP1-D6S (40). All sequences
were veriﬁed by DNA sequencing (LGC Genomics, Germany).
Expression and puriﬁcation of I107T-GCAP1 and L84F-GCAP1
Wild-type, I107T and L84F-GCAP1 were overexpressed in BL21-
CodonPlus Escherichia coli cells and subsequently puriﬁed to
homogeneity as described before (10). In order to myristoylate
GCAP1 variants, cells were co-transformed with the plasmid
pBB131 containing a gene for the yeast (Saccharomyces cerevisiae)
NMT. After cell lysis, GCAP1 wild-type and mutants were isolated
from the insoluble fraction. Brieﬂy, GCAP1 variants were ex-
tracted from inclusion bodies by homogenization in 6  guanidi-
nium hydrochloride and dialyzed against 3 l Tris-buffer (20 m
Tris–HCl, 150 mNaCl, 1 mDTT pH 7.5). Subsequently, the pro-
tein was applied onto a size exclusion column (Superdex 75, GE
Healthcare, Germany) equilibrated in Tris-buffer with 2 m
EGTA. Fractions containing GCAP1 were further puriﬁed with an
anion exchange column (HiLoad 26/10 Q Sepharose; GE Health-
care) equilibrated in Tris-bufferwith 2 m EGTA (40). Chromatog-
raphy was performed with a gradient of 200–550 m NaCl in
40 ml. The purity of the obtained GCAP1 forms was veriﬁed by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis.
Proteins were decalciﬁed, aliquoted and lyophilized until use.
CD spectroscopy and thermal denaturation proﬁles
CDspectroscopystudieswereperformedwitha Jasco J-710 spectro-
polarimeter equipped with a Peltier type thermostated cell holder.
Both near UV (250–320 nm) and far UV (200–250 nm) spectra were
recorded at 37° C at a scan rate of 50 nm min−1, a bandwidth of
1 nm and an integration time of 4 s. Five accumulations were aver-
aged foreachsample, the spectrumof the buffer (5 mTris–HClpH
7.5, 150 m KCl, 2 m DTT) was recorded before each set of mea-
surements and subtracted. Protein concentration for farUV spectra
was ∼6 µ in 0.1 cm cuvettes, while for near UV spectra, it was
∼26 µ in 1.0 cmcuvettes. Both farUVandnearUVspectrawere re-
corded: (i) in the presence of >15-fold excess EGTA with respect to
protein concentration; (ii) after addition of 1 mMgCl2 or 2-fold ex-
cess CaCl2 with respect to the concentration of EGTA; and (iii) after
the addition of the other salt, not added in the previous step. Ther-
mal denaturation was monitored between 20°C and 96°C in the
same conditions as for far UV spectra, as far as protein, EGTA,
MgCl2 and CaCl2 concentrations are concerned. The ellipticity sig-
nal at λ = 208 nm (θ208) was recorded at a scan rate of 1°C min
−1
and a response time of 4 s. The thermal denaturation analysis
was performed assuming a two-state transition process, where
the θ208 signal recorded as a function of temperature represents
the fraction of folded and unfolded protein. When possible, ther-
mal denaturation curves were ﬁtted to a four-parameter Hill sig-
moid and a value for the melting temperature was estimated.
The equation for the ﬁtting curve was:
y ¼ bn þ
jbn # bujTH
THm þ T
H
where bn is the baseline value (θ208) of the native protein, bu the
baseline value of the partly unfolded protein, T the temperature,
H the Hill coefﬁcient and Tm is the melting temperature.
DLS experiments
DLS measurements were performed with a Zetasizer Nano-S
(Malvern Instruments) using a polystyrene low-volume disposable
sizing cuvette (ZEN0112). Viscosityand refractive index of the aque-
ous solvent were set at 0.8872 cP and 1.330, refractive index of the
protein was set to 1.45, protein absorption was set to 0.001 and
the temperature was set to 25° C with 2 min equilibration time.
The measurement angle was 173° backscatter and the analysis
model was set to multiple narrow modes. For each measurement,
a minimum of 24 determinations were performed, each consisting
of at least 10 repetitions. All experiments were performed in 5 m
Tris–HCl, 150 m KCl, pH= 7.5 buffer previously ﬁltered through a
Jet Bioﬁlm 0.22 µm membrane; protein solutions were ﬁltered
through a 0.02 µm Anotop 10 ﬁlter (Whatman). The time evolution
of themeancount rate over 350 minwasmonitored for L84F-GCAP1
in the same conditions as above,where each pointwas anaccumu-
lation of 10 measurements performed during 1 min time frame.
High performance liquid chromatography
Puriﬁed protein samples (100 µg) were analyzed for the presence
of monomeric, dimeric and/or aggregated GCAP1 forms by em-
ploying SEC on a BioSep-SEC S2000 column (Phenomenex,
Aschaffenburg, Germany). All experiments were performed in
30 m Mops-KOH pH 7.2, 50 m KCl, 4 m NaCl, 1 m DTT.
One millimolar EGTA, 0.3 m CaCl2 and/or 3.5 m MgCl2 were
added, respectively.
Fluorescence spectroscopy and Mg2+ and Ca2+ titrations
The emission ﬂuorescence spectra after excitation at λ = 290 nm
were recorded using a Jasco FP-750 spectroﬂuorimeter between
300 and 380 nm at 25°C, in 1 cm quartz cuvette and at a scan
rate of 60 nm min−1. The excitation and emission bandwidth
were set to 5 nm. All experiments were performed in 5 m
Tris–HCl pH 7.5, 150 m KCl, 1 m DTT buffer. The collected
data were obtained by subtracting the signal from the buffer to
an average of three accumulations. The protein concentration
for all ﬂuorescence spectra measurements was∼8 µ in the pres-
ence of 1 m EGTA, after addition of 1 m MgCl2 and after add-
ition of 1 m free CaCl2.
Ca2+ buffers and Mg2+ buffers used for ﬂuorescence titration ex-
periments were prepared using 5 m Tris–HCl pH 7.5, 150 m KCl,
100 µ EGTA and CaCl2 or MgCl2 at variable concentrations, every-
thing was dissolved in or diluted with the aforementioned buffer.
Free Ca2+ andMg2+ concentration for each titration pointwas calcu-
lated according to the Ca-Mg-ATP-EGTA Calculator software using
NIST database (http://maxchelator.stanford.edu/CaMgATPEGTA-
NIST.htm) by ﬁxing T = 25°C, pH = 7.5 and ionic strength =0.15 M.
By mixing these solutions, the ﬁnal free Ca2+ concentration was
varied in the 2 n–100 µ range, while the free Mg2+ concentration
was varied in the 9 µ–10 m range. Protein concentration was
∼0.7 µ for each titration point. After recording three accumula-
tions of the spectrum in the presence of 100 µ EGTA, only the
intensity at the wavelength corresponding to the maximum ﬂuor-
escence emission intensity was monitored for the other titration
points, which were expected to change according to Ca2+ or Mg2+
binding. For the data reported in Figure 6, Y-axis has been normal-
ized in the following way: Y = (F340−Fmin)/(Fmax−Fmin), where F340 is
the ﬂuorescence intensity of each titration point, Fmin the minimal
ﬂuorescence intensity recorded and Fmax themaximalﬂuorescence
intensity recorded.
Guanylate cyclase assay
Guanylate cyclase activities were determined as described in
(33,41) with buffer-washed ROSmembranes as a source for native
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ROS-GC1 [∼96% of the total cyclase activity in the membranes
from bovine ROS is provided by ROS-GC1 (41)] with the following
modiﬁcations: for the determination of EC50-values, the
GCAP1 concentration was varied between 0.05 and 10 µ. Ca2+-
dependent GC activities were obtained by keeping GCAP1 con-
centrations ﬁxed at 5 µ and varying the free [Ca2+] using a
K2H2EGTA/ CaH2EGTA buffer system as described previously
(33,42). The free Mg2+-concentration was 1 m. All incubation
steps were performed under very dim red light; the reactions
were stopped and further processed for analysis as described.
Determination of Ca2+-binding constants using a chromophoric
chelator
Calciumbinding to GCAP1 variants wasmonitored bya precise ti-
tration method described previously (30,32) based on the compe-
tition for Ca2+ between the protein and a chromophoric chelator,
5,5′Br2-BAPTA, whose absorbance changes upon Ca
2+ concentra-
tion. Brieﬂy, a Ca2+-free solution of 5,5′Br2-BAPTA was prepared
by dissolving the chelator in the previously decalciﬁed 5 m
Tris–HCl pH 7.5, 150 m KCl buffer. Chelator concentration ran-
ged between 17 and 26 µ, while initial Ca2+ concentration was
0.9–2.1 µ. For each titration experiment, Ca2+-free lyophilized
proteins were dissolved in the chelator solution, and the ﬁnal
concentration (13–16 µ) was measured with the Bradford
assay (43). In each experiment, 0.8–1 ml of chelator-protein solu-
tion was inserted in 1.0 cm cuvette and the absorbance at 263 nm
(λmax for the Ca
2+ free chelator) was monitored upon titration
with ﬁxed amounts (0.8–1 µl, respectively) of 3 m CaCl2. Titra-
tions were performed until no signiﬁcant change in absorbance
was detected. Three or four replications of each titration experi-
ment were performed, data (Fig. 5) were ﬁtted using a Newton–
Raphson direct least-square ﬁtting procedure implemented in
the CaLigator software (30) to obtain individual macroscopic
binding constants (log KA, Table 2), which were further used to
determine apparent afﬁnity values (KD
app, Table 2) allowing for
quantitative comparisons between the Ca2+ afﬁnity of the wild-
type and the mutants. With the same argument as in previous
works (17,31), we deﬁned the apparent afﬁnity of each mutant
from the average of the logarithms of the ﬁrst two macroscopic
binding constants [KD
app = 10−(logK1 + logK2)/2]. Given the much
lower afﬁnity for the third site, this apparent afﬁnity is not af-
fected by the poorly accurate information on the low afﬁnity
binding site (i.e. log K3 for I107T-GCAP1, Table 2).
All Ca2+ titrations were performed at room temperature. Axes
in Figure 5 were normalized as follows: Y = (A263−ACa)/(A0−ACa),
where A263 is the absorbance at λ = 263 nm, ACa the absorbance at
saturating [Ca2+] and A0 the absorbance at the lowest [Ca
2+]; X =
[Ca2+]tot/([Q]+3[P]), where [Ca
2+]tot is the total Ca
2+ concentration,
[Q] the concentration of the chelator (µ), 3 is the maximum
number of binding sites per protein and [P] themeasured concen-
tration of the protein (µ).
MD simulations and analyses
A homology model of human myristoylated GCAP1 was built
using the three-dimensional structure of chicken GCAP1 in its
Ca2+-bound form as a template (44) according to a procedure elu-
cidated in a previous work (17). Simulated states were modeled
either by removing Ca2+ ions from each respective EF-hand bind-
ing site or by substitution with an Mg2+ ion as elucidated in (7).
MD simulations of EF2Mg2+ wild-type GCAP1 and of EF2Ca2+
EF3Ca2+ EF4Ca2+ wild-type GCAP1 are the ﬁrst 150 ns of the trajec-
tories produced in (7). EF2Mg2+ I107T-GCAP1 and EF2Ca2+EF3Ca2+
EF4Ca2+ L84F-GCAP1 mutants were built using the structures of
the states simulated in (7) as a template, by replacing themutated
residuewith the highest-scored rotamer proposed by the ‘Mutate
Residue’ function implemented in Maestro (Schrodinger)
software.
MD simulations of the two mutants were performed using
GROMACS 4.6.3 simulation package (45), with the CHARMM27
all-atom force ﬁeld (46). CHARMM27 parameters for describing
the post-translational myristoylation were generated manually,
and are available upon request for academic use. All settings
for MD simulations were the same as in (7), in which details are
provided. The system was equilibrated at 310 K for 2 ns of back-
bone position-restrained MD simulations and then at 310 K for
2 ns of unrestricted MD simulations, and the resulting structure
was used as a reference in RMSD and RMSF calculations. After
equilibration, the systemunderwent 150 nsunrestrained isother-
mal–isobaric (NPT ensemble; T = 310 K, P = 1 atm) MD simulation.
Generated MD trajectories were subjected to different ana-
lyses. The solvent accessible surface area (SASA) and the α-car-
bon RMSD were calculated over the 150 ns trajectory, the latter
being referred to each structure after the 4 ns equilibration. The
intrinsic ﬂexibility of the system was evaluated by computing
the RMSF for each amino acid, in the time frame of the simula-
tion, deﬁned as time averaged-RMSD with respect to the refer-
ence structure:
RMSFi ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
T
XT
tj¼1
jriðtjÞ # r
ref
i j
2
vuut
where T is the 150 ns MD time frame and ri(tj) and ri
ref represent
the coordinates of the Cα atom of each residue at the time tj and
after 4 ns equilibration, respectively.
RMSF analysis was applied only on all α-carbons, RMSD ana-
lysis was applied on α-carbons of both the entire protein and se-
lected residues, while the SASA was calculated on the atoms
forming up the myristoyl group. RMSD, RMSF and SASA analyses
were performed using Wordom software (47,48).
Persistence over the 150 ns time frame of hydrophobic inter-
actions involving the myristoyl group was calculated as the
ratio of frames, in which hydrophobic interaction could be de-
tected between hydrophobic residues and the myristoyl group,
over the total number of frames. Hydrophobic interactions were
present if the distance between the center of mass of the side
chain of hydrophobic residues and the myristoyl group was
smaller than 5.5 Å. This analysis was performed using the PyIn-
teraph software (49).
Supplementary material
Supplementary Material is available at HMG online.
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Abstract
Macular dystrophy leads to progressive loss of central vision and shows symptoms similar to age-relatedmacular degeneration.
Genetic screening of patients diagnosed withmacular dystrophy disclosed a novel mutation in the GUCA1A gene, namely a
c.526C>T substitution leading to the amino acid substitution p.L176F in the guanylate cyclase-activating protein 1 (GCAP1). The
same variant was found in three families showing an autosomal dominantmode of inheritance. For a full functional characteriza-
tion of the L176Fmutant we expressed and purified themutant protein andmeasured key parameters of its activating properties,
its Ca2þ/Mg2þ-binding, and its Ca2þ-induced conformational changes in comparison to the wildtype protein. Themutant was less
sensitive to changes in free Ca2þ, resulting in a constitutively active form under physiological Ca2þ-concentration, showed signifi-
cantly higher activation rates than the wildtype (90-fold versus 20-fold) and interacted with an higher apparent affinity with its tar-
get guanylate cyclase. However, direct Ca2þ-binding of themutant was nearly similar to the wildtype; binding of Mg2þoccurred
with higher affinity. We performedmolecular dynamics simulations for comparing the Ca2þ-saturated inhibiting state of GCAP1
with the Mg2þ-bound activating states. The L176Fmutant exhibited significantly lower flexibility, when three Ca2þor two
Mg2þwere bound forming probably the structural basis for themodified GCAP1 function.
Introduction
Hereditary retinal disorders cause many different forms of reti-
nal disease that can lead to severe visual impairment or blind-
ness. Disease forms are often classified according to phenotype,
for example, whether the peripheral retina is affected first or
whether the cells in the macula are the early and most promi-
nent site of degeneration.
Age-related macular degeneration (AMD) is a late-onset dis-
ease leading to progressive loss of central vision (1–4). AMD has
been associated with genetic and non-genetic factors. The latter
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involve nutritional, lifestyle (smoking) or environmental factors,
which in combination with aging lead to a higher risk of disease
progression. Genetic and genomic studies have identified
genetic risk loci and susceptibility genes that are expressed in
the photoreceptor layer and its support system consisting of the
retinal pigment epithelium (RPE) Bruchs membrane (BM) and
the choroid. Phenotypic features of AMD can include the loss of
large numbers of photoreceptors in the central macula and pro-
tein and lipid deposits in the BM or between BM and RPE (5).
Macular dystrophy (MD) presents similar symptoms but is
linked to a different set of genetic mutations and, in contrast to
AMD, is monogenic and not considered multifactorial (6). In
addition, MD is a heterogeneous disease (caused by monoallelic
or biallelic mutation/s in one out of many genes) with a variable
age of onset (usually 5–50 years). One form of MD involves
mutations in the GUCA1A gene (7), which encodes the guanylate
cyclase-activating protein 1 (GCAP1) in rod and cone photore-
ceptor cells.
GCAP1 and its cognate GCAP2 regulate the activities of mem-
brane bound guanylate cyclases (GC) in response to light-
dependent changes of the cytoplasmic free Ca2þ-concentration
([Ca2þ]) and thereby are critical factors for Ca2þ-cGMP homeo-
stasis in the outer segments of rods and cones (8). Function of
GCAP1 and GCAP2 is not redundant as they operate in a Ca2þ-
relay fashion (9,10), which is based on different molecular prop-
erties of GCAPs like, for example, differences in Ca2þ-binding,
Ca2þ-sensitive operation, target regulation and conformational
dynamics (10–14). The exact activation mechanism of GCAPs on
the target GC at low free [Ca2þ] and inhibition at high free [Ca2þ]
is unclear. Peshenko et al. (15) recently employed mutants of
GCAP1 by inserting a phenylalanine (F) in critical amino acid
positions around the ‘myristoyl cavity’ and found a major effect
for the mutant L176F leading to a suggested ‘Ca2þ-myristoyl tug
mechanism’ of GCAP1 action (15).
By genetic screening of patients diagnosed with MD we iden-
tified the novel variant c.526C>T (p.L176F) in the GUCA1A gene,
which is identical to the mutant employed by Peshenko et al.
(15) for investigating the intramolecular connections between
the myristoyl group and Ca2þ-sensing. The aim of the present
work was to understand which cellular and molecular events
lead to the MD associated with L176F substitution. We present a
characterization of the clinical phenotype and investigate key
molecular properties of the expressed and purified mutant pro-
tein. Molecular dynamics simulations further provide us with
insight into protein dysfunction with respect to its conforma-
tional dynamics.
Results
Genetic screening and clinical evaluation of patients
Sanger sequencing of the GUCA1A gene in family 1 revealed a
novel variant c.526C>T (p.L176F) which is not reported in public
sequence repositories (including the ExAC database, http://exac.
broadinstitute.org). Mutations in other macular dystrophy-/
cone dystrophy-related genes had been previously excluded in
this family by ASPER chips and/or Sanger sequencing. The same
variant was identified in family 2 upon a panel-based next-gen-
eration sequencing approach and in family 3 upon whole exome
sequencing. All three families show an autosomal dominant
mode of inheritance (Fig. 1). Detailed clinical characteristics of
the patients are displayed in Table 1. Briefly, paracentral and
central scotomas in the central visual field were present in all
patients. Scotopic standard ganzfeld ERGs had normal
amplitudes and implicit times in all patients except in patient
II:1 from family 3. Photopic ERGs were reduced only in families
2 and 3. Multifocal ERGs were performed in patients from fami-
lies 2 and 3 only and showed diminished central responses,
whereas the outer ring averages revealed reduced amplitudes
and delayed implicit times only in patient II:1 from family 3.
Fundus abnormalities were typically confined to the macula
(Supplementary Material, Fig. S1). Optical coherence tomogra-
phy in families 1 and 2 revealed a thinner photoreceptor layer
in the foveal area.
Functional characterization of L176F-GCAP1, activation
of target GC1
Regulatory properties of L176F GCAP1 were compared with
those of WT GCAP1. For this purpose, the GCAP1 target human
GC1 was heterologously expressed in HEK293 cells and HEK293
cell membranes were isolated and reconstituted with purified
myristoylated (m) and non-myristoylated (nm) GCAP1 variants.
Basic features of GCAP1 function were preserved in the WT and
the mutant, namely activating the target GC1 at low free [Ca2þ]
and inhibiting it at increasing free [Ca2þ] (Fig. 2A and B).
However, characteristic differences were observed in the IC50
values ([Ca2þ] at which activation is halfmaximal) of the activa-
tion profiles: these were at 0.416 0.05 mM free [Ca2þ] for mWT
GCAP1 and shifted to 7.0961.4 mM [Ca2þ] for mL176F-GCAP1
(Table 2). A different and less pronounced effect was seen with
nmGCAP1 forms. Here, activation of human GC1 with WT
GCAP1 was halfmaximal at an IC50 of 0.676 0.18 mM [Ca
2þ]; the
L176F substitution in nmGCAP1 caused a slight shift to lower
free [Ca2þ] at of 0.556 0.06 mM (Fig. 2 and Table 2). These results
were broadly consistent with those reported by Peshenko et al.
(15), although the shift in Ca2þ-sensitivity (IC50-value), which we
observed for the L176F mutant was more than 17-fold, whereas
Peshenko et al. observed a shift of about 8-fold.
Figure 1. Segregation of the mutant allele harboring the c.526C>T transition in
three families.
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A second feature concerning the activation properties of
GCAP1 is the apparent affinity for the target GC1. An indirect
way to measure apparent affinity values is GC1 activation as a
function of the GCAP1 concentration resulting in EC50 values.
The apparent affinity expressed in EC50 values was highest
for mL176F and decreased in the following order:
mL176F>nmL176mWT>nmWT GCAP1 (Fig. 2C and D,
Table 2).
A third profound alteration of GCAP1 function became appa-
rent when we analysed the x-fold activation (expressed as
GCmax - GCmin divided by GCmin). The mutants showed signifi-
cantly higher x-fold activation rates than both WT GCAP1
forms. An x-fold activation of 91 for the mL176F mutants (Fig. 2E
and Table 2) was the largest we have observed in disease-
related GCAP1 mutants that we investigated in our laboratory in
recent years (16–18). The x-fold activation of nmL176F was
lower than mL176F, but still higher than mWT GCAP1.
Ca2þbinding to L176F in the presence/absence of Mg2þ
The distortion of Ca2þ-sensitive regulatory properties of GCAP1
could principally originate from changes in the Ca2þand/or
Mg2þ-binding properties (19). Therefore, we tested whether
Ca2þ-binding constants were affected in the mutant protein
employing a chromophoric chelator assay. Both mGCAP1 and
nmGCAP1 variants were titrated with Ca2þ in the presence of
the competing chelator/chromophore 5,5Br2-BAPTA. In
Figure 2. Functional analysis of the L176F GCAP1 mutant. Ca2þ-dependent regulation of human GC1 expressed in HEK293 cells was measured in the presence of non-
myristoylated (A) and myristoylated (B) GCAP1 variants (WT and L176F). Corresponding IC50 are listed in Table 2. Nonmyristoylated (C) and myristoylated (D) GCAP1
variants activate human GC1 at low [Ca2þ] yielding values of apparent affinity, EC50 listed in Table 2. X-fold activation by GCAP1 variants is shown in panel (E).
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addition, we tested the influence of Mg2þat physiological con-
centration in the buffer. Examples of chelator titrations are
shown in Fig. 3; we employed a three binding sites model for fit-
ting all data, which yielded macroscopic binding constants
listed in Table 2. Two Ca2þ-binding sites in WT GCAP1 are of
high to medium affinity and could easily be detected. Binding to
the third binding site occurred with much lower affinity and val-
ues were intrinsically less robust due to the detection limit of
the assay. We used the two macroscopic binding constants for
calculating KappD as previously described (18) yielding a K
app
D of
0.14 mM and 0.13 mM for nmWT and mWT GCAP1, respectively.
Adding Mg2þshifted the KappD to slightly higher values (0.20 mM
for nmWT and 0.38 mM for mWT). Titrations with WT GCAP1
served as a positive control and confirmed our previous results
thus showing that the assay is suitable for testing the mutant.
In the absence of Mg2þaffinities for Ca2þwere slightly lower for
the nmL176F than for nmWT (KappD ¼ 0.17 mM), but were not
altered for mL176F (KappD ¼ 0.13 mM). Presence of Mg
2þdecreased
the Ca2þ-affinity slightly for nmL176F (KappD ¼ 0.30 mM), and for
mL176F (KappD ¼ 0.47 mM).
Figure 3. Determination of Ca2þ-binding to GCAP1 variants using the chelator assay. (A) nmWT; (B) mWT; (C) nmL176F; (D) mL176F. All data sets were fitted using a
three-binding site model implemented in the Caligator software.
Table 2. Ca2þ-binding and GC regulation of GCAP1WT and the L176F mutant
log K1
a log K2
a log K3
a KD
app (mM)b IC50 (mM)
c EC50 (mM)
d X-folde
nmWT 7.260.2 6.560.3 3.561.1 0.14 0.6760.37 8.6061.02 5.264.0
nmWTMg2þ 6.8360.06 6.5760.12 5.6360.12 0.2 – – –
mWT 6.960.4 6.960.4 4.160.7 0.13 0.4160.01 4.1060.94 2062.2
mWTMg2þ 6.9760.15 5.8760.06 2.460.4 0.38 – – –
nmL176F 7.4760.06 6.0760.06 2.361.2 0.17 0.5560.12 4.2361.02 42620.4
nmL176F Mg2þ 6.7760.12 6.2760.06 4.060.3 0.30 – – –
mL176F 7.5260.13 6.260.2 – 0.13 7.0962.78 2.1360.23 9169.1
mL176F Mg2þ 6.760.1 5.9660.15 2.461.9 0.47 – – –
aDecimal logarithm of macroscopic binding constants for three Ca2þbinding sites; experimental data obtained from the chelator assay were fitted to a model with three
binding sites; errors represent standard deviation of at least three repetitions.
bApparent affinity obtained by averaging the significant macroscopic binding constants (see Materials and Methods for details).
cIC50 is the Ca
2þconcentration at which the GC activity is half maximal.
dEC50 is the concentration of GCAP1 at which the GC activity at low [Ca
2þ] is half maximal.
eX-fold activation is calculated according to GCmax - GCmin divided by GCmin.
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Ca2þ-induced conformational changes and thermal
stability of L176F
GCAPs undergo Ca2þ-induced conformational changes, which
trigger a subsequent increase of target GC activities (15,18).
Conformational changes in the GCAP1 structure can therefore
serve as good indicators for dysfunctional features in a mutant
(16,17,20). An electrophoretic Ca2þ-shift assay done with all
GCAP1 variants showed that binding of Ca2þcaused a higher
electrophoretic mobility for all tested variants (Fig. 4A) indicat-
ing that WT and mutant L176F undergo a similar conforma-
tional transition, which, however, might differ with respect to
the exact Ca2þ-dependence. To better investigate this depend-
ence, we monitored the intrinsic W fluorescence of GCAP1 var-
iants as a function of the free Ca2þ. The fluorescence pattern of
GCAP1 changed in a biphasic fashion, which is assigned to spe-
cific W positions (W21, W54 and W94; ref. 21). We observed that
phase I at low free [Ca2þ] up to 1 mM was significantly dimin-
ished in mL176F and that fluorescence emission intensities
were lower than those of the mWT (Fig. 4B) indicating that the
environment of W21 or W54 is altered in the mutant. Phase II
above 1 mM [Ca2þ] was very similar for all tested variants show-
ing that exposure of W94 to a more hydrophobic environment is
similar for WT and mutant. The emission patterns for nmWT
and nmL176F were nearly identical. Presence of Mg2þ reduced
the extent of phase I in mWT (21), but to a lesser degree in
mL176F. The nonmyristoylated GCAP1 variants showed a nearly
identical phase I (data not shown).
We further investigated the Mg2þ/Ca2þ-induced conforma-
tional transitions of both mL176F and nmL176F by circular
dichroism (CD) spectroscopy in the far and in the near UV, to
monitor respectively changes in the protein secondary and ter-
tiary structure. Results are reported in Fig. 5 (mL176F) and in
Supplementary Material, Fig. S2 (nmL176F). The overall fold of
L176F is that of an all a-helix protein (Fig. 5A; Supplementary
Material, Fig. S2), in line with all other GCAP1 mutants analysed
so far in our group (17,18,22). Addition of 1mM Mg2þ led to
changes in far UV ellipticity only for nmL176F (compare
Supplementary Material, Fig. S2A with Fig. 5A), while saturating
Ca2þ led for both cases to an increased ellipticity that is a more
negative signal. Quantitative far UV spectral properties
observed for both variants in the three analysed states were
overall very similar and are reported in Supplementary
Material, Table T1. The selective sensing capability of L176F for
the different cations was clearly visible in the near UV spectra
(Fig. 5B and Supplementary Material, Fig. S2B), where the
dichroic signal was completely positive in contrast to that previ-
ously observed for the WT (22,23). This observation is most
likely due to the addition of an aromatic residue, with conse-
quent perturbation of the F band. Slight conformational rear-
rangements were observed for nmL176F by the addition of 1mM
Mg2þespecially in the F band (Supplementary Material, Fig.
S2A), and changes became more apparent upon addition of sat-
urating Ca2þ for both variants, with significant increases in ellip-
ticity in the Y and W bands (Fig. 5B and Supplementary
Material, Fig. S2A).
By taking advantage of the all-a helix secondary structure of
the protein we could monitor the thermal stability of L176F over
the 20–96 C range by monitoring the ellipticity at 208nm (Fig. 5C
and Supplementary Material, Fig. S2C). While the apo forms of m/
nmL176F showed a similar transition temperature (Tm¼48.2 C
and 47.6 C respectively, Supplementary Material, Table T1), the
Mg2þ-bound form of mL176F was approximately 6 C more stable
than nmL176F. However, the addition of saturating Ca2þstabilized
more significantly mL176F, for which no transition could be
detected, at odds with nmL176F, for which the transition was esti-
mated to occur at 71.8 C (Supplementary Material, Table T1).
Changes in hydrodynamic size of L176F following
Ca2þbinding
We monitored the effects that Ca2þbinding exerted on the
hydrodynamic properties of both mL176F and nmL176F by per-
forming Ca2þ-titration experiments and measuring the protein
hydrodynamic diameter by dynamic light scattering. Overall,
DLS data were consistent with a monomeric protein, substan-
tially monodispersed (PDI 0.17 to 0.37) and showing satisfactory
colloidal properties. Examples of average DLS spectra obtained
for m/nmL176F at different free [Ca2þ] are reported in the
Supplementary Material, Fig. S3.
Results of Ca2þ titrations starting from suspended Ca2þ-free
protein in the presence of 1mMMg2þare reported in Fig. 6. Non-
monotonic changes in the hydrodynamic diameter were
observed for mL176F below 120 lM [Ca2þ] where a maximum
was observed at 60–90 lM Ca2þcorresponding to a diameter of
approx 7.1 nm (Fig. 6, black line), thus significantly different
from that (6.4nm) measured in the absence of Ca2þ. The size
monotonically decreased above 150 lM Ca2þ to reach a stable
diameter of approx. 6.6nm. Similarly, nmL176F showed an
Figure 4. Ca2þ-induced conformational changes in L176F. (A) Ca2þ-dependent electrophoresis mobility shift in an SDS-polyacrylamide gel electrophoresis. (B) Ca2þ-
titration of W fluorescence emission for GCAP1 variants as indicated. Emission was recorded at 336nm (excitation at 280nm).
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initial increase of hydrodynamic size from6.7nm up to 6.9nm
(at 30 lM Ca2þ), but overall the observed changes were lower
compared to mL176F (Fig. 6, gray line).
Response of L176F to Mg2þ
While the presence of 1mM Mg2þdid not significantly affect the
Ca2þ-affinity of mL176F (Fig. 3 and Table 2), thermal denatura-
tion studies suggest a significant stabilization in the presence of
Mg2þ. This prompted us to investigate specifically the binding of
Mg2þby monitoring the intrinsic W fluorescence emission, in
comparison with WT GCAP1. Fluorescence patterns of m/
nmL176F were all compatible with those of a Mg2þ-binding pro-
tein, with significantly different affinities from the WT form
(Fig. 5D and Supplementary Material, Fig. S2D). Binding of
Mg2þ to mL176F occurred with 10-fold higher affinity than to
mWT (Kappd  120.6 lM vs. 1.22mM; Fig. 5D) and with signifi-
cantly higher cooperativity (Hill coefficient hL176F¼2.47 vs.
hWT¼0.94). Binding parameters of nmL176F differed as affinity
for Mg2þwas approximately 5-fold higher than for nmWT
(Kappd  218 lM vs. 1.17mM; Supplementary Material, Fig. S2),
and the binding process showed low cooperativity (hL176F¼ 0.55;
Figure 6. Ca2þ titration effects on the average hydrodynamic size measured by
Dynamic Light Scattering for 44 mM mL176F (black) and 33 mM nmL176F (gray).
All experiments were performed at T¼25 C in 5mM Tris-HCl pH 7.5, 150mM
KCl, 500 mM EGTA, 1mM Mg2þ. Both profiles are an average of at least 14 runs,
each of which was an accumulation of at least 13 measurements.
Figure 5. Structural changes occurring in mL176F upon binding of Ca2þand Mg2þmonitored by CD spectroscopy and intrinsic fluorescence emission. (A) Far UV CD
spectra of 5 mM mL176F in 200 mM EGTA (black, solid line); after addition of 1mM Mg2þ (gray, solid line) and further addition of 200 mM free Ca2þ (gray, dashed line). (B)
Near UV CD spectra of 22 mM mL176F in 400 mM EGTA (black, solid line); after addition of 1mM Mg2þ (gray, solid line) and further addition of 400 mM free Ca2þ (gray,
dashed line). (C) Thermal denaturation profiles over the 20–96 C range temperature of 10 mM mL176F in the presence of 200 mM EGTA (black circles), 1mM Mg2þ (gray
diamonds) and further addition of 200 mM free Ca2þ (gray triangles). Denaturation was followed by monitoring the ellipticity signal at 208nm; experimental data were
fitted with a four-parameter Hill sigmoidal function, estimated values are reported in Supplementary Material, Table T1. (D) Mg2þ titration of mL176F (kem¼342nm)
and mWT (kem¼340nm) performed by exciting W residues (kex¼290nm) and monitoring the intrinsic W fluorescence emission. Three replicates were accumulated
and results are shown as an average6 standard deviation. Data were fitted to a four-parameter Hill sigmoidal function.
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hWT¼ 1.72;) . Both mL176F and nmL176F forms thus exhibited a
remarkable affinity for Mg2þ.
Molecular dynamics simulations
In order to gain structural insights into the dynamic properties
of the different GC-regulatory states of mL176F, we performed
200ns molecular dynamics simulations and compared the
results with those for mWT. Similar to what was done in pre-
vious studies (17), proteins were simulated in their GC-
inhibiting and activating states. It is well established that the
maximal GC inhibition by GCAP1 is achieved when each canoni-
cal EF hand is occupied by a Ca2þ ion (17,19–21,24). We therefore
simulated the GC-inhibiting state EF2CaEF3CaEF4Ca. The GC-
activating states are instead associated to GCAP1 with a
Mg2þ ion bound in EF2, and possibly in EF3 too (19,20,23), we
therefore simulated also the activating states EF2Mg and EF2Mg
EF3Mg.
As observed in other GCAP1 mutants as well as in the WT
(17,23), molecular dynamics simulations highlighted slightly dif-
ferent local dynamics according to the specific cation-bound
state. In particular, the Root-Mean Square Fluctuation (RMSF), an
index representative for local protein flexibility, was generally
reduced for L176F compared to WT in the EF2CaEF3CaEF4Ca state
(Supplementary Material, Fig. S4A). This indicated a lower flexi-
bility of the mutant structure in the GC-inhibiting state, in partic-
ular in the entering helix of EF2 and in its cation-binding loop,
and in the exiting helix of the EF3 motif. On the contrary, the
L176F form with just one Mg2þ ion bound to EF2 was extremely
flexible throughout the primary structure, compared to the WT
(Supplementary Material, Fig. S4B). Interestingly, the EF2Mg EF3Mg
form showed again a significant rigidity, especially in the Mg2þ-
binding loop of EF2 (Supplementary Material, Fig. S4C).
While no significant changes in the solvent accessible sur-
face area (data not shown) were detected for L176F compared to
the WT in any of the GC-regulatory states, some important dif-
ferences were observed when analysing the Root-Mean Square
Deviation (RMSD). The coordinates of the Ca carbons of the
essential bidentate Ca2þcoordinating residues in each EF hand
structure, namely E75 (EF2), E111 (EF3) and E155 (EF4) (Fig. 7)
were calculated with respect to the pre-production phase in the
time-frame of the MD simulations. Results are summarized in
the Supplementary Material, Table T2. The EF2Mg-L176F form
showed rather high RMSD values (2.7–2.9 A˚; Supplementary
Material, Table T2) for each bidentate Ca2þcoordinating residue,
which is in line with the observed flexibility of this form com-
pared to the WT and to the other cation-bound states in the
same mutant. However, two findings deserve particular atten-
tion. First, in the EF2CaEF3CaEF4Ca state, L176F showed approxi-
mately halved RMSD compared to the WT for E111 (1.1 A˚ vs. 2.0
A˚), and approximately 35% lower flexibility for E155 located in
EF4 (0.8 vs 1.2 A˚). Second, the EF2Mg EF3Mg form, in which the
EF4 motif is unloaded, is also significantly less flexible in the
L176F (RMSD¼ 1.2 A˚) compared to the WT (RMSD¼ 2.1 A˚).
Discussion
Disturbance of the CGMP-Ca2þhomeostasis
The L176F substitution had severe consequences for the key
regulatory properties of GCAP1: the Ca2þ-sensitive regulation of
the target GC1 was shifted from the submicromolar to the
micromolar range, the x-fold activation of the GC by GCAP1
reached a value of 91-fold, and the mutant had an apparent
higher affinity than the WT for the GC (Fig. 2). Peshenko et al.
(15) constructed and investigated the L176F mutant in a differ-
ent context (see also Results section) proposing that the interac-
tion between the myristoyl group and the amino acids in the
hydrophobic cavity has a regulatory and therefore functional
impact. By screening patients showing clinical symptoms of MD
we detected the missense mutation leading to the L176F substi-
tution in the protein. Most of the patients in this study had mac-
ulopathy only, although two patients, each from a different
family, had some evidence of more widespread photoreceptor
involvement. Other reports tend to describe a widespread cone
(or cone and rod) involvement (7,25,26), but there are also exam-
ples of maculopathy patients in these articles. In other words,
there is likely to be a spectrum of phenotypes associated with
GUCA1A mutations from maculopathy only to cone or cone-rod
dystrophy. The message for clinicians is that a GUCAIA muta-
tion can be a cause of an ad maculopathy as well as a more
widespread retinal disease expression. The present study aimed
at combining genotype description, phenotype analysis and
molecular investigation of protein properties of this MD causing
mutation.
The disturbed regulation of GC1 by L176F is, at least in part,
repeating a pattern often observed with other dystrophy-related
GCAP1 mutants (16,17,26–31). A prominent feature of these
cases is that the Ca2þ-sensitive regulation of GC1 is halfmaxi-
mal at higher than normal physiological levels of cytoplasmic
[Ca2þ] making these mutants constitutionally active, which
would dramatically affect the Ca2þ-cGMP homeostasis in cone
and rod cells. However, it is noteworthy that the x-fold activa-
tion of the mutant, both the nonmyristoylated and particularly
the myristoylated one was very high in comparison to the con-
trol WT forms (42-fold and 91-fold, respectively; Fig. 2). In a cell,
expressing a constitutively active mutant the permanent syn-
thesis of cGMP would lead to a high percentage of CNG-
channels kept open most of the time, thus allowing the passage
of Ca2þ-ions up to a very high micromolar level. At a certain
cytoplasmic [Ca2þ] however, the GC activation by the GCAP1
mutant switches back to the non-activated stage and the CNG-
channels close during illumination having the consequence
Figure 7. Three-dimensional cartoon representation of the homology model of
human L176F GCAP1 mutant. EF1 is colored in yellow, EF2 in green, EF3 in
orange and EF4 in blue. N- and C-terminals are colored in pale grey and pale
cyan, respectively, the myristoyl group is represented as grey spheres, Ca2þ ions
are shown as red spheres, F176 is represented in magenta sticks, bidentate
Ca2þ-coordinating residues are shown in sticks colored like the EF-hand they
belong to.
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that the cytoplasmic [Ca2þ] would decrease again turning on the
cGMP synthesis. The high x-fold activation like in the case of
the L176F mutant would then immediately replenish the cGMP
to a higher value than normal keeping again a high percentage
of CNG-channels open.
Dell’Orco et al. (22) recently modelled the cellular consequen-
ces of a photoreceptor cell expressing 50% WT and 50% mutant
for other GUCA1A/GCAP1 cone-dystrophy mutations of autoso-
mal dominant inheritance. These investigated mutations
shared the constitutive activation profile with L176F and simu-
lated photocurrents showed higher response peak amplitudes,
prolongation of response duration and a lower current value
after complete photoresponse recovery. However, the overall
effects on the photoresponse were not large, but significant
enough to cause distortion of normal cell physiology. We pre-
dict a similar shaping of the photoresponse in the case of the
L176F mutation, but with a stronger impact on the dynamics of
the photocurrents ON- and OFF-states due to the more powerful
activation rate of L176F.
Is the perturbation of GC activation and Ca2þ-sensitive
regulation due to impaired Ca2þ-binding of L176F?
Results from chelator assays suggest that L176F is WT-like in
terms of affinity for Ca2þ, similar to what we reported for
another GCAP1 mutant L84F (17). The observed GC perturbation
is therefore not due to a reduced Ca2þ-sensing capability char-
acteristic of most other COD/CORD mutants (17,18,31).
Interestingly, Mg2þaffected the Ca2þ-affinity of the WT mGCAP1
less than for its mL176F variant. Moreover, fluorescence titra-
tions showed a noteworthy affinity of Ca2þ-free L176F for Mg2þ.
Further, Mg2þhad a significant effect on the thermal stability of
the myristoylated form, and MD simulations showed that the
L176F with two Mg2þbound (EF2Mg EF3Mg) was structurally and
dynamically more stable than the form with only one Mg2þ ion
bound to EF2. These results suggest that L176F always harbours
a Mg2þ ion bound to an EF-hand, presumably EF2, and the GC
regulatory activity is triggered by cation exchanges in EF3.
Moreover, the GC activating state for this mutant seems to be
characterized by two Mg2þ ions bound respectively to EF2 and
EF3, at odds with the WT where due to the much lower affinity
probably only one Mg2þ ion is bound to EF2 (23). Thus, the con-
stitutive activation of GC1 associated with the pathogenic L176F
seems to be related to a higher propensity of this variant to bind
Mg2þ rather than to a lower affinity for Ca2þ, which was the case
for many other COD/CORD GCAP1 mutants.
Conformational dynamics of L176F
Impaired Ca2þ-sensitive function of L176F seems to correlate
more to changes in protein conformation than to changes in
Ca2þ-affinity. DLS data showed that L176F conformation
dynamically responds to variations in [Ca2þ] and its hydrody-
namic radius changes until the [Ca2þ] is high enough to fully
saturate the three protein binding sites. The hydrodynamic
diameter of the Ca2þ-free versus the Ca2þ-saturated form was
opposite to what Sulmann et al. (32) reported for the myristoy-
lated WT, although Sulmann et al. performed DLS measure-
ments in the absence of Mg2þ. Changes for the
nonmyristoylated form were however less prominent, in line
with what was observed for the WT form (32).
Molecular dynamics simulations suggest that the structural/
dynamical perturbations introduced by the L176F substitution
are not only local and protein flexibility is affected in distal
regions. In particular: i) the EF2 motif in the EF2CaEF3CaEF4Ca
state becomes more rigid; ii) the EF2Mg state becomes signifi-
cantly more flexible in general; iii) in the EF2Mg EF3Mg state, the
EF2 binding loop is again less flexible. Most importantly, MD
simulations clearly suggest that the local L176F perturbation
reaches also distal residues fundamental for coordinating
Ca2þbinding. Indeed, even in the absence of Ca2þbound to EF4
(EF2Mg EF3Mg state), the mutation stabilizes the structural
dynamics of the EF4 loop through a long-range allosteric effect,
presumably modulating its Ca2þsensing capability. This finding
is substantially in line with the proposed myristoyl tug mecha-
nism (15). A similar allosteric effect is suggested to occur to a
lower extent in the EF2CaEF3CaEF4Ca state, but it seems to be
especially important in the EF2Mg EF3Mg state (likely the GC-
activating state for L176F). Indeed, this especially stable state
might decrease the capacity of EF4 to bind again a Ca2þ ion,
which would be essential to restore the GC-inhibiting state,
thus contributing to GC constitutive activation.
Materials and Methods
Patient studies
Patients from 3 families with macular dystrophy were included
(Table 1). Informed consent was obtained; procedures followed
the Declaration of Helsinki and had institutional review board
approval. All patients underwent a complete eye examination,
genetic analyses, as well as specialized tests of retinal and vis-
ual function. DNA isolation and Sanger sequencing of the
GUCA1A gene was performed as described before (16).
Cloning, protein expression and purification
The sequence variant c.526T>C (p.L176F) was created by PCR
site-directed in vitro mutagenesis (primers available upon
request). The amplified PCR product was cut with NdeI and NheI
and ligated into the expression vector pET11-bGCAP1-D6 as pre-
viously described for other variants (16,17,24). All sequences
were verified by DNA sequencing (LGC Genomics, Germany).
Heterologous expression of GCAP1 forms was performed in
BL21-CodonPlus E. coli cells. Overexpressed proteins were subse-
quently purified to homogeneity as described before (16,17,24).
We co-transformed E.coli cells with the plasmid pBB131 contain-
ing the gene for yeast (S. cerevisiae) N-myristoyl transferase to
allow posttranslational modification of WT and mutant GCAP1
with a myristoyl group (24). Proteins were purified after cell lysis
using chromatographic procedures exactly as described before
for other GCAP1 forms (16,17,24). Methods for determining pro-
tein concentration and procedures for gel electrophoresis were
done according to standard laboratory protocols exactly as
described before (16,17,24).
Cell culture and GC assays
Recombinant human photoreceptor GC1 (assigned as GC-E and
alternatively named ROS-GC1, retGC1) was expressed in in HEK
flip 293 cells as described (33). Cell membranes were reconsti-
tuted with GCAP1 forms and GC activity was measured as
described before (33,34). Samples with 10 mM GCAP1 (WT or
mutant forms) were incubated at different free [Ca2þ] using a
Ca2þ-EGTA buffer system (11,33,34). The [Ca2þ], at which the
activation is half-maximal (IC50) was determined. A further way
to analyse activation of GC by GCAPs is the x-fold activation
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expressed as GCmax - GCmin divided by GCmin; GCmax is meas-
ured at<10nM free [Ca2þ], GCmin at 100 mM free [Ca
2þ]. Free
[Mg2þ] is 1mM. Activity measurements at constant low [Ca2þ]
and increasing concentrations of GCAP1 forms yielded apparent
affinities (EC50-values) of GCAPs for human photoreceptor GC1.
Activity values were obtained from at least 4–5 different data
sets and were used to calculate the mean6 standard deviation
(s.d.).
Ca2þ-binding
Calcium binding to GCAP1 variants was monitored by the chela-
tor assay (35,36) exactly as described previously (18). Briefly,
Ca2þ-free lyophilized proteins (18) were dissolved in the chela-
tor solution at a final concentration of 13–16 mM. The decalcified
buffer consisted of 5mM Tris–HCl pH 7.5, 150mM KCl. Chelator
concentration was between 17–26 mM, while initial
Ca2þconcentration was 0.9–2.1 mM. The assay is based on the
competition for Ca2þbetween the protein and a chromophoric
chelator 5,5’Br2-BAPTA. Absorbance changes upon
Ca2þconcentration were measured at k¼ 263nm. Data were fit-
ted using a Newton-Raphson direct least-square fitting proce-
dure implemented in the CaLigator software (35,36) to obtain
individual macroscopic binding constants (log KA, Table 2),
which were further used to determine apparent affinity values
(KappD , Table 2; K
app
D ¼ 10
-(logK1þ logK2)/2).
Circular dichroism (CD) spectroscopy and thermal
denaturation profiles
CDmeasurements were performed with a Jasco J-710 spectropo-
larimeter with a Peltier thermostated cell holder. Reported spec-
tra were subtracted with the spectrum of the buffer (5mM Tris-
HCl pH 7.5, 150mM KCl, 1mM DTT) and were recorded at 37 C,
using the following parameters: scan rate 50nm/min, band-
width 1nm, response time 4 s, accumulations 5.
Protein concentration for far UV spectra and thermal dena-
turations was 5–10 mM in 0.1 cm quartz cuvettes, for near UV it
was 22–26 mM in 1 cm quartz cuvettes, measured with Bradford
assay (37). CD spectra were recorded: (1) in the presence of>15-
fold EGTA concentration with respect to the protein concentra-
tion, (2) after addition of 1mM MgCl2, (3) after addition of 2-fold
excess CaCl2 with respect to the EGTA concentration.
Experimental conditions for thermal denaturations between 20
and 96 C were substantially the same as for far UV spectra.
Setting parameters were as follows: wavelength 208nm, scan
rate 1 C/min, data pitch 0.1 C, response time 4 s. Experimental
data were fitted for melting temperature estimation to a 4-
parameter Hill sigmoid, whose equation is:
y ¼ bf þ
jbf ÿ bnjT
H
THm þ T
H
Where bf stands for the value of the folded protein, bu for the
value of the unfolded protein, T for temperature, H for Hill coef-
ficient and Tm for melting temperature.
DLS experiments
DLS measurements were obtained with a Zetasizer Nano-S
(Malvern Instruments) using disposable ZEN0112 polystyrene
cuvettes. Machine settings were the following: solvent
refractive index 1.330, viscosity 0.8872 cP, protein refractive
index 1.450, protein absorption 0.001, temperature 25 C, equili-
bration 2min, measurement angle 173 backscatter, analysis
model multiple narrow modes. Each experiment consisted of at
least 14 runs, each of which was an average of 13 repetitions.
Experiments were performed in the following buffer: 5mM Tris-
HCl pH 7.5, 150mM KCl, 1mM DTT, 1mM MgCl2, 500 mM EGTA.
Protein concentration was measured (Bradford assays) after fil-
tering with a 0.02 mm Anotop 10 filter (Whatman) and turned
out to be 33–44 mM. Ca2þconcentration for each titration point
was calculated using the Ca-Mg-ATP-EGTA Calculator software
with the following settings: database NIST, T¼ 25 C, pH 7.5,
ionic strength 0.15 M (http://maxchelator.stanford.edu/
CaMgATPEGTA-NIST.htm). Initial Ca2þconcentration was< 5.
3nM, Ca2þ titration steps were 30 mM, final Ca2þconcentration
was 300 mM.
Tryptophan fluorescence titrations
Intrinsic W Fluorescence titrations were performed by two pro-
cedures: Ca2þ-titration experiments were done on a spectrome-
ter form Photon Technology International (Birmingham, New
Jersey, USA) as described before (16,34). Data were normalized
to the maximal value (16,34). Spectra of Mg2þ-titration experi-
ments were recorded with a Jasco FP-750 spectrofluorimeter in
Tris/HCl 5mM, KCl 150mM, DTT 1mM, pH 7.5, EGTA 100 mM in
1 cm quartz cuvettes at 25 C. Parameters were as follows: scan
rate 60nm/min, excitation wavelength 290nm, emission
between 300 and 380nm, excitation and emission bandwidth
5nm. Mg2þconcentration for each titration point was calculated
using the Ca-Mg-ATP-EGTA Calculator software with the follow-
ing settings: database NIST, T¼ 25 C, pH 7.5, ionic strength 0.15
M (http://maxchelator.stanford.edu/CaMgATPEGTA-NIST.htm).
Protein concentration was 0.3 mM for mWT and mL176F, 0.4lM
for nmWT and nmL176F for each titration point. Fluorescence
emission intensity was monitored at the wavelength corre-
sponding to the maximal emission of the protein in the sole
presence of 100 mM EGTA. Initial Mg2þconcentration was 9 mM,
while it reached 10mM after complete titration. Due to the
experimental set-up we could not absolutely exclude aging of
the sample during a titrations set taking place for several hours.
Therefore, data were normalized as follows NF ¼ (F–Fmin)/(Fmax–
Fmin), where F is the fluorescence emission at the specific wave-
length (340nm for m/nmWT GCAP1, 342nm for mL176F, and
343nm for nmL176F), Fmin and Fmax are the minimum and the
maximum fluorescence intensity values of the dataset.
Molecular dynamics simulations and analyses
Three-dimensional models and states used for mWT GCAP1
were built using chicken GCAP1 as a template (38) using the
same procedure as in (23). Mutation mL176F was generated in
silico using the highest-scored rotamer estimated by the
‘mutate residue’ function of the Maestro (Schrodinger) software
using the modelled mWT GCAP1 as a template.
Molecular dynamics simulations were performed using
GROMACS 5.0.4 simulation package (39) using the CHARMM27
all-atom force field (40).
All settings for molecular dynamics simulations were taken
from Marino et al. (23), in which details are provided, with the
only difference in the production phase, which in this study
consisted of 200ns of simulations.
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Resulting trajectories were subjected to Root-Mean Square
Deviation (RMSD) and Root-Mean Square Fluctuations (RMSF)
analyses. RMSD of the a-carbon of bidentate Glu residues of EF2,
EF3 and EF4 (E75, E111, E155 respectively) was calculated using
the ‘gmx rms’ function implemented in GROMACS 5.0.4 with
respect to the starting structure of the production phase. RMSF
of the a-carbon of all residues was calculated by the Wordom
software (41,42), and represents the time averaged-RMSD with
respect to the initial structure of the production phase, and is
calculated as follows:
RMSFi ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
T
XT
tj¼1
riðtjÞ ÿ r
ref
i 2

vuut
where T is the 200ns timeframe ri(tj) and rrefi are the atomic
coordinates of a-carbon i at time tj and in the structure after 4ns
equilibration, respectively.
Supplementary Material
Supplementary Material is available at HMG online.
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intermolecular!communication!routes.
Conformational changes adopted by calcium-sensor proteins in response to Ca2+-binding allow them to selec-
tively recognize and regulate their targets, thereby contributing to the control of several biological processes1. For 
some calcium sensors such as the ubiquitous calmodulin the conformational switch is substantial and associated 
to a high degree of structural plasticity, which allows the recognition and regulation of a variety of di!erent tar-
gets2,3. Other Ca2+-sensors, however, are selectively expressed in speci"c cell types and regulate only a few, some-
times even unique biological targets. #is is the case for the neuronal calcium sensors (NCS) family4,5.
Guanylate cyclase activating proteins (GCAPs) are NCS involved in the early steps of vertebrate vision, which 
shape the photoresponse of rods and cones under di!erent light conditions, thus contributing to the second 
messenger-controlled recovery of the phototransduction machinery following light stimulation6. By binding up 
to three Ca2+ ions with high, submicromolar a$nity and up to two Mg2+ ions with lower a$nity in their three 
functional EF-hand motifs, GCAPs show a remarkable and rather unique regulatory capability. #e same pro-
tein indeed acts as an inhibitor of the membrane bound guanylate cyclase (GC) at high (250–800 nM) intracel-
lular [Ca2+] corresponding to dark-adapted conditions, while it switches to an activator of the enzyme at low 
(20–100 nM) [Ca2+], thereby stimulating the synthesis of the second messenger cGMP necessary to switch o! 
the light-activated cascade7–9. Two to eight GCAP isoforms have been observed in species from "sh to human 
and the role of di!erent GCAPs in rods and cones is well described by a Ca2+-relay model, in which the control 
of photoreceptor physiological response depends on incremental changes in the cytoplasmic [Ca2+] sensed by 
GCAPs with slightly di!erent a$nity for Ca2+ 10–12.
GCAP1 is expressed both in rods and cones and has raised particular interest among other GCAPs as up to "f-
teen missense mutations in its codifying gene have been associated to retinal dystrophies13,14, a heterogeneous set 
of vision-threatening diseases o%en leading to complete blindness. Biochemical investigations revealed that the 
majority of GCAP1 molecules carrying the mutations exhibit a more or less severe disturbance in Ca2+-sensing 
properties, resulting in the constitutive activation of GC over the physiological range of [Ca2+], in which they 
normally switch between activating and inhibiting regulatory modes15–20. Some mutants have been shown to 
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a!ect the binding of Ca2+ and Mg2+ to one of the three speci"c EF-hands in GCAP115,21, however, in spite of the 
remarkable deregulation observed in GC activation, some other mutant showed no signi"cant change in metal 
ion a$nity compared to the wild type18.
Biochemical and biophysical investigations established that it is the selective binding of either Ca2+ or Mg2+ 
ions to speci"c EF-hands that triggers the switch of GCAP1 from its GC inhibitory (three Ca2+ ions bound to EF2, 
EF3 and EF4) to its GC activating form (one Mg2+ ion bound to EF2, and putatively to EF3)7–9. More recently, it 
was suggested that the covalent myristoylation at its N-terminal, which controls the a$nity of the GCAP1-GC 
interaction22,23, is also involved in intramolecular communication with the opposite C-terminal domain by con-
trolling the Ca2+ sensitivity of EF424,25. A dynamic connection between the myristoyl moiety and EF4 was thus 
proposed, which implies a "nely regulated allosteric communication between the N and C domains of GCAP1, 
however the mechanism by which Mg2+/ Ca2+ exchange determines the fate of GCAP1 as a Ca2+ sensor and 
GC-regulator remains largely unknown.
We present a thorough structural analysis of both myristoylated and nonmyristoylated GCAP1 based on 
exhaustive Molecular Dynamics (MD) simulations that unveiled intramolecular communication pathways 
involved in the speci"c switch between GC activator/inhibitor states. Our "ndings suggest that the binding of 
either Ca2+ or Mg2+ to speci"c EF-hands is crucial for routing the information transfer from the ion binding 
site to distal sites where the interaction with the target GC occurs. Some key residues appear to be especially 
important to structurally interconnect distal sites via robust allosteric pathways that are only partially over-
lapped in the activating and inhibitory states. Finally, we found that several residues that are target of retinal 
dystrophy-associated mutations constitute important intramolecular hubs for the communication routes in 
GCAP1 thus playing a particularly important role in maintaining its GC inhibitory state. Perturbation of speci"c 
intramolecular communication pathways likely results in a lack of complete inhibition of the target GC.
Results
????????????????????????????????????????????????????? ??????????????????????????????????????
????????? ????????? ?????????? ?????????? Myristoylated and nonmyristoylated GCAP1 (mGCAP1 
and nmGCAP1, respectively) were simulated in their GC-inhibiting and activating states. Several independent 
studies (see Ref. 10 for a review) con"rmed that the maximal GC inhibition by GCAP1 is achieved when each 
canonical EF hand is occupied by a Ca2+ ion. We therefore indicate the GC-inhibiting state as EF2CaEF3CaEF4Ca 
throughout this paper. #e GC-activating state is instead associated to GCAP1 with a Mg2+ ion bound in EF2, 
and possibly in EF3 too7–9,26. We therefore indicate these activating states as EF2Mg and EF2MgEF3Mg, respectively.
Five replicas of 200 ns MD simulations were run for each GCAP1 state and results were considered both 
individually and by concatenating the trajectories to form a comprehensive 1 µ s trajectory. Root-mean square 
deviation plots calculated on Cα -atoms (RMSD) with respect to the equilibrated structures for the "ve 200 ns 
replicas of each simulated state are reported in Supplementary Figure S1. RMSD average values ranged between 
2.18 ± 0.29 Å and 2.95 ± 0.67 Å, indicative of good reproducibility across each replica. However, it is well estab-
lished that independent MD trajectories of the same system at the same temperature may sample slightly di!erent 
portions of the conformational landscape, therefore RMSD per se is not an accurate index for sampling con-
vergence27. We therefore performed Principal Component Analysis (PCA) of Cα 'uctuations on each individ-
ual trajectory in order to de"ne a low-dimensional subspace, in which essential protein dynamics can be better 
described. Projections of the MD trajectory from each replica along the "rst two principal components (PC1 and 
PC2) are shown in Fig. 1. #e substantial overlapping of the scatter plots in the PC space sampled is consistent 
with a homogeneous sampling for each replica.
#e similarity and therefore consistency between the conformational subspaces sampled by each replica and, 
comprehensively, by the concatenated trajectory was probed by computing the Root-Mean-Square Inner Product 
(RMSIP) of the "rst 20 PC, representing eigenvectors of the covariance matrix of each replica or of the whole con-
catenated trajectory (Fig. 2). Satisfactory values were obtained in all cases as proven by RMSIP values approaching 
unity both when comparing each replica with one another and when the comparison was extended to the con-
catenated comprehensive 1 µ s trajectory. RMSIP values for nonmyristoylated GCAP1 were on average smaller 
compared to the myristoylated case, however they did not decrease below 0.65 (Fig. 2).
A further proof of conformational sampling convergence was provided by the computation of the cosine 
content c1 of the "rst PC (PC1), which represents a necessary condition for the sampling convergence. It was 
demonstrated that insu$cient sampling could lead to high (close to unity) ci values, where i refers to any PCi27,28. 
#e c1 of the six concatenated trajectories of GCAP1 states ranged between 0.0008 and 0.4246, while the average 
c1 of the "ve 200 ns replicas for each simulated GCAP1 state ranged between 0.2490 and 0.6873. Since c1 relative to 
the 1 µ s concatenated trajectories were found to be lower than the average c1’s of each replica, the conformational 
sampling achieved when the concatenated trajectory was considered was generally signi"cant and satisfactory.
Overall, these results con"rm that each 200 ns MD replica represents an independent and conformationally 
consistent dynamic description of GCAP1 in all the tested states, and that the concatenated 1 µ s trajectories con-
stitute a suitable framework where to exhaustively investigate essential dynamic properties.
?????????????????????????????????????????? ?????????????????? ????????????????????? ????
?????????????????????????????????????????????????????? Hydrophobic, electrostatic and H-bond 
interactions between residues within the protein milieu may be highly transient or signi"cantly persist in time, 
when they are aimed at maintaining a noncovalent contact necessary to transfer the information intramolecularly. 
Monitoring the time course of noncovalent interactions along the concatenated 1 µ s MD trajectory of GCAP1 
hence allowed us to eventually determine whether and how long would contacts persist between groups of inter-
actions, in which amino acids are nodes and interactions are edges or arches in a graph representing the Protein 
Structure Network (PSN)29–31.
www.nature.com/scientificreports/
3SCIENTIFIC REPORTS????????????? ?????????????????????
The dynamic PSN calculated with the software PyInteraph (see Methods) over 1 µ s MD simulations of 
EF2CaEF3CaEF4Ca mGCAP1 is shown in Fig. 3 as an example. #e analysis highlighted the presence of some amino 
acids and ions forming persistent contacts with many neighboring residues, thus constituting hubs for the net-
work. Persistence thresholds (pT) for each simulated GCAP1 state were estimated (see Methods) in order to "lter 
out transient interactions between residues, and ranged between 19.5% and 28.2%. Persistent interactions repre-
sented by edges in the PSN graph connect nodes located in even distal positions within GCAP1 tertiary structure. 
A thorough analysis of the degree of each hub, representing the number of neighboring residues per hub, as well as 
its position within the GCAP1 fold revealed important features for mGCAP1 and nmGCAP1 speci"c for each GC 
regulatory state. #e highest degree hubs (degree = 7 or 8) in EF2CaEF3CaEF4Ca mGCAP1 are located in both the 
N- and C-terminal domains (Fig. 4, top), while they mostly concentrate in the C-domain in the EF2Mg mGCAP1 
state. #e EF2MgEF3Mg putative GC activating state of mGCAP1 showed a broader distribution, with 13 high-degree 
hubs compared to the 7 ones in the EF2CaEF3CaEF4Ca and EF2Mg mGCAP1 states (Supplementary Table T1 and 
Fig. 4, top). Interestingly, D64 and D100, respectively the "rst Ca2+-coordinator residues of EF2 and EF3 were 
found among the highest-degree hubs in all mGCAP1 states, while other high-degree hubs varied depending on 
the GC regulatory state (Fig. 4, Supplementary Table T1). While the same two residues constituted high-degree 
hubs also for nmGCAP1 in all the three tested GC regulatory states (Supplementary Table T2 and Fig. 4, 
bottom), the GCAP1 variant lacking the myristoyl modi"cation showed many more high-degree hubs (11 vs. 7) 
in the EF2CaEF3CaEF4Ca state, and less in the EF2Mg and EF2MgEF3Mg states (5 hubs for nmGCAP1 versus 7 and 13 
for mGCAP1, respectively; Supplementary Tables T1 and T2 and Fig. 4).
Interestingly, the analysis of PSN hubs with a degree down to 4 highlighted for both mGCAP1 and nmGCAP1 
the presence of several residues target of retinal dystrophies, especially in the EF2CaEF3CaEF4Ca GC-inhibitory 
state (Supplementary Tables T1 and T2). On the contrary, the myristoyl moiety was never found among the 
high-degree hubs (Supplementary Table T1), indicating the presence of many hydrophobic, yet non-persistent 
interactions along the 1 µ s simulations.
An alternative PSN analysis performed using the elastic network analysis implemented in the WebPSN so%-
ware (see Methods) overall suggested a similar role for the most important hubs already found by the dynamic 
analysis (Supplementary Table T3), although the consistency was in general not high.
????????????????????????????????????? ???????????????????????????????????????????????
????????????????????????????? ??????????????????????????? #e conformational switch of GCAP1 
between GC activating/inhibiting states following the speci"c exchange of metal ions in its EF-hands must be 
Figure 1. Projections of the frames extracted from each of the !ve 200 ns MD simulation replicas (R1 
to R5) along the !rst two Principal Components (PC1 and PC2) calculated on the concatenated 1 µs 
trajectories of mGCAP1 (top panels) and nmGCAP1 (bottom panels) in their EF2CaEF3CaEF4Ca (le"), 
EF2Mg (center) and EF2MgEF3Mg (right) forms. R1 frames are represented in red, R2 frames are black, R3 
frames are blue, R4 frames are green, R5 frames are yellow.
www.nature.com/scientificreports/
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communicated to the target via a speci"c protein-protein interface. Several groups used di!erent techniques to 
determine the putative GCAP1/GC interface32–34 and consistently identi"ed speci"c regions in EF1 and in the 
exiting helix of EF2 as the main constituents of the binding interface32–34. In addition, other residues located in the 
entering helix of EF3 have been shown to be important for GC binding and activation32,34.
We considered all the residues suggested to form the putative GCAP1/GC binding interface, which is repre-
sented in Fig. 5. Overall, the identi"ed interface shows somewhat disconnected areas, which seems prima facie 
incompatible with a unique GCAP1/GC binding mode. However, it might be possible that the interface follows 
Figure 2. Root-Mean Square Inner Product (RMSIP) of the !rst 20 Principal Components representing 
the low frequency motions of each of the !ve 200 ns MD simulation replicas (R1 to R5) of mGCAP1 (top 
panels) and nmGCAP1 (bottom panels) in their EF2CaEF3CaEF4Ca (le"), EF2Mg (center) and EF2MgEF3Mg 
(right) forms. #e RMSIP is calculated for each replica against each other and against the concatenated 
trajectory (1 µ s) and is represented in a color scale from blue (0) to dark red (1).
Figure 3. Example of Protein Structure Network calculated with PyInteraph for 1 µs MD simulation of 
EF2CaEF3CaEF4Ca mGCAP1. Secondary structure is represented in green cartoons, Ca2+ ions are shown as red 
spheres, the myristoyl group is represented by teal sticks, edges representing persistent interactions between 
residues (nodes) are shown as grey sticks connecting Cα -atoms or ions.
www.nature.com/scientificreports/
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the conformational switch of GCAP1 between its GC inhibiting/activating states, thereby plastically remodeling 
itself to cover speci"c regions in the di!erent regulatory states. We therefore explicitly considered all plausible 
binding sites between GCAP1 and GC and investigated how the information may route into speci"c pathways 
interconnecting each EF-hand to each putative GC binding site.
In order for a communication pathway connecting two nodes A and B to be robust, some requirements should 
be ful"lled. According to the parsimony principle, the higher the number of shortest paths connecting A and B 
and the more persistent the noncovalent interactions de"ning the path itself, the more robust the communication 
pathway. We translated these requirements into a simple de"nition of the communication robustness (CR) index 
de"ned in Equation 1:
σ
=
⋅
CR
p
l (1)
AB T
where σAB indicates the number of paths with the shortest length connecting A and B, pT is the signi"cance 
threshold for the interaction persistence (see Methods) and l is the length of the shortest paths. #e CR index 
de"ned above allowed us to systematically investigate the robustness of all identi"ed pathways interconnecting 
each EF hand, where the Ca2+/Mg2+ binding occurs, with each putative GC binding site, in all the GC regulatory 
states of GCAP1. As a residue representative for the corresponding EF hand we chose to consider the glutamate 
providing the bidentate oxygen ligands for Ca2+, namely E75 for EF2, E111 for EF3 and E155 for EF4. Results of 
the analyses for mGCAP1 are reported in Fig. 6.
As a general trend, no particularly high-robustness pathway for GC regulation was found starting from EF2 
(E75) considering the relatively short distance between the Ca2+/Mg2+ binding region and most of the GC puta-
tive binding residues (Fig. 5). #e computed CR index indeed never exceeded 0.3, the value observed for E38 
in the EF2Mg state, and no major di!erence was observed for the tested mGCAP1 regulatory states (Fig. 6). In 
contrast, the highest a$nity binding site for Ca2+ E111 (EF3) resulted to be more robustly connected to GC 
interfacial residues, especially in the EF2CaEF3CaEF4Ca-GC inhibiting state, mostly via the Y22, C29, Y37 and 
K87 residues (Fig. 6). Switching to GC activating states, either EF2Mg or EF2MgEF3Mg signi"cantly decreased the 
communication robustness, except for E38, which showed an opposite trend, where CR increased from 0.14 to 
0.24–0.26. E38 thus seems to be an essential residue to mediate target inhibition by ensuring the communication 
Figure 4. Highest degree hubs identi!ed by PyInteraph in the PSN of mGCAP1 (top panels) and 
nmGCAP1 (bottom panels) in their EF2CaEF3CaEF4Ca (le"), EF2Mg (center) and EF2MgEF3Mg (right) forms. 
Secondary structure is represented in grey cartoons, Ca2+ ions are shown as red spheres, Mg2+ ions are shown 
as green spheres, the myristoyl group is represented as teal sticks, Cα of degree 7 hub residues are represented 
in blue spheres, Cα of degree 8 hub residues are represented in orange spheres with increased radius. Residues 
whose mutation is associated with cone, cone-rod or macular dystrophies are labelled in bold and framed.
www.nature.com/scientificreports/
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of the Ca2+-loaded state of EF3. Interestingly, the relatively high distance between EF4 (E155) and all putative GC 
binding sites did not prevent the emergence of some particularly robust communication pathways (Fig. 6). While 
generally E155 showed a low CR index (≤ 0.1) for many GC interfacial residues, four of them showed remarkably 
high robustness, namely E38 in its EF2CaEF3CaEF4Ca (CR = 0.5) and EF2Mg (CR = 0.7) states, Y22, K23 and C29 in 
the GC activating states (EF2Mg or EF2MgEF3Mg; CR values between 0.3 and 0.6). #e particularly high CR values 
in the Mg2+-bound states for Y22 and K23 suggest that these two residues are important for communicating to 
the GC the unloaded status of EF4. In general, the metal-bound state of the distal EF4 motif in mGCAP1 has to 
be therefore precisely and robustly communicated to speci"c GC binding residues to ensure the target switch 
between its operational states.
Interestingly, only a few residues forming the GC binding interface show robust intramolecular communica-
tion with all three EF hands in each GC regulatory state. E38, located at the exiting helix in the EF1 motif (Fig. 5) 
seems to be well connected to both EF2 (CR between 0.25 and 0.30 with E75 in the EF2CaEF3CaEF4Ca and EF2Mg 
states, respectively) and EF3 (CR 0.16–0.28 with E111), and as noticed extremely well connected to EF4, giving 
the highest CR index in this case (CR 0.5–0.7 with E155) (see Fig. 6). #erefore, E38 seems to be an essential res-
idue to communicate to the target GC about the loading status of the distal EF-hand 4. Particularly apparent was 
also the robustness of the communication pathways found between EF3 and C29 (Fig. 6), located in the entering 
helix in EF1 not far from E38, however robustness was limited to the EF2CaEF3CaEF4Ca state (CR = 0.48 vs. 0.12 
in the EF2Mg state). #is could imply that the contact between GC and C29 is necessary to keep the target in its 
inhibiting state. Other speci"c patterns of less robust communication could be observed between each EF hand 
and GC interfacial site (Fig. 6).
Figure 5. Residues of mGCAP1 involved in the putative interface with the target Guanylate Cyclase. #e 
EF2CaEF3CaEF4Ca form is represented in grey cartoons together with its molecular surface, Ca2+ ions are shown 
as red spheres, the myristoyl group is represented in teal sticks, residues belonging to the putative GC interface 
are represented as blue sticks together with their molecular surface. Residues forming the putative GCAP1/GC 
interface have been identi"ed in former studies (see text and refs 32,33,34).
www.nature.com/scientificreports/
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The dynamic PSN analysis further allowed us to determine for each amino acid (or node) the selective 
betweenness centrality (SB, see Methods), indicative of the number of shortest paths between speci"c vertices 
that pass through that node. Figure 7 and the Supplementary Videos V1, V2 and V3 show the pathways identi"ed 
by nodes with the highest SB connecting each EF hand bidentate ligand with the residue in the putative GC bind-
ing interface, for which the CR was maximal. As seen above (Fig. 6), EF2 (E75 residue) was mostly connected to 
E38 (Fig. 7, top) in both GC activating (blue path) and inhibiting (yellow path) states, while EF3 (E111 residue) 
Figure 6. Communication Robustness between bidentate Glu residues of EF2 (top), EF3 (middle), EF4 
(bottom) and residues belonging to the GC binding interface of mGCAP1 in its EF2CaEF3CaEF4Ca (black), 
EF2Mg (red) and EF2MgEF3Mg (green) forms. 
www.nature.com/scientificreports/
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showed higher robustness in communication with C29 (Fig. 7, middle) in the GC inhibiting state (yellow path) 
and with E38 in the GC activating state (blue path). Finally, EF4 (E155 residue) was robustly connected to E38 
Figure 7. Paths constituted by nodes with the highest selective betweenness connecting bidentate Glu 
residues of EF2 (top), EF3 (middle) and EF4 (bottom) and the residues belonging to the GC binding 
interface with the highest CR. Secondary structure is represented in grey cartoons, Ca2+ ions are shown as 
red spheres, the myristoyl group is shown as teal sticks, Cα of the residues belonging to the paths are shown as 
spheres, edges are shown as sticks, the sidechains of the extremes of the paths are represented as sticks. Nodes 
and edges speci"c of the EF2CaEF3CaEF4Ca form are represented in yellow, those speci"c of the EF2Mg form are 
blue, those in common are green. Residue G159, whose mutation in V is associated with retinal dystrophies, is 
represented in orange.
www.nature.com/scientificreports/
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(Fig. 7, bottom) in both the GC activating (blue path) and inhibiting (yellow path) states. It is worth noting that 
the individuated communication pathways can be partly overlapped (green paths), meaning that some residues 
are important both for transferring the information to the proper GC binding site in the GC activating and inhib-
iting states of GCAP1 (Fig. 7).
????????????????????????????????????????????????? ??????? !e analysis of intramolecular 
communication in GCAP1 in its various GC regulatory states was performed also to unveil potential allosteric 
mechanisms involving the metal ion-binding sites. We therefore calculated the CR index along the 1 µ s MD tra-
jectory between each bidentate ion ligand in EF2, EF3 and EF4. Results for mGCAP1 are shown in Fig. 8 (top). 
No signicantly robust communication pathway could be identied that connects EF2 with the contiguous EF3 or 
EF3 with EF4. Surprisingly, a signicantly high CR (approximately 0.3) was detected for the connection between 
EF2 and EF4, both in the EF2CaEF3CaEF4Ca-GC inhibiting and EF2Mg-GC activating states. !e connection lost 
robustness in the EF2MgEF3Mg state (CR ≈ 0.06; Fig. 8, top).
????? ?? ???????????? ????????? ????????????????????????? ??? ???????????????? !e GCAP1 form 
lacking the myristoyl moiety showed a somewhat di"erent pattern of intramolecular communication robustness 
concerning the connections between EF hands and putative GC binding sites (Supplementary Figure S4). While 
a general trend of decreased robustness could be observed in all the tested GCAP1 states (compare Fig. 6 and 
Supplementary Figure S4), the most apparent di"erences are the following: a) an almost complete loss of robust 
communication pathways between EF4 (E155) and the putative GC-binding sites was found for nmGCAP1 
(Supplementary Figure S4, bottom), the only exceptions being the mildly robust communication with E38 and 
G32 in the EF2MgEF3Mg state; b) the highly robust communication pathways identied between EF3 (E111) and 
some GC-interface residues in the GC-inhibiting state were replaced by some lower robustness communica-
tion pathways with G32, Y37 and F73 (Supplementary Figure S4, middle) in the EF2Mg, GC-activating state; 
c) the interaction between E38 and EF2 (E75) remained highly robust for nmGCAP1 (CR = 0.32) only in the 
Figure 8. Communication Robustness among bidentate Glu residues of EF2, EF3 and EF4 of mGCAP1 
(top) and nmGCAP1 (bottom) in their EF2CaEF3CaEF4Ca (black), EF2Mg (red) and EF2MgEF3Mg (green) 
forms. 
www.nature.com/scientificreports/
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EF2CaEF3CaEF4Ca-GC inhibiting state, at odds with the myristoylated form, for which both GC regulatory states 
had robust connections (Supplementary Figure S4, top, vs Fig. 6, top).
Signicant di"erences could be observed for nmGCAP1 compared to the myristoylated form also regarding 
the inter EF-hand communication (Fig. 8, bottom). Interestingly, no signicantly robust communication was 
observed between either couple of EF-hands in each tested GC regulatory state for nmGCAP1, in particular the 
distal robust communication between EF2 and EF4 observed for mGCAP1 in both GC activating and inhibitory 
states was completely lost (Fig. 8, bottom).
We also checked whether robust communication pathways could be identied between the myristoyl moiety 
and the putative GC binding site. Results reported in Supplementary Figure S2 (top) showed that this is not gen-
erally the case. Indeed, except for M74 in the EF2CaEF3CaEF4Ca and EF2MgEF3Mg states (CR ≈ 0.18), R93 in both 
Mg2+-bound states (CR≈ 0.14) and Y37 in the EF2CaEF3CaEF4Ca state (CR ≈ 0.12) all other residues were not con-
nected to the myristoyl by robust pathways. Mildly robust communication pathways were detected between the 
myristoyl and EF2 in the EF2CaEF3CaEF4Ca state (CR ≈ 0.25), however CR was halved in both Mg2+-bound states 
(Supplementary Figure S2, bottom). Except for the GC-inhibiting state, for which a signicant CR was detected 
for the communication with EF3 (E111) no other state showed signicant values for the communication robust-
ness, in particular no robust path could be identied that connects the myristoyl moiety with EF4 (Supplementary 
Figure S2, bottom).
Discussion
GCAPs share their general three-dimensional fold with the other members of the NCS family. However, they 
show the rather unique feature of being at the same time activators and inhibitors of their biological GC target 
depending on the level of intracellular calcium. Understanding the mechanism by which relatively small protein 
conformational changes result in such diverse biochemical properties is not trivial, and yet it would be crucial to 
shed light on the molecular basis of some inherited retinal diseases caused by the deregulation of second messen-
ger homeostasis in photoreceptors. !is is especially true for GCAP1, for which up to 15 point mutations have 
been found to date that cause cone, cone/rod and/or macular dystrophies13–20.
We performed exhaustive MD simulations of both myristoylated and nonmyristoylated GCAP1 in each GC 
regulatory state. A comprehensive and consistent sampling of the conformational space has been achieved by 
the analysis of protein essential dynamics (Figs 1 and 2), which focuses on collective motions to unveil protein 
conformational transitions35. Previous MD studies by us8,36 and others37 as well as dedicated biophysical experi-
ments38,39 showed that the Ca2+ binding induces relatively small conformational changes in GCAP1, and that its 
replacement with Mg2+ in specic binding sites may signicantly perturb protein compactness and #exibility8. 
In the present study we investigated the details of GCAP1 structural dynamics by carrying out a set of more 
extensive MD simulations. We concatenated the trajectories from ve 200 ns replicas of GCAP1, thus ending up 
in a consistent 1 µ s trajectory where we could perform network-level analyses and highlight long-range commu-
nication pathways. !e PSN paradigm applied to su$ciently long and convergent MD trajectories has a great 
potential to nd out connections between conformational dynamics and allostery mechanisms, as it has been 
shown recently in other protein systems30,40.
An important nding in our study is that the Mg2+/Ca2+ exchange in specic EF hands creates selective intra-
molecular pathways connecting directly the metal ion binding sites with the GC binding sites. According to the 
PSN paradigm, in which amino acids are nodes and the interaction among them edges, some residues acquire the 
role of hubs for they mediate many persistent interactions (Figs 3 and 4). !e number and the distribution of high 
degree hubs was shown to depend on the specic GC regulating state and the presence or absence of the myristoyl 
modication (Fig. 4 and Supplementary Tables T1-T3). !e dynamic analysis performed with PyInteraph high-
lighted the constant presence of D64 and D100 among the highest-degree hubs, a particularly important result 
since D100 is the target of the cone-dystrophy related D100E/G mutations17,41. Other residues target of retinal 
dystrophy-associated point mutations were found among high-degree hubs both in the GC activating and inhib-
iting states of mGCAP1 and, to a lower extent, of nmGCAP1 (Supplementary Tables T1 and T2). Partly consistent 
results were found when the elastic network/PSN analysis was carried out with the WebPSN tool (Supplementary 
Table T3). Some level of discrepancy with the results obtained by PyInteraph is indeed not surprising, as WebPSN 
is based on a simple armonic potential applied to a static starting structure, therefore the approach keeps a mem-
ory of such initial conditions. Nonetheless, the method suggested a similar role for the most important hubs 
(Supplementary Table T3).
!e communication pathways in GCAP1 are determined by the persistent contacts between contiguous 
amino acids, which dene specic routes extending within the protein structure. !ese selective routes stabilize 
specic interaction patterns that are necessary for achieving GC inhibition or activation. !is concept may help 
solving the puzzling evidence of disconnected GC/GCAP1 interfacial areas observed in independent studies32–34. 
According to the Mg2+/Ca2+ loading status of each EF-hand, specic communication routes are created within 
GCAP1 structure that end up in appropriate residues to communicate and trigger GC activation or inhibition. As 
a consequence, the GCAP1/GC interface might therefore “plastically” adapt to the specic GCAP1 status in order 
to optimize the protein-protein contacts for proper information transfer. !e close proximity of such residues 
(Fig. 5) would allow the interface optimization to occur without major conformational changes.
Our network-level analysis permitted the identication of specic long range communication pathways con-
necting distal GCAP1 regions belonging to the N- and C-terminal domains, and to assess the role of myristoyla-
tion in mediating such interactions. In spite of the relatively long distance from the putative GC binding sites, EF4 
has been shown to robustly communicate with some residues at the GC interfacial region, including the spatially 
close E38 and C29 (Fig. 5), which are also the ending points of very robust intramolecular routes originated in 
EF3 and, to a lower extent, EF2 (Figs 6 and 7). Pathways made up of nodes with the highest SB route the informa-
tion transfer to close or identical interfacial residues of mGCAP1 in its di"erent GC regulatory states, however 
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they are only partly overlapped (Fig. 7). !e pattern of intramolecular communication pathways was shown to 
be considerably di"erent for nmGCAP1 (Supplementary Figure S4). In general, no signicantly robust commu-
nication was observed in this case between EF4 and the GC putative binding sites (Supplementary Figure S4, 
bottom). !e myristoyl group was never found among the highest-degree hubs (Supplementary Tables T1-T3), 
and its communication robustness with the GC putative binding sites was modest in each simulated mGCAP1 
state (Supplementary Figure S2, top). !e fact that the communication robustness with GCAP1 EF hands was 
found to be signicant only for the nearby EF2 in its GC-inhibiting state (Supplementary Figure S2, bottom) sug-
gests that the myristoyl is a transient connector of important intramolecular interactions rather that a central hub. 
Its presence is however essential to guarantee the correct routing of the information transfer about the loading 
state from EF4 to the GC binding site. !is nding is substantially in line with the “tug” mechanism proposed by 
Peshenko et al.25, in which a dynamic connection between the myristoyl and EF4 was hypothesized to attenuate 
the e$ciency of GC activation in exchange for optimal Ca2+ sensitivity. !e importance of Ca2+ binding to EF4 in 
propagating the conformational information to the GC binding interface, thus leading to the inhibiting/activating 
switch was recently highlighted by Lim et al. in an NMR study, in which the largest Ca2+-dependent structural 
di"erences were observed in the EF4 region and in the adjacent so called “switch helix” composed by the 164–174 
stretch24. Our results are fully consistent with this observation, as all the pathways constituted by nodes with 
the highest SB connecting EF4 and GC putative binding interface residues include residues belonging to the 
switch helix (Fig. 7). Our study thus conrms the role of this helical stretch, which may act as a conduit relaying 
Ca2+-induced structural changes in EF4 to the GC binding site24.
Another important result from the dynamic analysis performed here is that a robust long range commu-
nication between EF2 and EF4, which are distal metal ion binding motifs belonging to the N- and C-terminal 
domains respectively, was clearly detected both for the GC activating and inhibiting state of mGCAP1 (Fig. 8). 
!is interdomain allosteric interaction takes place only in the presence of the N-terminal myristoylation (Fig. 8), 
and is likely crucial for GCAP1 switch function as it connects the two metal ion binding sites with intermediate 
(EF4) and lowest (EF2) a$nity for Ca2+, which have respectively negligible and highest a$nity for Mg2+ 7,9. It has 
been long established that the Ca2+-mediated activation of GC by GCAPs is highly cooperative42 although bio-
physical evidence strongly suggests that Ca2+ binding to GCAP1 occurs without any apparent cooperativity15,43, 
except for one case (L84F mGCAP1) in which cooperativity was observed18. Our data show that an allosteric 
mechanism may connect two metal ion binding sites without observed cooperative e"ects on the binding a$nity. 
!e presence or the absence of a specic ion bound to an EF hand can then be communicated to a distal EF hand 
without a"ecting the metal ion a$nity of this latter.
In conclusion, our analysis suggests that GCAP1 capability of switching between di"erent GC regulatory states 
depends on the Mg2+/Ca2+ binding states and the way the information is transferred to specic residues at the 
interface with the target. Post translational myristoylation is fundamental to mediate long range allosteric inter-
actions although the fatty acid per se is not a hub for intramolecular interactions. Some amino acids with high 
selective betweenness centrality in the PSN may largely perturb the intramolecular communication pathways 
necessary for switching between GCAP1 regulatory modes, and the fact that some hubs are target of retinal dys-
trophy mutants suggests that the lack of complete inhibition of the target GC observed in many cases is likely due 
to the perturbation of these intermolecular routes. More in general, our computational approach can be applied 
to other NCS proteins and extended to investigate intermolecular as well as intramolecular communication, thus 
being of great potential for unveiling poorly understood molecular mechanisms under physiological and altered 
conditions.
Methods
?????????? ?????????? ????????? ?? ???????????? ???????????????????????????????? !e homology 
model of human mGCAP1 in its EF2CaEF3CaEF4Ca state was built using the structure of chicken mGCAP144 as 
template using a previously elucidated protocol15. Models of nmGCAP1 were built by removing the myristoyl 
group, EF2Mg and EF2MgEF3Mg m/nmGCAP1 states were modeled either by removing Ca2+ ions from the respec-
tive EF-hand or by replacing them with Mg2+ ions as reported in ref. 8.
MD simulations of all GCAP1 states were performed using GROMACS 5.0.4 simulation package45 with the 
CHARMM27 all-atom force eld46. All settings for MD simulation and CHARMM27 parameters for the myris-
toyl group were the same as in ref. 8, in which details are provided. All structures were subjected to energy 
minimization, rst with the steepest descent (Fmax = 1000 kJ mol−1 nm−1), then with the conjugate gradients 
(Fmax = 500 kJ mol−1 nm−1) algorithm, by keeping the position of backbone atoms and ions xed in both cases. 
!e systems were equilibrated at 310 K for 2 ns of backbone position-restrained MD simulations and then at 
310 K for 2 ns of unrestricted MD simulations. A%er equilibration, all systems underwent 200 ns unrestrained 
isothermal-isobaric (NPT ensemble, T = 310 K, P = 1 atm) MD simulation. To achieve an exhaustive sampling of 
the conformational space, ve independent replicas of each system were generated by changing the random seed 
for the generation of initial velocities of the two equilibration and the production phases.
In order to assess the stability of the simulations, the RMSD for the ve 200 ns replicas of each state was calcu-
lated on Cα atoms with respect to the relative structure a%er 4 ns equilibration. !e average RMSD values ranged 
between 2.18 and 2.95 Å in the tested GCAP1 states.
Principal!Component!Analysis.! PCA is a widely-known tool to lter high-frequency motions in MD tra-
jectories, taking advantage of the eigenvectors and eigenvalues of the mass-weighted covariance matrix (C) of the 
atomic positional #uctuations47. !e C matrix was calculated for each state on protein alpha-carbons (Cα ) of each 
replica and of the concatenated trajectories a%er superimposition to a reference structure, which was chosen as 
the conformation observed a%er the 4 ns equilibration phase in one of the ve di"erent replicas.
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!e PCA technique is based on the diagonalization of matrix C allowing for the identication of a set of 
eigenvectors and eigenvalues describing, respectively, direction and amplitude of the collective atomic motions 
or principal components (PC). Eigenvalues are ranked in decreasing order, therefore PC1 is the direction which 
describes the largest collective motion of the system, PC2 accounts for the second largest motion and so on. In 
order to analyze the consistency of the conformational space sampled by each replica, we projected the simulated 
trajectories on the rst two PCs for the comparison of the main collective motions (Fig. 1).
It is possible to dene the Essential Subspace (ES) as a subset of PCs which accounts for a percentage of total 
motion, in order to remove the noise represented by high frequency motions. Such percentage can be computed 
as the ratio between cumulative eigenvalues relative to the eigenvectors belonging to the ES and the sum of all 
eigenvalues of the system. !e ES was dened by the rst 20 PC of each replica and concatenated trajectories, 
describing at least 80% of the variance.
!e sampling convergence of each individual MD replica as well as the concatenated trajectories was assessed 
by computing both the cosine content and the RMSIP indexes for each GCAP1 simulated state. !e cosine con-
tent (c1)48 of the rst PC (p1) of C dening the ES was calculated as dened in Equation 2:
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where T is the total simulation time.
!e RMSIP index, a measure of similarity between the ES describing each replica and concatenated trajec-
tory49, was computed as dened in Equation 3:
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where nAi and nBj are the eigenvectors of the ES of the replicas A and B to be compared and S is the dimensionality 
of the ES (S= 20 in this case).
????? ?????????????????????????????? !e average structure for each concatenated trajectory was com-
puted. For each frame of the concatenated trajectory the Cα -RMSD with respect to the average structure was 
calculated and the average RMSD value (ranging between 1.72 and 2.32 Å in all the tested GCAP1 states)  was 
adopted as the cuto" for the cluster analysis.
Cα -RMSD matrices were computed with respect to the reference average structure dened above to per-
form cluster analysis of the concatenated trajectories. In order to reduce matrix dimensionality (originally 
100,000 × 100,000 frames), 1 out of 4 frames of the concatenated trajectories were considered for the computa-
tion of the matrix. RMSD matrices were then processed using the Linkage50 and Gromos51 clustering algorithms, 
using the aforementioned average RMSD value as the cuto". !e Linkage and Gromos algorithms gave di"erent 
results in terms of number of identied clusters. !e Linkage algorithm identied only one cluster, at odds with 
the Gromos algorithm, which identied 20 to 38 clusters, depending on the state. Since the most populated cluster 
identied by Gromos algorithm always contained the cluster centers identied by Linkage algorithm, these latter 
only were used for the analyses done by WebPSN and for structural representations in Figs 3, 4, 5 and 7.
PyInteraph.! Concatenated trajectories were subjected to a dynamic network analysis provided by 
PyInteraph52, a so%ware that generates a graph of intramolecular connections based on di"erent types of interac-
tions, namely salt bridges, H-bonds and hydrophobic interactions. !e so%ware computes an index of persistence 
of interaction based on the percentage of frames, for which distance cuto" constraints for the specic interaction 
are satised. Parameters for hydrophobic and electrostatic interactions for ions and the myristoyl group were 
generated manually and are available upon request. !e cuto"s for distance and angle of H-bonds were set to 
default values (3.5 Å and 120° respectively), as well as that for electrostatic interactions (4.5 Å). !e cuto" for the 
distance between the center of mass of the hydrophobic residue-side chains (including the myristoyl group) was 
set to 5.5 Å; the mass for each single atom was dened according to the CHARMM27 force eld. !e size of largest 
hydrophobic connected component (cluster) is the most restrictive constraint for the creation of the PSN53, there-
fore its value was calculated at 5% persistence intervals to determine the signicance threshold for interaction 
persistence pT, which was computed as shown in Supplementary Figure S3. !e pT parameter was calculated for 
each GCAP1 simulated state (Supplementary Figure S3) and used to lter all three respective interaction graphs 
(e.g., electrostatic, H-bonds and hydrophobic), which were then joined in a single PSN representing the specic 
GCAP1 state.
????????????????????????????????? Selective betweenness (SB) was computed based on the denition of 
betweenness, taking into account only the shortest paths between residues A and B (σAB) and not all possible 
shortest paths between all nodes of the PSN. In detail, SB was dened as in Equation 4:
σ
σ
=SB v
v
( )
( )
(4)
AB
AB
where σAB(v) is the number of shortest paths between residues A and B that pass through residue v.
???????? !e cluster centers identied for each GCAP1 simulated state were used as reference structures 
for the analysis performed by the WebPSN server54. !e so%ware employs an Elastic Network Model – Normal 
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Mode Analysis (ENM-NMA) strategy to generate a PSN to investigate network properties of macromolecules. 
ENM-NMA was computed based on Cα atoms of the residues, Ca2+ and Mg2+ ions and the carbonyl C of the 
myristic group using 50 modes and Kovacs potential. !e normalization factors for ions and the myristoyl group 
were computed based on the pdb structure, the distance cuto" for PSN calculation was set to 4.5 Å. Relationship 
between adjacent residues and N- and C-terminal residues were excluded and the minimum degree for the de-
nition of a hub residue was set to 3.
??????????
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